
<html lang="en"     class="pb-page"  data-request-id="9ae16a88-03e4-4926-b21a-54034f36dca5"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2020.63.issue-17;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;article:article:10.1021/acs.jmedchem.0c01016;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="A Novel Redox Modulator Induces a GPX4-Mediated Cell Death That Is Dependent on Iron and Reactive Oxygen Species" /></meta><meta name="dc.Creator" content="Shuai  Hu" /></meta><meta name="dc.Creator" content="Mario  Sechi" /></meta><meta name="dc.Creator" content="Pankaj Kumar  Singh" /></meta><meta name="dc.Creator" content="Lipeng  Dai" /></meta><meta name="dc.Creator" content="Sean  McCann" /></meta><meta name="dc.Creator" content="Duxin  Sun" /></meta><meta name="dc.Creator" content="Mats  Ljungman" /></meta><meta name="dc.Creator" content="Nouri  Neamati" /></meta><meta name="dc.Description" content="Redox modulators have been developed as an attractive approach to treat cancer. Herein, we report the synthesis, identification, and biological evaluation of a quinazolinedione reactive oxygen spec..." /></meta><meta name="Description" content="Redox modulators have been developed as an attractive approach to treat cancer. Herein, we report the synthesis, identification, and biological evaluation of a quinazolinedione reactive oxygen spec..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="August 18, 2020" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.0c01016" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright Â© 2020 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c01016" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.0c01016" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c01016" /></link>
        
    
    

<title>A Novel Redox Modulator Induces a GPX4-Mediated Cell Death That Is Dependent on Iron and Reactive Oxygen Species | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.0c01016" /></meta><meta property="og:title" content="A Novel Redox Modulator Induces a GPX4-Mediated Cell Death That Is Dependent on Iron and Reactive Oxygen Species" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01016/20200903/images/large/jm0c01016_0016.jpeg" /></meta><meta property="og:description" content="Redox modulators have been developed as an attractive approach to treat cancer. Herein, we report the synthesis, identification, and biological evaluation of a quinazolinedione reactive oxygen species (ROS) inducer, QD394, with significant cytotoxicity in pancreatic cancer cells. QD394 shows a transcriptomic profile remarkably similar to napabucasin, a cancer stemness inhibitor. Both small molecules inhibit STAT3 phosphorylation, increase cellular ROS, and decrease the GSH/GSSG ratio. Moreover, QD394 causes an iron- and ROS-dependent, GPX4 mediated cell death, suggesting ferroptosis as a major mechanism. Importantly, QD394 decreases the expression of LRPPRC and PNPT1, two proteins involved in mitochondrial RNA catabolic processes and both negatively correlated with the overall survival of pancreatic cancer patients. Pharmacokinetics-guided lead optimization resulted in the derivative QD394-Me, which showed improved plasma stability and reduced toxicity in mice compared to QD394. Overall, QD394 and QD394-Me represent novel ROS-inducing drug-like compounds warranting further development for the treatment of pancreatic cancer." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.0c01016"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01016">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-13/achre4.2021.54.issue-13/20210706/achre4.2021.54.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-6/amrcda.2021.2.issue-6/20210625/amrcda.2021.2.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-6/aabmcb.2021.4.issue-6/20210621/aabmcb.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-6/aaembp.2021.3.issue-6/20210622/aaembp.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-6/aaemcq.2021.4.issue-6/20210628/aaemcq.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-26/aamick.2021.13.issue-26/20210707/aamick.2021.13.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-6/aanmf6.2021.4.issue-6/20210625/aanmf6.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-13/accacs.2021.11.issue-13/20210702/accacs.2021.11.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-6/acscii.2021.7.issue-6/20210623/acscii.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-6/acbcct.2021.16.issue-6/20210618/acbcct.2021.16.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-3/achsc5.2021.28.issue-3/20210524/achsc5.2021.28.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-13/acncdm.2021.12.issue-13/20210707/acncdm.2021.12.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-6/aesccq.2021.5.issue-6/20210617/aesccq.2021.5.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-5/afsthl.2021.1.issue-5/20210618/afsthl.2021.1.issue-5.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-6/amlccd.2021.10.issue-6/20210615/amlccd.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-6/ancac3.2021.15.issue-6/20210622/ancac3.2021.15.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-27/acsodf.2021.6.issue-27/20210713/acsodf.2021.6.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-6/apchd5.2021.8.issue-6/20210616/apchd5.2021.8.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-6/ascefj.2021.6.issue-6/20210625/ascefj.2021.6.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-27/ascecg.2021.9.issue-27/20210712/ascecg.2021.9.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-6/asbcd6.2021.10.issue-6/20210618/asbcd6.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-27/ancham.2021.93.issue-27/20210713/ancham.2021.93.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-27/bichaw.2021.60.issue-27/20210713/bichaw.2021.60.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-6/bcches.2021.32.issue-6/20210616/bcches.2021.32.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-24/cgeabj.2021.99.issue-24/20210628-01/cgeabj.2021.99.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-6/crtoec.2021.34.issue-6/20210621/crtoec.2021.34.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-12/chreay.2021.121.issue-12/20210623/chreay.2021.121.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-13/cmatex.2021.33.issue-13/20210713/cmatex.2021.33.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-13/enfuem.2021.35.issue-13/20210701/enfuem.2021.35.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-13/esthag.2021.55.issue-13/20210706/esthag.2021.55.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-26/iecred.2021.60.issue-26/20210707/iecred.2021.60.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-13/inocaj.2021.60.issue-13/20210705/inocaj.2021.60.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-6/jaaucr.2021.1.issue-6/20210628/jaaucr.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-26/jafcau.2021.69.issue-26/20210707/jafcau.2021.69.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-6/jcisd8.2021.61.issue-6/20210628/jcisd8.2021.61.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/jmcmar.2021.64.issue-13/20210708/jmcmar.2021.64.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-6/jnprdf.2021.84.issue-6/20210625/jnprdf.2021.84.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-13/joceah.2021.86.issue-13/20210702/joceah.2021.86.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-26/jpcafh.2021.125.issue-26/20210708/jpcafh.2021.125.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-26/jpcbfk.2021.125.issue-26/20210708/jpcbfk.2021.125.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-26/jpccck.2021.125.issue-26/20210708/jpccck.2021.125.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-26/jpclcd.2021.12.issue-26/20210708/jpclcd.2021.12.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-26/jacsat.2021.143.issue-26/20210707/jacsat.2021.143.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-27/langd5.2021.37.issue-27/20210713/langd5.2021.37.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-13/mamobx.2021.54.issue-13/20210713/mamobx.2021.54.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-12/nalefd.2021.21.issue-12/20210623/nalefd.2021.21.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-13/orlef7.2021.23.issue-13/20210702/orlef7.2021.23.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-6/oprdfk.2021.25.issue-6/20210618/oprdfk.2021.25.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-13/orgnd7.2021.40.issue-13/20210712/orgnd7.2021.40.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.0c01016&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.0c01016&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.0c01016&amp;href=/doi/10.1021/acs.jmedchem.0c01016" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2020</span><span class="cit-fg-volume">, 63</span><span class="cit-fg-issue">, 17</span><span class="cit-fg-pageRange">, 9838-9855</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/63/17" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.0c00983" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.0c01020" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">A Novel Redox Modulator Induces a GPX4-Mediated Cell Death That Is Dependent on Iron and Reactive Oxygen Species</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Shuai Hu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Shuai Hu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Departments of Medicinal Chemistry, College of Pharmacy, Rogel Cancer center, University of Michigan, Ann Arbor, Michigan 48109, United States</div><div class="loa-info-affiliations-info">Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, Michigan 48109, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Shuai++Hu">Shuai Hu</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Mario Sechi</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Mario Sechi</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry and Pharmacy, University of Sassari, Via Vienna 2, 07100 Sassari, Italy</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#375a56455e58194452545f5e7742595e4444195e43"><span class="__cf_email__" data-cfemail="aac7cbd8c3c584d9cfc9c2c3eadfc4c3d9d984c3de">[emailÂ protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Mario++Sechi">Mario Sechi</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-2983-6090" title="Orcid link">http://orcid.org/0000-0003-2983-6090</a></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Pankaj Kumar Singh</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Pankaj Kumar Singh</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry and Pharmacy, University of Sassari, Via Vienna 2, 07100 Sassari, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Pankaj+Kumar++Singh">Pankaj Kumar Singh</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4774-6358" title="Orcid link">http://orcid.org/0000-0002-4774-6358</a></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Lipeng Dai</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Lipeng Dai</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmaceutical Sciences, College of Pharmacy, University of Michigan, Ann Arbor, Michigan 48109, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Lipeng++Dai">Lipeng Dai</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Sean McCann</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sean McCann</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Departments of Medicinal Chemistry, College of Pharmacy, Rogel Cancer center, University of Michigan, Ann Arbor, Michigan 48109, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sean++McCann">Sean McCann</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Duxin Sun</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Duxin Sun</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmaceutical Sciences, College of Pharmacy, University of Michigan, Ann Arbor, Michigan 48109, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Duxin++Sun">Duxin Sun</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-6406-2126" title="Orcid link">http://orcid.org/0000-0002-6406-2126</a></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Mats Ljungman</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Mats Ljungman</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Radiation Oncology, Rogel Cancer Center and Center for RNA Biomedicine, University of Michigan, Ann Arbor, Michigan 48109, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Mats++Ljungman">Mats Ljungman</a></span></div></div></span></li><span class="comma-separator">,Â andÂ </span><li><span><span class="hlFld-ContribAuthor">Nouri Neamati</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Nouri Neamati</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Departments of Medicinal Chemistry, College of Pharmacy, Rogel Cancer center, University of Michigan, Ann Arbor, Michigan 48109, United States</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#e08e85818d819489a0958d898388ce858495"><span class="__cf_email__" data-cfemail="29474c4844485d40695c44404a41074c4d5c">[emailÂ protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Nouri++Neamati">Nouri Neamati</a></span></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c01016&amp;href=/doi/10.1021%2Facs.jmedchem.0c01016" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2020</span></span><span class="cit-volume">, 63</span><span class="cit-issue">, 17</span><span class="cit-pageRange">, 9838â9855</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">August 18, 2020</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>15 June 2020</li><li><span class="item_label"><b>Published</b> online</span>18 August 2020</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 10 September 2020</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.0c01016" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01016</a></div><div class="article_header-article-copyright"><strong>Copyright Â© 2020 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D9838%26pageCount%3D18%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DShuai%2BHu%252C%2BMario%2BSechi%252C%2BPankaj%2BKumar%2BSingh%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D63%26issueNum%3D17%26contentID%3Dacs.jmedchem.0c01016%26title%3DA%2BNovel%2BRedox%2BModulator%2BInduces%2Ba%2BGPX4-Mediated%2BCell%2BDeath%2BThat%2BIs%2BDependent%2Bon%2BIron%2Band%2BReactive%2BOxygen%2BSpecies%26numPages%3D18%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D9855%26publicationDate%3DSeptember%2B2020">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.0c01016"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1612</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">3</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.0c01016" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;A Novel Redox Modulator Induces a GPX4-Mediated Cell Death That Is Dependent on Iron and Reactive Oxygen Species&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Shuai&quot;,&quot;last_name&quot;:&quot;Hu&quot;},{&quot;first_name&quot;:&quot;Mario&quot;,&quot;last_name&quot;:&quot;Sechi&quot;},{&quot;first_name&quot;:&quot;Pankaj&quot;,&quot;last_name&quot;:&quot;Kumar Singh&quot;},{&quot;first_name&quot;:&quot;Lipeng&quot;,&quot;last_name&quot;:&quot;Dai&quot;},{&quot;first_name&quot;:&quot;Sean&quot;,&quot;last_name&quot;:&quot;McCann&quot;},{&quot;first_name&quot;:&quot;Duxin&quot;,&quot;last_name&quot;:&quot;Sun&quot;},{&quot;first_name&quot;:&quot;Mats&quot;,&quot;last_name&quot;:&quot;Ljungman&quot;},{&quot;first_name&quot;:&quot;Nouri&quot;,&quot;last_name&quot;:&quot;Neamati&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2020&quot;,&quot;month&quot;:&quot;08&quot;,&quot;day&quot;:&quot;18&quot;,&quot;issue&quot;:&quot;17&quot;,&quot;volume&quot;:&quot;63&quot;,&quot;pages&quot;:&quot;9838-9855&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.0c01016&quot;},&quot;abstract&quot;:&quot;Redox modulators have been developed as an attractive approach to treat cancer. Herein, we report the synthesis, identification, and biological evaluation of a quinazolinedione reactive oxygen species (ROS) inducer, QD394, with significant cytotoxicity in pancreatic cancer cells. QD394 shows a transcriptomic profile remarkably similar to napabucasin, a cancer stemness inhibitor. Both small molecules inhibit STAT3 phosphorylation, increase cellular ROS, and decrease the GSH/GSSG ratio. Moreover, QD394 causes an iron- and ROS-dependent, GPX4 mediated cell death, suggesting ferroptosis as a major mechanism. Importantly, QD394 decreases the expression of LRPPRC and PNPT1, two proteins involved in mitochondrial RNA catabolic processes and both negatively correlated with the overall survival of pancreatic cancer patients. Pharmacokinetics-guided lead optimization resulted in the derivative QD394-Me, which showed improved plasma stability and reduced toxicity in mice compared to QD394. Overall, QD394 and QD394-Me re&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01016&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01016" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01016&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01016" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01016&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01016" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c01016&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01016&amp;href=/doi/10.1021/acs.jmedchem.0c01016" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.0c01016" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.0c01016" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (5 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.0c01016%26sid%3Dliteratum%253Aachs%26pmid%3D32809827%26genre%3Darticle%26aulast%3DHu%26date%3D2020%26atitle%3DA%2BNovel%2BRedox%2BModulator%2BInduces%2Ba%2BGPX4-Mediated%2BCell%2BDeath%2BThat%2BIs%2BDependent%2Bon%2BIron%2Band%2BReactive%2BOxygen%2BSpecies%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D63%26issue%3D17%26spage%3D9838%26epage%3D9855%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">Â»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=291439" title="Genetics">Genetics</a>,</li><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=290808" title="Toxicity">Toxicity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/63/17" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/jmcmar.2020.63.issue-17/20200910/jmcmar.2020.63.issue-17.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01016/20200903/images/medium/jm0c01016_0016.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01016/20200903/images/large/jm0c01016_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01016&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Redox modulators have been developed as an attractive approach to treat cancer. Herein, we report the synthesis, identification, and biological evaluation of a quinazolinedione reactive oxygen species (ROS) inducer, QD394, with significant cytotoxicity in pancreatic cancer cells. QD394 shows a transcriptomic profile remarkably similar to napabucasin, a cancer stemness inhibitor. Both small molecules inhibit STAT3 phosphorylation, increase cellular ROS, and decrease the GSH/GSSG ratio. Moreover, QD394 causes an iron- and ROS-dependent, GPX4 mediated cell death, suggesting ferroptosis as a major mechanism. Importantly, QD394 decreases the expression of LRPPRC and PNPT1, two proteins involved in mitochondrial RNA catabolic processes and both negatively correlated with the overall survival of pancreatic cancer patients. Pharmacokinetics-guided lead optimization resulted in the derivative QD394-Me, which showed improved plasma stability and reduced toxicity in mice compared to QD394. Overall, QD394 and QD394-Me represent novel ROS-inducing drug-like compounds warranting further development for the treatment of pancreatic cancer.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83755" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83755" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Pancreatic cancer is the fourth leading cause of cancer death in the United States, and its incidence and mortality rates are continuing to increase worldwide.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1,2)</a> It is predicted to be the second leading cause of cancer death in the United States by 2030.<a onclick="showRef(event, 'ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref2 ref3">(2,3)</a> Pancreatic cancer is primarily diagnosed at a late stage because early-stage symptoms are nonspecific. The 5-year survival rate at the advanced stage is only around 3%.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> The current standard-of-care, FOLFIRINOX (folinic acid, 5-fluorouracil (5-FU), irinotecan, and oxaliplatin), and gemcitabine together with nab-paclitaxel show modest efficacy because of drug resistance and systemic toxicity.<a onclick="showRef(event, 'ref2 ref4'); return false;" href="javascript:void(0);" class="ref ref2 ref4">(2,4)</a> Therefore, it is imperative to find new improved therapies to treat pancreatic cancer.</div><div class="NLM_p">Reprogramming energy metabolism and oxidative stress are two hallmarks of cancer.<a onclick="showRef(event, 'ref5 ref6 ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref5 ref6 ref7 ref8">(5â8)</a> Therefore, treating cancer with small-molecule reactive oxygen species (ROS) inducers may selectively overwhelm cancer cells. Cellular redox homeostasis is closely related to ROS production and elimination. Cancer cells have higher redox requirements than normal cells due to their increased cell metabolism, dysfunctional mitochondria, scarce nutrients, and oxygen-poor microenvironment.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Higher intracellular ROS levels force cancer cells to develop robust antioxidant systems to adapt to oxidative stress. At low or moderate levels, ROS serve as signaling molecules to promote cell growth, while at high levels, ROS induce oxidation of lipids, proteins, and DNA, ultimately leading to cell death. Several ROS inducers are in clinical trials to evaluate efficacy and safety profiles in cancer.<a onclick="showRef(event, 'ref10 ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref12">(10â12)</a> ARQ761, a beta-lapachone (<a class="ref internalNav" href="#cht1" aria-label="Chart 1">Chart 1</a>) prodrug that reacts with NAD(P) H Quinone Dehydrogenase 1 (NQO1) to generate ROS, showed modest efficacy in an open-label, dose-escalation Phase I study.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Napabucasin (<a class="ref internalNav" href="#cht1" aria-label="Chart 1">Chart 1</a>) is an orally administered cancer stemness inhibitor with a quinone scaffold and has been tested in Phase III clinical trials in multiple cancers.<a onclick="showRef(event, 'ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref11 ref12">(11,12)</a> Napabucasin inhibits Signal Transducer and Activator of Transcription 3 (STAT3) signaling and increases ROS levels predominately by NQO1 bioactivation.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Therefore, inducing cellular ROS is a promising method to treat pancreatic cancer.</div><figure id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01016/20200903/images/medium/jm0c01016_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01016/20200903/images/large/jm0c01016_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Structures of Representative ROS Inducers under Clinical Evaluation, and Design of Novel Quinazolinedione-Based ROS Modulators</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01016/20200903/images/large/jm0c01016_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01016&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Previously, we developed a series of quinazolinedione (QD)-based ROS inducers that were tested for their utility in preclinical models of pancreatic cancer.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> In this study, we have conducted a lead optimization on the most effective compound (i.e., QD325, <a class="ref internalNav" href="#cht1" aria-label="Chart 1">Chart 1</a>) to select compounds inducing maximum ROS production. A series of structural modifications on the arylamino substituent at position 6 of the quinazoline-5,8-dione backbone were made to modulate its physicochemical properties. A set of QD derivatives were synthesized (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>, <a class="ref internalNav" href="#cht1" aria-label="Chart 1">Chart 1</a>), and the Me-<i>N</i>-piperazino analog, i.e., QD394, was selected for mechanistic studies.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01016/20200903/images/medium/jm0c01016_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01016/20200903/images/large/jm0c01016_0012.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Preparation of QD385 to QD395<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01016/20200903/images/large/jm0c01016_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01016&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) CeCl<sub>3</sub>Â·7H<sub>2</sub>O, abs EtOH, rt, 1.5 h.</p></p></figure><div class="NLM_p">Herein, we show for the first time that this new prototype, QD394, displays highly similar transcriptomic profiles to napabucasin, suggesting similar downstream signaling effects. Combination with cell death signaling inhibitors reveals that QD394 induces ferroptosis but not caspase-dependent apoptosis, necroptosis, or autophagy. We further demonstrate that QD394 induces lipid peroxidation, iron-, ROS-, and glutathione peroxidase 4 (GPX4)-mediated cell death, all of which are closely related to ferroptosis. Ferroptosis was first described in 2012 to represent an iron-dependent regulated cell death with increased lipid peroxidation.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Intrinsic mechanisms of ferroptosis depend on the activity of GPX4 and lipid peroxidation.<a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16,17)</a> At least four classes of ferroptosis inducers have been developed, including (1) SLC7A11 inhibitor (erastin), (2) GPX4 inhibitor (RSL3), (3) FIN56 (depleting GPX4 protein), and (4) FINO<sub>2</sub> (indirectly inhibiting GPX4).<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Ferroptosis inducers show synergistic antitumor efficacy with select chemotherapies<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> and sensitize cancer cells to radiation.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> We also observed synergy between QD394 and select FDA-approved drugs, suggesting that combination studies with redox modulators as ferroptosis inducers could be a viable approach to treat pancreatic cancer.</div><div class="NLM_p last">Additionally, we performed proteomics analysis and observed a significant decrease in LRPPRC and PNPT1 expression, two proteins involved in mitochondrial RNA catabolic processes.<a onclick="showRef(event, 'ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref20 ref21">(20,21)</a> Expression of these two genes is negatively correlated with the survival of pancreatic cancer patients in our analysis using the TCGA PAAD data set. Furthermore, a pharmacokinetics (PK)-guided lead optimization campaign was conducted to develop a QD394 analog, QD394-Me, with improved PK properties.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i5">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15357" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15357" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Chemistry</h3><div class="NLM_p">Eleven analogs of QD394 were synthesized to characterize their cytotoxicity in pancreatic cancer cells. The target compounds QD385 to QD395 were synthesized by regioselective coupling of quinazoline-5,8-dione <b>1</b> with appropriate amines in the presence of Ce(III) ions (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>) under mild conditions. The key synthon <b>1</b> was prepared by following our previously reported procedure (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>).<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Briefly, nitration of the dimethoxybenzaldehyde <b>2</b> with concentrated nitric acid in the presence of acetic anhydride under simple magnetic stirring afforded the desired 3,6-dimethoxy-2-nitrobenzaldehyde (<b>3</b>) regioisomer, which was isolated in good yield by flash chromatography. Next, <b>3</b> was converted to the diformamido-derivative <b>4</b> by adding formamide, followed by exposure to gaseous HCl under controlled temperature. Then, compound <b>4</b> was treated with zinc powder and acetic acid to obtain the dimethoxyquinazoline <b>5</b>. Final oxidation of <b>5</b> with cerium ammonium nitrate resulted in the production of <b>1</b>, which was used for final amino conjugation.</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01016/20200903/images/medium/jm0c01016_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01016/20200903/images/large/jm0c01016_0013.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthetic Route for the Preparation of the Synthon <b>1</b> and Its Intermediates<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01016/20200903/images/large/jm0c01016_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01016&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) conc. HNO<sub>3</sub>, (CH<sub>3</sub>CO)<sub>2</sub>O, 0 Â°C, 1.5 h; (ii) H<sub>2</sub>NCHO, HCl<sub>(g)</sub> from 40 to 80 Â°C, 1 h; (iii) glacial CH<sub>3</sub>COOH, Zn, 0 Â°C for 2 h, rt for 4 h; (iv) (NH<sub>4</sub>)<sub>2</sub>Ce(NO<sub>3</sub>)<sub>6</sub>, CH<sub>3</sub>CN/H<sub>2</sub>O, 0 Â°C, 20 min. For synthetic details, see ref <a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a>.</p></p></figure><div class="NLM_p">The QD394-Me (namely, QD430) was synthesized starting from 2,5-dimethoxy-4-methylbenzaldehyde by adapting the abovementioned synthetic route (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>), except for the first step. An <i>ipso</i>-nitration on the starting material occurred in the first step reaction, and 1,4-dimethoxy-2-methyl-5-nitrobenzene (<b>6</b>) was obtained as the main product, while the desired nitrobenzaldehyde <b>7</b> was isolated in very low yields (â¼5%) after chromatographic separation. Scale up of this reaction was needed to reach the necessary amount of intermediate <b>7</b>, which resulted in increased consumption of the reagent that dramatically affected the overall yield of this synthetic route. However, 7-methyl-quinazoline-5,8-dione (<b>10</b>), bearing the methyl at the position 7 on the quinazolinedione ring, was easily obtained after oxidation of <b>9</b>, which was prepared by cyclizing the diformamido-derivative <b>8</b> in the same reaction conditions used for the preparation of the nonmethylated analog.</div><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01016/20200903/images/medium/jm0c01016_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01016/20200903/images/large/jm0c01016_0014.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthetic Route for the Preparation of QD394-Me<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01016/20200903/images/large/jm0c01016_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01016&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) conc. HNO<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, rt, 24 h; (ii) H<sub>2</sub>NCHO, HCl<sub>(g)</sub> from 40 to 80 Â°C, 1 h; (iii) glacial CH<sub>3</sub>COOH, Zn, 0 Â°C for 2 h, rt for 4 h; (iv) (NH<sub>4</sub>)<sub>2</sub>Ce(NO<sub>3</sub>)<sub>6</sub>, CH<sub>3</sub>CN/H<sub>2</sub>O, 0 Â°C, 20 min; (v) CeCl<sub>3</sub>Â·7H<sub>2</sub>O, abs EtOH, rt, 1.5 h.</p></p></figure><div class="NLM_p">In an attempt to expand the preparation of another QD394-Me isomer, where the methyl substituent was placed at position 6 (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>), we set up an alternative way to prepare QD394 with improved overall yield. Specifically, the key methyldiketone <b>15</b> was obtained by a two-step ring closure of the N-protected intermediate <b>12</b>. The latter was prepared by reducing the nitroderivative <b>6</b> with ammonium formate and Pd/C to give <b>11</b> quantitatively, followed by protection of the amino functionality with ethyl chloroacetate in THF. Compound <b>12</b> was then reacted with hexamethylenetetramine (HMTA) in trifluoroacetic acid (TFA) to give the dihydroquinazoline <b>13</b> after an intramolecular cyclization.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Finally, oxidative dehydrogenation using potassium ferricyanide in aqueous ethanolic potassium hydroxide of derivative <b>13</b> afforded the synthon <b>15</b> in good yield. Instead of the expected QD394-Me isomer, coupling of <b>15</b> with 4-(4-methylpiperazin-1-yl)aniline in the presence of cerium ammonium nitrate resulted in the nucleophilic substitution of the methyl group, which led to the isolation of QD394 (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>), but with about 10-fold lesser overall yields than the previous synthetic route.</div><figure id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01016/20200903/images/medium/jm0c01016_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01016/20200903/images/large/jm0c01016_0015.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Alternative Synthetic Route for the Preparation of QD394<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01016/20200903/images/large/jm0c01016_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01016&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) HCOONH<sub>4</sub>, Pd/C; (ii) ClCO<sub>2</sub>Et, THF; (iii) (1) HMTA, TFA; (iv) KOH, aqueous EtOH, K<sub>3</sub>Fe(CN)<sub>6</sub>; (v) (NH<sub>4</sub>)<sub>2</sub>Ce(NO<sub>3</sub>)<sub>6</sub>, CH<sub>3</sub>CN/H<sub>2</sub>O; (vi) 4-(4-methylpiperazin-1-yl)aniline, CeCl<sub>3</sub>Â·7H<sub>2</sub>O, abs EtOH.</p></p></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> QD394 Shows Remarkable Similarity to Napabucasin and H<sub>2</sub>O<sub>2</sub> in Transcriptomic Profiles</h3><div class="NLM_p">Among 11 originally synthesized analogs (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01016/suppl_file/jm0c01016_si_001.pdf" class="ext-link">Tables S1</a>, <a href="/doi/suppl/10.1021/acs.jmedchem.0c01016/suppl_file/jm0c01016_si_001.pdf" class="ext-link">S2</a>, <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>), QD394 had the highest cytotoxicity in MIA PaCa-2 cells and similar cytotoxicity in PANC-1 and BxPC-3 cells (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). QD394 induced the highest level of intracellular ROS after 1 h of compound treatment (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01016/suppl_file/jm0c01016_si_001.pdf" class="ext-link">Figure S1</a>). QD394 (IC<sub>50</sub>, 0.64 Â± 0. 04 Î¼M) is slightly more cytotoxic and induces more ROS as compared to our previously described QD325 compound (IC<sub>50</sub>, 0.9 Â± 0.2 Î¼M) (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01016/suppl_file/jm0c01016_si_001.pdf" class="ext-link">Figure S2</a>).<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> To better elucidate its mechanism of action, we performed Bru-seq, a nascent RNA-seq technique that uses bromouridine to label newly synthesized RNAs.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> This method detects early changes in the transcriptome caused by drugs and is useful in understanding their mechanisms of action and toxicity. We discovered that the transcriptomic profile of QD394 was highly similar to those of napabucasin and H<sub>2</sub>O<sub>2</sub>. The shrunkenLFC (shrunken log2FoldChange) of genes in QD394 Bru-seq samples significantly correlated with those of the napabucasin (<i>r</i> = 0.92) and H<sub>2</sub>O<sub>2</sub> (<i>r</i> = 0.88) samples, indicating similar transcription regulation (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>A). ShrunkenLFC reduces the effect of low-expressing genes that result in overinflated Log2FoldChange values. Gene Set Enrichment Analysis (GSEA) revealed 82 upregulated and 51 downregulated enriched gene sets in common between QD394 and napabucasin using the C2 curated gene sets from Molecular Signatures (MSigDB) Database v7.0 with an FDR below 0.001 (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>B,C, <a href="/doi/suppl/10.1021/acs.jmedchem.0c01016/suppl_file/jm0c01016_si_001.pdf" class="ext-link">Table S3</a>). For the Hallmark and KEGG pathway gene sets shared between QD394 and napabucasin, TNFA signaling, UV response, and hypoxia hallmark gene sets were upregulated and RNA degradation KEGG gene set was downregulated (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>D,E). TNF signaling and ROS are interconnected in the regulation of cell homeostasis, survival, and death in inflammatory diseases and cancers. ROS is closely related to TNF-related downstream signaling, such as NF-ÎºB and JNK activation, and TNF can induce an antioxidant NRF2 pathway to protect cells from elevated ROS.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> UV radiation can cause DNA damage and corresponding cell death via oxidative stress.<a onclick="showRef(event, 'ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref25 ref26">(25,26)</a> Moreover, cellular and mitochondrial ROS activate a series of transcription factors (TFs), which trigger the expression of a number of genes involved in the hypoxic response.<a onclick="showRef(event, 'ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref27 ref28">(27,28)</a> It is interesting to note that QD394 affects RNA degradation in the KEGG pathway gene set, and this is consistent with our proteomics study (see below).</div><figure id="fig1" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01016/20200903/images/medium/jm0c01016_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01016/20200903/images/large/jm0c01016_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Transcriptomic profile of QD394 is similar to those of napabucasin (napa) and H<sub>2</sub>O<sub>2</sub>. (A) Pearson correlation between QD394, napabucasin, and H<sub>2</sub>O<sub>2</sub> samples calculated in R. ShrunkenLFC was used to build heatmaps. (B,C) Upregulated and downregulated gene sets in GSEA from QD394 and napabucasin Bru-seq samples. GSEA plots of upregulated (D) and downregulated (E) enriched gene sets from the QD394 samples that are shared with napabucasin are depicted (FDR < 0.001). NES, normalized enrichment score. (F) Cells were treated with QD394 for 4 h at indicated concentrations and analyzed by immunoblot with STAT3, pSTAT3, GAPDH, and pH2AX antibodies.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01016/20200903/images/large/jm0c01016_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01016&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Cytotoxicities of QD Compounds in MIA PaCa-2, PANC-1, and BxPC-3 Pancreatic Cancer Cell Lines<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="Â±" /></col><col align="char" char="Â±" /></col><col align="char" char="Â±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Â </th><th class="rowsep1 colsep0" colspan="3" align="center" char="Â±">IC<sub>50</sub> (Î¼M)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">ID</th><th class="colsep0 rowsep0" align="center" char="Â±">MIA PaCa-2</th><th class="colsep0 rowsep0" align="center" char="Â±">PANC-1</th><th class="colsep0 rowsep0" align="center" char="Â±">BxPC-3</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">QD385</td><td class="colsep0 rowsep0" align="char" char="Â±">2.4Â Â±Â 0.1</td><td class="colsep0 rowsep0" align="char" char="Â±">2.3Â Â±Â 0.3</td><td class="colsep0 rowsep0" align="char" char="Â±">5.1 Â± 1.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">QD386</td><td class="colsep0 rowsep0" align="char" char="Â±">9.7 Â± 4.0</td><td class="colsep0 rowsep0" align="char" char="Â±">4.4 Â± 1.9</td><td class="colsep0 rowsep0" align="char" char="Â±">10.1Â Â±Â 2.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">QD387</td><td class="colsep0 rowsep0" align="char" char="Â±">3.1 Â± 0.2</td><td class="colsep0 rowsep0" align="char" char="Â±">1.9 Â± 0.2</td><td class="colsep0 rowsep0" align="char" char="Â±">3.3 Â± 1.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">QD388</td><td class="colsep0 rowsep0" align="char" char="Â±">2.4 Â± 0.6</td><td class="colsep0 rowsep0" align="char" char="Â±">1.4 Â± 0.5</td><td class="colsep0 rowsep0" align="char" char="Â±">2.5 Â± 0.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">QD389</td><td class="colsep0 rowsep0" align="char" char="Â±">1.5 Â± 0.3</td><td class="colsep0 rowsep0" align="char" char="Â±">0.8 Â± 0.3</td><td class="colsep0 rowsep0" align="char" char="Â±">2.3 Â± 0.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">QD390</td><td class="colsep0 rowsep0" align="char" char="Â±">3.1 Â± 1.5</td><td class="colsep0 rowsep0" align="char" char="Â±">4.7 Â± 1.5</td><td class="colsep0 rowsep0" align="char" char="Â±">4.5 Â± 0.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">QD391</td><td class="colsep0 rowsep0" align="char" char="Â±">2.2 Â± 0.7</td><td class="colsep0 rowsep0" align="char" char="Â±">1.6 Â± 0.8</td><td class="colsep0 rowsep0" align="char" char="Â±">2.6 Â± 0.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">QD392</td><td class="colsep0 rowsep0" align="char" char="Â±">1.5 Â± 0.7</td><td class="colsep0 rowsep0" align="char" char="Â±">2.3 Â± 0.3</td><td class="colsep0 rowsep0" align="char" char="Â±">1.6 Â± 0.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">QD393</td><td class="colsep0 rowsep0" align="char" char="Â±">1.2 Â± 0.2</td><td class="colsep0 rowsep0" align="char" char="Â±">0.9 Â± 0.4</td><td class="colsep0 rowsep0" align="char" char="Â±">0.5 Â± 0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">QD394</td><td class="colsep0 rowsep0" align="char" char="Â±">0.64 Â± 0. 04</td><td class="colsep0 rowsep0" align="char" char="Â±">0.34 Â± 0.03</td><td class="colsep0 rowsep0" align="char" char="Â±">0.9 Â± 0.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">QD395</td><td class="colsep0 rowsep0" align="char" char="Â±">2.0 Â± 0.7</td><td class="colsep0 rowsep0" align="char" char="Â±">0.8 Â± 0.2</td><td class="colsep0 rowsep0" align="char" char="Â±">2.7 Â± 0.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">QD394-Me</td><td class="colsep0 rowsep0" align="char" char="Â±">3.63 Â± 0.37</td><td class="colsep0 rowsep0" align="char" char="Â±">0.38 Â± 0.01</td><td class="colsep0 rowsep0" align="char" char="Â±">0.87 Â± 0.15</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">The IC<sub>50</sub> values are shown as mean Â± sd. Mean and standard deviation were calculated from three independent experiments.</p></div></div></div><div class="NLM_p last">Since napabucasin is a STAT3 signaling inhibitor and exhibited a similar transcriptomic profile to QD394, we sought to determine whether QD394 affected STAT3 signaling. Indeed, QD394 inhibited the phosphorylation of STAT3 in MIA PaCa-2 and PANC-1 cells, and it also increased the phosphorylation of H2AX, a DNA damage biomarker (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>F).</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> QD394 Induces ROS-Mediated Cell Death and Decreases the GSH/GSSG Ratio</h3><div class="NLM_p">As a redox modulator, QD394 caused time-dependent cellular ROS accumulation within the first 4 h of treatment in MIA PaCa-2 cells (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A). The significant increase of the ROS level could be reduced in 30 min by the antioxidant <i>N</i>-acetylcysteine (NAC) (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>B). Additionally, NAC significantly increased the IC<sub>50</sub> of QD394 from 0.53 to 1.11 Î¼M (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>C) and rescued colony formation inhibition by QD394 (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>D). Thus, the cytotoxicity of QD394 is partially dependent on ROS induction.</div><figure id="fig2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01016/20200903/images/medium/jm0c01016_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01016/20200903/images/large/jm0c01016_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. QD394 increases the cellular ROS level and reduces the GSH/GSSG ratio in MIA PaCa-2 cells. (A) QD394 increased fluorescence (RFU) indicating cellular ROS generation across treatment times (0â4 h). TBHP was used as a positive control. (B) At 30 min, a significant increase of ROS was determined in QD394- and TBHP-treated cells, and NAC (3 mM) reduced the elevated ROS levels. ** denotes <i>p</i> < 0.005, *** denotes <i>p</i> < 0.0005. (C) NAC significantly decreased the cytotoxicity of QD394 in the MTT assay. (D) NAC protected the inhibition of colony formation caused by QD394. (E) QD394 reduced the cellular GSH/GSSG ratio, mainly resulting from GSSG formation. RLU, relative luminescence unit. * denotes <i>p</i> < 0.05, ** denotes <i>p</i> < 0.005, *** denotes <i>p</i> < 0.0005.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01016/20200903/images/large/jm0c01016_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01016&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Glutathione is a well-known cellular ROS scavenger. In the GSH/GSSG-Glo assay, QD394 significantly decreased the GSH/GSSG ratio at both 2 and 4 h of treatment, similar to napabucasin (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>E). The decrease in the ratio is due to the reduced GSH level or increased GSSG level or both. The reduction from QD394 treatment was caused by oxidation of GSH to GSSG, rather than the direct decrease of the GSH level (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01016/suppl_file/jm0c01016_si_001.pdf" class="ext-link">Figure S3</a>). Buthionine sulfoximine (BSO) is an inhibitor of GSH synthesis, and both napabucasin and BSO significantly lowered the GSH level (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>E and <a href="/doi/suppl/10.1021/acs.jmedchem.0c01016/suppl_file/jm0c01016_si_001.pdf" class="ext-link">Figure S3</a>).</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> QD394 Causes Iron-Dependent and GPX4-Mediated Cell Death</h3><div class="NLM_p">Since we observed that QD394 modulated the GSH/GSSG ratio and its cytotoxicity was dependent on ROS, we hypothesized that QD394 could induce ferroptosis. To determine the cell death mechanism, we combined QD394 with a panel of signaling inhibitors (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). We identified that deferoxamine (DFO) and deferasirox, two iron chelators, prevented cell death caused by QD394, indicating that iron is a contributing factor to its cytotoxicity (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A and <a href="/doi/suppl/10.1021/acs.jmedchem.0c01016/suppl_file/jm0c01016_si_001.pdf" class="ext-link">Figure S4</a>). Two known ferroptosis inhibitors had different effects on cell death rescue. Liproxstatin-1 modestly rescued cell death caused by QD394, while ferrostatin-1 did not. Z-VAD (a caspase-dependent apoptosis inhibitor) and necrostatin-1 (a necroptosis inhibitor) did not rescue cell death, and chloroquine (an autophagy inhibitor) slightly rescued cell death in the colony formation assay (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01016/suppl_file/jm0c01016_si_001.pdf" class="ext-link">Figure S4</a>). Interestingly, necrostatin-1 blocked the inhibition of colony formation caused by napabucasin, indicating that cell death by napabucasin may proceed via necroptosis. The link between napabucasin and necroptosis has not been previously reported. Moreover, these results demonstrate that QD394 and napabucasin have different cell death mechanisms.</div><figure id="fig3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01016/20200903/images/medium/jm0c01016_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01016/20200903/images/large/jm0c01016_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. QD394 induces iron-dependent and GPX4-mediated ferroptosis in MIA PaCa-2 cells. (A) DFO decreased the inhibition of colony formation caused by QD394. (B) QD394 significantly induced lipid peroxidation after 24 h of treatment, similar to TBHP, RSL3, and erastin. * denotes <i>p</i> < 0.05, ** denotes <i>p</i> < 0.005. (C) The potential interaction between QD394 and GPX4 was determined by the cellular thermal shift assay. Detailed procedures are described in the <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a>. QD394 decreased the melting temperature of the GPX4 protein. ImageJ and GraphPad Prism were used for quantification. QD394 was tested at 100 Î¼M for 1 h. RT: room temperature, around 21 Â°C. (D) Knockdown of GPX4 significantly reduced cytotoxicity of QD394. siNC: samples treated with scrambled siRNA; siGPX4: samples treated with GPX4 siRNA. * denotes <i>p</i> < 0.05. Cells were immunoblotted with the GPX4 antibody to validate GPX4 knockdown. (E) RSL3 inhibited colony formation in pancreatic cancer cells, and QD394 rescued its effect.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01016/20200903/images/large/jm0c01016_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01016&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Select Cell Death Inhibitors That Were Combined with QD394 in Pancreatic Cancer Cells</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">cell death</th><th class="colsep0 rowsep0" align="center">target</th><th class="colsep0 rowsep0" align="center">inhibitor</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">apoptosis</td><td class="colsep0 rowsep0" align="left">all caspases</td><td class="colsep0 rowsep0" align="left">Z-VAD-FMK</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left">necroptosis</td><td class="colsep0 rowsep0" align="left">RIP1 kinase</td><td class="colsep0 rowsep0" align="left">necrostatin-1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">selective inhibitor of RIP1</td><td class="colsep0 rowsep0" align="left">necrostatin-1s</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="3" align="left">ferroptosis</td><td class="colsep0 rowsep0" align="left">iron; iron-dependent prolyl hydroxylases; lysosomal ROS inhibitor by chelating lysosomal redox-active iron</td><td class="colsep0 rowsep0" align="left">deferoxamine (DFO), deferasirox</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">inhibit autooxidation of lipids by trapping peroxyl radicals; not rescue H<sub>2</sub>O<sub>2</sub>-induced cell death</td><td class="colsep0 rowsep0" align="left">ferrostatin-1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">inhibit ferroptosis induced by <span class="smallcaps smallerCapital">l</span>-buthionine sulfoximine (BSO), erastin, and (1<i>S</i>,3<i>R</i>)-RSL3; inhibit autooxidation of lipids by trapping peroxyl radicals</td><td class="colsep0 rowsep0" align="left">liproxstatin-1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left">autophagy</td><td class="colsep0 rowsep0" align="left">impair autophagosome fusion with lysosomes</td><td class="colsep0 rowsep0" align="left">chloroquine</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">inhibit PI3K activity and the initial phase of the autophagic process</td><td class="colsep0 rowsep0" align="left">3-methyladenine</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left">parthanatos</td><td class="colsep0 rowsep0" align="left">PARP inhibitors</td><td class="colsep0 rowsep0" align="left">olaparib</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AIF release inhibitors</td><td class="colsep0 rowsep0" align="left"><i>N</i>-phenylmaleimide</td></tr></tbody></table></div></div><div class="NLM_p last">The final step in ferroptosis is an increase in lipid peroxidation.<a onclick="showRef(event, 'ref15 ref16 ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref15 ref16 ref17 ref18">(15â18)</a> We measured the lipid ROS level in QD394-treated cells using the BODIPY C11 dye to validate QD394-induced ferroptosis cell death. QD394 significantly increased lipid ROS in a dose-dependent manner (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B). TBHP (a ROS inducer), RSL3 (a GPX4 inhibitor), and erastin (a SLC7A11 inhibitor) all increased lipid ROS. Besides iron and lipid peroxidation, GPX4 is another central mediator of ferroptosis. GPX4 catalyzes the reduction of hydrogen peroxide, organic hydroperoxides, and lipid hydroperoxides and thereby protects cells against oxidative damage.<a onclick="showRef(event, 'ref15 ref29'); return false;" href="javascript:void(0);" class="ref ref15 ref29">(15,29)</a> Therefore, we investigated whether there is a connection between QD394 and GPX4. In the cellular thermal shift assay (CETSA), QD394 destabilized the GPX4 protein, indicated by the reduction in its melting temperature (from 60.34 to 57.62 Â°C) in MIA PaCa-2 cells (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>C). Destabilization of GPX4 by QD394 was also observed in PANC-1 cells (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01016/suppl_file/jm0c01016_si_001.pdf" class="ext-link">Figure S5</a>). Binding to a protein generally stabilizes it; however, QD394 destabilized GPX4, and it may be caused by an alternative binding mode or indirect interaction between them. Furthermore, the cytotoxicity of QD394 was significantly decreased in MIA PaCa-2 cells with GPX4 knocked down using siRNA, further suggesting that QD394 regulates GPX4-mediated cell death (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>D). Additionally, QD394 rescued the cytotoxicity of RSL3 in pancreatic cancer cells, suggesting that QD394 targets GPX4 (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>E). We hypothesized that QD394 and RSL3 may work as competitive inhibitors to bind to the same site of GPX4, thus blocking both their activities when they were combined at certain concentrations. In summary, QD394 induces an iron-dependent and GPX4-mediated cell death, which is closely related to ROS induction.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> QD394 Interferes with Mitochondrial Gene Expression and RNA Catabolic Process</h3><div class="NLM_p">To further investigate the Bru-seq results at the protein level, we performed proteomics and measured the changes caused by QD394. QD394 increased the expression of 84 proteins and decreased the expression of 146 proteins by at least 1.5-fold (FDR < 0.05) after 24 h of treatment in MIA PaCa-2 cells (<i>n</i> = 2). There are 17 upregulated and 35 downregulated genes/proteins in common between the proteomics and Bru-seq analysis (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A). In the STRING analysis,<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> the 17 proteins with increased expression were involved in response to endoplasmic reticulum (ER) stress, the unfolded protein response, and the transcription from RNA polymerase II promoter related to oxidative stress (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01016/suppl_file/jm0c01016_si_001.pdf" class="ext-link">Table S4</a>). Furthermore, the 35 proteins with decreased protein expression had a close connection with mitochondrial genes, mitochondrial translation regulation, and cellular metabolic processes (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01016/suppl_file/jm0c01016_si_001.pdf" class="ext-link">Table S5</a>, <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>B). QD394 reduced expression of proteins involved in mitochondrial RNA catabolic processes, which is consistent with the Bru-seq GSEA analysis showing that QD394 downregulated the KEGG RNA degradation gene set. We observed that LRPPRC and PNPT1 were involved in many of the biological processes downregulated by QD394 (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01016/suppl_file/jm0c01016_si_001.pdf" class="ext-link">Table S5</a>). LRPPRC (Leucine Rich Pentatricopeptide Repeat Containing) encodes a protein localized primarily to mitochondria, and it may regulate RNA metabolism and transcription in both nuclei and mitochondria. PNPT1 (Polyribonucleotide Nucleotidyltransferase 1) encodes a mitochondrial intermembrane protein in the polynucleotide phosphorylase family composed of phosphate-dependent 3â²-to-5â² exoribonucleases implicated in RNA processing and degradation. More importantly, we discovered that high expression of both genes significantly correlated with reduced overall survival of pancreatic cancer patients in the TCGA PAAD data set (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>C). In the 24 h proteomics experiment, QD394 reduced the expression of these two proteins (FDR < 0.05); additionally, QD394 significantly decreased their expression at 4 h (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>D). Napabucasin also decreased the protein expression of these two genes at 4 h, while H<sub>2</sub>O<sub>2</sub> did not. We combined NAC and dicoumarol (a NQO1 inhibitor) with QD394 and napabucasin to assess the effects on the expression of LRPPRC and PNPT1 (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01016/suppl_file/jm0c01016_si_001.pdf" class="ext-link">Figure S6</a>). NAC did not affect the downregulation of these two proteins caused by QD394 and napabucasin; however, dicoumarol blocked the reduction, indicating that NQO1 is a potential regulator in this process. Moreover, in PANC-1 cells, which have little intrinsic NQO1 expression, we did not observe the downregulation of LRPPRC and PNPT1 proteins by QD394 and napabucasin (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01016/suppl_file/jm0c01016_si_001.pdf" class="ext-link">Figure S6</a>).</div><figure id="fig4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01016/20200903/images/medium/jm0c01016_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01016/20200903/images/large/jm0c01016_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Common genes/proteins between Bru-seq and proteomics analysis reveal that QD394 interferes with mitochondrial gene expression and RNA catabolic process. (A) Venn diagrams of upregulated and downregulated genes/proteins between Bru-seq (fold change over 2) and proteomics (fold change over 1.5) analysis. (B) STRING analysis of 35 downregulated genes/proteins in common between Bru-seq and proteomics studies. The red circle highlights the genes involved in mitochondrial gene and translation regulation. The blue circle indicates the genes associated with the oxidation reduction process. (C) LRPPRC and PNPT1 are significantly related to the overall survival of pancreatic adenocarcinoma patients in the TCGA data set. (D) QD394 decreased the protein expression of LRPPRC and PNPT1 in MIA PaCa-2 cells. QD394 and napabucasin were tested at 3 Ã IC<sub>50</sub> for 1 and 4 h. QD394 was tested at 2 Ã IC<sub>50</sub> for 24 h. H<sub>2</sub>O<sub>2</sub> was used at 150 Î¼M. * denotes <i>p</i> < 0.05, ** denotes <i>p</i> < 0.005, *** denotes <i>p</i> < 0.0005. (E) The expression levels of mitochondrial proteins decreased in the QD394-treated MIA PaCa-2 cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01016/20200903/images/large/jm0c01016_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01016&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Besides these two mitochondrial proteins related to RNA processing, QD394 also reduced expression of other mitochondrial proteins in the proteomics study, substantiating its possible role in affecting mitochondrial function (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>E). Overall, QD394 downregulated mitochondrial proteins, including LRPPRC and PNPT1, in both Bru-seq and proteomics experiments.</div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> QD394 Is Synergistic with Napabucasin and Select FDA-Approved Drugs</h3><div class="NLM_p">ROS inducers sensitize cancer cells to standard-of-care chemotherapy and radiation.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> QD394 and napabucasin showed synergism in the colony formation assay in both MIA PaCa-2 and PANC-1 cells (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>A and <a href="/doi/suppl/10.1021/acs.jmedchem.0c01016/suppl_file/jm0c01016_si_001.pdf" class="ext-link">Figure S7</a>), suggesting the potential development of combination studies between redox modulator QD394 and cancer stemness inhibitors such as napabucasin. We next tested whether QD394 would act in synergy with the ROS inducer arsenic trioxide (As<sub>2</sub>O<sub>3</sub>), which is approved to treat acute promyelocytic leukemia. As<sub>2</sub>O<sub>3</sub> has been shown to reduce protein expression of Bcl-2, increase cellular ROS, induce permeability transition pore complex opening, and impair cell proliferation and apoptosis.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> QD394 sensitizes cells to As<sub>2</sub>O<sub>3</sub>, supporting synergistic potential between QD394 and different redox modulators (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>B). Since QD394 causes DNA damage, we assessed the synergy between QD394 and compounds regulating DNA repair. Olaparib, a poly(ADP-ribose) polymerase (PARP) inhibitor, is an FDA-approved drug to treat breast, ovarian, and pancreatic cancer. Combination of QD394 and olaparib resulted in synergistic effects in the colony formation assay (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>C). The full colony formation assay images and their synergism calculation using Highest Single Agent (HSA) and Bliss models in the Combenefit software are shown in <a href="/doi/suppl/10.1021/acs.jmedchem.0c01016/suppl_file/jm0c01016_si_001.pdf" class="ext-link">Figure S8</a>. Cumulatively, QD394 is synergistic with cancer stemness inhibitors, other redox modulators, and PARP inhibitors.</div><figure id="fig5" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01016/20200903/images/medium/jm0c01016_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01016/20200903/images/large/jm0c01016_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. QD394 is synergistic with select FDA-approved drugs in pancreatic cancer cells. Napabucasin (A), As<sub>2</sub>O<sub>3</sub> (B), and olaparib (C) were added 1 h before QD394. Cells were treated with drugs for 24 h. Red rectangles label the wells showing synergy.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01016/20200903/images/large/jm0c01016_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01016&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> QD394-Me Shows Improved Plasma Stability and Reduced Toxicity in Mice as Compared to QD394</h3><div class="NLM_p">We determined the stability of QD394 in mouse liver microsomes and plasma. The half-life of QD394 is over 60 min in mouse liver microsomes, yet only 6 min in mouse plasma, indicating that it has good microsomal stability but poor metabolic stability in plasma (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). We then determined its potential metabolites in mouse plasma to better guide the design of more metabolically stable derivatives (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>A). M1 and M2 metabolites have hydroxyl groups on the rings, and M3 and M4 metabolites are produced through Michael addition. We then synthesized QD394-Me with a methyl group to block Michael addition (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>B). This improved the plasma stability of QD394 from 6 min to over 2 h. Next, we calculated the PK parameters of QD394 and QD394-Me in CD-1 mice following intraperitoneal injection (IP, 10 mg/kg), oral administration (PO, 20 mg/kg), or intravenous (IV, 10 mg/kg) injection. Plasma concentrations of both QD394 and QD394-Me rapidly decreased within the first 2 h (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01016/suppl_file/jm0c01016_si_001.pdf" class="ext-link">Figure S9</a>). Notably, two out of three mice administered with QD394 via IV injection died, likely due to systemic toxicity, while all three mice that received IV injections of QD394-Me survived throughout the study (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). Therefore, QD394-Me appears to be less toxic and more tolerable in mice than QD394.</div><figure id="fig6" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01016/20200903/images/medium/jm0c01016_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01016/20200903/images/large/jm0c01016_0008.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Pharmacokinetics-guided optimization of QD394 led to QD394-Me having better stability in mouse plasma. (A) Potential metabolites of QD394 in mouse plasma. The hydroxyl groups could be on either ring highlighted by circles. (B) Structures of QD394 and QD394-Me.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01016/20200903/images/large/jm0c01016_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01016&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. PK Optimization of QD394<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="," /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Â </th><th class="rowsep1 colsep0" align="center">microsomal stability <i>t</i><sub>1/2</sub> (min)</th><th class="rowsep1 colsep0" colspan="2" align="center">plasma stability <i>t</i><sub>1/2</sub> (min)</th><th class="rowsep1 colsep0" colspan="3" align="center">concentration at 7 h in mouse plasma (ng/mL)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center">mouse</th><th class="colsep0 rowsep0" align="center">mouse</th><th class="colsep0 rowsep0" align="center">human</th><th class="colsep0 rowsep0" align="center">IP (<i>n</i>Â =Â 2)</th><th class="colsep0 rowsep0" align="center" char=",">PO (<i>n</i>Â =Â 2)</th><th class="colsep0 rowsep0" align="center">IV (<i>n</i>Â =Â 3)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">QD394</td><td class="colsep0 rowsep0" align="left">>60</td><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="left">5.0, 4.5</td><td class="colsep0 rowsep0" align="char" char=",">23.3, 25.8</td><td class="colsep0 rowsep0" align="left">2 out of 3 mice died</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">QD394-Me</td><td class="colsep0 rowsep0" align="left">44.6</td><td class="colsep0 rowsep0" align="left">>120</td><td class="colsep0 rowsep0" align="left">>120</td><td class="colsep0 rowsep0" align="left">6.7, 1.1</td><td class="colsep0 rowsep0" align="char" char=",">4.2, 3.4</td><td class="colsep0 rowsep0" align="left">3.4Â Â±Â 1.2</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">Microsomal stability, plasma stability, and PK studies were performed to evaluate the PK profiles of QD394 and its analog QD394-Me. Key parameters for each experiment are listed.</p></div></div></div><div class="NLM_p">To understand why the concentration of QD394-Me rapidly decreased in the plasma, we assessed tissue distribution of QD394-Me administered via IV and PO in mice. After 1 h of treatment, colon had the highest concentration of QD394-Me, although this was relatively low compared to the dosage (colon: around 0.3 mg/kg, PO: 20 mg/kg, IV: 10 mg/kg) (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01016/suppl_file/jm0c01016_si_001.pdf" class="ext-link">Table S6</a>). Besides distribution to organs, we identified potential metabolites of QD394-Me. The major metabolite of QD394-Me contains two hydroxyl groups on the right benzene or piperazine ring (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01016/suppl_file/jm0c01016_si_001.pdf" class="ext-link">Figure S10</a>). As early as 15 min, we observed the major metabolite in the plasma; however, both the parent compound and metabolite were distributed and excreted quickly over time (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01016/suppl_file/jm0c01016_si_001.pdf" class="ext-link">Figure S10</a>).</div><div class="NLM_p last">On the basis of tissue distribution results, e.g., where colon tissue had much higher concentration of QD394-Me than pancreas, we conducted a preliminary animal study in immunocompetent Balb/c mice using mouse colon cancer cell line CT-26. Three out of five mice displayed tumor shrinkage in the QD394-Me IV (10 mg/kg) and QD394 IP (20 mg/kg) treatment groups. (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01016/suppl_file/jm0c01016_si_001.pdf" class="ext-link">Figure S11</a>). A full assessment of in vivo efficacy studies in orthotopic models of colon and pancreatic cancers will be published in due course.</div></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> QD394-Me and QD394 Share Similar Cell Death Mechanisms</h3><div class="NLM_p">QD394-Me and QD394 show similar cytotoxicity in PANC-1 and BxPC-3 cells, while QD394-Me is less potent than QD394 in MIA PaCa-2 cells (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). QD394-Me also significantly increased cellular ROS in MIA PaCa-2 cells, and NAC blocked the induction of ROS (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>A). Similar to QD394, QD394-Me increased lipid ROS significantly in a dose-dependent manner (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>B). QD394-Me destabilized the GPX4 protein in pancreatic cancer cells in the CETSA experiments (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>C and <a href="/doi/suppl/10.1021/acs.jmedchem.0c01016/suppl_file/jm0c01016_si_001.pdf" class="ext-link">Figure S4</a>), and its cytotoxicity was significantly reduced in the GPX4-knockdown experiments (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>D, <a href="/doi/suppl/10.1021/acs.jmedchem.0c01016/suppl_file/jm0c01016_si_001.pdf" class="ext-link">Table S7</a>). Moreover, QD394-Me significantly decreased protein expression of LRPPRC and PNPT1 at 4 h, consistent with QD394 in MIA PaCa-2 cells (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>E). Therefore, QD394-Me shows a similar mechanism of action to QD394 in pancreatic cancer cells but has improved plasma stability and less in vivo toxicity.</div><figure id="fig7" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01016/20200903/images/medium/jm0c01016_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01016/20200903/images/large/jm0c01016_0009.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. QD394-Me has a similar cellular profile to QD394. (A) QD394-Me increased the cellular ROS level, and NAC reduced the induction of ROS at 30 min. ** denotes <i>p</i> < 0.005, *** denotes <i>p</i> < 0.0005. (B) QD394-Me significantly increased lipid peroxidation in MIA PaCa-2 cells. (C) QD394-Me destabilizes the GPX4 protein in MIA PaCa-2 cells. QD394-Me was tested at 100 Î¼M. (D) The cytotoxicity of QD394-Me was significantly reduced in the GPX4-knockdown MIA PaCa-2 cells. siNC: samples treated with scrambled siRNA; siGPX4: samples treated with GPX4 siRNA. (E) QD394-Me reduced the protein expression of LRPPRC and PNPT1 significantly at 4 h in MIA PaCa-2 cells. QD394-Me was tested at 3 Ã IC<sub>50</sub> for 1 and 4 h and 2 Ã IC<sub>50</sub> for 24 h. * denotes <i>p</i> < 0.05, ** denotes <i>p</i> < 0.005.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01016/20200903/images/large/jm0c01016_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01016&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Bru-seq Analysis of QD394-Me</h3><div class="NLM_p">We analyzed the gene expression profile of QD394-Me in MIA PaCa-2 using Bru-seq. QD394-Me induced hallmark gene sets related to TNF signaling and hypoxia, which is similar to QD394. Additionally, QD394-Me increased unfolded protein response, suggesting potential ER stress (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>, <a href="/doi/suppl/10.1021/acs.jmedchem.0c01016/suppl_file/jm0c01016_si_001.pdf" class="ext-link">Table S8</a>). QD394-Me also induced ROS pathway and JAK/STAT3 signaling hallmark gene sets, supporting its ROS-inducing capability and STAT3-targeting effects (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01016/suppl_file/jm0c01016_si_001.pdf" class="ext-link">Table S8</a>). KEGG pathways related to the proteasome, ribosome, and spliceosome were enriched by QD394-Me, indicating its downstream effects on protein and gene regulations (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>, <a href="/doi/suppl/10.1021/acs.jmedchem.0c01016/suppl_file/jm0c01016_si_001.pdf" class="ext-link">Table S9</a>). There are no common downregulated enriched gene sets between QD394 and QD394-Me Bru-seq samples.</div><figure id="fig8" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01016/20200903/images/medium/jm0c01016_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01016/20200903/images/large/jm0c01016_0010.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Select enriched gene sets of QD394-Me in MIA PaCa-2 Bru-seq samples.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01016/20200903/images/large/jm0c01016_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01016&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i21">Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32405" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32405" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">ROS induction alters the activity of multiple transcription factors, including STAT3, NF-ÎºB, and hypoxia-inducible factor-1Î± (HIF-1A).<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> STAT3 signaling is downstream of MAPK, JAK, and Src pathways. Redox modulation can inactivate these kinases leading to either activation or inhibition of STAT3 signaling, depending on cellular context and duration of ROS generation.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> TNFA signaling and hypoxia hallmark gene sets were upregulated by QD394 and napabucasin. TNFA/TNF are important cytokines for maintaining cellular homeostasis and mediating the activation of NF-ÎºB, which in turn regulates downstream prosurvival genes, MAPK signaling, and cell death in cancers and inflammatory diseases.<a onclick="showRef(event, 'ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref35 ref36">(35,36)</a> The transcription factor HIF-1A is activated by hypoxic conditions and responds to accumulated ROS via NF-ÎºB activation.<a onclick="showRef(event, 'ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref37 ref38">(37,38)</a> ROS induction by QD394 and napabucasin can trigger these signaling pathways. Napabucasin is a cancer stemness inhibitor that reduces the proliferation, invasion, and stemness of cancer cells.<a onclick="showRef(event, 'ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref39 ref40">(39,40)</a> Napabucasin is bioactivated by NQO1 and generates ROS to induce DNA damage and cell death.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> In this study, we report that necrostatin-1 rescued napabucasin-mediated cell death, suggesting that napabucasin induces necroptotic cell death in pancreatic cancer cells. However, QD394 did not cause necroptosis, but iron-, ROS-dependent, and GPX4-mediated ferroptosis (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>).</div><figure id="fig9" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01016/20200903/images/medium/jm0c01016_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01016/20200903/images/large/jm0c01016_0011.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Summary of the working mechanisms of QD394 and QD394-Me in pancreatic cancer cells. QD394 and QD394-Me increase the cellular ROS level, induce DNA damage, decrease mitochondrial proteins, and promote accumulation of lipid ROS. They oxidize GSH to GSSG and destabilize GPX4 in the cells. Their cytotoxicity is dependent on iron, ROS, and GPX4 expression. Ferroptosis and necrosis are potentially involved in their cell death mechanisms.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01016/20200903/images/large/jm0c01016_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01016&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Liproxstatin-1 inhibits ferroptosis induced by erastin, BSO, and RSL3 in vitro, and it prevents ferroptosis and ROS accumulation in GPX4 knockout cells both in vitro and in vivo.<a onclick="showRef(event, 'ref41 ref42'); return false;" href="javascript:void(0);" class="ref ref41 ref42">(41,42)</a> Ferrostatin-1 is a first-generation ferroptosis inhibitor that rescues cell death caused by erastin and RSL3.<a onclick="showRef(event, 'ref15 ref43'); return false;" href="javascript:void(0);" class="ref ref15 ref43">(15,43)</a> Additionally, both compounds are effective radical-trapping antioxidants in the lipid bilayers.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> However, ferrostatin-1 did not prevent H<sub>2</sub>O<sub>2</sub>-induced necrosis, although ferroptosis is defined as a necrotic-like cell death.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> The fact that QD394 induces ROS may explain why ferrostatin-1 did not rescue QD394-induced cell death. Although ferrostatin-1 blocked lipid peroxidation and ferroptosis, QD394 could cause other ROS-involved DNA damage and necrotic cell death (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>). Therefore, we suggest that QD394 and QD394-Me kill cells through a combination of different cell death pathways and ferroptosis is an essential mechanism since GPX4 protein expression regulates the cytotoxicities of QD394 and QD394-Me. Interestingly, we determined potential interactions between QD394, QD394-Me, and GPX4 in the cells, but the detailed binding site requires further investigation.</div><div class="NLM_p last">LRPPRC and PNPT1 are closely related to mitochondrial translation and RNA catabolic processes in different diseases.<a onclick="showRef(event, 'ref20 ref21 ref44 ref45'); return false;" href="javascript:void(0);" class="ref ref20 ref21 ref44 ref45">(20,21,44,45)</a> LRPPRC deficiency alters the mitochondrial electron transport chain, mitochondrial permeability, and transmembrane ROS diffusion.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> PNPT1 regulates the correct maturation of mitochondrial ND6 transcripts and efficient mitochondrial RNA degradation.<a onclick="showRef(event, 'ref21 ref45'); return false;" href="javascript:void(0);" class="ref ref21 ref45">(21,45)</a> Both proteins are involved in mitochondrial function and negatively associated with the survival of pancreatic adenocarcinoma patients. Our redox modulators, QD394 and QD394-Me, decreased the expression of these two proteins, which could be used as potential pharmacodynamic biomarkers in pancreatic cancer (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>). Meanwhile, further understanding of the connection between overexpression of these two genes and pancreatic cancer is needed and may lead to novel approaches to treat pancreatic cancer.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_14111" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_14111" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In this study, we developed a novel redox modulator QD394 and comprehensively studied its mechanisms of action in pancreatic cancer cells. QD394 shares a highly similar transcriptomic profile to napabucasin, inhibits STAT3 phosphorylation, increases ROS levels, and induces DNA damage. However, while napabucasin causes necroptosis, QD394 induces an iron-, ROS-dependent, and GPX4-mediated cell death. An essential cell death mechanism of QD394 is ferroptosis since QD394 increases lipid peroxidation, destabilizes the GPX4 protein, and its cytotoxicity is dependent on GPX4. Bru-seq and proteomics analysis reveal that QD394 decreases both nascent transcripts and protein expression of LRPPRC and PNPT1. Furthermore, QD394 acts in synergy with several FDA-approved drugs, suggesting its potential utility to overcome drug resistance. A PK-guided optimization campaign resulted in QD394-Me with improved mouse plasma stability and less systemic toxicity in mice.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i23">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20124" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20124" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Chemistry</h3><div id="sec5_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> General Methods</h4><div class="NLM_p last">All solvents and other chemicals were obtained from Sigma-Aldrich, Alfa Aesar, Carlo Erba (analytical or anhydrous grade) or Apollo Scientific Limited, Oakwood Chemical, Combi Blocks, Enamine (for amines) and were used without further purification. All reactions involving air- or moisture-sensitive compounds were performed under a nitrogen atmosphere using oven-dried glassware and syringes to transfer solutions. Melting points (mp) were determined using an electrothermal melting point or a KÃ¶fler apparatus and are uncorrected. Nuclear magnetic resonance (<sup>1</sup>H-NMR, <sup>13</sup>C-NMR) spectra were determined in CDCl<sub>3</sub> or DMSO-<i>d</i><sub>6</sub> and were recorded on a 400 MHz Bruker Avance III. Chemical shifts are reported in parts per million (ppm) downfield from tetramethylsilane (TMS) and used as an internal standard. Splitting patterns are designated as follows: s, singlet; d, doublet; t, triplet; q, quadruplet; m, multiplet; brs, broad singlet; dd, double doublet. The assignment of exchangeable protons (OH and NH) was confirmed by the addition of D<sub>2</sub>O. Mass spectra were obtained on a Hewlett-Packard 5989 mass engine spectrometer or a MALDI micro MX (Waters, Micromass) equipped with a reflector analyzer. Analytical thin-layer chromatography (TLC) was carried out on Merck silica gel F-254 plates. Flash chromatography purifications were performed on a Merck Silica gel 60 (230â400 mesh ASTM) as a stationary phase. Analytical HPLC for the lead compounds was carried out on an Agilent 1260 Infinity II Quaternary pump (Agilent Technologies, Italia S.p.A.). Elemental analyses for tested compounds were performed on a PerkinElmer 2400 spectrometer at Laboratorio di Microanalisi, Dipartimento di Chimica, UniversitÃ  di Sassari (Italy) and were within Â±0.4% of the theoretical values (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01016/suppl_file/jm0c01016_si_001.pdf" class="ext-link">Table S1</a>), thus confirming â¥95% purity.</div></div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> General Method for the Preparation of Compounds QD385â395</h3><div class="NLM_p">A solution of quinazoline-5,8-dione (<b>1</b>), cerium(III) chloride heptahydrate (CeCl<sub>3</sub>Â·7H<sub>2</sub>O, 1.1 equiv.), and substituted aniline (1.0 equiv.) in absolute ethanol was stirred at room temperature for 1.5 h. Next, after removing most of the ethanol under vacuum, the crude residue was diluted with water, extracted with CH<sub>2</sub>Cl<sub>2</sub>, and washed with water. The organic layers were dried over sodium sulfate (Na<sub>2</sub>SO<sub>4</sub>) and concentrated to dryness. Then, the product was purified by flash chromatography to give the desired compound.</div><div id="sec5_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> 6-(Biphenyl-3-ylamino)quinazoline-5,8-dione [QD385]</h4><div class="NLM_p last">Quinazoline-5,8-dione (<b>1</b>, 0.050 g, 0.312 mmol), cerium(III) chloride heptahydrate (CeCl<sub>3</sub>Â·7H<sub>2</sub>O, 1.1 equiv., 0.128 g, 0.343 mmol), 3-aminobiphenyl (1.0 equiv., 0.053 g, 0.312 mmol), and absolute ethanol (6 mL). Flash chromatography (dichloromethane/methanol = 9.8:0.2) gave compound QD385 as a violet powder. Yield: 20%. <i>R</i>f: 0.41 (ether petroleum/ethyl acetate = 3:7). mp: 199â200 Â°C. <sup>1</sup>H-NMR 400 MHz (DMSO-<i>d</i><sub>6</sub>): Î´ 9.63 (s, 1H), 9.43 (s, 1H), 7.69â7.67 (m, 3H), 7.61â7.59 (d, 2H), 7.49â7.46 (t, 2H), 7.41â7.36 (t, 3H), 6.34 (s, 1H). <sup>13</sup>C-NMR (DMSO-<i>d</i><sub>6</sub>): Î´ 163.78, 130.33, 129.03, 127.15, 125.61, 121.74, 105.15. MS: <i>m</i>/<i>z</i> 327 (M<sup>+</sup>).</div></div><div id="sec5_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> 6-(4â²-Chlorobiphenyl-4-ylamino)quinazoline-5,8-dione [QD386]</h4><div class="NLM_p last">Quinazoline-5,8-dione (<b>1</b>, 0.050 g, 0.312 mmol), cerium(III) chloride heptahydrate (CeCl<sub>3</sub>Â·7H<sub>2</sub>O, 1.1 equiv., 0.128 g, 0.343 mmol), 4-amino-4â²-chlorobiphenyl (1.0 equiv., 0.064 g, 0.312 mmol), and absolute ethanol (6 mL). Flash chromatography (ethyl acetate/petroleum ether = 5:5) gave compound QD386 as a violet powder. Yield: 95%. <i>R</i>f: 0.20 (ethyl acetate/petroleum ether = 7:3). mp: 292â293 Â°C. <sup>1</sup>H-NMR (DMSO-<i>d</i><sub>6</sub>): Î´ 9.62 (s, 2H), 9.42 (s, 1H), 7.79â7.77 (d, 2H), 7.76â7.74 (d, 2H), 7.55â7.53 (d, 2H), 7.50â7.48 (d, 2H), 6.35 (s, 1H). <sup>13</sup>C-NMR (DMSO-<i>d</i><sub>6</sub>): Î´ 180.52, 180.03, 162.59, 155.67, 153.74, 145.89, 138.07, 137.42, 135.77, 132.34, 128.91, 128.26, 127.53, 124.06, 104.06. MS: <i>m</i>/<i>z</i> 361 (M<sup>+</sup>).</div></div><div id="sec5_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> 6-(3â²,5â²-Dichlorobiphenyl-4-ylamino)quinazoline-5,8-dione [QD387]</h4><div class="NLM_p last">Quinazoline-5,8-dione (<b>1</b>, 0.050 g, 0.312 mmol), cerium(III) chloride heptahydrate (CeCl<sub>3</sub>Â·7H<sub>2</sub>O, 1.1 equiv., 0.128 g, 0.343 mmol), 4-amino-3â²,5â²-dichlorobiphenyl (1.0 equiv., 0.074 g, 0.312 mmol), and absolute ethanol (6 mL). Flash chromatography (ethyl acetate/petroleum ether = 5:5) gave compound QD387 as a violet powder. Yield: 95%. <i>R</i>f: 0.50 (ethyl acetate/petroleum ether = 7:3). mp: 260â261 Â°C. <sup>1</sup>H-NMR (DMSO-<i>d</i><sub>6</sub>): Î´ 9.63 (s, 2H), 9.43 (s, 1H), 7.87â7.85 (d, 2H), 7.79 (s, 2H), 7.61 (s, 1H), 7.52â7.50 (d, 2H), 6.38 (s, 1H). <sup>13</sup>C-NMR (DMSO-<i>d</i><sub>6</sub>): Î´ 180.47, 180.15, 162.60, 155.70, 153.68, 145.75, 142.80, 138.28, 134.68, 133.99, 128.02, 125.20, 123.91, 104.34. MS: <i>m</i>/<i>z</i> 395 (M<sup>+</sup>).</div></div><div id="sec5_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> 6-(4-(Piperidin-1-yl)phenylamino)quinazoline-5,8-dione [QD388]</h4><div class="NLM_p last">Quinazoline-5,8-dione (<b>1</b>, 0.050 g, 0.312 mmol), cerium(III) chloride heptahydrate (CeCl<sub>3</sub>Â·7H<sub>2</sub>O, 1.1 equiv., 0.128 g, 0.343 mmol), 4-(1-piperidinyl)aniline (1.0 equiv., 0.055 g, 0.312 mmol), and absolute ethanol (6 mL). Flash chromatography (ethyl acetate/petroleum ether = 7:3) gave compound QD388 as a violet powder. Yield: 66%. <i>R</i>f: 0.29 (ethyl acetate/petroleum ether = 7:3). mp: 209 Â°C. <sup>1</sup>H-NMR (DMSO-<i>d</i><sub>6</sub>): Î´ 9.60 (s, 1H), 9.38 (s, 1H), 7.45 (s, 1H), 7.22â7.20 (d, 2H), 7.02â7.00 (d, 2H), 6.13 (s, 1H), 3.16 (s, 4H), 1.63â1.56 (d, 6H). <sup>13</sup>C-NMR (DMSO-<i>d</i><sub>6</sub>): Î´ 180.65, 179.30, 162.59, 155.51, 154.08, 149.52, 146.47, 127.71, 124.93, 124.12, 115.91, 102.59, 49.23, 25.09, 23.83. MS: <i>m</i>/<i>z</i> 334 (M<sup>+</sup>).</div></div><div id="sec5_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> 6-(4-Morpholinophenylamino)quinazoline-5,8-dione [QD389]</h4><div class="NLM_p last">Quinazoline-5,8-dione (<b>1</b>, 0.050 g, 0.312 mmol), cerium(III) chloride heptahydrate (CeCl<sub>3</sub>Â·7H<sub>2</sub>O, 1.1 equiv., 0.128 g, 0.343 mmol), 4-(4-morpholinyl)aniline (1.0 equiv., 0.056 g, 0.312 mmol), and absolute ethanol (6 mL). Flash chromatography (ethyl acetate/petroleum ether = 7:3) gave compound QD389 as a violet powder. Yield: 88%. <i>R</i>f: 0.10 (ethyl acetate/petroleum ether = 7:3). mp: 226â227 Â°C. <sup>1</sup>H-NMR (DMSO-<i>d</i><sub>6</sub>): Î´ 9.60 (s, 1H), 9.47 (s, 1H, HâN), 9.39 (s, 1H), 7.26â7.24 (d, 2H), 7.05â7.03 (d, 2H), 6.14 (s, 1H), 3.76 (s, 4H), 3.15 (s, 4H). <sup>13</sup>C-NMR (DMSO-<i>d</i><sub>6</sub>): Î´ 180.62, 179.41, 162.59, 155.53, 149.03, 146.49, 128.56, 124.97, 115.40, 102.70, 66.00, 48.18. MS: <i>m</i>/<i>z</i> 336 (M<sup>+</sup>).</div></div><div id="sec5_2_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> 6-(9<i>H</i>-Fluoren-4-ylamino)quinazoline-5,8-dione [QD390]</h4><div class="NLM_p last">Quinazoline-5,8-dione (<b>1</b>, 0.050 g, 0.312 mmol), cerium(III) chloride heptahydrate (CeCl<sub>3</sub>Â·7H<sub>2</sub>O, 1.1 equiv., 0.128 g, 0.343 mmol), 1-aminofluorene (1.0 equiv., 0.057 g, 0.312 mmol), and absolute ethanol (6 mL). Flash chromatography (ethyl acetate/petroleum ether = 7:3) gave compound QD390 as a violet powder. Yield: 69%. <i>R</i>f: 0.46 (ethyl acetate/petroleum ether = 7:3). mp: 217 Â°C. <sup>1</sup>H-NMR (CDCl<sub>3</sub>): Î´ 9.68 (s, 1H), 9.53 (s, 1H), 7.57â7.55 (d, 2H), 7.52â7.49 (t, 1H), 7.45â7.41 (t, 1H), 7.38â7.35 (t, 1H), 7.31â7.29 (d, 1H), 6.43 (s, 1H), 3.86 (s, 2H). <sup>13</sup>C-NMR (CDCl<sub>3</sub>): Î´ 163.78, 156.33, 128.79, 127.74, 127.25, 125.18, 121.70, 120.42, 119.04, 105.53. MS: <i>m</i>/<i>z</i> 339 (M<sup>+</sup>).</div></div><div id="sec5_2_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 6-(9<i>H</i>-Fluoren-2-ylamino)quinazoline-5,8-dione [QD391]</h4><div class="NLM_p last">Quinazoline-5,8-dione (<b>1</b>, 0.050 g, 0.312 mmol), cerium(III) chloride heptahydrate (CeCl<sub>3</sub>Â·7H<sub>2</sub>O, 1.1 equiv., 0.128 g, 0.343 mmol), 2-aminofluorene (1.0 equiv., 0.057 g, 0.312 mmol), and absolute ethanol (6 mL). Flash chromatography (ethyl acetate/petroleum ether = 5:5) gave compound QD391 as a violet powder. Yield: 92%. <i>R</i>f: 0.14 (ethyl acetate/petroleum ether = 7:3). mp: 236â237 Â°C. <sup>1</sup>H-NMR (DMSO-<i>d</i><sub>6</sub>): Î´ 9.62 (s, 2H), 9.43 (s, 1H), 8.00â7.97 (d, 1H), 7.92â7.91 (d, 1H), 7.62â7.60 (d, 2H), 7.43â7.39 (t, 2H), 7.35â7.32 (t, 1H), 6.35 (s, 1H), 4.00 (s, 1H). <sup>13</sup>C-NMR (DMSO-<i>d</i><sub>6</sub>): Î´ 155.64, 153.82, 146.13, 144.27, 143.19, 140.42, 138.78, 136.25, 126.84, 125.13, 124.14, 122.77, 120.67, 120.54, 119.99, 103.74, 65.70. MS: <i>m</i>/<i>z</i> 339 (M<sup>+</sup>).</div></div><div id="sec5_2_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 6-(4â²-Ethylbiphenyl-4-ylamino)quinazoline-5,8-dione [QD392]</h4><div class="NLM_p last">Quinazoline-5,8-dione (<b>1</b>, 0.050 g, 0.312 mmol), cerium(III) chloride heptahydrate (CeCl<sub>3</sub>Â·7H<sub>2</sub>O, 1.1 equiv., 0.128 g, 0.343 mmol), 4-amino-4â²-ethylbiphenyl (1.0 equiv., 0.061 g, 0.312 mmol), and absolute ethanol (6 mL). Flash chromatography (ethyl acetate/petroleum ether = 5:5) gave compound QD392 as a violet powder. Yield: 77%. <i>R</i>f: 0.19 (ether petroleum/ethyl acetate = 5:5). mp: 247 Â°C. <sup>1</sup>H-NMR 400 MHz (DMSO-<i>d</i><sub>6</sub>): Î´ 9.63 (s, 2H), 9.43 (s, 1H), 7.76â7.74 (d, 2H), 7.64â7.62 (d, 2H), 7.49â7.47 (d, 2H), 7.33â7.31 (d, 2H), 6.36 (s, 1H), 2.69â2.63 (m, 2H), 1.24â1.21 (t, 3H). <sup>13</sup>C-NMR 100 MHz (DMSO-<i>d</i><sub>6</sub>): Î´ 185.78, 185.24, 167.73, 161.00, 159.01, 151.19, 148.40, 142.53, 141.91, 133.63, 132.54, 131.68, 129.33, 109.12, 33.02, 20.77. MS: <i>m</i>/<i>z</i> 355 (M<sup>+</sup>).</div></div><div id="sec5_2_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> 6-(4-Cyclohexylphenylamino)quinazoline-5,8-dione [QD393]</h4><div class="NLM_p last">Quinazoline-5,8-dione (<b>1</b>, 0.050 g, 0.312 mmol), cerium(III) chloride heptahydrate (CeCl<sub>3</sub>Â·7H<sub>2</sub>O, 1.1 equiv., 0.128 g, 0.343 mmol), 4-cyclohexylaniline (1.0 equiv., 0.055 g, 0.312 mmol), and absolute ethanol (6 mL). Flash chromatography (ethyl acetate/petroleum ether = 5:5) gave compound QD393 as a violet powder. Yield 53%. <i>R</i>f: 0.24 (ether petroleum/ethyl acetate = 5:5). mp: 234 Â°C. <sup>1</sup>H-NMR (DMSO-<i>d</i><sub>6</sub>): Î´ 9.61 (s, 1H), 9.53 (s, 1H), 9.40 (s, 1H), 7.34â7.28 (m, 4H), 6.21 (s, 1H), 1.82â1.80 (m, 5H), 1.73â1.70 (d, 1H), 1.47â1.33 (m, 5H). <sup>13</sup>C-NMR (DMSO-<i>d</i><sub>6</sub>): Î´ 180.60, 162.58, 155.59, 153.85, 145.32, 127.53, 123.91, 43.26, 38.87, 26.29, 25.53. MS: <i>m</i>/<i>z</i> 333 (M<sup>+</sup>).</div></div><div id="sec5_2_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> 6-(4-(4-Methylpiperazin-1-yl)phenylamino)quinazoline-5,8-dione [QD394]</h4><div class="NLM_p last">Quinazoline-5,8-dione (<b>1</b>, 0.050 g, 0.312 mmol), cerium(III) chloride heptahydrate (CeCl<sub>3</sub>Â·7H<sub>2</sub>O, 1.1 equiv., 0.128 g, 0.343 mmol), 4-(4-methylpiperazin-1-yl)aniline (1.0 equiv., 0.060 g, 0.312 mmol), and absolute ethanol (6 mL). Flash chromatography (dicloromethane/methanol = 8:2) gave compound QD394 as a violet powder. Yield: 70%. <i>R</i>f: 0.30 (dicloromethane/methanol = 8:2). mp: 204â205 Â°C. <sup>1</sup>H-NMR (DMSO-<i>d</i><sub>6</sub>): Î´ 9.60 (s, 1H), 9.46 (s, 1H), 9.39 (s, 1H), 7.24â7.22 (d, 2H), 7.04â7.01 (d, 2H), 6.13 (s, 1H), 3.19â3.17 (m, 4H), 2.47 (s, 4H), 2.23 (s, 3H). MS: <i>m</i>/<i>z</i> 349 (M<sup>+</sup>).</div></div><div id="sec5_2_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 6-(4-(Pyridin-2-yl)phenylamino)quinazoline-5,8-dione [QD395]</h4><div class="NLM_p last">Quinazoline-5,8-dione (<b>1</b>, 0.075 g, 0.468 mmol), cerium(III) chloride heptahydrate (CeCl<sub>3</sub>Â·7H<sub>2</sub>O, 1.1 equiv., 0.192 g, 0.515 mmol), 4-(2-pyridyl)aniline (1.0 equiv., 0.080 g, 0.468 mmol), and absolute ethanol (9 mL). Flash chromatography (ether petroleum/ethyl acetate = 5:5) gave compound QD395 as a violet powder. Yield: 54%. <i>R</i>f: 0.16 (ether petroleum/ethyl acetate = 2:8). mp: 239 Â°C. <sup>1</sup>H-NMR (DMSO-<i>d</i><sub>6</sub>): Î´ 9.67(s, 1H), 9.63 (s, 1H), 9.44 (s, 1H), 8.69â8.65 (d, 1H), 8.21â8.18 (d, 2H), 8.01â7.99 (d, 1H), 7.92â7.88 (m, 1H), 7.56â7.53 (dd, 2H), (m, 1H), 6.43 (s, 1H). MS: <i>m</i>/<i>z</i> 328 (M<sup>+</sup>).</div></div><div id="sec5_2_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> 2,5-Dimethoxy-4-methylnitrobenzene [<b>6</b>]</h4><div class="NLM_p last">Yield: 80%. <i>R</i>f = 0.90 (ethyl acetate/petroleum ether 3:7). mp: 116 Â°C. <sup>1</sup>H-NMR 400 MHz (CDCl<sub>3</sub>): Î´ 10.29 (s, 1H), 6.93 (s, 1H), 3.95 (s, 3H), 3.87 (s, 3H), 2.42 (s, 3H). <sup>13</sup>C-NMR 400 MHz (CDCl<sub>3</sub>): Î´ 150.98, 147.69, 136.77, 135.25, 116.46, 107.05, 57.10, 56.00, 16.83. MS: <i>m</i>/<i>z</i> 198 [M + H]<sup>+</sup>.</div></div><div id="sec5_2_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> 3,6-Dimethoxy-4-methyl-2-nitrobenzaldehyde [<b>7</b>]</h4><div class="NLM_p last">To a solution of 3,6-dimethoxy-4-methyl benzaldehyde (1 equiv., 4.0 g, 24.07 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (50 mL), conc. HNO<sub>3</sub> (4.54 equiv., 6 mL) in CH<sub>2</sub>Cl<sub>2</sub> (25 mL) was added at room temperature under stirring. After 24 h, the obtained clear solution was cautiously poured onto aqueous Na<sub>2</sub>SO<sub>4</sub>. The organic layer was separated and dried over Na<sub>2</sub>SO<sub>4</sub>. The obtained crude product was then purified by flash chromatography on silica gel using ethyl acetate/petroleum ether (2.5:7.5) to give first the major side product, 2,5-dimethoxy-4-methylnitrobenzene (<b>6</b>), and then (by further elution with only ethyl acetate) the desired compound (<b>7</b>). Yield: 5%. <i>R</i>f = 0.60 (ethyl acetate/petroleum ether 3:7). mp: 85 Â°C. <sup>1</sup>H-NMR 400 MHz (CDCl<sub>3</sub>): Î´ 10.29 (s, 1H), 6.93 (s, 1H), 3.95 (s, 3H), 3.87 (s, 3H), 2.42 (s, 3H). <sup>13</sup>C-NMR 400 MHz (CDCl<sub>3</sub>): Î´ 185.46, 157.60, 143.47, 142.28, 117.58, 115.54, 114.09, 62.90, 56.63, 17.47. MS: <i>m</i>/<i>z</i> 226 [M + H]<sup>+</sup>.</div></div><div id="sec5_2_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> <i>N</i>,<i>N</i>â²-((3,6-Dimethoxy-4-methyl-2-nitrophenyl)methanediyl)diformamide [<b>8</b>]</h4><div class="NLM_p last">A solution of 3,6-dimethoxy-4-methyl-2-nitrobenzaldehyde (<b>7</b>, 1.1 g, 4.87 mmol) in formamide (66.5 equiv., 13 mL, 325 mmol), heated at 40 Â°C, was exposed to dry HCl gas (1 h) until the temperature reached 80 Â°C. Then, the solution was cooled to room temperature, and water/ice was added. A pale brownish yellow colored precipitate was formed, which was filtered, dried, and triturated with ethyl acetate and petroleum ether to yield the desired compound. Yield: 70%. <i>R</i>f = 0.16 (dichloromethane/methanol 9.5:0.5). mp: 238 Â°C. <sup>1</sup>H-NMR 400 MHz (DMSO-<i>d</i><sub>6</sub>): Î´ 8.65 (d, 2H), 7.91 (s, 2H), 7.21 (s, 1H), 6.72 (t, 1H), 3.89 (s, 3H), 3.71 (s, 3H), 2.50 (s, 3H). <sup>13</sup>C-NMR 400 MHz (DMSO-<i>d</i><sub>6</sub>): Î´ 160.14, 152.82, 141.76, 134.61, 119.71, 116.23, 116.09, 62.31, 56.54, 15.89. MS: <i>m</i>/<i>z</i> 298 [M + H]<sup>+</sup>.</div></div><div id="sec5_2_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> 5,8-Dimethoxy-7-methylquinazoline [<b>9</b>]</h4><div class="NLM_p last">Zinc powder (15 equiv., 1.4 g, 22 mmol) was added to a suspension of <i>N</i>,<i>N</i>â²-((3,6-dimethoxy-4-methyl-2-nitrophenyl)methanediyl)diformamide (<b>8</b>, 0.45 g, 1.5 mmol) in triturated ice and glacial acetic acid (2 mL), under constant magnetic stirring. The reaction mixture was stirred for 2 h in an ice bath and for 4 h at room temperature. After filtration of the reaction mixture through filter paper, the resulting solution was dropped on cooled 50% NaOH (5 mL), and the yellow colored suspension thus formed was left without stirring for 1 h. Next, the suspension was filtered, and the solid was dried (at 30â40 Â°C) to give a yellow powder. The solid was then solubilized in ethyl acetate, filtered, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and concentrated to dryness yielding the desired compound. Yield: 50%. <i>R</i>f = 0.30 (ethyl acetate/petroleum ether 3:7). mp: 132 Â°C. <sup>1</sup>H-NMR 400 MHz (CDCl<sub>3</sub>): Î´ 9.65 (s, 1H), 9.31 (s, 1H), 6.72 (s, 1H), 4.02 (s, 3H), 4.00 (s, 3H), 2.51 (s, 3H). <sup>13</sup>C-NMR 400 MHz (CDCl<sub>3</sub>): Î´ 155.68, 155.27, 151.35, 146.12, 144.83, 136.39, 117.04, 108.33, 61.81, 55.86, 17.21. MS: <i>m</i>/<i>z</i> 205 [M + H]<sup>+</sup>.</div></div><div id="sec5_2_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> 7-Methylquinazoline-5,8-dione [<b>10</b>]</h4><div class="NLM_p last">A solution of 5,8-dimethoxy-7-methylquinazoline (<b>9</b>, 0.15 g, 0.75 mmol) in (7:3) acetonitrile/water (5 mL) was cooled at 0 Â°C in an ice bath, and a solution of ceric ammonium nitrate (3 equiv., 1.2 g, 2.1 mmol) in (9:1) acetonitrile/water (5 mL) was added dropwise. The reaction mixture was stirred for 20 min and then poured into ice/water and extracted (8â10 times) with dichloromethane. The organic layer was washed (5â6 times) with water, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and concentrated to dryness to give a brown powder. Yield: 90%. <i>R</i>f = 0.52 (ethyl acetate/petroleum ether 3:7). mp: 118 Â°C. <sup>1</sup>H-NMR 400 MHz (CDCl<sub>3</sub>): Î´ 9.68 (s, 1H), 9.51 (s, 1H), 6.97 (s, 1H), 2.30 (s, 3H). <sup>13</sup>C-NMR 400 MHz (CDCl<sub>3</sub>): Î´ 183.29, 182.88, 162.84, 157.23, 152.51, 149.59, 135.12, 124.24, 16.81. MS: <i>m</i>/<i>z</i> 175 [M + H]<sup>+</sup>.</div></div><div id="sec5_2_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> 7-Methyl-6-((4-(4-methylpiperazin-1-yl)phenyl)amino)quinazoline-5,8-dione [QD394-Me]</h4><div class="NLM_p last">A solution of 7-methylquinazoline-5,8-dione (<b>10</b>, 0.050 g, 0.312 mmol), cerium(III) chloride heptahydrate (CeCl<sub>3</sub>Â·7H<sub>2</sub>O, 1.1 equiv., 0.128 g, 0.343 mmol), and 4-(4-methylpiperazin-1-yl)aniline (1.0 equiv., 0.060 g, 0.312 mmol) in absolute ethanol (6 mL) was stirred at room temperature for 1â2 h. Next, most of the ethanol was removed under vacuum, and water was added followed by extraction with dichloromethane. The organic layers were washed with water and brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and concentrated to dryness. Then, the crude product was purified by flash chromatography to give the expected product. Yield: 90%. <i>R</i>f = 0.30 (dichloromethane/methanol 9.5:0.5); mp: 142 Â°C. <sup>1</sup>H-NMR 400 MHz (DMSO-<i>d</i><sub>6</sub>): Î´ 9.57 (s, 1H), 9.33 (s, 1H), 8.85 (s, 1H), 7.00 (d, 1H), 6.91 (d, 1H), 3.14 (m, 4H), 2.50 (m, 4H), 2.27 (s, 3H), 1.62 (s, 3H). <sup>13</sup>C-NMR 400 MHz (DMSO-<i>d</i><sub>6</sub>): Î´ 180.92, 180.54, 162.35, 155.21, 153.86, 147.78, 143.71, 131.55, 124.33, 123.77, 117.20, 115.11, 54.40, 47.94, 45.42, 13.22. MS: <i>m</i>/<i>z</i> 364 [M + H]<sup>+</sup>.</div></div><div id="sec5_2_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> 4-Methyl-2,5-dimethoxyaniline [<b>11</b>]</h4><div class="NLM_p last">To a stirred suspension of 2,5-dimethoxy-4-methylnitrobenzene (<b>6</b>, 1 g, 5.07 mmol) and 10% Pd/C (0.4 g) in dry methanol (20 mL), ammonium formate (4.5 equiv., 1.5 g, 23.79 mmol) was added in a single portion. The resulting mixture was stirred at room temperature for 40 min, and the catalyst was removed by filtration through a celite pad and washed with dry methanol. The filtrate was evaporated either under reduced or at normal pressure. The resulting residue was extracted with dichloromethane/water. Yield: 70%. <i>R</i>f = 0.20 (ethyl acetate/petroleum ether 3:7). mp: 255 Â°C. <sup>1</sup>H-NMR 400 MHz (DMSO-<i>d</i><sub>6</sub>): Î´ 6.61 (s, 1H), 6.35 (s, 1H), 3.79 (s, 3H), 3.74 (s, 3H), 2.13 (s, 3H).</div></div><div id="sec5_2_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> Ethyl (2,5-Dimethoxy-4-methylphenyl)carbamate [<b>12</b>]</h4><div class="NLM_p last">To a solution of 4-methyl-2,5-dimethoxyaniline (<b>11</b>, 0.5 g, 2.99 mmol) in tetrahydrofuran (30 mL), ethyl chloroformate (0.65 g, 0.57 mL, 2 equiv., 6 mmol) was added. Further trimethylamine (1 mL, 2 equiv., 6 mmol) was added into the reaction mixture and stirred at room temperature for 1 h. The reaction mixture was concentrated and extracted in ethyl acetate/water to obtain the product. Yield: 60%. <i>R</i>f = 0.10 (ethyl acetate/petroleum ether 3:7). mp: 106 Â°C. <sup>1</sup>H-NMR 400 MHz (CDCl<sub>3</sub>): Î´ 7.76 (s, 1H), 7.15 (s, 1H), 6.66 (s, 1H), 4.20 (q, 2H), 3.81 (s, 3H), 3.80 (s, 3H), 2.17 (s, 3H), 1.32 (t, 3H).</div></div><div id="sec5_2_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> Ethyl-5,8-dimethoxy-6-methylquinazoline-1-(2<i>H</i>)-carboxylate [<b>13</b>]</h4><div class="NLM_p last">A mixture of N-protected 4-methyl-2,5-dimethoxyaniline (<b>12</b>, 0.2 g, 0.84 mmol) and hexamethylenetetramine (HMTA, 9 equiv., 0.84 g, 7.2 mmol) in trifluoroacetic acid (TFA, 4 mL) was refluxed for 1 h. After cooling, the mixture was diluted with cold water, neutralized with NaHCO<sub>3</sub>, and extracted with ethyl acetate. The organic phase was evaporated, and the residue was treated with cyclohexane. The undissolved solid was filtered off, and the solution was evaporated under reduced pressure to give the product. Yield: 50%. <i>R</i>f = 0.45 (ethyl acetate/petroleum ether 3:7). mp: >320 Â°C. <sup>1</sup>H-NMR 400 MHz (CDCl<sub>3</sub>): 8.58 (s, 1H), 6.83 (d, 2H), 6.56 (s, 1H), 4.14 (q, 2H), 3.94 (s, 3H), 3.84 (s, 3H), 2.30 (s, 3H), 1.28 (t, 3H).</div></div><div id="sec5_2_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> 5,8-Dimethoxy-6-methylquinazoline [<b>14</b>]</h4><div class="NLM_p last">To a solution of 10% KOH in water/EtOH in a 1:1 ratio (25 mL), quinazoline carboxylate (<b>13</b>, 0.55 g, 1.97 mmol) was added and refluxed for 1 h. After cooling, potassium ferricyanide (45 equiv., 3.24 g, 89.12 mmol) was added, and the mixture was refluxed for 4 h. After cooling, the mixture was diluted with water and extracted with dichloromethane, and the organic phase was evaporated under reduced pressure. The residue was dissolved in a minimum amount of methanol and diluted with water to obtain the pure product. Yield: 35%. <i>R</i>f = 0.30 (ethyl acetate/petroleum ether 3:7). mp: >320 Â°C. <sup>1</sup>H-NMR 400 MHz (CDCl<sub>3</sub>): Î´ 9.59 (s, 1H), 9.31 (s, 1H), 7.04 (s, 1H), 4.06 (s, 3H), 3.92 (s, 3H), 2.49 (s, 3H).</div></div><div id="sec5_2_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> 6-Methyl Quinazoline-5,8-dione [<b>15</b>]</h4><div class="NLM_p last">A solution of 5,8-dimethoxy-6-methylquinazoline (0.15 g, 0.75 mmol) in (7:3) acetonitrile/water (5 mL) was cooled at 0 Â°C in an ice bath, and a solution of ceric ammonium nitrate (3 equiv., 1.2 g, 2.1 mmol) in (9:1) acetonitrile/water (5 mL) was added dropwise. The reaction mixture was stirred for 20 min, then poured into ice/water, and extracted (8â10 times) with dichloromethane. The organic layer was washed (5â6 times) with water, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and concentrated to dryness to give a brown powder. Yield: 90%. <i>R</i>f = 0.52 (ethyl acetate/petroleum ether 3:7). mp: > 320 Â°C. <sup>1</sup>H-NMR 400 MHz (CDCl<sub>3</sub>): Î´ 9.67 (s, 1H), 9.54 (s, 1H), 7.10 (s, 1H), 2.27 (s, 3H). MS: <i>m</i>/<i>z</i> 175 [M + H]<sup>+</sup>.</div></div><div id="sec5_2_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> Alternative Procedure for the Preparation of 6-(4-(4-Methylpiperazin-1-yl)phenylamino)quinazoline-5,8-dione [QD394]</h4><div class="NLM_p last">A solution of 6-methylquinazoline-5, 8-dione (<b>15</b>, 0.050 g, 0.312 mmol), cerium(III) chloride heptahydrate (CeCl<sub>3</sub>Â·7H<sub>2</sub>O, 1.1 equiv., 0.128 g, 0.343 mmol), and 4-(4-methylpiperazin-1-yl)aniline (1.0 equiv., 0.060 g, 0.312 mmol) in absolute ethanol (6 mL) was stirred at room temperature for 1â2 h. Next, most of the ethanol was removed under vacuum, and water was added followed by extraction with dichloromethane. The organic layers were washed with water and brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and concentrated to dryness. Then, the crude product was purified by flash chromatography (dichloromethane/methanol = 8:2) to give the expected product. Yield: 30%. <i>R</i>f = 0.30 (dichloromethane/methanol 9.5:0.5). mp: >320 Â°C. See the previous preparation of QD394 for full characterization.</div></div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> HPLC Analyses</h3><div class="NLM_p last">Analytical HPLC was carried out on an Agilent 1260 Infinity II Quaternary pump HPLC apparatus with a Poroshell 120 EC-C18 reversed column (4.6 Ã 100 mM, 4 Î¼m) at a flow rate of 0.5 mL/min (injection volume 20 Î¼L) and detected at 254 nm. The mobile phases were mixtures of A = acetonitrile + 0.1% trifluoroacetic acid and B = H<sub>2</sub>O + 0.1% trifluoroacetic acid and are indicated as the ratio A/B. QD 394, HPLC (A/B = 60:40), <i>R</i>t 1.72 min (100%). QD 394-Me, HPLC (A/B = 60:40), <i>R</i>t 1.76 min (99.98%).</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> Chemicals</h3><div class="NLM_p last">Stock solutions of QD compounds and napabucasin were made in dimethyl sulfoxide (DMSO) at 10 mM and were stored at â20 Â°C. Napabucasin was purchased from Medchem Express. <i>N</i>-Acetylcysteine (Sigma) and deferoxamine mesylate salt (Sigma) were dissolved in ultrapure water (Gibco). Z-VAD (MedChemExpress), necrostatin-1 (Selleckchem), RSL3 (Cayman Chemical), deferasirox (Cayman Chemical), liproxstatin-1 (Cayman Chemical), ferrostatin-1 (Cayman Chemical), chloroquine phosphate (LKT LABS), olaparib (MedChemExpress), 3-methyladenine (Cayman Chemical), and <i>N</i>-phenylmaleimide (Oakwood Chemical) were dissolved in DMSO to provide 10 mM stock solution.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> Cell Lines and Cell Culture</h3><div class="NLM_p last">Pancreatic cancer cell lines (MIA PaCa-2, PANC-1, and BxPC-3) were purchased from ATCC. All cell lines were maintained in RPMI 1640 (Gibco) containing 10% FBS (Gibco) at 37 Â°C in a humidified atmosphere of 5% CO<sub>2</sub>. All cell lines were in culture under 35 passages and determined to be free of mycoplasma contamination using the Plasmo Test (InvivoGen, San Diego, CA).</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> MTT Assay</h3><div class="NLM_p last">Cytotoxicity was determined by a 3-(4,5-dimethylthiazol-2-yl)-2,5- diphenyltetrazolium bromide (MTT) assay. Cells were seeded in 96-well tissue culture plates and allowed to attach overnight. Subsequently, cells were treated with compounds or DMSO for 72 h. MTT solution (0.3 mg/mL) was added to each well for 3 h in an incubator. After removal of the media, DMSO was added, and the plates were shaken for 15 min before measuring the absorbance at a wavelength of 570 nm using a microplate reader (Molecular Devices). IC<sub>50</sub> values were calculated using GraphPad Prism.</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> Colony Formation Assay</h3><div class="NLM_p last">Cells were seeded in 96-well tissue culture plates at 300 cells (MIA PaCa-2) or 600 cells (PANC-1 and BxPC-3) per well. After overnight attachment, cells were treated with compounds continuously. Cell death inhibitors or signaling pathway inhibitors were added 1 h prior to compound treatment. Plates were incubated for 7â9 days until cells in the control wells became 80â90% confluent. Media were removed, and cells were stained with 0.05% crystal violet solution for 30 min. Cells were then washed with ddH<sub>2</sub>O to remove excess stain, and the plates were imaged using Odyssey Imaging Systems (LI-COR Biosciences) after overnight drying. Quantification was performed using Image Studio, and synergism was calculated using the HSA and Bliss models in the Combenefit software.</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> ROS Measurement</h3><div class="NLM_p last">Cells were seeded in 96-well flat clear-bottom black tissue-culture plates (Corning #3603) at a density of 1.8 Ã 10<sup>4</sup> cells per well. After overnight attachment, cells were stained with the CM-H2DCFDA dye (10 Î¼M, Thermo Fisher, C6827) in HBSS for 40 min at 37 Â°C. Cells were washed with prewarmed DPBS (Gibco) twice, and 80 Î¼L of HBSS was added. Compounds were added in HBSS at designated concentrations. Fluorescence signal was measured using a CLARIO Star plate reader (Ex: 483â15 nm; Em: 530â20 nm; BMG LABTECH).</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> GSH/GSSG-Glo Assay</h3><div class="NLM_p last">A GSH/GSSG-Glo assay kit (Promega) was used to determine the GSH/GSSG ratio in cells with drugs or DMSO. 15000â20000 cells per well were seeded into solid opaque 96-well tissue culture plates (Falcon). After overnight attachment and compound treatment, the medium was removed, and cells were lysed with 50 Î¼L of Total or Oxidized Glutathione Reagent per well. The plate was shaken for 5 min, and 50 Î¼L of fresh Luciferin Generation Reagent was added to each well. After 30 min of incubation at room temperature, 100 Î¼L of Luciferin Detection Reagent was added. Luminescence was detected using a CLARIOstar plate reader (BMG LABTECH) after 15 min of equilibration. The GSH/GSSG ratio was calculated with net RLU, using the formula (net vehicle total glutathione RLU â net vehicle GSSG RLU)/(net vehicle GSSG RLU/2).</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> Bru-seq Experiments and Analysis</h3><div class="NLM_p last">Nascent RNA Bru-seq experiments were performed as previously reported.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Briefly, 2 Ã 10<sup>6</sup> cells were seeded in 10 cm dishes in duplicate. After overnight attachment, cells were treated with the compounds (3 Ã IC<sub>50</sub>) for 4 h. Bromouridine was added to the cell culture at a final concentration of 2 mM and incubated at 37 Â°C for the last 30 min of the drug treatments. Cells were then collected and lysed in TRIzol, and total RNA was isolated. The bromouridine-containing RNAs were captured using anti-BrdU antibodies conjugated to magnetic beads and converted to cDNA libraries (Illumina TrueSeq), which were sent for deep sequencing at the University of Michigan Sequencing Core. Sequencing reads were mapped to the hg38 reference genome, and DESeq2 was used to determine differentially expressed genes. The shrunkenLFC (shrunken log2FoldChange) was calculated from DESeq2. We used shrunkenLFC for the heatmap and GSEA analysis. Downstream signaling pathways were identified using GSEA. Heatmaps and statistics were generated using the R programming language.</div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> Immunoblot</h3><div class="NLM_p last">Cells were seeded in 6-well tissue culture plates at 3.5 Ã 10<sup>5</sup> cells per well. After compound treatments, cells were washed with DPBS (Gibco) and lysed with RIPA buffer containing 1Ã protease inhibitor (Sigma) and 1Ã phosphatase inhibitor (Sigma). Cell lysates were sonicated before centrifugation at 14000 rpm for 10 min at 4 Â°C, and the supernatant was collected for the BCA protein assay (Thermo Scientific). 25 Î¼g of proteins from each sample was resolved on 10% SDS polyacrylamide gels and electrotransferred to PVDF membranes (Trans-Blot Turbo RTA Mini PVDF Transfer Kit, Bio-Rad). After blocking with 5% milk in 1Ã TBS for 1 h at room temperature, membranes were probed with primary antibodies (1:500â1:1000) in 5% milk in 1Ã TBST or 5% BSA in 1Ã TBST overnight at 4 Â°C. The membranes were then washed with TBST three times and probed with an anti-rabbit or anti-mouse secondary antibody (Dylight 800 4Ã PEG conjugated; Thermo Scientific; 1:6000) for 1 h at room temperature. Membranes were imaged with Odyssey Imaging Systems (LI-COR Biosciences). Protein expression was quantified with ImageJ and normalized to loading controls.</div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> Lipid ROS Measurement</h3><div class="NLM_p last">MIA PaCa-2 cells were treated with compounds for the designated time before 10 Î¼M C11-BODIPY (Thermo Fisher) was added, and cells were incubated for 30 min at 37 Â°C. Cells were washed with DPBS (Gibco) twice, and 100 Î¼L of HBSS was added before measurement using a CLARIOstar plate reader (BMG LABTECH). Plates were read with two filter sets: one at an excitation/emission of 581/591 nm (Texas Red) for the reduced dye and the other at an excitation/emission of 488/510 nm (FITC) for the oxidized dye. The ratio of the emission fluorescence intensities using the Texas Red and FITC filters was calculated in Microsoft Excel, and the <i>p</i> value was determined using unpaired Studentâs <i>t</i> test.</div></div><div id="sec5_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> Cellular Thermal Shift Assay (CETSA)</h3><div class="NLM_p last">Cells were seeded at 3 Ã 10<sup>6</sup> cells per 10 cm cell culture dish. After overnight attachment, 100 Î¼M QD394, QD394-Me, or DMSO was added to the cells for 1 h. Cells were then trypsinized, washed with DPBS, and suspended in 650 Î¼L of DPBS. The suspensions were split into 100 Î¼L aliquots, heated at indicated temperatures for 3 min in a Veriti Thermal Cycler (Applied Biosystems), and incubated for 3 min at room temperature. Each aliquot was flash-frozen three times and spun at 12000 rpm for 20 min at 4 Â°C. Supernatants were collected, and 25 Î¼L of each sample was loaded onto a 10% SDS polyacrylamide gel for immunoblot analysis using the protocol detailed above.</div></div><div id="sec5_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> siRNA Knockdown of GPX4</h3><div class="NLM_p last">GPX4 siRNA (s6110) and negative control siRNA (4390843) were purchased from Thermo Fisher. According to the manufacturerâs instructions, 3.5 Ã 10<sup>5</sup> cells were seeded in 6-well tissue culture plates for overnight attachment. The siRNA transfection reagent complex was formed by combining 30 pmol of siRNA in 150 Î¼L of Opti-MEM medium (Thermo Fisher) with 9 Î¼L of Lipofectamine RNAiMAX Reagent (Thermo Fisher) in 150 Î¼L of Opti-MEM medium. After 15 min of incubation, this complex was added to each well with fresh medium for 48 h. One half of these cells were harvested for immunoblot, and the other half were seeded for the 24 h MTT assay to determine the cytotoxicities of QD394, QD394-Me, and napabucasin.</div></div><div id="sec5_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> Proteomics Study</h3><div class="NLM_p last">MIA PaCa-2 cells were treated with 1.2 Î¼M QD394 or DMSO control for 24 h before collecting the cell lysates in RIPA buffer. 75 Î¼g of proteins of each sample was processed at the Proteomics Core at the University of Michigan in duplicate. A TMT10plex Mass Tag Labeling Kit (ThermoFisher) was used to quantify the proteins in each sample, and the Abundance Ratio and log2 Abundance Ratio were calculated as treatment over control. STRING analysis was performed using proteins with adjusted <i>p</i> values <0.05.</div></div><div id="sec5_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> Survival Analysis of LRPPRC and PNPT1</h3><div class="NLM_p last">Patient sample RNASeq RSEM normalized gene expression values and related survival metadata were sourced from the TCGA GDAC Firehose.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> When multiple samples were available for a given patient, barcodes were sorted alphabetically and the first was selected for analysis. TCGA disease patient samples were evaluated for reduced survivability by comparing survival outcomes for patients with high and low expression of LRPPRC and PNPT1. Thresholding for high- and low-expression patient populations was evaluated using five different quantile cutoffs: 95, 90, 75, 50, and 25%. A log-rank test statistic was calculated for each cutoff to compare the survival distributions of high- and low-expression patient populations with the null hypothesis that there was no difference in survival curves. Survival analysis was performed using the R statistical programming language.</div></div><div id="sec5_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> Microsomal Stability Test</h3><div class="NLM_p last">10 mM stock solutions of QD394, QD394-Me, and verapamil (positive control) were prepared in DMSO. Solutions were diluted to 1 mM with acetonitrile and further diluted to 10 Î¼M with 0.1 M phosphate buffer (3.3 mM MgCl<sub>2</sub>). NADPH (1 mg) was dissolved in 60 Î¼L of 0.1 M phosphate buffer (3.3 mM MgCl<sub>2</sub>). 330 Î¼L of 0.1 M phosphate buffer (3.3 mM MgCl<sub>2</sub>) and 40 Î¼L of 10 Î¼M test compounds were added to 10 Î¼L of microsomes (20 mg/mL). Data points were collected at 0, 5, 10, 15, 30, 45, and 60 min. Solutions were centrifuged at 3500<i>g</i> for 10 min to pellet precipitated proteins. The supernatant was used for LCâMS/MS analysis. Natural log peak area ratios (compound peak area/internal standard peak area) were plotted against time, and the gradient of the line was determined to calculate the half-life (<i>t</i><sub>1/2</sub>) of the test compound in microsomes.</div></div><div id="sec5_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> Plasma Stability Test</h3><div class="NLM_p last">Pooled mouse plasma was stored at â80 Â°C prior to use. Compounds were dissolved in DMSO to obtain a concentration of 500 Î¼M. 1 Î¼L of compound was added to 500 Î¼L of plasma. Samples were collected at time points of 0, 0.17, 0.5, 1, 2, and 4 h. The solution was centrifuged at 3500<i>g</i> for 10 min to pellet precipitated proteins. The supernatant was used for LCâMS/MS analysis. Natural log peak area ratios (compound peak area/internal standard peak area) were plotted against time, and the gradient of the line was determined to calculate the half-life (<i>t</i><sub>1/2</sub>) of the test compound in plasma.</div></div><div id="sec5_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> PK Study</h3><div class="NLM_p last">QD394 and QD394-Me were administered by IP injection (10 mg/kg), oral PO (20 mg/kg), or IV injection (10 mg/kg) into CD-1 mice. At the given time points (0.5, 2, 4, and 7 h), blood samples were collected using heparinized calibrated pipettes. Samples were centrifuged at 15000 rpm for 10 min. Subsequently, blood plasma was collected from the upper layer. The plasma was frozen at â80 Â°C for LCâMS/MS analysis.</div></div><div id="sec5_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> Metabolite Identification</h3><div class="NLM_p last">QD394 and QD394-Me were incubated with mouse plasma under the same conditions as the plasma stability test. Samples were collected at 0.5 h to determine potential metabolites of QD394 or QD394-Me using LCâMS/MS analysis. Indicated metabolites were also measured in vivo after 1 h of QD394-Me treatment.</div></div><div id="sec5_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> Tissue Distribution Analysis</h3><div class="NLM_p last">Mice were dosed with QD394 at 20 mg/kg PO and QD394-Me at 10 mg/kg IV. After 1 h, indicated organs were collected for later analysis. Dissociation solvent was added at fivefold the tissue weight into each homogenization tube with beads for tissue homogenization, and 30 Î¼L of homogenate was isolated for sample preparation. For calibration curve samples, 30 Î¼L of blank homogenate was mixed with 30 Î¼L of standard solution and 140 Î¼L of internal standard solution; for dosed samples, 30 Î¼L of homogenate was mixed with 30 Î¼L of blank acetonitrile and 140 Î¼L of internal standard solution. Samples were vortexed and centrifuged at 3500<i>g</i> for 10 min, and the supernatant was isolated for LCâMS analysis.</div></div><div id="sec5_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> Mice Study</h3><div class="NLM_p last">All animal studies were approved by the animal care facility at the University of Michigan-Ann Arbor (Protocol number: PRO00009185) and were handled in accordance with the Institutional Animal Use and Care Committee. Female Balb/c mice were purchased from Envigo. At the time of implantation, all mice were aged 5â6 weeks. Mice were implanted subcutaneously in the right flank with 1 Ã 10<sup>6</sup> CT-26 cells in 100 Î¼L of DPBS. Seven days after implantation, mice were randomized into groups (<i>n</i> = 5) with mean tumor volumes ranging from 97 to 117 mm<sup>3</sup>. The negative control group was dosed daily in the intraperitoneal cavity (IP) with the same vehicle used for QD394. QD394 was dosed at 10 mg/kg IP, and QD394-Me was dosed three times weekly intravenously (IV) at 20 mg/kg. After 17 days of dosing, 4 h post-dose, negative control and treated groups were euthanized by CO<sub>2</sub> asphyxiation followed by cervical dislocation. The end of the study was chosen as the first day that any mouse reached humane euthanasia criteria determined by the animal use protocol.</div></div><div id="sec5_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> Statistical Analysis</h3><div class="NLM_p last">For the Bru-seq analysis, the Pearson correlation and <i>p</i> value were calculated using function cor.test() in R (version 3.3.2). Significance levels for assays and immunoblots were calculated using unpaired Studentâs <i>t</i> test in Microsoft Excel. Results are shown as mean Â± standard deviation from at least three independent experiments.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i71"><a href="/doi/suppl/10.1021/acs.jmedchem.0c01016" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72635" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72635" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.0c01016?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01016</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">ROS assay of QD394 analogs; colony formation assay of QD394 analogs; GSH levels in pancreatic cancer cells treated with QD394, napabucasin, and BSO; colony formation assay of combination studies; CETSA in PANC-1 cells; combination of NAC, dicoumarol with QD394, QD394-Me, napabucasin, and H<sub>2</sub>O<sub>2</sub> in probing LRPPRC and PNPT1 in pancreatic cancer cells; combination of QD394 and napabucasin in PANC-1 cells; plasma concentrations of QD394 and QD394-Me in CD-1 mice; major metabolite of QD394-Me in mouse plasma and its abundance profiles in mice; in vivo study with female Balb/c mice implanted subcutaneously with CT-26 cells; HPLC analyses for QD394 and QD394-Me; elemental analyses for QD394 analogs; molecular formula strings for all QD394 analogs; top 25 upregulated and downregulated enriched C2 gene sets in QD394-treated MIA PaCa-2 cells; STRING analysis of 17 upregulated genes/proteins in common between Bru-seq and proteomics; STRING analysis of 35 downregulated genes/proteins in common between Bru-seq and proteomics; tissue distribution of QD394-Me in mouse; cytotoxicities of QD394, QD394-Me, and napabucasin in GPX4-knockdown PANC-1 and BxPC-3 cells; top upregulated and downregulated enriched hallmark gene sets in QD394-Me-treated MIA PaCa-2 cells; top upregulated enriched KEGG gene sets in QD394-Me-treated MIA PaCa-2 cells (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01016/suppl_file/jm0c01016_si_001.pdf" class="ext-link">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01016/suppl_file/jm0c01016_si_001.pdf">jm0c01016_si_001.pdf (1.39 MB)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.0c01016" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74650" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74650" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mario Sechi</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry and Pharmacy, University of
Sassari, Via Vienna 2, 07100 Sassari, Italy</span>;Â 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-2983-6090" title="Orcid link">http://orcid.org/0000-0003-2983-6090</a>;Â 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#0865697a6167267b6d6b6061487d66617b7b26617c"><span class="__cf_email__" data-cfemail="4b262a39222465382e2823220b3e2522383865223f">[emailÂ protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nouri Neamati</span> - <span class="hlFld-Affiliation affiliation">Departments
of Medicinal Chemistry, College of Pharmacy, Rogel Cancer center, University of Michigan, Ann Arbor, Michigan 48109, United States</span>;Â 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#92fcf7f3fff3e6fbd2e7fffbf1fabcf7f6e7"><span class="__cf_email__" data-cfemail="d6b8b3b7bbb7a2bf96a3bbbfb5bef8b3b2a3">[emailÂ protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shuai Hu</span> - <span class="hlFld-Affiliation affiliation">Departments
of Medicinal Chemistry, College of Pharmacy, Rogel Cancer center, University of Michigan, Ann Arbor, Michigan 48109, United States</span>;Â 
    <span class="hlFld-Affiliation affiliation">Department
of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, Michigan 48109, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pankaj Kumar Singh</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry and Pharmacy, University of
Sassari, Via Vienna 2, 07100 Sassari, Italy</span>;Â 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4774-6358" title="Orcid link">http://orcid.org/0000-0002-4774-6358</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lipeng Dai</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmaceutical Sciences, College of Pharmacy, University of Michigan, Ann Arbor, Michigan 48109, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sean McCann</span> - <span class="hlFld-Affiliation affiliation">Departments
of Medicinal Chemistry, College of Pharmacy, Rogel Cancer center, University of Michigan, Ann Arbor, Michigan 48109, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Duxin Sun</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmaceutical Sciences, College of Pharmacy, University of Michigan, Ann Arbor, Michigan 48109, United States</span>;Â 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-6406-2126" title="Orcid link">http://orcid.org/0000-0002-6406-2126</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mats Ljungman</span> - <span class="hlFld-Affiliation affiliation">Department
of Radiation Oncology, Rogel Cancer Center and Center for RNA Biomedicine, University of Michigan, Ann Arbor, Michigan 48109, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i72">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_03302" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_03302" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by NIH grant R01 CA188252 and a grant from the University of Michigan Forbes Institute for Cancer Discovery. We thank the Fondazione di Sardegna for its partial support. We thank our colleagues Christine Cuthbertson, Andrea Shergalis, and Maha Hanafi for helpful suggestions on the manuscript and Zahra Arabzada for technical assistance. We thank Armand Bankhead III for assistance in the survival analysis. We also thank Federico Ladu for his help and assistance and Vanna Sanna (Nanomater s.r.l.) for the HPLC analyses. We gratefully acknowledge the University of Michigan DNA Sequencing Core and Proteomics Core facilities for their excellent technical assistance.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">ROS</td><td class="NLM_def"><p class="first last">reactive oxygen species</p></td></tr><tr><td class="NLM_term">STAT3</td><td class="NLM_def"><p class="first last">signal transducer and activator of transcription 3</p></td></tr><tr><td class="NLM_term">GSH</td><td class="NLM_def"><p class="first last">glutathione</p></td></tr><tr><td class="NLM_term">GSSG</td><td class="NLM_def"><p class="first last">glutathione disulfide</p></td></tr><tr><td class="NLM_term">GPX4</td><td class="NLM_def"><p class="first last">glutathione peroxidase 4</p></td></tr><tr><td class="NLM_term">5-FU</td><td class="NLM_def"><p class="first last">5-fluorouracil</p></td></tr><tr><td class="NLM_term">NQO1</td><td class="NLM_def"><p class="first last">NAD(P)H quinone dehydrogenase 1</p></td></tr><tr><td class="NLM_term">QD</td><td class="NLM_def"><p class="first last">quinazolinedione</p></td></tr><tr><td class="NLM_term">napa</td><td class="NLM_def"><p class="first last">napabucasin</p></td></tr><tr><td class="NLM_term">HMTA</td><td class="NLM_def"><p class="first last">hexamethylenetetramine</p></td></tr><tr><td class="NLM_term">Bru-seq</td><td class="NLM_def"><p class="first last">bromouridine sequencing</p></td></tr><tr><td class="NLM_term">GSEA</td><td class="NLM_def"><p class="first last">gene set enrichment analysis</p></td></tr><tr><td class="NLM_term">MSigDB</td><td class="NLM_def"><p class="first last">molecular signatures database</p></td></tr><tr><td class="NLM_term">FDR</td><td class="NLM_def"><p class="first last">false discovery rate</p></td></tr><tr><td class="NLM_term">KEGG</td><td class="NLM_def"><p class="first last">Kyoto Encyclopedia of Genes and Genomes</p></td></tr><tr><td class="NLM_term">TF</td><td class="NLM_def"><p class="first last">transcription factor</p></td></tr><tr><td class="NLM_term">NAC</td><td class="NLM_def"><p class="first last"><i>N</i>-acetylcysteine</p></td></tr><tr><td class="NLM_term">BSO</td><td class="NLM_def"><p class="first last">buthionine sulfoximine</p></td></tr><tr><td class="NLM_term">DFO</td><td class="NLM_def"><p class="first last">deferoxamine</p></td></tr><tr><td class="NLM_term">CETSA</td><td class="NLM_def"><p class="first last">cellular thermal shift assay</p></td></tr><tr><td class="NLM_term">ER</td><td class="NLM_def"><p class="first last">endoplasmic reticulum</p></td></tr><tr><td class="NLM_term">LRPPRC</td><td class="NLM_def"><p class="first last">leucine rich pentatricopeptide repeat containing</p></td></tr><tr><td class="NLM_term">PNPT1</td><td class="NLM_def"><p class="first last">polyribonucleotide nucleotidyltransferase 1</p></td></tr><tr><td class="NLM_term">TCGA</td><td class="NLM_def"><p class="first last">The Cancer Genome Atlas</p></td></tr><tr><td class="NLM_term">PAAD</td><td class="NLM_def"><p class="first last">pancreatic adenocarcinoma</p></td></tr><tr><td class="NLM_term">As<sub>2</sub>O<sub>3</sub></td><td class="NLM_def"><p class="first last">arsenic trioxide</p></td></tr><tr><td class="NLM_term">PARP</td><td class="NLM_def"><p class="first last">poly(ADP-ribose) polymerase</p></td></tr><tr><td class="NLM_term">HIF-1A</td><td class="NLM_def"><p class="first last">hypoxia-inducible factor-1Î±</p></td></tr><tr><td class="NLM_term">H<sub>2</sub>O<sub>2</sub></td><td class="NLM_def"><p class="first last">hydrogen peroxide</p></td></tr><tr><td class="NLM_term">FBS</td><td class="NLM_def"><p class="first last">fetal bovine serum</p></td></tr><tr><td class="NLM_term">MTT</td><td class="NLM_def"><p class="first last">3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide</p></td></tr><tr><td class="NLM_term">DPBS</td><td class="NLM_def"><p class="first last">Dulbeccoâs phosphate buffered saline</p></td></tr><tr><td class="NLM_term">HBSS</td><td class="NLM_def"><p class="first last">Hanksâ balanced salt solution</p></td></tr><tr><td class="NLM_term">RLU</td><td class="NLM_def"><p class="first last">relative luminescence units</p></td></tr><tr><td class="NLM_term">RFU</td><td class="NLM_def"><p class="first last">relative fluorescence units</p></td></tr><tr><td class="NLM_term">shrunkenLFC</td><td class="NLM_def"><p class="first last">shrunken log2FoldChange</p></td></tr><tr><td class="NLM_term">LCâMS</td><td class="NLM_def"><p class="first last">liquid chromatographyâmass spectrometry</p></td></tr><tr><td class="NLM_term">HPLC</td><td class="NLM_def"><p class="first last">high-performance liquid chromatography</p></td></tr><tr><td class="NLM_term">HSA</td><td class="NLM_def"><p class="first last">highest single agent</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i74">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51312" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51312" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 47 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jemal, A.</span></span> <span> </span><span class="NLM_article-title">Cancer statistics, 2020</span>. <i>Ca-Cancer J. Clin.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">7</span>â <span class="NLM_lpage">30</span>, <span class="refDoi">Â DOI: 10.3322/caac.21590</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=10.3322%2Fcaac.21590" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=31912902" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=1%3ACAS%3A280%3ADC%252BB3Mbns1emug%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2020&pages=7-30&author=R.+L.+Siegelauthor=K.+D.+Millerauthor=A.+Jemal&title=Cancer+statistics%2C+2020&doi=10.3322%2Fcaac.21590"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer statistics, 2020</span></div><div class="casAuthors">Siegel Rebecca L; Miller Kimberly D; Jemal Ahmedin</div><div class="citationInfo"><span class="NLM_cas:title">CA: a cancer journal for clinicians</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">7-30</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths that will occur in the United States and compiles the most recent data on population-based cancer occurrence.  Incidence data (through 2016) were collected by the Surveillance, Epidemiology, and End Results Program; the National Program of Cancer Registries; and the North American Association of Central Cancer Registries.  Mortality data (through 2017) were collected by the National Center for Health Statistics.  In 2020, 1,806,590 new cancer cases and 606,520 cancer deaths are projected to occur in the United States.  The cancer death rate rose until 1991, then fell continuously through 2017, resulting in an overall decline of 29% that translates into an estimated 2.9 million fewer cancer deaths than would have occurred if peak rates had persisted.  This progress is driven by long-term declines in death rates for the 4 leading cancers (lung, colorectal, breast, prostate); however, over the past decade (2008-2017), reductions slowed for female breast and colorectal cancers, and halted for prostate cancer.  In contrast, declines accelerated for lung cancer, from 3% annually during 2008 through 2013 to 5% during 2013 through 2017 in men and from 2% to almost 4% in women, spurring the largest ever single-year drop in overall cancer mortality of 2.2% from 2016 to 2017.  Yet lung cancer still caused more deaths in 2017 than breast, prostate, colorectal, and brain cancers combined.  Recent mortality declines were also dramatic for melanoma of the skin in the wake of US Food and Drug Administration approval of new therapies for metastatic disease, escalating to 7% annually during 2013 through 2017 from 1% during 2006 through 2010 in men and women aged 50 to 64 years and from 2% to 3% in those aged 20 to 49 years; annual declines of 5% to 6% in individuals aged 65 years and older are particularly striking because rates in this age group were increasing prior to 2013.  It is also notable that long-term rapid increases in liver cancer mortality have attenuated in women and stabilized in men.  In summary, slowing momentum for some cancers amenable to early detection is juxtaposed with notable gains for other common cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQjOzlnUMKF5EwlCcfExbvbfW6udTcc2ebJDbuRohPAQ7ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3Mbns1emug%253D%253D&md5=a54b884bbc3c3f592921026db34b29db</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.3322%2Fcaac.21590&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3322%252Fcaac.21590%26sid%3Dliteratum%253Aachs%26aulast%3DSiegel%26aufirst%3DR.%2BL.%26aulast%3DMiller%26aufirst%3DK.%2BD.%26aulast%3DJemal%26aufirst%3DA.%26atitle%3DCancer%2520statistics%252C%25202020%26jtitle%3DCa-Cancer%2520J.%2520Clin.%26date%3D2020%26volume%3D70%26spage%3D7%26epage%3D30%26doi%3D10.3322%2Fcaac.21590" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kamisawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itoi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takaori, K.</span></span> <span> </span><span class="NLM_article-title">Pancreatic cancer</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>388</i></span>,  <span class="NLM_fpage">73</span>â <span class="NLM_lpage">85</span>, <span class="refDoi">Â DOI: 10.1016/S0140-6736(16)00141-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=10.1016%2FS0140-6736%2816%2900141-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=26830752" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhsl2mtb8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=388&publication_year=2016&pages=73-85&author=T.+Kamisawaauthor=L.+D.+Woodauthor=T.+Itoiauthor=K.+Takaori&title=Pancreatic+cancer&doi=10.1016%2FS0140-6736%2816%2900141-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Pancreatic cancer</span></div><div class="casAuthors">Kamisawa, Terumi; Wood, Laura D.; Itoi, Takao; Takaori, Kyoichi</div><div class="citationInfo"><span class="NLM_cas:title">Lancet</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">388</span>
        (<span class="NLM_cas:issue">10039</span>),
    <span class="NLM_cas:pages">73-85</span>CODEN:
                <span class="NLM_cas:coden">LANCAO</span>;
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Pancreatic cancer is a highly lethal disease, for which mortality closely parallels incidence.  Most patients with pancreatic cancer remain asymptomatic until the disease reaches an advanced stage.  There is no std. program for screening patients at high risk of pancreatic cancer (eg, those with a family history of pancreatic cancer and chronic pancreatitis).  Most pancreatic cancers arise from microscopic non-invasive epithelial proliferations within the pancreatic ducts, referred to as pancreatic intraepithelial neoplasias.  There are four major driver genes for pancreatic cancer: KRAS, CDKN2A, TP53, and SMAD4.  KRAS mutation and alterations in CDKN2A are early events in pancreatic tumorigenesis.  Endoscopic ultrasonog. and endoscopic ultrasonog.-guided fine-needle aspiration offer high diagnostic ability for pancreatic cancer.  Surgical resection is regarded as the only potentially curative treatment, and adjuvant chemotherapy with gemcitabine or S-1, an oral fluoropyrimidine deriv., is given after surgery.  FOLFIRINOX (fluorouracil, folinic acid [leucovorin], irinotecan, and oxaliplatin) and gemcitabine plus nanoparticle albumin-bound paclitaxel (nab-paclitaxel) are the treatments of choice for patients who are not surgical candidates but have good performance status.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowv4Kc18l117Vg90H21EOLACvtfcHk0ljbBLKLXcHMZw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhsl2mtb8%253D&md5=008fad5f1be8c3c6f3534c5bc3c3ea3a</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2816%2900141-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252816%252900141-0%26sid%3Dliteratum%253Aachs%26aulast%3DKamisawa%26aufirst%3DT.%26aulast%3DWood%26aufirst%3DL.%2BD.%26aulast%3DItoi%26aufirst%3DT.%26aulast%3DTakaori%26aufirst%3DK.%26atitle%3DPancreatic%2520cancer%26jtitle%3DLancet%26date%3D2016%26volume%3D388%26spage%3D73%26epage%3D85%26doi%3D10.1016%2FS0140-6736%2816%2900141-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rahib, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aizenberg, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenzweig, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fleshman, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matrisian, L. M.</span></span> <span> </span><span class="NLM_article-title">Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>74</i></span>,  <span class="NLM_fpage">2913</span>â <span class="NLM_lpage">2921</span>, <span class="refDoi">Â DOI: 10.1158/0008-5472.CAN-14-0155</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=10.1158%2F0008-5472.CAN-14-0155" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=24840647" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=1%3ACAS%3A528%3ADC%252BC2cXovFalur0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2014&pages=2913-2921&author=L.+Rahibauthor=B.+D.+Smithauthor=R.+Aizenbergauthor=A.+B.+Rosenzweigauthor=J.+M.+Fleshmanauthor=L.+M.+Matrisian&title=Projecting+cancer+incidence+and+deaths+to+2030%3A+the+unexpected+burden+of+thyroid%2C+liver%2C+and+pancreas+cancers+in+the+United+States&doi=10.1158%2F0008-5472.CAN-14-0155"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States</span></div><div class="casAuthors">Rahib, Lola; Smith, Benjamin D.; Aizenberg, Rhonda; Rosenzweig, Allison B.; Fleshman, Julie M.; Matrisian, Lynn M.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2913-2921</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Cancer incidence and deaths in the United States were projected for the most common cancer types for the years 2020 and 2030 based on changing demographics and the av. annual percentage changes in incidence and death rates.  Breast, prostate, and lung cancers will remain the top cancer diagnoses throughout this time, but thyroid cancer will replace colorectal cancer as the fourth leading cancer diagnosis by 2030, and melanoma and uterine cancer will become the fifth and sixth most common cancers, resp.  Lung cancer is projected to remain the top cancer killer throughout this time period.  However, pancreas and liver cancers are projected to surpass breast, prostate, and colorectal cancers to become the second and third leading causes of cancer-related death by 2030, resp.  Advances in screening, prevention, and treatment can change cancer incidence and/or death rates, but it will require a concerted effort by the research and healthcare communities now to effect a substantial change for the future.  Cancer Res; 74(11); 2913-21. Â©2014 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHGt66quENkbVg90H21EOLACvtfcHk0liHp3cesnJg-Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXovFalur0%253D&md5=893d688f1ccba88ee094b743f7e4f152</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-14-0155&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-14-0155%26sid%3Dliteratum%253Aachs%26aulast%3DRahib%26aufirst%3DL.%26aulast%3DSmith%26aufirst%3DB.%2BD.%26aulast%3DAizenberg%26aufirst%3DR.%26aulast%3DRosenzweig%26aufirst%3DA.%2BB.%26aulast%3DFleshman%26aufirst%3DJ.%2BM.%26aulast%3DMatrisian%26aufirst%3DL.%2BM.%26atitle%3DProjecting%2520cancer%2520incidence%2520and%2520deaths%2520to%25202030%253A%2520the%2520unexpected%2520burden%2520of%2520thyroid%252C%2520liver%252C%2520and%2520pancreas%2520cancers%2520in%2520the%2520United%2520States%26jtitle%3DCancer%2520Res.%26date%3D2014%26volume%3D74%26spage%3D2913%26epage%3D2921%26doi%3D10.1158%2F0008-5472.CAN-14-0155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mohammad, A. A.</span></span> <span> </span><span class="NLM_article-title">Advanced pancreatic cancer: the standard of care and new opportunities</span>. <i>Oncol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">370</span>, <span class="refDoi">Â DOI: 10.4081/oncol.2018.370</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=10.4081%2Foncol.2018.370" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=30344961" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=1%3ACAS%3A280%3ADC%252BB3cvhslSrtA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2018&pages=370&author=A.+A.+Mohammad&title=Advanced+pancreatic+cancer%3A+the+standard+of+care+and+new+opportunities&doi=10.4081%2Foncol.2018.370"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Advanced pancreatic cancer: The standard of care and new opportunities</span></div><div class="casAuthors">Mohammad Amrallah A</div><div class="citationInfo"><span class="NLM_cas:title">Oncology reviews</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">370</span>
        ISSN:<span class="NLM_cas:issn">1970-5565</span>.
    </div><div class="casAbstract">Presentation of pancreatic cancer is localized, locally advanced or metastatic.  With the later represented the main bulk (more than 80%).  Despite the significant innovation in molecular analysis and therapeutic approach in many types of cancer in the last two decades, still the outcome of advanced pancreatic cancer is disappointing and the mortality rate approximately unchanged.  In this mandated review we intended to highlight the standard of care and emerging agents for advanced pancreatic cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTaPmT8sn-38zjk2McQZ6XmfW6udTcc2eaj7SPnwWKRaLntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cvhslSrtA%253D%253D&md5=1f1821cafc5687f69982120b364702af</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.4081%2Foncol.2018.370&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4081%252Foncol.2018.370%26sid%3Dliteratum%253Aachs%26aulast%3DMohammad%26aufirst%3DA.%2BA.%26atitle%3DAdvanced%2520pancreatic%2520cancer%253A%2520the%2520standard%2520of%2520care%2520and%2520new%2520opportunities%26jtitle%3DOncol.%2520Rev.%26date%3D2018%26volume%3D12%26spage%3D370%26doi%3D10.4081%2Foncol.2018.370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hanahan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinberg, R. A.</span></span> <span> </span><span class="NLM_article-title">Hallmarks of cancer: the next generation</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>144</i></span>,  <span class="NLM_fpage">646</span>â <span class="NLM_lpage">674</span>, <span class="refDoi">Â DOI: 10.1016/j.cell.2011.02.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=10.1016%2Fj.cell.2011.02.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=21376230" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsFeqtrk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=144&publication_year=2011&pages=646-674&author=D.+Hanahanauthor=R.+A.+Weinberg&title=Hallmarks+of+cancer%3A+the+next+generation&doi=10.1016%2Fj.cell.2011.02.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Hallmarks of cancer: the next generation</span></div><div class="casAuthors">Hanahan, Douglas; Weinberg, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">144</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">646-674</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  The hallmarks of cancer comprise six biol. capabilities acquired during the multistep development of human tumors.  The hallmarks constitute an organizing principle for rationalizing the complexities of neoplastic disease.  They include sustaining proliferative signaling, evading growth suppressors, resisting cell death, enabling replicative immortality, inducing angiogenesis, and activating invasion and metastasis.  Underlying these hallmarks are genome instability, which generates the genetic diversity that expedites their acquisition, and inflammation, which fosters multiple hallmark functions.  Conceptual progress in the last decade has added two emerging hallmarks of potential generality to this list-reprogramming of energy metab. and evading immune destruction.  In addn. to cancer cells, tumors exhibit another dimension of complexity: they contain a repertoire of recruited, ostensibly normal cells that contribute to the acquisition of hallmark traits by creating the "tumor microenvironment.".  Recognition of the widespread applicability of these concepts will increasingly affect the development of new means to treat human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTcpqXALcb6LVg90H21EOLACvtfcHk0liHp3cesnJg-Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsFeqtrk%253D&md5=b36f160c417a712e83cb83c577f0018e</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2011.02.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2011.02.013%26sid%3Dliteratum%253Aachs%26aulast%3DHanahan%26aufirst%3DD.%26aulast%3DWeinberg%26aufirst%3DR.%2BA.%26atitle%3DHallmarks%2520of%2520cancer%253A%2520the%2520next%2520generation%26jtitle%3DCell%26date%3D2011%26volume%3D144%26spage%3D646%26epage%3D674%26doi%3D10.1016%2Fj.cell.2011.02.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fouad, Y. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aanei, C.</span></span> <span> </span><span class="NLM_article-title">Revisiting the hallmarks of cancer</span>. <i>Am. J. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">1016</span>â <span class="NLM_lpage">1036</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=28560055" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvFOju77N" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=1016-1036&author=Y.+A.+Fouadauthor=C.+Aanei&title=Revisiting+the+hallmarks+of+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Revisiting the hallmarks of cancer</span></div><div class="casAuthors">Fouad, Yousef Ahmed; Aanei, Carmen</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Cancer Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1016-1036</span>CODEN:
                <span class="NLM_cas:coden">AJCRFT</span>;
        ISSN:<span class="NLM_cas:issn">2156-6976</span>.
    
            (<span class="NLM_cas:orgname">e-Century Publishing Corp.</span>)
        </div><div class="casAbstract">The hallmarks of cancer described by Hanahan and Weinberg have proved seminal in our understanding of cancer's common traits and in rational drug design.  Not free of critique and with understanding of different aspects of tumorigenesis coming into clearer focus in the recent years, we attempt to draw a more organized and updated picture of the cancer hallmarks.  We define seven hallmarks of cancer: selective growth and proliferative advantage, altered stress response favoring overall survival, vascularization, invasion and metastasis, metabolic rewiring, an abetting microenvironment, and immune modulation, while highlighting some considerations for the future of the field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQWd_TRJpAJbVg90H21EOLACvtfcHk0lgw0netJLP3cw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvFOju77N&md5=f3e523fdecbad82fa94bd3d6c9f365ae</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFouad%26aufirst%3DY.%2BA.%26aulast%3DAanei%26aufirst%3DC.%26atitle%3DRevisiting%2520the%2520hallmarks%2520of%2520cancer%26jtitle%3DAm.%2520J.%2520Cancer%2520Res.%26date%3D2017%26volume%3D7%26spage%3D1016%26epage%3D1036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hornsveld, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dansen, T. B.</span></span> <span> </span><span class="NLM_article-title">The hallmarks of cancer from a redox perspective</span>. <i>Antioxid. Redox Signaling</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">300</span>â <span class="NLM_lpage">325</span>, <span class="refDoi">Â DOI: 10.1089/ars.2015.6580</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=10.1089%2Fars.2015.6580" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=27353526" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlehsLrJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2016&pages=300-325&author=M.+Hornsveldauthor=T.+B.+Dansen&title=The+hallmarks+of+cancer+from+a+redox+perspective&doi=10.1089%2Fars.2015.6580"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">The Hallmarks of Cancer from a Redox Perspective</span></div><div class="casAuthors">Hornsveld, Marten; Dansen, Tobias B.</div><div class="citationInfo"><span class="NLM_cas:title">Antioxidants & Redox Signaling</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">300-325</span>CODEN:
                <span class="NLM_cas:coden">ARSIF2</span>;
        ISSN:<span class="NLM_cas:issn">1523-0864</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">Significance: For a healthy cell to turn into a cancer cell and grow out to become a tumor, it needs to undergo a series of complex changes and acquire certain traits, summarized as "The Hallmarks of Cancer.  " These hallmarks can all be regarded as the result of altered signal transduction cascades and an understanding of these cascades is essential for cancer treatment.  Recent Advances: Redox signaling is a long overlooked form of signal transduction that proceeds through the reversible oxidn. of cysteines in proteins and that uses hydrogen peroxide as a second messenger.  Crit. Issues: In this article, we provide examples that show that redox signaling is involved in the regulation of proteins and signaling cascades that play roles in every hallmark of cancer.  Future Directions: An understanding of how redox signaling and "classical" signal transduction are intertwined could hold promising strategies for cancer therapy in the future.  Antioxid. Redox Signal. 25, 300-325.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqg8Ibw049azbVg90H21EOLACvtfcHk0lgw0netJLP3cw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlehsLrJ&md5=43a0fffc6b1765fff0d4b9ce34a04510</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1089%2Fars.2015.6580&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fars.2015.6580%26sid%3Dliteratum%253Aachs%26aulast%3DHornsveld%26aufirst%3DM.%26aulast%3DDansen%26aufirst%3DT.%2BB.%26atitle%3DThe%2520hallmarks%2520of%2520cancer%2520from%2520a%2520redox%2520perspective%26jtitle%3DAntioxid.%2520Redox%2520Signaling%26date%3D2016%26volume%3D25%26spage%3D300%26epage%3D325%26doi%3D10.1089%2Fars.2015.6580" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pavlova, N. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, C. B.</span></span> <span> </span><span class="NLM_article-title">The emerging hallmarks of cancer metabolism</span>. <i>Cell Metab.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">27</span>â <span class="NLM_lpage">47</span>, <span class="refDoi">Â DOI: 10.1016/j.cmet.2015.12.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=10.1016%2Fj.cmet.2015.12.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=26771115" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=1%3ACAS%3A528%3ADC%252BC28XjtFSrtw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2016&pages=27-47&author=N.+N.+Pavlovaauthor=C.+B.+Thompson&title=The+emerging+hallmarks+of+cancer+metabolism&doi=10.1016%2Fj.cmet.2015.12.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The Emerging Hallmarks of Cancer Metabolism</span></div><div class="casAuthors">Pavlova, Natalya N.; Thompson, Craig B.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Metabolism</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">27-47</span>CODEN:
                <span class="NLM_cas:coden">CMEEB5</span>;
        ISSN:<span class="NLM_cas:issn">1550-4131</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Tumorigenesis is dependent on the reprogramming of cellular metab. as both direct and indirect consequence of oncogenic mutations.  A common feature of cancer cell metab. is the ability to acquire necessary nutrients from a frequently nutrient-poor environment and utilize these nutrients to both maintain viability and build new biomass.  The alterations in intracellular and extracellular metabolites that can accompany cancer-assocd. metabolic reprogramming have profound effects on gene expression, cellular differentiation, and the tumor microenvironment.  In this Perspective, we have organized known cancer-assocd. metabolic changes into six hallmarks: (1) deregulated uptake of glucose and amino acids, (2) use of opportunistic modes of nutrient acquisition, (3) use of glycolysis/TCA cycle intermediates for biosynthesis and NADPH prodn., (4) increased demand for nitrogen, (5) alterations in metabolite-driven gene regulation, and (6) metabolic interactions with the microenvironment.  While few tumors display all six hallmarks, most display several.  The specific hallmarks exhibited by an individual tumor may ultimately contribute to better tumor classification and aid in directing treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmqSfgRFEvTrVg90H21EOLACvtfcHk0lgw0netJLP3cw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjtFSrtw%253D%253D&md5=d33d8226a68aa5eba6d92a33280ccf2c</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.cmet.2015.12.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmet.2015.12.006%26sid%3Dliteratum%253Aachs%26aulast%3DPavlova%26aufirst%3DN.%2BN.%26aulast%3DThompson%26aufirst%3DC.%2BB.%26atitle%3DThe%2520emerging%2520hallmarks%2520of%2520cancer%2520metabolism%26jtitle%3DCell%2520Metab.%26date%3D2016%26volume%3D23%26spage%3D27%26epage%3D47%26doi%3D10.1016%2Fj.cmet.2015.12.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">DeBerardinis, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandel, N. S.</span></span> <span> </span><span class="NLM_article-title">Fundamentals of cancer metabolism</span>. <i>Sci. Adv.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>2</i></span>, <span class="NLM_elocation-id">e1600200</span> <span class="refDoi">Â DOI: 10.1126/sciadv.1600200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=10.1126%2Fsciadv.1600200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=27386546" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2016&author=R.+J.+DeBerardinisauthor=N.+S.+Chandel&title=Fundamentals+of+cancer+metabolism&doi=10.1126%2Fsciadv.1600200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1126%2Fsciadv.1600200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fsciadv.1600200%26sid%3Dliteratum%253Aachs%26aulast%3DDeBerardinis%26aufirst%3DR.%2BJ.%26aulast%3DChandel%26aufirst%3DN.%2BS.%26atitle%3DFundamentals%2520of%2520cancer%2520metabolism%26jtitle%3DSci.%2520Adv.%26date%3D2016%26volume%3D2%26doi%3D10.1126%2Fsciadv.1600200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gerber, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beg, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fattah, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frankel, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fatunde, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arriaga, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowell, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bisen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leff, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meek, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Putnam, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kallem, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subramaniyan, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolluyt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarode, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boothman, D. A.</span></span> <span> </span><span class="NLM_article-title">Phase 1 study of ARQ 761, a beta-lapachone analogue that promotes NQO1-mediated programmed cancer cell necrosis</span>. <i>Br. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>119</i></span>,  <span class="NLM_fpage">928</span>â <span class="NLM_lpage">936</span>, <span class="refDoi">Â DOI: 10.1038/s41416-018-0278-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=10.1038%2Fs41416-018-0278-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=30318513" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvFChtrvN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2018&pages=928-936&author=D.+E.+Gerberauthor=M.+S.+Begauthor=F.+Fattahauthor=A.+E.+Frankelauthor=O.+Fatundeauthor=Y.+Arriagaauthor=J.+E.+Dowellauthor=A.+Bisenauthor=R.+D.+Leffauthor=C.+C.+Meekauthor=W.+C.+Putnamauthor=R.+R.+Kallemauthor=I.+Subramaniyanauthor=Y.+Dongauthor=J.+Bolluytauthor=V.+Sarodeauthor=X.+Luoauthor=Y.+Xieauthor=B.+Schwartzauthor=D.+A.+Boothman&title=Phase+1+study+of+ARQ+761%2C+a+beta-lapachone+analogue+that+promotes+NQO1-mediated+programmed+cancer+cell+necrosis&doi=10.1038%2Fs41416-018-0278-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Phase 1 study of ARQ 761, a Î²-lapachone analogue that promotes NQO1-mediated programmed cancer cell necrosis</span></div><div class="casAuthors">Gerber, David E.; Beg, M. Shaalan; Fattah, Farjana; Frankel, Arthur E.; Fatunde, Oluwatomilade; Arriaga, Yull; Dowell, Jonathan E.; Bisen, Ajit; Leff, Richard D.; Meek, Claudia C.; Putnam, William C.; Kallem, Raja Reddy; Subramaniyan, Indhumathy; Dong, Ying; Bolluyt, Joyce; Sarode, Venetia; Luo, Xin; Xie, Yang; Schwartz, Brian; Boothman, David A.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">928-936</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Background: NAD(P)H:quinone oxidoreductase 1 (NQO1) is a two-electron oxidoreductase expressed in multiple tumor types.  ARQ 761 is a Î²-lapachone (Î²-lap) analog that exploits the unique elevation of NQO1 found in solid tumors to cause tumor-specific cell death.  Methods: We performed a 3+3 dose escalation study of 3 schedules (weekly, every other week, 2/3 wk) of ARQ 761 in patients with refractory advanced solid tumors.  Tumor tissue was analyzed for NQO1 expression.  After 20 patients were analyzed, enrolment was restricted to patients with NQO1-high tumors (H-score â¥ 200).  Results: A total of 42 patients were treated.  Median no. of prior lines of therapy was 4.  Maximum tolerated dose was 390 mg/m2 as a 2-h infusion every other week.  Dose-limiting toxicity was anemia.  The most common treatment-related adverse events were anemia (79%), fatigue (45%), hypoxia (33%), nausea (17%), and vomiting (17%).  Transient grade 3 hypoxia, reflecting possible methemoglobinemia, occurred in 26% of patients.  Among 32 evaluable patients, best response was stable disease (n = 12); 6 patients had tumor shrinkage.  There was a trend towards improved efficacy in NQO1-high tumors (P = 0.06).  Conclusions: ARQ 761 has modest single-agent activity, which appears assocd. with tumor NQO1 expression.  Principal toxicities include anemia and possible methemoglobinemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRXcIh4QP3ErVg90H21EOLACvtfcHk0lhd3R9YK5ZFTw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvFChtrvN&md5=934a577154a762f8db5fa81e82979371</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fs41416-018-0278-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41416-018-0278-4%26sid%3Dliteratum%253Aachs%26aulast%3DGerber%26aufirst%3DD.%2BE.%26aulast%3DBeg%26aufirst%3DM.%2BS.%26aulast%3DFattah%26aufirst%3DF.%26aulast%3DFrankel%26aufirst%3DA.%2BE.%26aulast%3DFatunde%26aufirst%3DO.%26aulast%3DArriaga%26aufirst%3DY.%26aulast%3DDowell%26aufirst%3DJ.%2BE.%26aulast%3DBisen%26aufirst%3DA.%26aulast%3DLeff%26aufirst%3DR.%2BD.%26aulast%3DMeek%26aufirst%3DC.%2BC.%26aulast%3DPutnam%26aufirst%3DW.%2BC.%26aulast%3DKallem%26aufirst%3DR.%2BR.%26aulast%3DSubramaniyan%26aufirst%3DI.%26aulast%3DDong%26aufirst%3DY.%26aulast%3DBolluyt%26aufirst%3DJ.%26aulast%3DSarode%26aufirst%3DV.%26aulast%3DLuo%26aufirst%3DX.%26aulast%3DXie%26aufirst%3DY.%26aulast%3DSchwartz%26aufirst%3DB.%26aulast%3DBoothman%26aufirst%3DD.%2BA.%26atitle%3DPhase%25201%2520study%2520of%2520ARQ%2520761%252C%2520a%2520beta-lapachone%2520analogue%2520that%2520promotes%2520NQO1-mediated%2520programmed%2520cancer%2520cell%2520necrosis%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2018%26volume%3D119%26spage%3D928%26epage%3D936%26doi%3D10.1038%2Fs41416-018-0278-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sonbol, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldstein, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okusaka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tabernero, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macarulla, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">OâNeil, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Cutsem, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bekaii-Saab, T.</span></span> <span> </span><span class="NLM_article-title">CanStem111P trial: a phase III study of napabucasin plus nab-paclitaxel with gemcitabine</span>. <i>Future Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">1295</span>â <span class="NLM_lpage">1302</span>, <span class="refDoi">Â DOI: 10.2217/fon-2018-0903</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=10.2217%2Ffon-2018-0903" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=30768369" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=1%3ACAS%3A528%3ADC%252BC1MXotlWmsbg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2019&pages=1295-1302&author=M.+B.+Sonbolauthor=D.+H.+Ahnauthor=D.+Goldsteinauthor=T.+Okusakaauthor=J.+Taberneroauthor=T.+Macarullaauthor=M.+Reniauthor=C.+P.+Liauthor=B.+O%E2%80%99Neilauthor=E.+Van+Cutsemauthor=T.+Bekaii-Saab&title=CanStem111P+trial%3A+a+phase+III+study+of+napabucasin+plus+nab-paclitaxel+with+gemcitabine&doi=10.2217%2Ffon-2018-0903"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">CanStem111P trial: a Phase III study of napabucasin plus nab-paclitaxel with gemcitabine</span></div><div class="casAuthors">Sonbol, Mohamad Bassam; Ahn, Daniel H.; Goldstein, David; Okusaka, Takuji; Tabernero, Josep; Macarulla, Teresa; Reni, Michele; Li, Chung-Pin; O'Neil, Bert; Van Cutsem, Eric; Bekaii-Saab, Tanios</div><div class="citationInfo"><span class="NLM_cas:title">Future Oncology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1295-1302</span>CODEN:
                <span class="NLM_cas:coden">FOUNBN</span>;
        ISSN:<span class="NLM_cas:issn">1744-8301</span>.
    
            (<span class="NLM_cas:orgname">Future Medicine Ltd.</span>)
        </div><div class="casAbstract">Napabucasin (also known as BBI-608 or BBI608) is an investigational, oral agent hypothesized to inhibit multiple oncogenic pathways.  In this article, we describe the design and rationale for the CanStem111P clin. trial, a multicenter, randomized, open-label, Phase III study designed to det. the efficacy and safety of combining napabucasin with nab-paclitaxel and gemcitabine for first-line treatment of patients with metastatic pancreatic adenocarcinoma (NCT02993731).  Patients were randomized in a 1:1 fashion to receive weekly gemcitabine and nab-paclitaxel with or without napabucasin.  The results of this study will help define the role of this novel agent in the management of advanced pancreatic cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoY0Bk1A2JAWrVg90H21EOLACvtfcHk0lhd3R9YK5ZFTw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXotlWmsbg%253D&md5=65a65f835bd6c32a16722fa919f9b5d9</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.2217%2Ffon-2018-0903&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2217%252Ffon-2018-0903%26sid%3Dliteratum%253Aachs%26aulast%3DSonbol%26aufirst%3DM.%2BB.%26aulast%3DAhn%26aufirst%3DD.%2BH.%26aulast%3DGoldstein%26aufirst%3DD.%26aulast%3DOkusaka%26aufirst%3DT.%26aulast%3DTabernero%26aufirst%3DJ.%26aulast%3DMacarulla%26aufirst%3DT.%26aulast%3DReni%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DC.%2BP.%26aulast%3DO%25E2%2580%2599Neil%26aufirst%3DB.%26aulast%3DVan%2BCutsem%26aufirst%3DE.%26aulast%3DBekaii-Saab%26aufirst%3DT.%26atitle%3DCanStem111P%2520trial%253A%2520a%2520phase%2520III%2520study%2520of%2520napabucasin%2520plus%2520nab-paclitaxel%2520with%2520gemcitabine%26jtitle%3DFuture%2520Oncol.%26date%3D2019%26volume%3D15%26spage%3D1295%26epage%3D1302%26doi%3D10.2217%2Ffon-2018-0903" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grothey, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshino, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Cutsem, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taieb, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tebbutt, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falcone, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cervantes, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borodyansky, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span> <span> </span><span class="NLM_article-title">CanStem303C trial: A phase III study of napabucasin (BBI-608) in combination with 5-fluorouracil (5-FU), leucovorin, irinotecan (FOLFIRI) in adult patients with previously treated metastatic colorectal cancer (mCRC)</span>. <i>J. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">TPS3619</span>, <span class="refDoi">Â DOI: 10.1200/JCO.2017.35.15_suppl.TPS3619</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=10.1200%2FJCO.2017.35.15_suppl.TPS3619" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2017&pages=TPS3619&author=A.+Grotheyauthor=M.+A.+Shahauthor=T.+Yoshinoauthor=E.+Van+Cutsemauthor=J.+Taiebauthor=R.+Xuauthor=N.+C.+Tebbuttauthor=A.+Falconeauthor=A.+Cervantesauthor=L.+Borodyanskyauthor=C.+Li&title=CanStem303C+trial%3A+A+phase+III+study+of+napabucasin+%28BBI-608%29+in+combination+with+5-fluorouracil+%285-FU%29%2C+leucovorin%2C+irinotecan+%28FOLFIRI%29+in+adult+patients+with+previously+treated+metastatic+colorectal+cancer+%28mCRC%29&doi=10.1200%2FJCO.2017.35.15_suppl.TPS3619"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1200%2FJCO.2017.35.15_suppl.TPS3619&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2017.35.15_suppl.TPS3619%26sid%3Dliteratum%253Aachs%26aulast%3DGrothey%26aufirst%3DA.%26aulast%3DShah%26aufirst%3DM.%2BA.%26aulast%3DYoshino%26aufirst%3DT.%26aulast%3DVan%2BCutsem%26aufirst%3DE.%26aulast%3DTaieb%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DR.%26aulast%3DTebbutt%26aufirst%3DN.%2BC.%26aulast%3DFalcone%26aufirst%3DA.%26aulast%3DCervantes%26aufirst%3DA.%26aulast%3DBorodyansky%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DC.%26atitle%3DCanStem303C%2520trial%253A%2520A%2520phase%2520III%2520study%2520of%2520napabucasin%2520%2528BBI-608%2529%2520in%2520combination%2520with%25205-fluorouracil%2520%25285-FU%2529%252C%2520leucovorin%252C%2520irinotecan%2520%2528FOLFIRI%2529%2520in%2520adult%2520patients%2520with%2520previously%2520treated%2520metastatic%2520colorectal%2520cancer%2520%2528mCRC%2529%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2017%26volume%3D35%26spage%3DTPS3619%26doi%3D10.1200%2FJCO.2017.35.15_suppl.TPS3619" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Froeling, F. E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swamynathan, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeschÃªnes, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chio, I. I. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brosnan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alagesan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucito, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, A.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trotman, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belleau, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogoff, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuveson, D. A.</span></span> <span> </span><span class="NLM_article-title">Bioactivation of napabucasin triggers reactive oxygen species-mediated cancer cell death</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">7162</span>â <span class="NLM_lpage">7174</span>, <span class="refDoi">Â DOI: 10.1158/1078-0432.CCR-19-0302</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=10.1158%2F1078-0432.CCR-19-0302" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=31527169" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhslWitLvN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2019&pages=7162-7174&author=F.+E.+M.+Froelingauthor=M.+M.+Swamynathanauthor=A.+Desch%C3%AAnesauthor=I.+I.+C.+Chioauthor=E.+Brosnanauthor=M.+A.+Yaoauthor=P.+Alagesanauthor=M.+Lucitoauthor=J.+Liauthor=A.-Y.+Changauthor=L.+C.+Trotmanauthor=P.+Belleauauthor=Y.+Parkauthor=H.+A.+Rogoffauthor=J.+D.+Watsonauthor=D.+A.+Tuveson&title=Bioactivation+of+napabucasin+triggers+reactive+oxygen+species-mediated+cancer+cell+death&doi=10.1158%2F1078-0432.CCR-19-0302"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Bioactivation of napabucasin triggers reactive oxygen species-mediated cancer cell death</span></div><div class="casAuthors">Froeling, Fieke E. M.; Swamynathan, Manojit Mosur; Deschenes, Astrid; Chio, Iok In Christine; Brosnan, Erin; Yao, Melissa A.; Alagesan, Priya; Lucito, Matthew; Li, Juying; Chang, An-Yun; Trotman, Lloyd C.; Belleau, Pascal; Park, Youngkyu; Rogoff, Harry A.; Watson, James D.; Tuveson, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">7162-7174</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: Napabucasin (2-acetylfuro-1,4-naphthoquinone or BBI-608) is a small mol. currently being clin. evaluated in various cancer types.  It has mostly been recognized for its ability to inhibit STAT3 signaling.  However, based on its chem. structure, we hypothesized that napabucasin is a substrate for intracellular oxidoreductases and therefore may exert its anticancer effect through redox cycling, resulting in reactive oxygen species (ROS) prodn. and cell death.  Exptl. Design: Binding of napabucasin to NAD(P)H:quinone oxidoreductase-1 (NQO1), and other oxidoreductases, was measured.  Pancreatic cancer cell lines were treated with napabucasin, and cell survival, ROS generation, DNA damage, transcriptomic changes, and alterations in STAT3 activation were assayed in vitro and in vivo.  Genetic knockout or pharmacol. inhibition with dicoumarol was used to evaluate the dependency on NQO1.  Results: Napabucasin was found to bind with high affinity to NQO1 and to a lesser degree to cytochrome P 450 oxidoreductase (POR).  Treatment resulted in marked induction of ROS and DNA damage with an NQO1- and ROS-dependent decrease in STAT3 phosphorylation.  Differential cytotoxic effects were obsd., where NQO1-expressing cells generating cytotoxic levels of ROS at low napabucasin concns. were more sensitive.  Cells with low or no baseline NQO1 expression also produced ROS in response to napabucasin, albeit to a lesser extent, through the one-electron reductase POR.  Conclusions: Napabucasin is bioactivated by NQO1, and to a lesser degree by POR, resulting in futile redox cycling and ROS generation.  The increased ROS levels result in DNA damage and multiple intracellular changes, one of which is a redn. in STAT3 phosphorylation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobkyO7Js1b7LVg90H21EOLACvtfcHk0ljDcG6FerABBA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhslWitLvN&md5=f2bbfdc3e8673c095f1118e361e6f81d</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-19-0302&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-19-0302%26sid%3Dliteratum%253Aachs%26aulast%3DFroeling%26aufirst%3DF.%2BE.%2BM.%26aulast%3DSwamynathan%26aufirst%3DM.%2BM.%26aulast%3DDesch%25C3%25AAnes%26aufirst%3DA.%26aulast%3DChio%26aufirst%3DI.%2BI.%2BC.%26aulast%3DBrosnan%26aufirst%3DE.%26aulast%3DYao%26aufirst%3DM.%2BA.%26aulast%3DAlagesan%26aufirst%3DP.%26aulast%3DLucito%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DChang%26aufirst%3DA.-Y.%26aulast%3DTrotman%26aufirst%3DL.%2BC.%26aulast%3DBelleau%26aufirst%3DP.%26aulast%3DPark%26aufirst%3DY.%26aulast%3DRogoff%26aufirst%3DH.%2BA.%26aulast%3DWatson%26aufirst%3DJ.%2BD.%26aulast%3DTuveson%26aufirst%3DD.%2BA.%26atitle%3DBioactivation%2520of%2520napabucasin%2520triggers%2520reactive%2520oxygen%2520species-mediated%2520cancer%2520cell%2520death%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2019%26volume%3D25%26spage%3D7162%26epage%3D7174%26doi%3D10.1158%2F1078-0432.CCR-19-0302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kuang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sechi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nurra, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ljungman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neamati, N.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of novel reactive oxygen species inducers for the treatment of pancreatic ductal adenocarcinoma</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">1576</span>â <span class="NLM_lpage">1594</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.7b01463</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01463" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=1%3ACAS%3A528%3ADC%252BC1cXotVyqtA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=1576-1594&author=Y.+Kuangauthor=M.+Sechiauthor=S.+Nurraauthor=M.+Ljungmanauthor=N.+Neamati&title=Design+and+synthesis+of+novel+reactive+oxygen+species+inducers+for+the+treatment+of+pancreatic+ductal+adenocarcinoma&doi=10.1021%2Facs.jmedchem.7b01463"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of Novel Reactive Oxygen Species Inducers for the Treatment of Pancreatic Ductal Adenocarcinoma</span></div><div class="casAuthors">Kuang, Yuting; Sechi, Mario; Nurra, Salvatore; Ljungman, Mats; Neamati, Nouri</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1576-1594</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Quinazolinediones such as I were prepd. as inducers of reactive oxygen species (ROS) for potential use as antitumor agents for the treatment of pancreatic ductal adenocarcinoma (PDAC); the inhibition of human PDAC cells was detd. for all of the compds. and the toxicities of selected compds. to normal pancreatic cells, and the effects on various cellular systems was detd. for selected compds.  I was the most potent redox modulator candidate of the tested compds., inducing substantial ROS prodn. in PDAC cells.  Nascent RNA sequencing following treatments with quinazolinediones revealed induction of stress responses in nucleus, endoplasmic reticulum, and mitochondria of pancreatic cancer cells; the quinazolinedione also induced Nrf2-mediated oxidative stress and unfolded protein responses as demonstrated by dose-dependent increases in RNA synthesis of representative genes such as NQO1, HMOX1, DDIT3, and HSPA5.  At 5.0 Î¼M, I blocked mitochondrial function by inhibiting mtDNA transcription and downregulating the mtDNA-encoded OXPHOS enzymes.  Treatment with I was well tolerated in vivo and significantly delayed tumor growth in mice; I was also tested in combination with the current pancreatic cancer agent gemcitabine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4BeZNm8i3TLVg90H21EOLACvtfcHk0ljDcG6FerABBA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXotVyqtA%253D%253D&md5=ec0cb6c8914a7841c7ff8906cf53ef49</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01463%26sid%3Dliteratum%253Aachs%26aulast%3DKuang%26aufirst%3DY.%26aulast%3DSechi%26aufirst%3DM.%26aulast%3DNurra%26aufirst%3DS.%26aulast%3DLjungman%26aufirst%3DM.%26aulast%3DNeamati%26aufirst%3DN.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520novel%2520reactive%2520oxygen%2520species%2520inducers%2520for%2520the%2520treatment%2520of%2520pancreatic%2520ductal%2520adenocarcinoma%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D1576%26epage%3D1594%26doi%3D10.1021%2Facs.jmedchem.7b01463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dixon, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemberg, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamprecht, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skouta, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaitsev, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gleason, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cantley, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrison, B.,  III</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stockwell, B. R.</span></span> <span> </span><span class="NLM_article-title">Ferroptosis: an iron-dependent form of nonapoptotic cell death</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>149</i></span>,  <span class="NLM_fpage">1060</span>â <span class="NLM_lpage">1072</span>, <span class="refDoi">Â DOI: 10.1016/j.cell.2012.03.042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=10.1016%2Fj.cell.2012.03.042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=22632970" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=1%3ACAS%3A528%3ADC%252BC38XnslSntrw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=149&publication_year=2012&pages=1060-1072&author=S.+J.+Dixonauthor=K.+M.+Lembergauthor=M.+R.+Lamprechtauthor=R.+Skoutaauthor=E.+M.+Zaitsevauthor=C.+E.+Gleasonauthor=D.+N.+Patelauthor=A.+J.+Bauerauthor=A.+M.+Cantleyauthor=W.+S.+Yangauthor=B.+Morrisonauthor=B.+R.+Stockwell&title=Ferroptosis%3A+an+iron-dependent+form+of+nonapoptotic+cell+death&doi=10.1016%2Fj.cell.2012.03.042"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death</span></div><div class="casAuthors">Dixon, Scott J.; Lemberg, Kathryn M.; Lamprecht, Michael R.; Skouta, Rachid; Zaitsev, Eleina M.; Gleason, Caroline E.; Patel, Darpan N.; Bauer, Andras J.; Cantley, Alexandra M.; Yang, Wan Seok; Morrison, Barclay; Stockwell, Brent R.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">149</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1060-1072</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Nonapoptotic forms of cell death may facilitate the selective elimination of some tumor cells or be activated in specific pathol. states.  The oncogenic RAS-selective lethal small mol. erastin triggers a unique iron-dependent form of nonapoptotic cell death that we term ferroptosis.  Ferroptosis is dependent upon intracellular iron, but not other metals, and is morphol., biochem., and genetically distinct from apoptosis, necrosis, and autophagy.  We identify the small mol. ferrostatin-1 as a potent inhibitor of ferroptosis in cancer cells and glutamate-induced cell death in organotypic rat brain slices, suggesting similarities between these two processes.  Indeed, erastin, like glutamate, inhibits cystine uptake by the cystine/glutamate antiporter (system xc-), creating a void in the antioxidant defenses of the cell and ultimately leading to iron-dependent, oxidative death.  Thus, activation of ferroptosis results in the nonapoptotic destruction of certain cancer cells, whereas inhibition of this process may protect organisms from neurodegeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzDzMapViBQ7Vg90H21EOLACvtfcHk0lg9R0oNlf2J4w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnslSntrw%253D&md5=5d3b8c55a053dfde7e758cc1701ef71b</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2012.03.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2012.03.042%26sid%3Dliteratum%253Aachs%26aulast%3DDixon%26aufirst%3DS.%2BJ.%26aulast%3DLemberg%26aufirst%3DK.%2BM.%26aulast%3DLamprecht%26aufirst%3DM.%2BR.%26aulast%3DSkouta%26aufirst%3DR.%26aulast%3DZaitsev%26aufirst%3DE.%2BM.%26aulast%3DGleason%26aufirst%3DC.%2BE.%26aulast%3DPatel%26aufirst%3DD.%2BN.%26aulast%3DBauer%26aufirst%3DA.%2BJ.%26aulast%3DCantley%26aufirst%3DA.%2BM.%26aulast%3DYang%26aufirst%3DW.%2BS.%26aulast%3DMorrison%26aufirst%3DB.%26aulast%3DStockwell%26aufirst%3DB.%2BR.%26atitle%3DFerroptosis%253A%2520an%2520iron-dependent%2520form%2520of%2520nonapoptotic%2520cell%2520death%26jtitle%3DCell%26date%3D2012%26volume%3D149%26spage%3D1060%26epage%3D1072%26doi%3D10.1016%2Fj.cell.2012.03.042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stockwell, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedmann Angeli, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bayir, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bush, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conrad, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dixon, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fulda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">GascÃ³n, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hatzios, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kagan, V. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noel, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linkermann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overholtzer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oyagi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pagnussat, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ran, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenfeld, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salnikow, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torti, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torti, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toyokuni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woerpel, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D. D.</span></span> <span> </span><span class="NLM_article-title">Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>171</i></span>,  <span class="NLM_fpage">273</span>â <span class="NLM_lpage">285</span>, <span class="refDoi">Â DOI: 10.1016/j.cell.2017.09.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=10.1016%2Fj.cell.2017.09.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=28985560" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1Wqs7%252FL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=171&publication_year=2017&pages=273-285&author=B.+R.+Stockwellauthor=J.+P.+Friedmann+Angeliauthor=H.+Bayirauthor=A.+I.+Bushauthor=M.+Conradauthor=S.+J.+Dixonauthor=S.+Fuldaauthor=S.+Gasc%C3%B3nauthor=S.+K.+Hatziosauthor=V.+E.+Kaganauthor=K.+Noelauthor=X.+Jiangauthor=A.+Linkermannauthor=M.+E.+Murphyauthor=M.+Overholtzerauthor=A.+Oyagiauthor=G.+C.+Pagnussatauthor=J.+Parkauthor=Q.+Ranauthor=C.+S.+Rosenfeldauthor=K.+Salnikowauthor=D.+Tangauthor=F.+M.+Tortiauthor=S.+V.+Tortiauthor=S.+Toyokuniauthor=K.+A.+Woerpelauthor=D.+D.+Zhang&title=Ferroptosis%3A+a+regulated+cell+death+nexus+linking+metabolism%2C+redox+biology%2C+and+disease&doi=10.1016%2Fj.cell.2017.09.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Ferroptosis: A regulated cell death nexus linking metabolism, redox biology, and disease</span></div><div class="casAuthors">Stockwell, Brent R.; Friedmann Angeli, Jose Pedro; Bayir, Hulya; Bush, Ashley I.; Conrad, Marcus; Dixon, Scott J.; Fulda, Simone; Gascon, Sergio; Hatzios, Stavroula K.; Kagan, Valerian E.; Noel, Kay; Jiang, Xuejun; Linkermann, Andreas; Murphy, Maureen E.; Overholtzer, Michael; Oyagi, Atsushi; Pagnussat, Gabriela C.; Park, Jason; Ran, Qitao; Rosenfeld, Craig S.; Salnikow, Konstantin; Tang, Daolin; Torti, Frank M.; Torti, Suzy V.; Toyokuni, Shinya; Woerpel, K. A.; Zhang, Donna D.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">171</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">273-285</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Ferroptosis is a form of regulated cell death characterized by the iron-dependent accumulation of lipid hydroperoxides to lethal levels.  Emerging evidence suggests that ferroptosis represents an ancient vulnerability caused by the incorporation of polyunsatd. fatty acids into cellular membranes, and cells have developed complex systems that exploit and defend against this vulnerability in different contexts.  The sensitivity to ferroptosis is tightly linked to numerous biol. processes, including amino acid, iron, and polyunsatd. fatty acid metab., and the biosynthesis of glutathione, phospholipids, NADPH, and coenzyme Q10.  Ferroptosis has been implicated in the pathol. cell death assocd. with degenerative diseases (i.e., Alzheimer's, Huntington's, and Parkinson's diseases), carcinogenesis, stroke, intracerebral hemorrhage, traumatic brain injury, ischemia-reperfusion injury, and kidney degeneration in mammals and is also implicated in heat stress in plants.  Ferroptosis may also have a tumor-suppressor function that could be harnessed for cancer therapy.  This Primer reviews the mechanisms underlying ferroptosis, highlights connections to other areas of biol. and medicine, and recommends tools and guidelines for studying this emerging form of regulated cell death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDa2kEYqbenLVg90H21EOLACvtfcHk0lg9R0oNlf2J4w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1Wqs7%252FL&md5=0f4684ef43ba7de994d68939e2867410</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2017.09.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2017.09.021%26sid%3Dliteratum%253Aachs%26aulast%3DStockwell%26aufirst%3DB.%2BR.%26aulast%3DFriedmann%2BAngeli%26aufirst%3DJ.%2BP.%26aulast%3DBayir%26aufirst%3DH.%26aulast%3DBush%26aufirst%3DA.%2BI.%26aulast%3DConrad%26aufirst%3DM.%26aulast%3DDixon%26aufirst%3DS.%2BJ.%26aulast%3DFulda%26aufirst%3DS.%26aulast%3DGasc%25C3%25B3n%26aufirst%3DS.%26aulast%3DHatzios%26aufirst%3DS.%2BK.%26aulast%3DKagan%26aufirst%3DV.%2BE.%26aulast%3DNoel%26aufirst%3DK.%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DLinkermann%26aufirst%3DA.%26aulast%3DMurphy%26aufirst%3DM.%2BE.%26aulast%3DOverholtzer%26aufirst%3DM.%26aulast%3DOyagi%26aufirst%3DA.%26aulast%3DPagnussat%26aufirst%3DG.%2BC.%26aulast%3DPark%26aufirst%3DJ.%26aulast%3DRan%26aufirst%3DQ.%26aulast%3DRosenfeld%26aufirst%3DC.%2BS.%26aulast%3DSalnikow%26aufirst%3DK.%26aulast%3DTang%26aufirst%3DD.%26aulast%3DTorti%26aufirst%3DF.%2BM.%26aulast%3DTorti%26aufirst%3DS.%2BV.%26aulast%3DToyokuni%26aufirst%3DS.%26aulast%3DWoerpel%26aufirst%3DK.%2BA.%26aulast%3DZhang%26aufirst%3DD.%2BD.%26atitle%3DFerroptosis%253A%2520a%2520regulated%2520cell%2520death%2520nexus%2520linking%2520metabolism%252C%2520redox%2520biology%252C%2520and%2520disease%26jtitle%3DCell%26date%3D2017%26volume%3D171%26spage%3D273%26epage%3D285%26doi%3D10.1016%2Fj.cell.2017.09.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Galluzzi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vitale, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aaronson, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abrams, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adam, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agostinis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alnemri, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altucci, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amelio, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrews, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Annicchiarico-Petruzzelli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antonov, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arama, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baehrecke, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barlev, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bazan, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernassola, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertrand, M. J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bianchi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagosklonny, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blomgren, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borner, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boya, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brenner, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campanella, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Candi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carmona-Gutierrez, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cecconi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, F. K.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandel, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chipuk, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cidlowski, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciechanover, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conrad, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cubillos-Ruiz, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czabotar, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DâAngiolella, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dawson, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dawson, V. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Laurenzi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Maria, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Debatin, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeBerardinis, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deshmukh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Daniele, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Virgilio, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dixit, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dixon, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duckett, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dynlacht, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Deiry, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elrod, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fimia, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fulda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">GarcÃ­a-SÃ¡ez, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garg, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garrido, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gavathiotis, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golstein, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gottlieb, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greene, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gronemeyer, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gross, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hajnoczky, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hardwick, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, I. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hengartner, M. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hetz, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ichijo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">JÃ¤Ã¤ttelÃ¤, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joseph, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jost, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Juin, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaufmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kepp, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimchi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitsis, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klionsky, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knight, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemasters, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levine, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linkermann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lipton, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lockshin, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LÃ³pez-OtÃ­n, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowe, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luedde, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lugli, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacFarlane, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madeo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malewicz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malorni, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manic, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marine, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinou, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medema, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehlen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meier, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melino, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molkentin, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moll, U. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MuÃ±oz-Pinedo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagata, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">NuÃ±ez, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oberst, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oren, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overholtzer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pagano, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panaretakis, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasparakis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Penninger, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pereira, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pervaiz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peter, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piacentini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinton, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prehn, J. H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puthalakath, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rabinovich, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rehm, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizzuto, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodrigues, C. M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubinsztein, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudel, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryan, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sayan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scorrano, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silke, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simon, H.-U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sistigu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stockwell, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strasser, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szabadkai, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tait, S. W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tavernarakis, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thorburn, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsujimoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turk, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanden Berghe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandenabeele, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vander Heiden, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villunger, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Virgin, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vousden, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vucic, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walczak, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallach, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zakeri, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhivotovsky, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zitvogel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melino, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kroemer, G.</span></span> <span> </span><span class="NLM_article-title">Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018</span>. <i>Cell Death Differ.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">486</span>â <span class="NLM_lpage">541</span>, <span class="refDoi">Â DOI: 10.1038/s41418-017-0012-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=10.1038%2Fs41418-017-0012-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=29362479" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=1%3ACAS%3A280%3ADC%252BC1MvjsFKgug%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2018&pages=486-541&author=L.+Galluzziauthor=I.+Vitaleauthor=S.+A.+Aaronsonauthor=J.+M.+Abramsauthor=D.+Adamauthor=P.+Agostinisauthor=E.+S.+Alnemriauthor=L.+Altucciauthor=I.+Amelioauthor=D.+W.+Andrewsauthor=M.+Annicchiarico-Petruzzelliauthor=A.+V.+Antonovauthor=E.+Aramaauthor=E.+H.+Baehreckeauthor=N.+A.+Barlevauthor=N.+G.+Bazanauthor=F.+Bernassolaauthor=M.+J.+M.+Bertrandauthor=K.+Bianchiauthor=M.+V.+Blagosklonnyauthor=K.+Blomgrenauthor=C.+Bornerauthor=P.+Boyaauthor=C.+Brennerauthor=M.+Campanellaauthor=E.+Candiauthor=D.+Carmona-Gutierrezauthor=F.+Cecconiauthor=F.+K.-M.+Chanauthor=N.+S.+Chandelauthor=E.+H.+Chengauthor=J.+E.+Chipukauthor=J.+A.+Cidlowskiauthor=A.+Ciechanoverauthor=G.+M.+Cohenauthor=M.+Conradauthor=J.+R.+Cubillos-Ruizauthor=P.+E.+Czabotarauthor=V.+D%E2%80%99Angiolellaauthor=T.+M.+Dawsonauthor=V.+L.+Dawsonauthor=V.+De+Laurenziauthor=R.+De+Mariaauthor=K.+M.+Debatinauthor=R.+J.+DeBerardinisauthor=M.+Deshmukhauthor=N.+Di+Danieleauthor=F.+Di+Virgilioauthor=V.+M.+Dixitauthor=S.+J.+Dixonauthor=C.+S.+Duckettauthor=B.+D.+Dynlachtauthor=W.+S.+El-Deiryauthor=J.+W.+Elrodauthor=G.+M.+Fimiaauthor=S.+Fuldaauthor=A.+J.+Garc%C3%ADa-S%C3%A1ezauthor=A.+D.+Gargauthor=C.+Garridoauthor=E.+Gavathiotisauthor=P.+Golsteinauthor=E.+Gottliebauthor=D.+R.+Greenauthor=L.+A.+Greeneauthor=H.+Gronemeyerauthor=A.+Grossauthor=G.+Hajnoczkyauthor=J.+M.+Hardwickauthor=I.+S.+Harrisauthor=M.+O.+Hengartnerauthor=C.+Hetzauthor=H.+Ichijoauthor=M.+J%C3%A4%C3%A4ttel%C3%A4author=B.+Josephauthor=P.+J.+Jostauthor=P.+P.+Juinauthor=W.+J.+Kaiserauthor=M.+Karinauthor=T.+Kaufmannauthor=O.+Keppauthor=A.+Kimchiauthor=R.+N.+Kitsisauthor=D.+J.+Klionskyauthor=R.+A.+Knightauthor=S.+Kumarauthor=S.+W.+Leeauthor=J.+J.+Lemastersauthor=B.+Levineauthor=A.+Linkermannauthor=S.+A.+Liptonauthor=R.+A.+Lockshinauthor=C.+L%C3%B3pez-Ot%C3%ADnauthor=S.+W.+Loweauthor=T.+Lueddeauthor=E.+Lugliauthor=M.+MacFarlaneauthor=F.+Madeoauthor=M.+Malewiczauthor=W.+Malorniauthor=G.+Manicauthor=J.+C.+Marineauthor=S.+J.+Martinauthor=J.+C.+Martinouauthor=J.+P.+Medemaauthor=P.+Mehlenauthor=P.+Meierauthor=S.+Melinoauthor=E.+A.+Miaoauthor=J.+D.+Molkentinauthor=U.+M.+Mollauthor=C.+Mu%C3%B1oz-Pinedoauthor=S.+Nagataauthor=G.+Nu%C3%B1ezauthor=A.+Oberstauthor=M.+Orenauthor=M.+Overholtzerauthor=M.+Paganoauthor=T.+Panaretakisauthor=M.+Pasparakisauthor=J.+M.+Penningerauthor=D.+M.+Pereiraauthor=S.+Pervaizauthor=M.+E.+Peterauthor=M.+Piacentiniauthor=P.+Pintonauthor=J.+H.+M.+Prehnauthor=H.+Puthalakathauthor=G.+A.+Rabinovichauthor=M.+Rehmauthor=R.+Rizzutoauthor=C.+M.+P.+Rodriguesauthor=D.+C.+Rubinszteinauthor=T.+Rudelauthor=K.+M.+Ryanauthor=E.+Sayanauthor=L.+Scorranoauthor=F.+Shaoauthor=Y.+Shiauthor=J.+Silkeauthor=H.-U.+Simonauthor=A.+Sistiguauthor=B.+R.+Stockwellauthor=A.+Strasserauthor=G.+Szabadkaiauthor=S.+W.+G.+Taitauthor=D.+Tangauthor=N.+Tavernarakisauthor=A.+Thorburnauthor=Y.+Tsujimotoauthor=B.+Turkauthor=T.+Vanden+Bergheauthor=P.+Vandenabeeleauthor=M.+G.+Vander+Heidenauthor=A.+Villungerauthor=H.+W.+Virginauthor=K.+H.+Vousdenauthor=D.+Vucicauthor=E.+F.+Wagnerauthor=H.+Walczakauthor=D.+Wallachauthor=Y.+Wangauthor=J.+A.+Wellsauthor=W.+Woodauthor=J.+Yuanauthor=Z.+Zakeriauthor=B.+Zhivotovskyauthor=L.+Zitvogelauthor=G.+Melinoauthor=G.+Kroemer&title=Molecular+mechanisms+of+cell+death%3A+recommendations+of+the+Nomenclature+Committee+on+Cell+Death+2018&doi=10.1038%2Fs41418-017-0012-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018</span></div><div class="casAuthors">Galluzzi Lorenzo; Galluzzi Lorenzo; Cubillos-Ruiz Juan R; Galluzzi Lorenzo; Kepp Oliver; Kroemer Guido; Vitale Ilio; Campanella Michelangelo; Cecconi Francesco; Manic Gwenola; Piacentini Mauro; Vitale Ilio; Campanella Michelangelo; Manic Gwenola; Aaronson Stuart A; Chipuk Jerry E; Abrams John M; Adam Dieter; Agostinis Patrizia; Garg Abhishek D; Alnemri Emad S; Altucci Lucia; Amelio Ivano; Antonov Alexey V; Knight Richard A; MacFarlane Marion; Malewicz Michal; Melino Gerry; Andrews David W; Andrews David W; Andrews David W; Annicchiarico-Petruzzelli Margherita; Candi Eleonora; Arama Eli; Kimchi Adi; Baehrecke Eric H; Barlev Nickolai A; Bazan Nicolas G; Bernassola Francesca; Candi Eleonora; Melino Gerry; Bertrand Mathieu J M; Vanden Berghe Tom; Vandenabeele Peter; Bertrand Mathieu J M; Vanden Berghe Tom; Vandenabeele Peter; Bianchi Katiuscia; Blagosklonny Mikhail V; Blomgren Klas; Kroemer Guido; Blomgren Klas; Borner Christoph; Borner Christoph; Boya Patricia; Brenner Catherine; Brenner Catherine; Campanella Michelangelo; Campanella Michelangelo; Carmona-Gutierrez Didac; Madeo Frank; Cecconi Francesco; Cecconi Francesco; Chan Francis K-M; Chandel Navdeep S; Cheng Emily H; Cidlowski John A; Ciechanover Aaron; Gottlieb Eyal; Cohen Gerald M; Conrad Marcus; Cubillos-Ruiz Juan R; Czabotar Peter E; Strasser Andreas; Czabotar Peter E; Silke John; D'Angiolella Vincenzo; Dawson Ted M; Dawson Valina L; Dawson Ted M; Dawson Valina L; Dawson Ted M; Dawson Ted M; Dawson Valina L; Dawson Valina L; De Laurenzi Vincenzo; De Maria Ruggero; Sistigu Antonella; Debatin Klaus-Michael; DeBerardinis Ralph J; Deshmukh Mohanish; Di Daniele Nicola; Di Virgilio Francesco; Pinton Paolo; Dixit Vishva M; Dixon Scott J; Duckett Colin S; Dynlacht Brian D; Dynlacht Brian D; Pagano Michele; El-Deiry Wafik S; El-Deiry Wafik S; Elrod John W; Fimia Gian Maria; Piacentini Mauro; Fimia Gian Maria; Fulda Simone; Fulda Simone; Fulda Simone; Garcia-Saez Ana J; Garrido Carmen; Garrido Carmen; Garrido Carmen; Gavathiotis Evripidis; Gavathiotis Evripidis; Kitsis Richard N; Gavathiotis Evripidis; Kitsis Richard N; Gavathiotis Evripidis; Kitsis Richard N; Golstein Pierre; Gottlieb Eyal; Ryan Kevin M; Tait Stephen W G; Green Douglas R; Greene Lloyd A; Gronemeyer Hinrich; Gronemeyer Hinrich; Gronemeyer Hinrich; Gronemeyer Hinrich; Gross Atan; Hajnoczky Gyorgy; Hardwick J Marie; Harris Isaac S; Yuan Junying; Hengartner Michael O; Hetz Claudio; Hetz Claudio; Hetz Claudio; Ichijo Hidenori; Jaattela Marja; Joseph Bertrand; Zhivotovsky Boris; Jost Philipp J; Juin Philippe P; Juin Philippe P; Juin Philippe P; Juin Philippe P; Kaiser William J; Karin Michael; Karin Michael; Karin Michael; Karin Michael; Kaufmann Thomas; Simon Hans-Uwe; Kepp Oliver; Zitvogel Laurence; Kepp Oliver; Kroemer Guido; Kepp Oliver; Kroemer Guido; Kepp Oliver; Kroemer Guido; Kepp Oliver; Kroemer Guido; Kitsis Richard N; Kitsis Richard N; Klionsky Daniel J; Klionsky Daniel J; Kumar Sharad; Lee Sam W; Lemasters John J; Lemasters John J; Levine Beth; Levine Beth; Levine Beth; Linkermann Andreas; Lipton Stuart A; Lipton Stuart A; Lipton Stuart A; Lockshin Richard A; Lockshin Richard A; Lopez-Otin Carlos; Lowe Scott W; Lowe Scott W; Luedde Tom; Lugli Enrico; Lugli Enrico; Madeo Frank; Malorni Walter; Marine Jean-Christophe; Marine Jean-Christophe; Martin Seamus J; Martinou Jean-Claude; Medema Jan Paul; Medema Jan Paul; Mehlen Patrick; Mehlen Patrick; Mehlen Patrick; Mehlen Patrick; Mehlen Patrick; Mehlen Patrick; Meier Pascal; Melino Sonia; Miao Edward A; Miao Edward A; Miao Edward A; Molkentin Jeffery D; Moll Ute M; Munoz-Pinedo Cristina; Nagata Shigekazu; Nunez Gabriel; Nunez Gabriel; Oberst Andrew; Oberst Andrew; Oren Moshe; Overholtzer Michael; Pagano Michele; Pagano Michele; Panaretakis Theocharis; Panaretakis Theocharis; Pasparakis Manolis; Pasparakis Manolis; Penninger Josef M; Pereira David M; Pervaiz Shazib; Pervaiz Shazib; Pervaiz Shazib; Peter Marcus E; Peter Marcus E; Pinton Paolo; Pinton Paolo; Prehn Jochen H M; Puthalakath Hamsa; Rabinovich Gabriel A; Rabinovich Gabriel A; Rehm Markus; Rehm Markus; Rizzuto Rosario; Szabadkai Gyorgy; Rodrigues Cecilia M P; Rubinsztein David C; Rudel Thomas; Sayan Emre; Scorrano Luca; Scorrano Luca; Shao Feng; Shi Yufang; Shi Yufang; Shi Yufang; Silke John; Sistigu Antonella; Stockwell Brent R; Stockwell Brent R; Szabadkai Gyorgy; Szabadkai Gyorgy; Vousden Karen H; Tang Daolin; Tang Daolin; Tang Daolin; Tang Daolin; Tang Daolin; Tang Daolin; Tavernarakis Nektarios; Thorburn Andrew; Tsujimoto Yoshihide; Turk Boris; Turk Boris; Vander Heiden Matthew G; Vander Heiden Matthew G; Vander Heiden Matthew G; Villunger Andreas; Virgin Herbert W; Vucic Domagoj; Wagner Erwin F; Walczak Henning; Wallach David; Wang Ying; Wells James A; Wood Will; Yuan Junying; Zakeri Zahra; Zhivotovsky Boris; Zitvogel Laurence; Zitvogel Laurence; Zitvogel Laurence; Kroemer Guido</div><div class="citationInfo"><span class="NLM_cas:title">Cell death and differentiation</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">486-541</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Over the past decade, the Nomenclature Committee on Cell Death (NCCD) has formulated guidelines for the definition and interpretation of cell death from morphological, biochemical, and functional perspectives.  Since the field continues to expand and novel mechanisms that orchestrate multiple cell death pathways are unveiled, we propose an updated classification of cell death subroutines focusing on mechanistic and essential (as opposed to correlative and dispensable) aspects of the process.  As we provide molecularly oriented definitions of terms including intrinsic apoptosis, extrinsic apoptosis, mitochondrial permeability transition (MPT)-driven necrosis, necroptosis, ferroptosis, pyroptosis, parthanatos, entotic cell death, NETotic cell death, lysosome-dependent cell death, autophagy-dependent cell death, immunogenic cell death, cellular senescence, and mitotic catastrophe, we discuss the utility of neologisms that refer to highly specialized instances of these processes.  The mission of the NCCD is to provide a widely accepted nomenclature on cell death in support of the continued development of the field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRVakKpC8MvO-R_TJajKxJDfW6udTcc2ebHt4DY0_MCPLntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MvjsFKgug%253D%253D&md5=4f2b2e5757ae4448c16f7114cd494a7c</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fs41418-017-0012-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41418-017-0012-4%26sid%3Dliteratum%253Aachs%26aulast%3DGalluzzi%26aufirst%3DL.%26aulast%3DVitale%26aufirst%3DI.%26aulast%3DAaronson%26aufirst%3DS.%2BA.%26aulast%3DAbrams%26aufirst%3DJ.%2BM.%26aulast%3DAdam%26aufirst%3DD.%26aulast%3DAgostinis%26aufirst%3DP.%26aulast%3DAlnemri%26aufirst%3DE.%2BS.%26aulast%3DAltucci%26aufirst%3DL.%26aulast%3DAmelio%26aufirst%3DI.%26aulast%3DAndrews%26aufirst%3DD.%2BW.%26aulast%3DAnnicchiarico-Petruzzelli%26aufirst%3DM.%26aulast%3DAntonov%26aufirst%3DA.%2BV.%26aulast%3DArama%26aufirst%3DE.%26aulast%3DBaehrecke%26aufirst%3DE.%2BH.%26aulast%3DBarlev%26aufirst%3DN.%2BA.%26aulast%3DBazan%26aufirst%3DN.%2BG.%26aulast%3DBernassola%26aufirst%3DF.%26aulast%3DBertrand%26aufirst%3DM.%2BJ.%2BM.%26aulast%3DBianchi%26aufirst%3DK.%26aulast%3DBlagosklonny%26aufirst%3DM.%2BV.%26aulast%3DBlomgren%26aufirst%3DK.%26aulast%3DBorner%26aufirst%3DC.%26aulast%3DBoya%26aufirst%3DP.%26aulast%3DBrenner%26aufirst%3DC.%26aulast%3DCampanella%26aufirst%3DM.%26aulast%3DCandi%26aufirst%3DE.%26aulast%3DCarmona-Gutierrez%26aufirst%3DD.%26aulast%3DCecconi%26aufirst%3DF.%26aulast%3DChan%26aufirst%3DF.%2BK.-M.%26aulast%3DChandel%26aufirst%3DN.%2BS.%26aulast%3DCheng%26aufirst%3DE.%2BH.%26aulast%3DChipuk%26aufirst%3DJ.%2BE.%26aulast%3DCidlowski%26aufirst%3DJ.%2BA.%26aulast%3DCiechanover%26aufirst%3DA.%26aulast%3DCohen%26aufirst%3DG.%2BM.%26aulast%3DConrad%26aufirst%3DM.%26aulast%3DCubillos-Ruiz%26aufirst%3DJ.%2BR.%26aulast%3DCzabotar%26aufirst%3DP.%2BE.%26aulast%3DD%25E2%2580%2599Angiolella%26aufirst%3DV.%26aulast%3DDawson%26aufirst%3DT.%2BM.%26aulast%3DDawson%26aufirst%3DV.%2BL.%26aulast%3DDe%2BLaurenzi%26aufirst%3DV.%26aulast%3DDe%2BMaria%26aufirst%3DR.%26aulast%3DDebatin%26aufirst%3DK.%2BM.%26aulast%3DDeBerardinis%26aufirst%3DR.%2BJ.%26aulast%3DDeshmukh%26aufirst%3DM.%26aulast%3DDi%2BDaniele%26aufirst%3DN.%26aulast%3DDi%2BVirgilio%26aufirst%3DF.%26aulast%3DDixit%26aufirst%3DV.%2BM.%26aulast%3DDixon%26aufirst%3DS.%2BJ.%26aulast%3DDuckett%26aufirst%3DC.%2BS.%26aulast%3DDynlacht%26aufirst%3DB.%2BD.%26aulast%3DEl-Deiry%26aufirst%3DW.%2BS.%26aulast%3DElrod%26aufirst%3DJ.%2BW.%26aulast%3DFimia%26aufirst%3DG.%2BM.%26aulast%3DFulda%26aufirst%3DS.%26aulast%3DGarc%25C3%25ADa-S%25C3%25A1ez%26aufirst%3DA.%2BJ.%26aulast%3DGarg%26aufirst%3DA.%2BD.%26aulast%3DGarrido%26aufirst%3DC.%26aulast%3DGavathiotis%26aufirst%3DE.%26aulast%3DGolstein%26aufirst%3DP.%26aulast%3DGottlieb%26aufirst%3DE.%26aulast%3DGreen%26aufirst%3DD.%2BR.%26aulast%3DGreene%26aufirst%3DL.%2BA.%26aulast%3DGronemeyer%26aufirst%3DH.%26aulast%3DGross%26aufirst%3DA.%26aulast%3DHajnoczky%26aufirst%3DG.%26aulast%3DHardwick%26aufirst%3DJ.%2BM.%26aulast%3DHarris%26aufirst%3DI.%2BS.%26aulast%3DHengartner%26aufirst%3DM.%2BO.%26aulast%3DHetz%26aufirst%3DC.%26aulast%3DIchijo%26aufirst%3DH.%26aulast%3DJ%25C3%25A4%25C3%25A4ttel%25C3%25A4%26aufirst%3DM.%26aulast%3DJoseph%26aufirst%3DB.%26aulast%3DJost%26aufirst%3DP.%2BJ.%26aulast%3DJuin%26aufirst%3DP.%2BP.%26aulast%3DKaiser%26aufirst%3DW.%2BJ.%26aulast%3DKarin%26aufirst%3DM.%26aulast%3DKaufmann%26aufirst%3DT.%26aulast%3DKepp%26aufirst%3DO.%26aulast%3DKimchi%26aufirst%3DA.%26aulast%3DKitsis%26aufirst%3DR.%2BN.%26aulast%3DKlionsky%26aufirst%3DD.%2BJ.%26aulast%3DKnight%26aufirst%3DR.%2BA.%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DS.%2BW.%26aulast%3DLemasters%26aufirst%3DJ.%2BJ.%26aulast%3DLevine%26aufirst%3DB.%26aulast%3DLinkermann%26aufirst%3DA.%26aulast%3DLipton%26aufirst%3DS.%2BA.%26aulast%3DLockshin%26aufirst%3DR.%2BA.%26aulast%3DL%25C3%25B3pez-Ot%25C3%25ADn%26aufirst%3DC.%26aulast%3DLowe%26aufirst%3DS.%2BW.%26aulast%3DLuedde%26aufirst%3DT.%26aulast%3DLugli%26aufirst%3DE.%26aulast%3DMacFarlane%26aufirst%3DM.%26aulast%3DMadeo%26aufirst%3DF.%26aulast%3DMalewicz%26aufirst%3DM.%26aulast%3DMalorni%26aufirst%3DW.%26aulast%3DManic%26aufirst%3DG.%26aulast%3DMarine%26aufirst%3DJ.%2BC.%26aulast%3DMartin%26aufirst%3DS.%2BJ.%26aulast%3DMartinou%26aufirst%3DJ.%2BC.%26aulast%3DMedema%26aufirst%3DJ.%2BP.%26aulast%3DMehlen%26aufirst%3DP.%26aulast%3DMeier%26aufirst%3DP.%26aulast%3DMelino%26aufirst%3DS.%26aulast%3DMiao%26aufirst%3DE.%2BA.%26aulast%3DMolkentin%26aufirst%3DJ.%2BD.%26aulast%3DMoll%26aufirst%3DU.%2BM.%26aulast%3DMu%25C3%25B1oz-Pinedo%26aufirst%3DC.%26aulast%3DNagata%26aufirst%3DS.%26aulast%3DNu%25C3%25B1ez%26aufirst%3DG.%26aulast%3DOberst%26aufirst%3DA.%26aulast%3DOren%26aufirst%3DM.%26aulast%3DOverholtzer%26aufirst%3DM.%26aulast%3DPagano%26aufirst%3DM.%26aulast%3DPanaretakis%26aufirst%3DT.%26aulast%3DPasparakis%26aufirst%3DM.%26aulast%3DPenninger%26aufirst%3DJ.%2BM.%26aulast%3DPereira%26aufirst%3DD.%2BM.%26aulast%3DPervaiz%26aufirst%3DS.%26aulast%3DPeter%26aufirst%3DM.%2BE.%26aulast%3DPiacentini%26aufirst%3DM.%26aulast%3DPinton%26aufirst%3DP.%26aulast%3DPrehn%26aufirst%3DJ.%2BH.%2BM.%26aulast%3DPuthalakath%26aufirst%3DH.%26aulast%3DRabinovich%26aufirst%3DG.%2BA.%26aulast%3DRehm%26aufirst%3DM.%26aulast%3DRizzuto%26aufirst%3DR.%26aulast%3DRodrigues%26aufirst%3DC.%2BM.%2BP.%26aulast%3DRubinsztein%26aufirst%3DD.%2BC.%26aulast%3DRudel%26aufirst%3DT.%26aulast%3DRyan%26aufirst%3DK.%2BM.%26aulast%3DSayan%26aufirst%3DE.%26aulast%3DScorrano%26aufirst%3DL.%26aulast%3DShao%26aufirst%3DF.%26aulast%3DShi%26aufirst%3DY.%26aulast%3DSilke%26aufirst%3DJ.%26aulast%3DSimon%26aufirst%3DH.-U.%26aulast%3DSistigu%26aufirst%3DA.%26aulast%3DStockwell%26aufirst%3DB.%2BR.%26aulast%3DStrasser%26aufirst%3DA.%26aulast%3DSzabadkai%26aufirst%3DG.%26aulast%3DTait%26aufirst%3DS.%2BW.%2BG.%26aulast%3DTang%26aufirst%3DD.%26aulast%3DTavernarakis%26aufirst%3DN.%26aulast%3DThorburn%26aufirst%3DA.%26aulast%3DTsujimoto%26aufirst%3DY.%26aulast%3DTurk%26aufirst%3DB.%26aulast%3DVanden%2BBerghe%26aufirst%3DT.%26aulast%3DVandenabeele%26aufirst%3DP.%26aulast%3DVander%2BHeiden%26aufirst%3DM.%2BG.%26aulast%3DVillunger%26aufirst%3DA.%26aulast%3DVirgin%26aufirst%3DH.%2BW.%26aulast%3DVousden%26aufirst%3DK.%2BH.%26aulast%3DVucic%26aufirst%3DD.%26aulast%3DWagner%26aufirst%3DE.%2BF.%26aulast%3DWalczak%26aufirst%3DH.%26aulast%3DWallach%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DWells%26aufirst%3DJ.%2BA.%26aulast%3DWood%26aufirst%3DW.%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DZakeri%26aufirst%3DZ.%26aulast%3DZhivotovsky%26aufirst%3DB.%26aulast%3DZitvogel%26aufirst%3DL.%26aulast%3DMelino%26aufirst%3DG.%26aulast%3DKroemer%26aufirst%3DG.%26atitle%3DMolecular%2520mechanisms%2520of%2520cell%2520death%253A%2520recommendations%2520of%2520the%2520Nomenclature%2520Committee%2520on%2520Cell%2520Death%25202018%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2018%26volume%3D25%26spage%3D486%26epage%3D541%26doi%3D10.1038%2Fs41418-017-0012-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, B.</span></span> <span> </span><span class="NLM_article-title">Ferroptosis, a new form of cell death: opportunities and challenges in cancer</span>. <i>J. Hematol. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">34</span>, <span class="refDoi">Â DOI: 10.1186/s13045-019-0720-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=10.1186%2Fs13045-019-0720-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=30925886" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=1%3ACAS%3A280%3ADC%252BB3cbpsFKhtg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2019&pages=34&author=Y.+Mouauthor=J.+Wangauthor=J.+Wuauthor=D.+Heauthor=C.+Zhangauthor=C.+Duanauthor=B.+Li&title=Ferroptosis%2C+a+new+form+of+cell+death%3A+opportunities+and+challenges+in+cancer&doi=10.1186%2Fs13045-019-0720-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Ferroptosis, a new form of cell death: opportunities and challenges in cancer</span></div><div class="casAuthors">Mou Yanhua; Wu Jinchun; Duan Chaojun; Li Bin; Mou Yanhua; Wang Jun; Duan Chaojun; Li Bin; He Dan; Zhang Chunfang; Duan Chaojun</div><div class="citationInfo"><span class="NLM_cas:title">Journal of hematology & oncology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">34</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Ferroptosis is a novel type of cell death with distinct properties and recognizing functions involved in physical conditions or various diseases including cancers.  The fast-growing studies of ferroptosis in cancer have boosted a perspective for its usage in cancer therapeutics.  Here, we review the current findings of ferroptosis regulation and especially focus on the function of ncRNAs in mediating the process of cell ferroptotic death and on how ferroptosis was in relation to other regulated cell deaths.  Aberrant ferroptosis in diverse cancer types and tissues were summarized, and we elaborated recent data about the novel actors of some "conventional" drugs or natural compounds as ferroptosis inducers in cancer.  Finally, we deliberate future orientation for ferroptosis in cancer cells and current unsettled issues, which may forward the speed of clinical use of ferroptosis induction in cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSuf8Ef-3V1dAqdek-gHSrIfW6udTcc2ebHt4DY0_MCPLntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cbpsFKhtg%253D%253D&md5=9b6f8daa2e7c5abde56200e8e86cc8b4</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1186%2Fs13045-019-0720-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13045-019-0720-y%26sid%3Dliteratum%253Aachs%26aulast%3DMou%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DHe%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DDuan%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DB.%26atitle%3DFerroptosis%252C%2520a%2520new%2520form%2520of%2520cell%2520death%253A%2520opportunities%2520and%2520challenges%2520in%2520cancer%26jtitle%3DJ.%2520Hematol.%2520Oncol.%26date%3D2019%26volume%3D12%26spage%3D34%26doi%3D10.1186%2Fs13045-019-0720-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ye, L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaudhary, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zandkarimi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harken, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinslow, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Upadhyayula, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dovas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higgins, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buonanno, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T. J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hei, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruce, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canoll, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stockwell, B. R.</span></span> <span> </span><span class="NLM_article-title">Radiation-induced lipid peroxidation triggers ferroptosis and synergizes with ferroptosis inducers</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">469</span>â <span class="NLM_lpage">484</span>, <span class="refDoi">Â DOI: 10.1021/acschembio.9b00939</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.9b00939" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=1%3ACAS%3A528%3ADC%252BB3cXjt1Gmtw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2020&pages=469-484&author=L.+F.+Yeauthor=K.+R.+Chaudharyauthor=F.+Zandkarimiauthor=A.+D.+Harkenauthor=C.+J.+Kinslowauthor=P.+S.+Upadhyayulaauthor=A.+Dovasauthor=D.+M.+Higginsauthor=H.+Tanauthor=Y.+Zhangauthor=M.+Buonannoauthor=T.+J.+C.+Wangauthor=T.+K.+Heiauthor=J.+N.+Bruceauthor=P.+D.+Canollauthor=S.+K.+Chengauthor=B.+R.+Stockwell&title=Radiation-induced+lipid+peroxidation+triggers+ferroptosis+and+synergizes+with+ferroptosis+inducers&doi=10.1021%2Facschembio.9b00939"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Radiation-Induced Lipid Peroxidation Triggers Ferroptosis and Synergizes with Ferroptosis Inducers</span></div><div class="casAuthors">Ye, Ling F.; Chaudhary, Kunal R.; Zandkarimi, Fereshteh; Harken, Andrew D.; Kinslow, Connor J.; Upadhyayula, Pavan S.; Dovas, Athanassios; Higgins, Dominique M.; Tan, Hui; Zhang, Yan; Buonanno, Manuela; Wang, Tony J. C.; Hei, Tom K.; Bruce, Jeffrey N.; Canoll, Peter D.; Cheng, Simon K.; Stockwell, Brent R.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">469-484</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Although radiation is widely used to treat cancers, resistance mechanisms often develop and involve activation of DNA repair and inhibition of apoptosis.  Therefore, compds. that sensitize cancer cells to radiation via alternative cell death pathways are valuable.  We report here that ferroptosis, a form of nonapoptotic cell death driven by lipid peroxidn., is partly responsible for radiation-induced cancer cell death.  Moreover, we found that small mols. activating ferroptosis through system xc- inhibition or GPX4 inhibition synergize with radiation to induce ferroptosis in several cancer types by enhancing cytoplasmic lipid peroxidn. but not increasing DNA damage or caspase activation.  Ferroptosis inducers synergized with cytoplasmic irradn., but not nuclear irradn.  Finally, administration of ferroptosis inducers enhanced the antitumor effect of radiation in a murine xenograft model and in human patient-derived models of lung adenocarcinoma and glioma.  These results suggest that ferroptosis inducers may be effective radiosensitizers that can expand the efficacy and range of indications for radiation therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzYjXEp7fuRrVg90H21EOLACvtfcHk0lj-TF5y6PNLkA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXjt1Gmtw%253D%253D&md5=2b067453923c02ae41a336bb156dcba5</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Facschembio.9b00939&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.9b00939%26sid%3Dliteratum%253Aachs%26aulast%3DYe%26aufirst%3DL.%2BF.%26aulast%3DChaudhary%26aufirst%3DK.%2BR.%26aulast%3DZandkarimi%26aufirst%3DF.%26aulast%3DHarken%26aufirst%3DA.%2BD.%26aulast%3DKinslow%26aufirst%3DC.%2BJ.%26aulast%3DUpadhyayula%26aufirst%3DP.%2BS.%26aulast%3DDovas%26aufirst%3DA.%26aulast%3DHiggins%26aufirst%3DD.%2BM.%26aulast%3DTan%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DBuonanno%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DT.%2BJ.%2BC.%26aulast%3DHei%26aufirst%3DT.%2BK.%26aulast%3DBruce%26aufirst%3DJ.%2BN.%26aulast%3DCanoll%26aufirst%3DP.%2BD.%26aulast%3DCheng%26aufirst%3DS.%2BK.%26aulast%3DStockwell%26aufirst%3DB.%2BR.%26atitle%3DRadiation-induced%2520lipid%2520peroxidation%2520triggers%2520ferroptosis%2520and%2520synergizes%2520with%2520ferroptosis%2520inducers%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2020%26volume%3D15%26spage%3D469%26epage%3D484%26doi%3D10.1021%2Facschembio.9b00939" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cui, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span> <span> </span><span class="NLM_article-title">LRPPRC: a multifunctional protein involved in energy metabolism and human disease</span>. <i>Front. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">595</span>, <span class="refDoi">Â DOI: 10.3389/fphys.2019.00595</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=10.3389%2Ffphys.2019.00595" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=31178748" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=1%3ACAS%3A280%3ADC%252BB3M3kslehsg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=595&author=J.+Cuiauthor=L.+Wangauthor=X.+Renauthor=Y.+Zhangauthor=H.+Zhang&title=LRPPRC%3A+a+multifunctional+protein+involved+in+energy+metabolism+and+human+disease&doi=10.3389%2Ffphys.2019.00595"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">LRPPRC: A Multifunctional Protein Involved in Energy Metabolism and Human Disease</span></div><div class="casAuthors">Cui Jie; Wang Li; Ren Xiaoyue; Zhang Yamin; Cui Jie; Wang Li; Ren Xiaoyue; Zhang Yamin; Zhang Hongyi; Zhang Hongyi</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in physiology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">595</span>
        ISSN:<span class="NLM_cas:issn">1664-042X</span>.
    </div><div class="casAbstract">The pentatricopeptide repeat (PPR) family plays a major role in RNA stability, regulation, processing, splicing, translation, and editing.  Leucine-rich PPR-motif-containing protein (LRPPRC), a member of the PPR family, is a known gene mutation that causes Leigh syndrome French-Canadian.  Recently, growing evidence has pointed out that LRPPRC dysregulation is related to various diseases ranging from tumors to viral infections.  This review presents available published data on the LRPPRC protein function and its role in tumors and other diseases.  As a multi-functional protein, LRPPRC regulates a myriad of biological processes, including energy metabolism and maturation and the export of nuclear mRNA.  Overexpression of LRPPRC has been observed in various human tumors and is associated with poor prognosis.  Downregulation of LRPPRC inhibits growth and invasion, induces apoptosis, and overcomes drug resistance in tumor cells.  In addition, LRPPRC plays a potential role in Parkinson's disease, neurofibromatosis 1, viral infections, and venous thromboembolism.  Further investigating these new functions of LRPPRC should provide novel opportunities for a better understanding of its pathological role in diseases from tumors to viral infections and as a potential biomarker and molecular target for disease treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTX1yhwJRUF1Awxfk_AGB-EfW6udTcc2eZ7jmlPtd3hirntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3M3kslehsg%253D%253D&md5=a15a14c87772c9b016196961dcabc513</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.3389%2Ffphys.2019.00595&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphys.2019.00595%26sid%3Dliteratum%253Aachs%26aulast%3DCui%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DRen%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DH.%26atitle%3DLRPPRC%253A%2520a%2520multifunctional%2520protein%2520involved%2520in%2520energy%2520metabolism%2520and%2520human%2520disease%26jtitle%3DFront.%2520Physiol.%26date%3D2019%26volume%3D10%26spage%3D595%26doi%3D10.3389%2Ffphys.2019.00595" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matilainen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carroll, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richter, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Euro, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pohjanpelto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paetau, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isohanni, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suomalainen, A.</span></span> <span> </span><span class="NLM_article-title">Defective mitochondrial RNA processing due to PNPT1 variants causes Leigh syndrome</span>. <i>Hum. Mol. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">3352</span>â <span class="NLM_lpage">3361</span>, <span class="refDoi">Â DOI: 10.1093/hmg/ddx221</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=10.1093%2Fhmg%2Fddx221" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=28645153" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=1%3ACAS%3A528%3ADC%252BC1cXmtVyit7s%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2017&pages=3352-3361&author=S.+Matilainenauthor=C.+J.+Carrollauthor=U.+Richterauthor=L.+Euroauthor=M.+Pohjanpeltoauthor=A.+Paetauauthor=P.+Isohanniauthor=A.+Suomalainen&title=Defective+mitochondrial+RNA+processing+due+to+PNPT1+variants+causes+Leigh+syndrome&doi=10.1093%2Fhmg%2Fddx221"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Defective mitochondrial RNA processing due to PNPT1 variants causes Leigh syndrome</span></div><div class="casAuthors">Matilainen, Sanna; Carroll, Christopher J.; Richter, Uwe; Euro, Liliya; Pohjanpelto, Max; Paetau, Anders; Isohanni, Pirjo; Suomalainen, Anu</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">3352-3361</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">1460-2083</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Leigh syndrome is a severe infantile encephalopathy with an exceptionally variable genetic background.  We studied the exome of a child manifesting with Leigh syndrome at one month of age and progressing to death by the age of 2.4 years, and identified novel compd. heterozygous variants in PNPT1, encoding the polynucleotide phosphorylase (PNPase).  Expression of the wild type PNPT1 in the subject's myoblasts functionally complemented the defects, and the pathogenicity was further supported by structural predictions and protein and RNA analyses.  PNPase is a key enzyme in mitochondrial RNA metab., with suggested roles in mitochondrial RNA import and degrdn.  The variants were predicted to locate in the PNPase active site and disturb the RNA processing activity of the enzyme.  The PNPase trimer formation was not affected, but specific RNA processing intermediates derived from mitochondrial transcripts of the ND6 subunit of Complex I, as well as small mRNA fragments, accumulated in the subject's myoblasts.  Mitochondrial RNA processing mediated by the degradosome consisting of hSUV3 and PNPase is poorly characterized, and controversy on the role and location of PNPase within human mitochondria exists.  Our evidence indicates that PNPase activity is essential for the correct maturation of the ND6 transcripts, and likely for the efficient removal of degrdn. intermediates.  Loss of its activity will result in combined respiratory chain deficiency, and a classic respiratory chain-deficiency-assocd. disease, Leigh syndrome, indicating an essential role for the enzyme for normal function of the mitochondrial respiratory chain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeWxcqF5TRfLVg90H21EOLACvtfcHk0lhOITUIAuddxA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXmtVyit7s%253D&md5=cee624126e68c67477d4a808a7742f1a</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2Fddx221&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252Fddx221%26sid%3Dliteratum%253Aachs%26aulast%3DMatilainen%26aufirst%3DS.%26aulast%3DCarroll%26aufirst%3DC.%2BJ.%26aulast%3DRichter%26aufirst%3DU.%26aulast%3DEuro%26aufirst%3DL.%26aulast%3DPohjanpelto%26aufirst%3DM.%26aulast%3DPaetau%26aufirst%3DA.%26aulast%3DIsohanni%26aufirst%3DP.%26aulast%3DSuomalainen%26aufirst%3DA.%26atitle%3DDefective%2520mitochondrial%2520RNA%2520processing%2520due%2520to%2520PNPT1%2520variants%2520causes%2520Leigh%2520syndrome%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2017%26volume%3D26%26spage%3D3352%26epage%3D3361%26doi%3D10.1093%2Fhmg%2Fddx221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chilin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marzaro, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zanatta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbieri, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pastorini, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manzini, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guiotto, A.</span></span> <span> </span><span class="NLM_article-title">A new access to quinazolines from simple anilines</span>. <i>Tetrahedron</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">12351</span>â <span class="NLM_lpage">12356</span>, <span class="refDoi">Â DOI: 10.1016/j.tet.2006.09.103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=10.1016%2Fj.tet.2006.09.103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1Cmtr7F" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2006&pages=12351-12356&author=A.+Chilinauthor=G.+Marzaroauthor=S.+Zanattaauthor=V.+Barbieriauthor=G.+Pastoriniauthor=P.+Manziniauthor=A.+Guiotto&title=A+new+access+to+quinazolines+from+simple+anilines&doi=10.1016%2Fj.tet.2006.09.103"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">A new access to quinazolines from simple anilines</span></div><div class="casAuthors">Chilin, Adriana; Marzaro, Giovanni; Zanatta, Samuele; Barbieri, Vera; Pastorini, Giovanni; Manzini, Paolo; Guiotto, Adriano</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">52</span>),
    <span class="NLM_cas:pages">12351-12356</span>CODEN:
                <span class="NLM_cas:coden">TETRAB</span>;
        ISSN:<span class="NLM_cas:issn">0040-4020</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A new synthetic pathway to quinazolines, e.g., I (R = Me or MeO) was described.  This new method used hexamethylenetetramine in TFA and potassium ferricyanide in aq. ethanolic KOH, starting from simple N-protected anilines.  The method afforded substituted quinazolines with high selectivities and good yields, reducing reaction-time and work-up operations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraKBxLSteff7Vg90H21EOLACvtfcHk0lhOITUIAuddxA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1Cmtr7F&md5=05b4070e94f2711c720df717cccd1722</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.tet.2006.09.103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tet.2006.09.103%26sid%3Dliteratum%253Aachs%26aulast%3DChilin%26aufirst%3DA.%26aulast%3DMarzaro%26aufirst%3DG.%26aulast%3DZanatta%26aufirst%3DS.%26aulast%3DBarbieri%26aufirst%3DV.%26aulast%3DPastorini%26aufirst%3DG.%26aulast%3DManzini%26aufirst%3DP.%26aulast%3DGuiotto%26aufirst%3DA.%26atitle%3DA%2520new%2520access%2520to%2520quinazolines%2520from%2520simple%2520anilines%26jtitle%3DTetrahedron%26date%3D2006%26volume%3D62%26spage%3D12351%26epage%3D12356%26doi%3D10.1016%2Fj.tet.2006.09.103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Paulsen, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veloso, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prasad, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bedi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ljungman, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magnuson, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ljungman, M.</span></span> <span> </span><span class="NLM_article-title">Use of Bru-Seq and BruChase-Seq for genome-wide assessment of the synthesis and stability of RNA</span>. <i>Methods</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">45</span>â <span class="NLM_lpage">54</span>, <span class="refDoi">Â DOI: 10.1016/j.ymeth.2013.08.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=10.1016%2Fj.ymeth.2013.08.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=23973811" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFeksbvN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2014&pages=45-54&author=M.+T.+Paulsenauthor=A.+Velosoauthor=J.+Prasadauthor=K.+Bediauthor=E.+A.+Ljungmanauthor=B.+Magnusonauthor=T.+E.+Wilsonauthor=M.+Ljungman&title=Use+of+Bru-Seq+and+BruChase-Seq+for+genome-wide+assessment+of+the+synthesis+and+stability+of+RNA&doi=10.1016%2Fj.ymeth.2013.08.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Use of Bru-Seq and BruChase-Seq for genome-wide assessment of the synthesis and stability of RNA</span></div><div class="casAuthors">Paulsen, Michelle T.; Veloso, Artur; Prasad, Jayendra; Bedi, Karan; Ljungman, Emily A.; Magnuson, Brian; Wilson, Thomas E.; Ljungman, Mats</div><div class="citationInfo"><span class="NLM_cas:title">Methods (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">45-54</span>CODEN:
                <span class="NLM_cas:coden">MTHDE9</span>;
        ISSN:<span class="NLM_cas:issn">1046-2023</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Gene expression studies commonly examine total cellular RNA, which only provides information about its steady-state pool of RNA.  It remains unclear whether differences in the steady-state reflects variable rates of transcription or RNA degrdn.  To specifically monitor RNA synthesis and degrdn. genome-wide, we developed Bru-Seq and BruChase-Seq.  These assays are based on metabolic pulse-chase labeling of RNA using bromouridine (Bru).  In Bru-Seq, recently labeled RNAs are sequenced to reveal spans of nascent transcription in the genome.  In BruChase-Seq, cells are chased in uridine for different periods of time following Bru-labeling, allowing for the isolation of RNA populations of specific ages.  Here we describe these methodologies in detail and highlight their usefulness in assessing RNA synthesis and stability as well as splicing kinetics with examples of specific genes from different human cell lines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkhkyBLXrRWrVg90H21EOLACvtfcHk0lhOITUIAuddxA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFeksbvN&md5=a18ef08d32830fe03bf5024aa7246fb9</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.ymeth.2013.08.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ymeth.2013.08.015%26sid%3Dliteratum%253Aachs%26aulast%3DPaulsen%26aufirst%3DM.%2BT.%26aulast%3DVeloso%26aufirst%3DA.%26aulast%3DPrasad%26aufirst%3DJ.%26aulast%3DBedi%26aufirst%3DK.%26aulast%3DLjungman%26aufirst%3DE.%2BA.%26aulast%3DMagnuson%26aufirst%3DB.%26aulast%3DWilson%26aufirst%3DT.%2BE.%26aulast%3DLjungman%26aufirst%3DM.%26atitle%3DUse%2520of%2520Bru-Seq%2520and%2520BruChase-Seq%2520for%2520genome-wide%2520assessment%2520of%2520the%2520synthesis%2520and%2520stability%2520of%2520RNA%26jtitle%3DMethods%26date%3D2014%26volume%3D67%26spage%3D45%26epage%3D54%26doi%3D10.1016%2Fj.ymeth.2013.08.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Blaser, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dostert, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mak, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brenner, D.</span></span> <span> </span><span class="NLM_article-title">TNF and ROS crosstalk in inflammation</span>. <i>Trends Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">249</span>â <span class="NLM_lpage">261</span>, <span class="refDoi">Â DOI: 10.1016/j.tcb.2015.12.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=10.1016%2Fj.tcb.2015.12.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=26791157" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitV2ntbvP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=249-261&author=H.+Blaserauthor=C.+Dostertauthor=T.+W.+Makauthor=D.+Brenner&title=TNF+and+ROS+crosstalk+in+inflammation&doi=10.1016%2Fj.tcb.2015.12.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">TNF and ROS Crosstalk in Inflammation</span></div><div class="casAuthors">Blaser, Heiko; Dostert, Catherine; Mak, Tak W.; Brenner, Dirk</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Cell Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">249-261</span>CODEN:
                <span class="NLM_cas:coden">TCBIEK</span>;
        ISSN:<span class="NLM_cas:issn">0962-8924</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Tumor necrosis factor (TNF) is tremendously important for mammalian immunity and cellular homeostasis.  The role of TNF as a master regulator in balancing cell survival, apoptosis and necroptosis has been extensively studied in various cell types and tissues.  Although these findings have revealed much about the direct impact of TNF on the regulation of NF-ÎºB and JNK, there is now rising interest in understanding the emerging function of TNF as a regulator of the generation of reactive oxygen species (ROS) and reactive nitrogen species (RNS).  In this review we summarize work aimed at defining the role of TNF in the control of ROS/RNS signaling that influences innate immune cells under both physiol. and inflammatory conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-8cerxIhhCLVg90H21EOLACvtfcHk0lgsiAhGt0x6fw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitV2ntbvP&md5=3005a700a89113c5f68e3bb4d3ee8273</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.tcb.2015.12.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tcb.2015.12.002%26sid%3Dliteratum%253Aachs%26aulast%3DBlaser%26aufirst%3DH.%26aulast%3DDostert%26aufirst%3DC.%26aulast%3DMak%26aufirst%3DT.%2BW.%26aulast%3DBrenner%26aufirst%3DD.%26atitle%3DTNF%2520and%2520ROS%2520crosstalk%2520in%2520inflammation%26jtitle%3DTrends%2520Cell%2520Biol.%26date%3D2016%26volume%3D26%26spage%3D249%26epage%3D261%26doi%3D10.1016%2Fj.tcb.2015.12.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nishigori, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hattori, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toyokuni, S.</span></span> <span> </span><span class="NLM_article-title">Role of reactive oxygen species in skin carcinogenesis</span>. <i>Antioxid. Redox Signaling</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">561</span>â <span class="NLM_lpage">570</span>, <span class="refDoi">Â DOI: 10.1089/152308604773934314</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=10.1089%2F152308604773934314" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=15130282" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjslahu7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2004&pages=561-570&author=C.+Nishigoriauthor=Y.+Hattoriauthor=S.+Toyokuni&title=Role+of+reactive+oxygen+species+in+skin+carcinogenesis&doi=10.1089%2F152308604773934314"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Role of Reactive Oxygen Species in Skin Carcinogenesis</span></div><div class="casAuthors">Nishigori, Chikako; Hattori, Yukari; Toyokuni, Shinya</div><div class="citationInfo"><span class="NLM_cas:title">Antioxidants & Redox Signaling</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">561-570</span>CODEN:
                <span class="NLM_cas:coden">ARSIF2</span>;
        ISSN:<span class="NLM_cas:issn">1523-0864</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">A review.  Reactive oxygen species (ROS) are assocd. not only with initiation, but also with promotion and progression in the multistage carcinogenesis model.  In the present review, we will focus on the involvement of ROS in skin carcinogenesis, esp. that induced by UV radiation.  UV-specific DNA damage has been well studied thus far.  However, recent reports have revealed the previously unknown participation of oxidative stress in UV-induced skin carcinogenesis.  Indeed, in addn. to transition-type mutations at dipyrimidine sites, G:C to T:A transversions, which may be induced by the presence of 8-oxoguanine during DNA replication, are frequently obsd. in the ras oncogene and p53 tumor suppressor gene in human skin cancers of sun-exposed areas and in UV-induced mouse skin cancers.  Recent studies have shown that not only UV-B, but also UV-A is involved in UV-induced carcinogenesis.  A wide variety of biol. phenomena other than direct influence by UV, such as inflammatory and immunol. responses and oxidative modifications of DNA and proteins, appear to play roles in UV-induced skin carcinogenesis.  Furthermore, it has become clear that genetic diseases such as xeroderma pigmentosum show deficient repair of oxidatively modified DNA lesions.  The involvement of ROS in skin carcinogeneisis caused by arsenic and chem. carcinogens will also be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVxlJEZ12RsbVg90H21EOLACvtfcHk0lgsiAhGt0x6fw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjslahu7g%253D&md5=80b014f80dee84b1586287253bbdaa14</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1089%2F152308604773934314&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252F152308604773934314%26sid%3Dliteratum%253Aachs%26aulast%3DNishigori%26aufirst%3DC.%26aulast%3DHattori%26aufirst%3DY.%26aulast%3DToyokuni%26aufirst%3DS.%26atitle%3DRole%2520of%2520reactive%2520oxygen%2520species%2520in%2520skin%2520carcinogenesis%26jtitle%3DAntioxid.%2520Redox%2520Signaling%26date%3D2004%26volume%3D6%26spage%3D561%26epage%3D570%26doi%3D10.1089%2F152308604773934314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rodust, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stockfleth, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ulrich, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leverkus, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eberle, J.</span></span> <span> </span><span class="NLM_article-title">UV-induced squamous cell carcinoma--a role for antiapoptotic signalling pathways</span>. <i>Br. J. Dermatol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>161</i></span>,  <span class="NLM_fpage">107</span>â <span class="NLM_lpage">115</span>, <span class="refDoi">Â DOI: 10.1111/j.1365-2133.2009.09458.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=10.1111%2Fj.1365-2133.2009.09458.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=19775366" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlGns7rE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=161&publication_year=2009&pages=107-115&author=P.+M.+Rodustauthor=E.+Stockflethauthor=C.+Ulrichauthor=M.+Leverkusauthor=J.+Eberle&title=UV-induced+squamous+cell+carcinoma%2D%2Da+role+for+antiapoptotic+signalling+pathways&doi=10.1111%2Fj.1365-2133.2009.09458.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">UV-induced squamous cell carcinoma - a role for antiapoptotic signalling pathways</span></div><div class="casAuthors">Rodust, P. M.; Stockfleth, E.; Ulrich, C.; Leverkus, M.; Eberle, J.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Dermatology, Supplement</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">161</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">107-115</span>CODEN:
                <span class="NLM_cas:coden">BJDSA9</span>;
        ISSN:<span class="NLM_cas:issn">0366-077X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  The incidence of nonmelanoma skin cancer including squamous cell carcinoma (SCC) and basal cell carcinoma (BCC) has dramatically increased in the last decades, and chronic sun exposure was identified as a main etiol. agent.  UV radiation may produce DNA damage either directly or through reactive oxygen species (ROS).  As mutations caused by UV may lead to skin cancer due to oncogene activation and tumor suppressor gene inactivation, efficient safeguard mechanisms have been developed during evolution.  These enclose induction of apoptosis and formation sunburn cells aiming at the removal of premalignant cells.  The keratinocyte apoptotic machinery in response to UV consists of both intrinsic/mitochondrial and extrinsic/death receptor-mediated cell-death pathways, which are particularly regulated by mitogen-activated protein kinases (MAPKs, JNK and p38) and the tumor-suppressor protein p53.  For development of skin cancer, it appears that crit. steps in apoptosis control are dysregulated leading to resistance both to death ligand-mediated and intrinsic proapoptotic pathways.  These particularly include inactivation of p53, as well as activation of EGFR, COX-2 and MAPKs, which result in specific regulation of Bcl-2 proteins, death ligands and death receptors.  The final unravelling of apoptosis regulation in epithelial skin cancer may allow the development of new targeted therapeutic strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkWBenLDU_3bVg90H21EOLACvtfcHk0lgsiAhGt0x6fw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlGns7rE&md5=76d098f052daa216c8150a627f64405c</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2133.2009.09458.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2133.2009.09458.x%26sid%3Dliteratum%253Aachs%26aulast%3DRodust%26aufirst%3DP.%2BM.%26aulast%3DStockfleth%26aufirst%3DE.%26aulast%3DUlrich%26aufirst%3DC.%26aulast%3DLeverkus%26aufirst%3DM.%26aulast%3DEberle%26aufirst%3DJ.%26atitle%3DUV-induced%2520squamous%2520cell%2520carcinoma--a%2520role%2520for%2520antiapoptotic%2520signalling%2520pathways%26jtitle%3DBr.%2520J.%2520Dermatol.%26date%3D2009%26volume%3D161%26spage%3D107%26epage%3D115%26doi%3D10.1111%2Fj.1365-2133.2009.09458.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">GÃ¶rlach, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dimova, E. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petry, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MartÃ­nez-Ruiz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernansanz-AgustÃ­n, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rolo, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmeira, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kietzmann, T.</span></span> <span> </span><span class="NLM_article-title">Reactive oxygen species, nutrition, hypoxia and diseases: Problems solved?</span>. <i>Redox. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">372</span>â <span class="NLM_lpage">385</span>, <span class="refDoi">Â DOI: 10.1016/j.redox.2015.08.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=10.1016%2Fj.redox.2015.08.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=26339717" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=1%3ACAS%3A280%3ADC%252BC287ptFOhsw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=372-385&author=A.+G%C3%B6rlachauthor=E.+Y.+Dimovaauthor=A.+Petryauthor=A.+Mart%C3%ADnez-Ruizauthor=P.+Hernansanz-Agust%C3%ADnauthor=A.+P.+Roloauthor=C.+M.+Palmeiraauthor=T.+Kietzmann&title=Reactive+oxygen+species%2C+nutrition%2C+hypoxia+and+diseases%3A+Problems+solved%3F&doi=10.1016%2Fj.redox.2015.08.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Reactive oxygen species, nutrition, hypoxia and diseases: Problems solved?</span></div><div class="casAuthors">Gorlach Agnes; Petry Andreas; Dimova Elitsa Y; Martinez-Ruiz Antonio; Hernansanz-Agustin Pablo; Rolo Anabela P; Palmeira Carlos M; Kietzmann Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Redox biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">372-385</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Within the last twenty years the view on reactive oxygen species (ROS) has changed; they are no longer only considered to be harmful but also necessary for cellular communication and homeostasis in different organisms ranging from bacteria to mammals.  In the latter, ROS were shown to modulate diverse physiological processes including the regulation of growth factor signaling, the hypoxic response, inflammation and the immune response.  During the last 60-100 years the life style, at least in the Western world, has changed enormously.  This became obvious with an increase in caloric intake, decreased energy expenditure as well as the appearance of alcoholism and smoking; These changes were shown to contribute to generation of ROS which are, at least in part, associated with the occurrence of several chronic diseases like adiposity, atherosclerosis, type II diabetes, and cancer.  In this review we discuss aspects and problems on the role of intracellular ROS formation and nutrition with the link to diseases and their problematic therapeutical issues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQqVAJA36KLIxgd2Wuil24tfW6udTcc2eaRFOpPyoRoV7ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC287ptFOhsw%253D%253D&md5=df38d36c035efdd048e6ef39509070d9</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.redox.2015.08.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.redox.2015.08.016%26sid%3Dliteratum%253Aachs%26aulast%3DG%25C3%25B6rlach%26aufirst%3DA.%26aulast%3DDimova%26aufirst%3DE.%2BY.%26aulast%3DPetry%26aufirst%3DA.%26aulast%3DMart%25C3%25ADnez-Ruiz%26aufirst%3DA.%26aulast%3DHernansanz-Agust%25C3%25ADn%26aufirst%3DP.%26aulast%3DRolo%26aufirst%3DA.%2BP.%26aulast%3DPalmeira%26aufirst%3DC.%2BM.%26aulast%3DKietzmann%26aufirst%3DT.%26atitle%3DReactive%2520oxygen%2520species%252C%2520nutrition%252C%2520hypoxia%2520and%2520diseases%253A%2520Problems%2520solved%253F%26jtitle%3DRedox.%2520Biol.%26date%3D2015%26volume%3D6%26spage%3D372%26epage%3D385%26doi%3D10.1016%2Fj.redox.2015.08.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tafani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sansone, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Limana, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arcangeli, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Santis, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polese, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russo, M. A.</span></span> <span> </span><span class="NLM_article-title">The interplay of reactive oxygen species, hypoxia, inflammation, and sirtuins in cancer initiation and progression</span>. <i>Oxid. Med. Cell. Longevity</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>2016</i></span>,  <span class="NLM_fpage">3907147</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=10.1155%2F2016%2F3907147" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=26798421" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=1%3ACAS%3A280%3ADC%252BC28njsFShug%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2016&publication_year=2016&pages=3907147&author=M.+Tafaniauthor=L.+Sansoneauthor=F.+Limanaauthor=T.+Arcangeliauthor=E.+De+Santisauthor=M.+Poleseauthor=M.+Finiauthor=M.+A.+Russo&title=The+interplay+of+reactive+oxygen+species%2C+hypoxia%2C+inflammation%2C+and+sirtuins+in+cancer+initiation+and+progression"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">The Interplay of Reactive Oxygen Species, Hypoxia, Inflammation, and Sirtuins in Cancer Initiation and Progression</span></div><div class="casAuthors">Tafani Marco; Sansone Luigi; Fini Massimo; Limana Federica; Russo Matteo A; Arcangeli Tania; De Santis Elena; Polese Milena</div><div class="citationInfo"><span class="NLM_cas:title">Oxidative medicine and cellular longevity</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">2016</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">3907147</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The presence of ROS is a constant feature in living cells metabolizing O2.  ROS concentration and compartmentation determine their physiological or pathological effects.  ROS overproduction is a feature of cancer cells and plays several roles during the natural history of malignant tumor.  ROS continuously contribute to each step of cancerogenesis, from the initiation to the malignant progression, acting directly or indirectly.  In this review, we will (a) underline the role of ROS in the pathway leading a normal cell to tumor transformation and progression, (b) define the multiple roles of ROS during the natural history of a tumor, (c) conciliate many conflicting data about harmful or beneficial effects of ROS, (d) rethink the importance of oncogene and tumor suppressor gene mutations in relation to the malignant progression, and (e) collocate all the cancer hallmarks in a mechanistic sequence which could represent a "physiological" response to the initial growth of a transformed stem/pluripotent cell, defining also the role of ROS in each hallmark.  We will provide a simplified sketch about the relationships between ROS and cancer.  The attention will be focused on the contribution of ROS to the signaling of HIF, NFÎºB, and Sirtuins as a leitmotif of cancer initiation and progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRm7LIamzojsg8IxFYvehhofW6udTcc2eaRFOpPyoRoV7ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28njsFShug%253D%253D&md5=c881ffb87b9adf92c8702f516e039fcb</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1155%2F2016%2F3907147&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2016%252F3907147%26sid%3Dliteratum%253Aachs%26aulast%3DTafani%26aufirst%3DM.%26aulast%3DSansone%26aufirst%3DL.%26aulast%3DLimana%26aufirst%3DF.%26aulast%3DArcangeli%26aufirst%3DT.%26aulast%3DDe%2BSantis%26aufirst%3DE.%26aulast%3DPolese%26aufirst%3DM.%26aulast%3DFini%26aufirst%3DM.%26aulast%3DRusso%26aufirst%3DM.%2BA.%26atitle%3DThe%2520interplay%2520of%2520reactive%2520oxygen%2520species%252C%2520hypoxia%252C%2520inflammation%252C%2520and%2520sirtuins%2520in%2520cancer%2520initiation%2520and%2520progression%26jtitle%3DOxid.%2520Med.%2520Cell.%2520Longevity%26date%3D2016%26volume%3D2016%26spage%3D3907147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stockwell, B. R.</span></span> <span> </span><span class="NLM_article-title">L-5 - Ferroptosis: death by lipid peroxidation</span>. <i>Free Radical Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>120</i></span>,  <span class="NLM_fpage">S7</span>, <span class="refDoi">Â DOI: 10.1016/j.freeradbiomed.2018.04.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=10.1016%2Fj.freeradbiomed.2018.04.034" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2018&pages=S7&author=B.+R.+Stockwell&title=L-5+-+Ferroptosis%3A+death+by+lipid+peroxidation&doi=10.1016%2Fj.freeradbiomed.2018.04.034"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2018.04.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2018.04.034%26sid%3Dliteratum%253Aachs%26aulast%3DStockwell%26aufirst%3DB.%2BR.%26atitle%3DL-5%2520-%2520Ferroptosis%253A%2520death%2520by%2520lipid%2520peroxidation%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2018%26volume%3D120%26spage%3DS7%26doi%3D10.1016%2Fj.freeradbiomed.2018.04.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Szklarczyk, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gable, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyon, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Junge, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wyder, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huerta-Cepas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simonovic, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doncheva, N. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bork, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mering, C. V.</span></span> <span> </span><span class="NLM_article-title">STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets</span>. <i>Nucleic Acids Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">D607</span>â <span class="NLM_lpage">D613</span>, <span class="refDoi">Â DOI: 10.1093/nar/gky1131</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=10.1093%2Fnar%2Fgky1131" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=30476243" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhs1Gqtr%252FM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2019&pages=D607-D613&author=D.+Szklarczykauthor=A.+L.+Gableauthor=D.+Lyonauthor=A.+Jungeauthor=S.+Wyderauthor=J.+Huerta-Cepasauthor=M.+Simonovicauthor=N.+T.+Donchevaauthor=J.+H.+Morrisauthor=P.+Borkauthor=L.+J.+Jensenauthor=C.+V.+Mering&title=STRING+v11%3A+protein-protein+association+networks+with+increased+coverage%2C+supporting+functional+discovery+in+genome-wide+experimental+datasets&doi=10.1093%2Fnar%2Fgky1131"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">STRING v11: protein-protein association networks with increased coverage supporting functional discovery in genome-wide experimental datasets</span></div><div class="casAuthors">Szklarczyk, Damian; Gable, Annika L.; Lyon, David; Junge, Alexander; Wyder, Stefan; Huerta-Cepas, Jaime; Simonovic, Milan; Doncheva, Nadezhda T.; Morris, John H.; Bork, Peer; Jensen, Lars J.; von Mering, Christian</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">D1</span>),
    <span class="NLM_cas:pages">D607-D613</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">1362-4962</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Proteins and their functional interactions form the backbone of the cellular machinery.  Their connectivity network needs to be considered for the full understanding of biol. phenomena, but the available information on protein-protein assocns. is incomplete and exhibits varying levels of annotation granularity and reliability.  The STRING database aims to collect, score and integrate all publicly available sources of protein-protein interaction information, and to complement these with computational predictions.  Its goal is to achieve a comprehensive and objective global network, including direct (phys.) as well as indirect (functional) interactions.  The latest version of STRING (11.0) more than doubles the no. of organisms it covers, to 5090.  The most important new feature is an option to upload entire, genome-wide datasets as input, allowing users to visualize subsets as interaction networks and to perform gene-set enrichment anal. on the entire input.  For the enrichment anal., STRING implements well-known classification systems such as Gene Ontol. and KEGG, but also offers addnl., new classification systems based on high-throughput text-mining as well as on a hierarchical clustering of the assocn. network itself.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7UX25KcxhhbVg90H21EOLACvtfcHk0ljeHDNfZOgqog"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhs1Gqtr%252FM&md5=43df05a2de505f1df210fb4aaa200f58</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgky1131&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgky1131%26sid%3Dliteratum%253Aachs%26aulast%3DSzklarczyk%26aufirst%3DD.%26aulast%3DGable%26aufirst%3DA.%2BL.%26aulast%3DLyon%26aufirst%3DD.%26aulast%3DJunge%26aufirst%3DA.%26aulast%3DWyder%26aufirst%3DS.%26aulast%3DHuerta-Cepas%26aufirst%3DJ.%26aulast%3DSimonovic%26aufirst%3DM.%26aulast%3DDoncheva%26aufirst%3DN.%2BT.%26aulast%3DMorris%26aufirst%3DJ.%2BH.%26aulast%3DBork%26aufirst%3DP.%26aulast%3DJensen%26aufirst%3DL.%2BJ.%26aulast%3DMering%26aufirst%3DC.%2BV.%26atitle%3DSTRING%2520v11%253A%2520protein-protein%2520association%2520networks%2520with%2520increased%2520coverage%252C%2520supporting%2520functional%2520discovery%2520in%2520genome-wide%2520experimental%2520datasets%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2019%26volume%3D47%26spage%3DD607%26epage%3DD613%26doi%3D10.1093%2Fnar%2Fgky1131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hevia, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patchva, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koh, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aggarwal, B. B.</span></span> <span> </span><span class="NLM_article-title">Upsides and downsides of reactive oxygen species for cancer: the roles of reactive oxygen species in tumorigenesis, prevention, and therapy</span>. <i>Antioxid. Redox Signaling</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">1295</span>â <span class="NLM_lpage">1322</span>, <span class="refDoi">Â DOI: 10.1089/ars.2011.4414</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=10.1089%2Fars.2011.4414" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=22117137" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=1%3ACAS%3A528%3ADC%252BC38Xls1Witbo%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2012&pages=1295-1322&author=S.+C.+Guptaauthor=D.+Heviaauthor=S.+Patchvaauthor=B.+Parkauthor=W.+Kohauthor=B.+B.+Aggarwal&title=Upsides+and+downsides+of+reactive+oxygen+species+for+cancer%3A+the+roles+of+reactive+oxygen+species+in+tumorigenesis%2C+prevention%2C+and+therapy&doi=10.1089%2Fars.2011.4414"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Upsides and Downsides of Reactive Oxygen Species for Cancer: The Roles of Reactive Oxygen Species in Tumorigenesis, Prevention, and Therapy</span></div><div class="casAuthors">Gupta, Subash C.; Hevia, David; Patchva, Sridevi; Park, Byoungduck; Koh, Wonil; Aggarwal, Bharat B.</div><div class="citationInfo"><span class="NLM_cas:title">Antioxidants & Redox Signaling</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1295-1322</span>CODEN:
                <span class="NLM_cas:coden">ARSIF2</span>;
        ISSN:<span class="NLM_cas:issn">1523-0864</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">A review.  Significance: Extensive research during the last quarter century has revealed that reactive oxygen species (ROS) produced in the body, primarily by the mitochondria, play a major role in various cell-signaling pathways.  Most risk factors assocd. with chronic diseases (e.g., cancer), such as stress, tobacco, environmental pollutants, radiation, viral infection, diet, and bacterial infection, interact with cells through the generation of ROS.  Recent Advances: ROS, in turn, activate various transcription factors (e.g., nuclear factor kappa-light-chain-enhancer of activated B cells [NF-ÎºB], activator protein-1, hypoxia-inducible factor-1Î±, and signal transducer and activator of transcription 3), resulting in the expression of proteins that control inflammation, cellular transformation, tumor cell survival, tumor cell proliferation and invasion, angiogenesis, and metastasis.  Paradoxically, ROS also control the expression of various tumor suppressor genes (p53, Rb, and PTEN).  Similarly, Î³-radiation and various chemotherapeutic agents used to treat cancer mediate their effects through the prodn. of ROS.  Interestingly, ROS have also been implicated in the chemopreventive and anti-tumor action of nutraceuticals derived from fruits, vegetables, spices, and other natural products used in traditional medicine.  Crit. Issues: These statements suggest both "upside" (cancer-suppressing) and "downside" (cancer-promoting) actions of the ROS.  Thus, similar to tumor necrosis factor-Î±, inflammation, and NF-ÎºB, ROS act as a double-edged sword.  This paradox provides a great challenge for researchers whose aim is to exploit ROS stress for the development of cancer therapies.  Future Directions: The various mechanisms by which ROS mediate paradoxical effects are discussed in this article.  The outstanding questions and future directions raised by our current understanding are discussed.  Antioxid. Redox Signal. 16, 1295-1322.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTBWYOs696DrVg90H21EOLACvtfcHk0lglrl55MXrEAg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xls1Witbo%253D&md5=13ac12b97d9ae9f86589125b070600fe</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1089%2Fars.2011.4414&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fars.2011.4414%26sid%3Dliteratum%253Aachs%26aulast%3DGupta%26aufirst%3DS.%2BC.%26aulast%3DHevia%26aufirst%3DD.%26aulast%3DPatchva%26aufirst%3DS.%26aulast%3DPark%26aufirst%3DB.%26aulast%3DKoh%26aufirst%3DW.%26aulast%3DAggarwal%26aufirst%3DB.%2BB.%26atitle%3DUpsides%2520and%2520downsides%2520of%2520reactive%2520oxygen%2520species%2520for%2520cancer%253A%2520the%2520roles%2520of%2520reactive%2520oxygen%2520species%2520in%2520tumorigenesis%252C%2520prevention%252C%2520and%2520therapy%26jtitle%3DAntioxid.%2520Redox%2520Signaling%26date%3D2012%26volume%3D16%26spage%3D1295%26epage%3D1322%26doi%3D10.1089%2Fars.2011.4414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carney, D. A.</span></span> <span> </span><span class="NLM_article-title">Arsenic trioxide mechanisms of action â looking beyond acute promyelocytic leukemia</span>. <i>Leuk. Lymphoma</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">1846</span>â <span class="NLM_lpage">1851</span>, <span class="refDoi">Â DOI: 10.1080/10428190802464745</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=10.1080%2F10428190802464745" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=18949607" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht12isb%252FF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2008&pages=1846-1851&author=D.+A.+Carney&title=Arsenic+trioxide+mechanisms+of+action+%E2%80%93+looking+beyond+acute+promyelocytic+leukemia&doi=10.1080%2F10428190802464745"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Arsenic trioxide mechanisms of action - looking beyond acute promyelocytic leukemia</span></div><div class="casAuthors">Carney, Dennis A.</div><div class="citationInfo"><span class="NLM_cas:title">Leukemia & Lymphoma</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1846-1851</span>CODEN:
                <span class="NLM_cas:coden">LELYEA</span>;
        ISSN:<span class="NLM_cas:issn">1042-8194</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  The research of Coe and Schimmer (2008) entitled, "Catalase activity and arsenic sensitivity in acute leukemia" is reviewed with commentary and refs.  The authors studied that factors linked with arsenic trioxide (As2O3) sensitivity in myeloid leukemic cell lines and how these may be targeted to improve the cytotoxicity of As2O3 in acute myeloid leukemia other than acute promyelocytic leukemia (APL).  They revealed an inverse assocn. between catalase activity and As2O3 sensitivity in a variety of myeloid leukemia cell lines.  Conversely, catalase inhibition in U937 and HL-60 cell lines did not adequately raise reactive oxygen species (ROS) levels to sensitize the cells to As2O3.  These results indicate other anti-oxidant enzymes and/or buffering mechanisms are active in these cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoS7X1sYQJlpLVg90H21EOLACvtfcHk0lglrl55MXrEAg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht12isb%252FF&md5=685e27488efe81f1bc2cf1c6c79de128</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1080%2F10428190802464745&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10428190802464745%26sid%3Dliteratum%253Aachs%26aulast%3DCarney%26aufirst%3DD.%2BA.%26atitle%3DArsenic%2520trioxide%2520mechanisms%2520of%2520action%2520%25E2%2580%2593%2520looking%2520beyond%2520acute%2520promyelocytic%2520leukemia%26jtitle%3DLeuk.%2520Lymphoma%26date%3D2008%26volume%3D49%26spage%3D1846%26epage%3D1851%26doi%3D10.1080%2F10428190802464745" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Prasad, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyagi, A. K.</span></span> <span> </span><span class="NLM_article-title">Reactive oxygen species (ROS) and cancer: role of antioxidative nutraceuticals</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>387</i></span>,  <span class="NLM_fpage">95</span>â <span class="NLM_lpage">105</span>, <span class="refDoi">Â DOI: 10.1016/j.canlet.2016.03.042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=10.1016%2Fj.canlet.2016.03.042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=27037062" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=1%3ACAS%3A528%3ADC%252BC28XltlOktLs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=387&publication_year=2017&pages=95-105&author=S.+Prasadauthor=S.+C.+Guptaauthor=A.+K.+Tyagi&title=Reactive+oxygen+species+%28ROS%29+and+cancer%3A+role+of+antioxidative+nutraceuticals&doi=10.1016%2Fj.canlet.2016.03.042"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Reactive oxygen species (ROS) and cancer: Role of antioxidative nutraceuticals</span></div><div class="casAuthors">Prasad, Sahdeo; Gupta, Subash C.; Tyagi, Amit K.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">387</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">95-105</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Extensive research over the past half a century indicates that reactive oxygen species (ROS) play an important role in cancer.  Although low levels of ROS can be beneficial, excessive accumulation can promote cancer.  One characteristic of cancer cells that distinguishes them from normal cells is their ability to produce increased nos. of ROS and their increased dependence on an antioxidant defense system.  ROS are produced as a byproduct intracellularly by mitochondria and other cellular elements and exogenously by pollutants, tobacco, smoke, drugs, xenobiotics, and radiation.  ROS modulate various cell signaling pathways, which are primarily mediated through the transcription factors NF-ÎºB and STAT3, hypoxia-inducible factor-1Î±, kinases, growth factors, cytokines and other proteins, and enzymes; these pathways have been linked to cellular transformation, inflammation, tumor survival, proliferation, invasion, angiogenesis, and metastasis of cancer.  ROS are also assocd. with epigenetic changes in genes, which is helpful in diagnosing diseases.  This review considers the role of ROS in the various stages of cancer development.  Finally, we provide evidence that nutraceuticals derived from Mother Nature are highly effective in eliminating cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpX83EBzqxUTrVg90H21EOLACvtfcHk0lglrl55MXrEAg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XltlOktLs%253D&md5=c33d48489b7872b1220d790176b2ef4b</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2016.03.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2016.03.042%26sid%3Dliteratum%253Aachs%26aulast%3DPrasad%26aufirst%3DS.%26aulast%3DGupta%26aufirst%3DS.%2BC.%26aulast%3DTyagi%26aufirst%3DA.%2BK.%26atitle%3DReactive%2520oxygen%2520species%2520%2528ROS%2529%2520and%2520cancer%253A%2520role%2520of%2520antioxidative%2520nutraceuticals%26jtitle%3DCancer%2520Lett.%26date%3D2017%26volume%3D387%26spage%3D95%26epage%3D105%26doi%3D10.1016%2Fj.canlet.2016.03.042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fang, B.</span></span> <span> </span><span class="NLM_article-title">Genetic interactions of STAT3 and anticancer drug development</span>. <i>Cancers</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">494</span>â <span class="NLM_lpage">525</span>, <span class="refDoi">Â DOI: 10.3390/cancers6010494</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=10.3390%2Fcancers6010494" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=24662938" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=1%3ACAS%3A528%3ADC%252BC2cXptVGmsro%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=494-525&author=B.+Fang&title=Genetic+interactions+of+STAT3+and+anticancer+drug+development&doi=10.3390%2Fcancers6010494"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Genetic interactions of STAT3 and anticancer drug development</span></div><div class="casAuthors">Fang, Bingliang</div><div class="citationInfo"><span class="NLM_cas:title">Cancers</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">494-525, 32 pp.</span>CODEN:
                <span class="NLM_cas:coden">CANCCT</span>;
        ISSN:<span class="NLM_cas:issn">2072-6694</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  Signal transducer and activator of transcription 3 (STAT3) plays crit. roles in tumorigenesis and malignant evolution and has been intensively studied as a therapeutic target for cancer.  A no. of STAT3 inhibitors have been evaluated for their antitumor activity in vitro and in vivo in exptl. tumor models and several approved therapeutic agents have been reported to function as STAT3 inhibitors.  Nevertheless, most STAT3 inhibitors have yet to be translated to clin. evaluation for cancer treatment, presumably because of pharmacokinetic, efficacy, and safety issues.  In fact, a major cause of failure of anticancer drug development is lack of efficacy.  Genetic interactions among various cancer-related pathways often provide redundant input from parallel and/or cooperative pathways that drives and maintains survival environments for cancer cells, leading to low efficacy of single-target agents.  Exploiting genetic interactions of STAT3 with other cancer-related pathways may provide mol. insight into mechanisms of cancer resistance to pathway-targeted therapies and strategies for development of more effective anticancer agents and treatment regimens.  This review focuses on functional regulation of STAT3 activity; possible interactions of the STAT3, RAS, epidermal growth factor receptor, and redn.-oxidn. pathways; and mol. mechanisms that modulate therapeutic efficacies of STAT3 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpS26NLTEhvDLVg90H21EOLACvtfcHk0lhftUeNcL3zcw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXptVGmsro%253D&md5=ab98f74d7682688e713d7b5ec6740b7d</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.3390%2Fcancers6010494&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fcancers6010494%26sid%3Dliteratum%253Aachs%26aulast%3DFang%26aufirst%3DB.%26atitle%3DGenetic%2520interactions%2520of%2520STAT3%2520and%2520anticancer%2520drug%2520development%26jtitle%3DCancers%26date%3D2014%26volume%3D6%26spage%3D494%26epage%3D525%26doi%3D10.3390%2Fcancers6010494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Annibaldi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meier, P.</span></span> <span> </span><span class="NLM_article-title">Checkpoints in TNF-induced cell death: implications in inflammation and cancer</span>. <i>Trends Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">49</span>â <span class="NLM_lpage">65</span>, <span class="refDoi">Â DOI: 10.1016/j.molmed.2017.11.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=10.1016%2Fj.molmed.2017.11.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=29217118" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFemsbfI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2018&pages=49-65&author=A.+Annibaldiauthor=P.+Meier&title=Checkpoints+in+TNF-induced+cell+death%3A+implications+in+inflammation+and+cancer&doi=10.1016%2Fj.molmed.2017.11.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Checkpoints in TNF-Induced Cell Death: Implications in Inflammation and Cancer</span></div><div class="casAuthors">Annibaldi, Alessandro; Meier, Pascal</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Molecular Medicine</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">49-65</span>CODEN:
                <span class="NLM_cas:coden">TMMRCY</span>;
        ISSN:<span class="NLM_cas:issn">1471-4914</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Tumor necrosis factor (TNF) is a proinflammatory cytokine that coordinates tissue homeostasis by regulating cytokine prodn., cell survival, and cell death.  However, how life and death decisions are made in response to TNF is poorly understood.  Many inflammatory pathologies are now recognized to be driven by aberrant TNF-induced cell death, which, in most circumstances, depends on the kinase Receptor-interacting serine/threonine-protein kinase 1 (RIPK1).  Recent advances have identified ubiquitin (Ub)-mediated phosphorylation of RIPK1 as belonging to crucial checkpoints for cell fate in inflammation and infection.  A better understanding of these checkpoints might lead to new approaches for the treatment of chronic inflammatory diseases fueled by aberrant RIPK1-induced cell death, and/or reveal novel strategies for anticancer immunotherapies, harnessing the ability of RIPK1 to trigger immunogenic cell death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6J_CUKMSRsLVg90H21EOLACvtfcHk0lhftUeNcL3zcw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFemsbfI&md5=5c8977c0a01478f91c76bad9f80cca52</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.molmed.2017.11.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molmed.2017.11.002%26sid%3Dliteratum%253Aachs%26aulast%3DAnnibaldi%26aufirst%3DA.%26aulast%3DMeier%26aufirst%3DP.%26atitle%3DCheckpoints%2520in%2520TNF-induced%2520cell%2520death%253A%2520implications%2520in%2520inflammation%2520and%2520cancer%26jtitle%3DTrends%2520Mol.%2520Med.%26date%3D2018%26volume%3D24%26spage%3D49%26epage%3D65%26doi%3D10.1016%2Fj.molmed.2017.11.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, C. H.</span></span> <span> </span><span class="NLM_article-title">Anti-cancer therapy with TNFÎ± and IFNÎ³: a comprehensive review</span>. <i>Cell Proliferation</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>51</i></span>, <span class="NLM_elocation-id">e12441</span> <span class="refDoi">Â DOI: 10.1111/cpr.12441</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=10.1111%2Fcpr.12441" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=29484738" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2018&author=J.+Shenauthor=Z.+Xiaoauthor=Q.+Zhaoauthor=M.+Liauthor=X.+Wuauthor=L.+Zhangauthor=W.+Huauthor=C.+H.+Cho&title=Anti-cancer+therapy+with+TNF%CE%B1+and+IFN%CE%B3%3A+a+comprehensive+review&doi=10.1111%2Fcpr.12441"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1111%2Fcpr.12441&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcpr.12441%26sid%3Dliteratum%253Aachs%26aulast%3DShen%26aufirst%3DJ.%26aulast%3DXiao%26aufirst%3DZ.%26aulast%3DZhao%26aufirst%3DQ.%26aulast%3DLi%26aufirst%3DM.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DHu%26aufirst%3DW.%26aulast%3DCho%26aufirst%3DC.%2BH.%26atitle%3DAnti-cancer%2520therapy%2520with%2520TNF%25CE%25B1%2520and%2520IFN%25CE%25B3%253A%2520a%2520comprehensive%2520review%26jtitle%3DCell%2520Proliferation%26date%3D2018%26volume%3D51%26doi%3D10.1111%2Fcpr.12441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Semenza, G. L.</span></span> <span> </span><span class="NLM_article-title">Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">625</span>â <span class="NLM_lpage">634</span>, <span class="refDoi">Â DOI: 10.1038/onc.2009.441</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=10.1038%2Fonc.2009.441" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=19946328" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsV2gt77N" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2010&pages=625-634&author=G.+L.+Semenza&title=Defining+the+role+of+hypoxia-inducible+factor+1+in+cancer+biology+and+therapeutics&doi=10.1038%2Fonc.2009.441"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics</span></div><div class="casAuthors">Semenza, G. L.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">625-634</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Adaptation of cancer cells to their microenvironment is an important driving force in the clonal selection that leads to invasive and metastatic disease.  O2 concns. are markedly reduced in many human cancers compared with normal tissue, and a major mechanism mediating adaptive responses to reduced O2 availability (hypoxia) is the regulation of transcription by hypoxia-inducible factor 1 (HIF-1).  This review summarizes the current state of knowledge regarding the mol. mechanisms by which HIF-1 contributes to cancer progression, focusing on (1) clin. data assocg. increased HIF-1 levels with patient mortality; (2) preclin. data linking HIF-1 activity with tumor growth; (3) mol. data linking specific HIF-1 target gene products to crit. aspects of cancer biol. and (4) pharmacol. data showing anticancer effects of HIF-1 inhibitors in mouse models of human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlXOi-2tydiLVg90H21EOLACvtfcHk0lhftUeNcL3zcw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsV2gt77N&md5=fb8c32b5f05bfad38f4a4ecef9bd98a7</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1038%2Fonc.2009.441&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2009.441%26sid%3Dliteratum%253Aachs%26aulast%3DSemenza%26aufirst%3DG.%2BL.%26atitle%3DDefining%2520the%2520role%2520of%2520hypoxia-inducible%2520factor%25201%2520in%2520cancer%2520biology%2520and%2520therapeutics%26jtitle%3DOncogene%26date%3D2010%26volume%3D29%26spage%3D625%26epage%3D634%26doi%3D10.1038%2Fonc.2009.441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bonello, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">ZÃ¤hringer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">BelAiba, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Djordjevic, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hess, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michiels, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kietzmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">GÃ¶rlach, A.</span></span> <span> </span><span class="NLM_article-title">Reactive oxygen species activate the HIF-1Î± promoter via a functional NFÎºB site</span>. <i>Arterioscler., Thromb., Vasc. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">755</span>â <span class="NLM_lpage">761</span>, <span class="refDoi">Â DOI: 10.1161/01.ATV.0000258979.92828.bc</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=10.1161%2F01.ATV.0000258979.92828.bc" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=17272744" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=1%3ACAS%3A528%3ADC%252BD2sXislCrsrc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2007&pages=755-761&author=S.+Bonelloauthor=C.+Z%C3%A4hringerauthor=R.+S.+BelAibaauthor=T.+Djordjevicauthor=J.+Hessauthor=C.+Michielsauthor=T.+Kietzmannauthor=A.+G%C3%B6rlach&title=Reactive+oxygen+species+activate+the+HIF-1%CE%B1+promoter+via+a+functional+NF%CE%BAB+site&doi=10.1161%2F01.ATV.0000258979.92828.bc"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Reactive oxygen species activate the HIF-1Î± promoter via a functional NFÎºB site</span></div><div class="casAuthors">Bonello, Steve; Zaehringer, Christian; BelAiba, Rachida S.; Djordjevic, Talija; Hess, John; Michiels, Carine; Kietzmann, Thomas; Goerlach, Agnes</div><div class="citationInfo"><span class="NLM_cas:title">Arteriosclerosis, Thrombosis, and Vascular Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">755-761</span>CODEN:
                <span class="NLM_cas:coden">ATVBFA</span>;
        ISSN:<span class="NLM_cas:issn">1079-5642</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Reactive oxygen species have been implicated as signaling mols. modulating the activity of redox-sensitive transcription factors such as nuclear factor kappa B (NF-ÎºB).  Recently, the transcription factor hypoxia-inducible factor-1 (HIF-1), known to mediate gene expression by hypoxia, has been found to be also activated by nonhypoxic factors in a redox-sensitive manner.  We therefore aimed to elucidate the link between these 2 important redox-sensitive transcription factors.  In pulmonary artery smooth muscle cells, reactive oxygen species generated either by exogenous H2O2 or by a NOX4-contg. NADPH oxidase stimulated by thrombin activated or induced NF-ÎºB and HIF-1Î±.  The reactive oxygen species-mediated HIF-1Î± induction occurred on the transcriptional level and was dependent on NF-ÎºB.  Transfection expts. with wild-type or mutant HIF-1Î± promoter constructs revealed the presence of a yet unidentified NF-ÎºB binding element.  Gel shift analyses and chromatin immunopptn. verified binding of NF-ÎºB to this site.  Furthermore, reactive oxygen species enhanced expression of plasminogen activator inhibitor-1, which was prevented by dominant-neg. IÎºB or mutation of the HIF-1 binding site within the plasminogen activator inhibitor-1 promoter.  These findings show for the first time to our knowledge that reactive oxygen species directly link HIF-1Î± and NF-ÎºB, implicating an important pathophysiol. role of this novel pathway in disorders assocd. with elevated levels of reactive oxygen species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqn7Xn8zlRrnrVg90H21EOLACvtfcHk0ljbjI9lBG7hKA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXislCrsrc%253D&md5=5df085dd8c8bd8aa48b04e8864a847e6</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1161%2F01.ATV.0000258979.92828.bc&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252F01.ATV.0000258979.92828.bc%26sid%3Dliteratum%253Aachs%26aulast%3DBonello%26aufirst%3DS.%26aulast%3DZ%25C3%25A4hringer%26aufirst%3DC.%26aulast%3DBelAiba%26aufirst%3DR.%2BS.%26aulast%3DDjordjevic%26aufirst%3DT.%26aulast%3DHess%26aufirst%3DJ.%26aulast%3DMichiels%26aufirst%3DC.%26aulast%3DKietzmann%26aufirst%3DT.%26aulast%3DG%25C3%25B6rlach%26aufirst%3DA.%26atitle%3DReactive%2520oxygen%2520species%2520activate%2520the%2520HIF-1%25CE%25B1%2520promoter%2520via%2520a%2520functional%2520NF%25CE%25BAB%2520site%26jtitle%3DArterioscler.%252C%2520Thromb.%252C%2520Vasc.%2520Biol.%26date%3D2007%26volume%3D27%26spage%3D755%26epage%3D761%26doi%3D10.1161%2F01.ATV.0000258979.92828.bc" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Han, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, D.</span></span> <span> </span><span class="NLM_article-title">Napabucasin, a novel STAT<sub>3</sub> inhibitor suppresses proliferation, invasion and stemness of glioblastoma cells</span>. <i>J. Exp. Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">289</span>, <span class="refDoi">Â DOI: 10.1186/s13046-019-1289-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=10.1186%2Fs13046-019-1289-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=31277685" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=1%3ACAS%3A280%3ADC%252BB3MzksFOkuw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2019&pages=289&author=D.+Hanauthor=T.+Yuauthor=N.+Dongauthor=B.+Wangauthor=F.+Sunauthor=D.+Jiang&title=Napabucasin%2C+a+novel+STAT3+inhibitor+suppresses+proliferation%2C+invasion+and+stemness+of+glioblastoma+cells&doi=10.1186%2Fs13046-019-1289-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Napabucasin, a novel STAT3 inhibitor suppresses proliferation, invasion and stemness of glioblastoma cells</span></div><div class="casAuthors">Han Dongfeng; Dong Nan; Wang Bo; Sun Fei; Jiang Dehua; Yu Tianfu; Yu Tianfu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of experimental & clinical cancer research : CR</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">289</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Glioblastoma (GBM) cells with stem cell-like properties are called glioma stem cells (GSCs).  GSCs display highly treatment resistance and are responsible for tumor recurrence.  Napabucasin (BBI608), a novel small molecule inhibitor of STAT3, has been identified to eliminate stemness-like tumor cells in some cancers.  However, the influence of Napabucasin on GBM cells, especially on GSCs, is currently unclear.  In this study, we explored the influence and underlying mechanisms of Napabucasin on GBM cells.  METHODS:  STAT3 expression and its correlation with the glioma grade and patient survival were analyzed using CGGA and TCGA glioma databases.  The influence of Napabucasin on proliferation, stemness, the cell cycle, apoptosis, and invasion of human GBM cell lines U87MG and LN229 was tested by CCK8, EdU incorporation, colony formation, Transwell invasion, and three-dimensional spheroid assays as well as flow cytometry, qPCR, and western blot analysis.  The ability of Napabucasin to inhibit cell proliferation of U87MG tumor xenografts in mice was assessed using a live animal bioluminescence imaging system and immunohistochemistry.  RESULTS:  Napabucasin suppressed the proliferation, colony formation, and invasion of U87MG and LN229 cells.  Furthermore, Napabucasin induced cell cycle arrest and apoptosis.  More importantly, Napabucasin treatment obviously inhibited expression of stemness-associated genes including STAT3 and suppressed the spheroid formation of glioma cells in vitro.  Napabucasin also disrupted the NF-ÎºB signaling pathway via downregulation of RelA (p65).  Finally, glioma growth was effectively impaired by Napabucasin in nude mice bearing intracranial glioma xenografts.  CONCLUSIONS:  Napabucasin treatment may be a novel approach for the treatment of GBM, particularly GSCs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSRIKHLY7Pb48yail4HZd-ifW6udTcc2eZtEnZny4v0NLntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3MzksFOkuw%253D%253D&md5=8a941303a4a70d3ba1400170ab2054ee</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1186%2Fs13046-019-1289-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13046-019-1289-6%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DD.%26aulast%3DYu%26aufirst%3DT.%26aulast%3DDong%26aufirst%3DN.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DSun%26aufirst%3DF.%26aulast%3DJiang%26aufirst%3DD.%26atitle%3DNapabucasin%252C%2520a%2520novel%2520STAT3%2520inhibitor%2520suppresses%2520proliferation%252C%2520invasion%2520and%2520stemness%2520of%2520glioblastoma%2520cells%26jtitle%3DJ.%2520Exp.%2520Clin.%2520Cancer%2520Res.%26date%3D2019%26volume%3D38%26spage%3D289%26doi%3D10.1186%2Fs13046-019-1289-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sugarman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plenker, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuveson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saif, M. W.</span></span> <span> </span><span class="NLM_article-title">Pharmacokinetics and pharmacodynamics of new drugs for pancreatic cancer</span>. <i>Expert Opin. Drug Metab. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">541</span>â <span class="NLM_lpage">552</span>, <span class="refDoi">Â DOI: 10.1080/17425255.2019.1637417</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=10.1080%2F17425255.2019.1637417" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=31241371" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtlaltr%252FO" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2019&pages=541-552&author=R.+Sugarmanauthor=R.+Patelauthor=S.+Sharmaauthor=D.+Plenkerauthor=D.+Tuvesonauthor=M.+W.+Saif&title=Pharmacokinetics+and+pharmacodynamics+of+new+drugs+for+pancreatic+cancer&doi=10.1080%2F17425255.2019.1637417"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics and pharmacodynamics of new drugs for pancreatic cancer</span></div><div class="casAuthors">Sugarman, Ryan; Patel, Rajvi; Sharma, Sandhya; Plenker, Dennis; Tuveson, David; Saif, Muhammad Wasif</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Metabolism & Toxicology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">541-552</span>CODEN:
                <span class="NLM_cas:coden">EODMAP</span>;
        ISSN:<span class="NLM_cas:issn">1742-5255</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">A review.  : Pancreatic cancer (PC) remains a disease with a dismal prognosis.  Despite accounting for only 3% of cancer diagnosis, 7% of all cancer deaths in the United States are from PC.  This is explained by many being diagnosed with late-stage disease and the cancer's resistance to chemotherapy.  Since 1996 there have only been two upfront regimens found to be superior to gemcitabine, FOLFIRINOX (5-fluorouracil/leucovorin and oxaliplatin) and gemcitabine plus nab-paclitaxel.: Clin. pharmacol. of newer agents that are either approved or being investigated in the management of PC.  Knowledge of their pharmacokinetics, pharmacodynamics, and pharmacogenetics can be used to predict outcomes for specific patient populations.  Drugs discussed include nanoliposomal irinotecan, pegvorhyaluronidase alfa, poly (ADP-ribose) polymerase enzyme inhibitors, larotrectinib, and napabucasin.: PC is a heterogeneous disease and outcomes are likely to improve as better predictive models of an individual's response to different therapies are developed.  This may be best accomplished through phase 0 studies and the use of tumor organoid models grown from initial biopsies or resected tissue.  The genetic and phys. makeup of the tumor as well as the functional characterization in patient-derived organoids (PDOs), can help guide which agents may be most efficacious or toxic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGry7xpjA8hxRLVg90H21EOLACvtfcHk0ljbjI9lBG7hKA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtlaltr%252FO&md5=b2a3a8415c681b9dafa96e54205962ca</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1080%2F17425255.2019.1637417&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F17425255.2019.1637417%26sid%3Dliteratum%253Aachs%26aulast%3DSugarman%26aufirst%3DR.%26aulast%3DPatel%26aufirst%3DR.%26aulast%3DSharma%26aufirst%3DS.%26aulast%3DPlenker%26aufirst%3DD.%26aulast%3DTuveson%26aufirst%3DD.%26aulast%3DSaif%26aufirst%3DM.%2BW.%26atitle%3DPharmacokinetics%2520and%2520pharmacodynamics%2520of%2520new%2520drugs%2520for%2520pancreatic%2520cancer%26jtitle%3DExpert%2520Opin.%2520Drug%2520Metab.%2520Toxicol.%26date%3D2019%26volume%3D15%26spage%3D541%26epage%3D552%26doi%3D10.1080%2F17425255.2019.1637417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Friedmann
Angeli, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proneth, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyurina, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyurin, V. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammond, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herbach, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aichler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walch, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eggenhofer, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basavarajappa, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">RÃ¥dmark, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seibt, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beck, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neff, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esposito, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wanke, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">FÃ¶rster, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yefremova, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinrichmeyer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bornkamm, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geissler, E. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stockwell, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">OâDonnell, V. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kagan, V. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schick, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conrad, M.</span></span> <span> </span><span class="NLM_article-title">Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice</span>. <i>Nat. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">1180</span>â <span class="NLM_lpage">1191</span>, <span class="refDoi">Â DOI: 10.1038/ncb3064</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=10.1038%2Fncb3064" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=25402683" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFKlsrrF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2014&pages=1180-1191&author=J.+P.+Friedmann%0AAngeliauthor=M.+Schneiderauthor=B.+Pronethauthor=Y.+Y.+Tyurinaauthor=V.+A.+Tyurinauthor=V.+J.+Hammondauthor=N.+Herbachauthor=M.+Aichlerauthor=A.+Walchauthor=E.+Eggenhoferauthor=D.+Basavarajappaauthor=O.+R%C3%A5dmarkauthor=S.+Kobayashiauthor=T.+Seibtauthor=H.+Beckauthor=F.+Neffauthor=I.+Espositoauthor=R.+Wankeauthor=H.+F%C3%B6rsterauthor=O.+Yefremovaauthor=M.+Heinrichmeyerauthor=G.+W.+Bornkammauthor=E.+K.+Geisslerauthor=S.+B.+Thomasauthor=B.+R.+Stockwellauthor=V.+B.+O%E2%80%99Donnellauthor=V.+E.+Kaganauthor=J.+A.+Schickauthor=M.+Conrad&title=Inactivation+of+the+ferroptosis+regulator+Gpx4+triggers+acute+renal+failure+in+mice&doi=10.1038%2Fncb3064"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice</span></div><div class="casAuthors">Friedmann Angeli, Jose Pedro; Schneider, Manuela; Proneth, Bettina; Tyurina, Yulia Y.; Tyurin, Vladimir A.; Hammond, Victoria J.; Herbach, Nadja; Aichler, Michaela; Walch, Axel; Eggenhofer, Elke; Basavarajappa, Devaraj; Radmark, Olof; Kobayashi, Sho; Seibt, Tobias; Beck, Heike; Neff, Frauke; Esposito, Irene; Wanke, Ruediger; Foerster, Heidi; Yefremova, Olena; Heinrichmeyer, Marc; Bornkamm, Georg W.; Geissler, Edward K.; Thomas, Stephen B.; Stockwell, Brent R.; O'Donnell, Valerie B.; Kagan, Valerian E.; Schick, Joel A.; Conrad, Marcus</div><div class="citationInfo"><span class="NLM_cas:title">Nature Cell Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1180-1191</span>CODEN:
                <span class="NLM_cas:coden">NCBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1465-7392</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Ferroptosis is a non-apoptotic form of cell death induced by small mols. in specific tumor types, and in engineered cells overexpressing oncogenic RAS.  Yet, its relevance in non-transformed cells and tissues is unexplored and remains enigmatic.  Here, we provide direct genetic evidence that the knockout of glutathione peroxidase 4 (Gpx4) causes cell death in a pathol. relevant form of ferroptosis.  Using inducible Gpx4-/- mice, we elucidate an essential role for the glutathione/Gpx4 axis in preventing lipid-oxidn.-induced acute renal failure and assocd. death.  We furthermore systematically evaluated a library of small mols. for possible ferroptosis inhibitors, leading to the discovery of a potent spiroquinoxalinamine deriv. called Liproxstatin-1, which is able to suppress ferroptosis in cells, in Gpx4-/- mice, and in a pre-clin. model of ischemia/reperfusion-induced hepatic damage.  In sum, we demonstrate that ferroptosis is a pervasive and dynamic form of cell death, which, when impeded, promises substantial cytoprotection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuBNbniop_ibVg90H21EOLACvtfcHk0ljBb_-C3wNLSg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFKlsrrF&md5=0d095f1a6206ab1dae7e04089847becf</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1038%2Fncb3064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncb3064%26sid%3Dliteratum%253Aachs%26aulast%3DFriedmann%2BAngeli%26aufirst%3DJ.%2BP.%26aulast%3DSchneider%26aufirst%3DM.%26aulast%3DProneth%26aufirst%3DB.%26aulast%3DTyurina%26aufirst%3DY.%2BY.%26aulast%3DTyurin%26aufirst%3DV.%2BA.%26aulast%3DHammond%26aufirst%3DV.%2BJ.%26aulast%3DHerbach%26aufirst%3DN.%26aulast%3DAichler%26aufirst%3DM.%26aulast%3DWalch%26aufirst%3DA.%26aulast%3DEggenhofer%26aufirst%3DE.%26aulast%3DBasavarajappa%26aufirst%3DD.%26aulast%3DR%25C3%25A5dmark%26aufirst%3DO.%26aulast%3DKobayashi%26aufirst%3DS.%26aulast%3DSeibt%26aufirst%3DT.%26aulast%3DBeck%26aufirst%3DH.%26aulast%3DNeff%26aufirst%3DF.%26aulast%3DEsposito%26aufirst%3DI.%26aulast%3DWanke%26aufirst%3DR.%26aulast%3DF%25C3%25B6rster%26aufirst%3DH.%26aulast%3DYefremova%26aufirst%3DO.%26aulast%3DHeinrichmeyer%26aufirst%3DM.%26aulast%3DBornkamm%26aufirst%3DG.%2BW.%26aulast%3DGeissler%26aufirst%3DE.%2BK.%26aulast%3DThomas%26aufirst%3DS.%2BB.%26aulast%3DStockwell%26aufirst%3DB.%2BR.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DV.%2BB.%26aulast%3DKagan%26aufirst%3DV.%2BE.%26aulast%3DSchick%26aufirst%3DJ.%2BA.%26aulast%3DConrad%26aufirst%3DM.%26atitle%3DInactivation%2520of%2520the%2520ferroptosis%2520regulator%2520Gpx4%2520triggers%2520acute%2520renal%2520failure%2520in%2520mice%26jtitle%3DNat.%2520Cell%2520Biol.%26date%3D2014%26volume%3D16%26spage%3D1180%26epage%3D1191%26doi%3D10.1038%2Fncb3064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, D.</span></span> <span> </span><span class="NLM_article-title">Ferroptosis: process and function</span>. <i>Cell Death Differ.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">369</span>â <span class="NLM_lpage">379</span>, <span class="refDoi">Â DOI: 10.1038/cdd.2015.158</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=10.1038%2Fcdd.2015.158" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=26794443" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhsl2jtbk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2016&pages=369-379&author=Y.+Xieauthor=W.+Houauthor=X.+Songauthor=Y.+Yuauthor=J.+Huangauthor=X.+Sunauthor=R.+Kangauthor=D.+Tang&title=Ferroptosis%3A+process+and+function&doi=10.1038%2Fcdd.2015.158"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Ferroptosis: process and function</span></div><div class="casAuthors">Xie, Y.; Hou, W.; Song, X.; Yu, Y.; Huang, J.; Sun, X.; Kang, R.; Tang, D.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Differentiation</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">369-379</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Ferroptosis is a recently recognized form of regulated cell death.  It is characterized morphol. by the presence of smaller than normal mitochondria with condensed mitochondrial membrane densities, redn. or vanishing of mitochondria crista, and outer mitochondrial membrane rupture.  It can be induced by exptl. compds. (e.g., erastin, Ras-selective lethal small mol. 3, and buthionine sulfoximine) or clin. drugs (e.g., sulfasalazine, sorafenib, and artesunate) in cancer cells and certain normal cells (e.g., kidney tubule cells, neurons, fibroblasts, and T cells).  Activation of mitochondrial voltage-dependent anion channels and mitogen-activated protein kinases, upregulation of endoplasmic reticulum stress, and inhibition of cystine/glutamate antiporter is involved in the induction of ferroptosis.  This process is characterized by the accumulation of lipid peroxidn. products and lethal reactive oxygen species (ROS) derived from iron metab. and can be pharmacol. inhibited by iron chelators (e.g., deferoxamine and desferrioxamine mesylate) and lipid peroxidn. inhibitors (e.g., ferrostatin, liproxstatin, and zileuton).  Glutathione peroxidase 4, heat shock protein beta-1, and nuclear factor erythroid 2-related factor 2 function as neg. regulators of ferroptosis by limiting ROS prodn. and reducing cellular iron uptake, resp.  In contrast, NADPH oxidase and p53 (esp. acetylation-defective mutant p53) act as pos. regulators of ferroptosis by promotion of ROS prodn. and inhibition of expression of SLC7A11 (a specific light-chain subunit of the cystine/glutamate antiporter), resp.  Misregulated ferroptosis has been implicated in multiple physiol. and pathol. processes, including cancer cell death, neurotoxicity, neurodegenerative diseases, acute renal failure, drug-induced hepatotoxicity, hepatic and heart ischemia/reperfusion injury, and T-cell immunity.  In this review, we summarize the regulation mechanisms and signaling pathways of ferroptosis and discuss the role of ferroptosis in disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPYoAemdpXQrVg90H21EOLACvtfcHk0ljBb_-C3wNLSg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhsl2jtbk%253D&md5=1d0b55e47c4ed56444149c7ba35efb58</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1038%2Fcdd.2015.158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcdd.2015.158%26sid%3Dliteratum%253Aachs%26aulast%3DXie%26aufirst%3DY.%26aulast%3DHou%26aufirst%3DW.%26aulast%3DSong%26aufirst%3DX.%26aulast%3DYu%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DSun%26aufirst%3DX.%26aulast%3DKang%26aufirst%3DR.%26aulast%3DTang%26aufirst%3DD.%26atitle%3DFerroptosis%253A%2520process%2520and%2520function%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2016%26volume%3D23%26spage%3D369%26epage%3D379%26doi%3D10.1038%2Fcdd.2015.158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shah, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Margison, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pratt, D. A.</span></span> <span> </span><span class="NLM_article-title">The potency of diarylamine radical-trapping antioxidants as inhibitors of ferroptosis underscores the role of autoxidation in the mechanism of cell death</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">2538</span>â <span class="NLM_lpage">2545</span>, <span class="refDoi">Â DOI: 10.1021/acschembio.7b00730</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.7b00730" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlOksLnM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&pages=2538-2545&author=R.+Shahauthor=K.+Margisonauthor=D.+A.+Pratt&title=The+potency+of+diarylamine+radical-trapping+antioxidants+as+inhibitors+of+ferroptosis+underscores+the+role+of+autoxidation+in+the+mechanism+of+cell+death&doi=10.1021%2Facschembio.7b00730"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">The Potency of Diarylamine Radical-Trapping Antioxidants as Inhibitors of Ferroptosis Underscores the Role of Autoxidation in the Mechanism of Cell Death</span></div><div class="casAuthors">Shah, Ron; Margison, Kaitlyn; Pratt, Derek A.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2538-2545</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Two arom. amines (ferrostatin-1 and liproxstatin-1) were recently identified from high-throughput screening efforts to uncover potent inhibitors of ferroptosis, the necrotic-like cell death induced by inhibition of glutathione peroxidase 4 (GPX4), deletion of the corresponding gpx4 gene, or starvation of GPX4 of its reducing cosubstrate, glutathione (GSH).  We have since demonstrated that these two arom. amines are highly effective radical-trapping antioxidants (RTAs) in lipid bilayers, suggesting that they subvert ferroptosis by inhibiting lipid peroxidn. (autoxidn.) and, thus, that this process drives the execution of ferroptosis.  Herein, we show that diarylamine RTAs used to protect petroleum-derived products from autoxidn. can be potent inhibitors of ferroptosis.  The diarylamines investigated include representative examples of additives to engine oils, greases and rubber (4,4'-dialkyldiphenylamines), core structures of dyes and pharmaceuticals (phenoxazines and phenothiazines), and aza-analogs of these three classes of compds. that we have recently shown can be modified to achieve much greater reactivity.  We find that regardless of how ferroptosis is induced (GPX4 inhibition, gpx4 deletion or GSH depletion), compds. which possess good RTA activity in org. soln. (kinh > 105 M-1 s-1) and lipid bilayers (kinh > 104 M-1 s-1) are generally potent inhibitors of ferroptosis (in mouse embryonic fibroblasts).  Likewise, structural analogs that do not possess RTA activity are devoid of antiferroptotic activity.  These results further support the argument that lipid peroxidn. (autoxidn.) plays a major role in the mechanism of cell death induced by either GPX4 inhibition, gpx4 deletion, or GSH depletion.  Moreover, it offers clear direction that ongoing medicinal chem. efforts on liproxstatin and ferrostatin derivs., which have been proposed as lead compds. for the treatment and/or prevention of ischemia/reperfusion injury, renal failure, and neurodegeneration, can be widened to include other aminic RTAs.  To aid in these efforts, some relevant structure-reactivity relationships are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGray_NCtHIr-bVg90H21EOLACvtfcHk0lhbZjEm0umdZg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlOksLnM&md5=fefdd6246359c57145f57e52148d8449</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Facschembio.7b00730&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.7b00730%26sid%3Dliteratum%253Aachs%26aulast%3DShah%26aufirst%3DR.%26aulast%3DMargison%26aufirst%3DK.%26aulast%3DPratt%26aufirst%3DD.%2BA.%26atitle%3DThe%2520potency%2520of%2520diarylamine%2520radical-trapping%2520antioxidants%2520as%2520inhibitors%2520of%2520ferroptosis%2520underscores%2520the%2520role%2520of%2520autoxidation%2520in%2520the%2520mechanism%2520of%2520cell%2520death%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2017%26volume%3D12%26spage%3D2538%26epage%3D2545%26doi%3D10.1021%2Facschembio.7b00730" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, X.</span></span> <span> </span><span class="NLM_article-title">Proteasome-independent protein knockdown by small-molecule inhibitor for the undruggable lung adenocarcinoma</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>141</i></span>,  <span class="NLM_fpage">18492</span>â <span class="NLM_lpage">18499</span>, <span class="refDoi">Â DOI: 10.1021/jacs.9b08777</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jacs.9b08777" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitVGmsb%252FO" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=141&publication_year=2019&pages=18492-18499&author=W.+Zhouauthor=G.+Sunauthor=Z.+Zhangauthor=L.+Zhaoauthor=L.+Xuauthor=H.+Yuanauthor=S.+Liauthor=Z.+Dongauthor=Y.+Songauthor=X.+Fang&title=Proteasome-independent+protein+knockdown+by+small-molecule+inhibitor+for+the+undruggable+lung+adenocarcinoma&doi=10.1021%2Fjacs.9b08777"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Proteasome-Independent Protein Knockdown by Small-Molecule Inhibitor for the Undruggable Lung Adenocarcinoma</span></div><div class="casAuthors">Zhou, Wei; Sun, Guogui; Zhang, Zhen; Zhao, Libo; Xu, Li; Yuan, Hongyu; Li, Shumu; Dong, Zaizai; Song, Yongmei; Fang, Xiaohong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">141</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">18492-18499</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Therapeutic target identification and corresponding drug development is a demanding task for the treatment of lung adenocarcinoma, esp. the most malignant proximal-proliferative subtype without druggable protein kinase mutations.  Using a cell-SELEX-generated aptamer, we discovered a new tumor driver protein, leucine-rich pentatricopeptide repeat-contg. protein (LRPPRC), which is specifically overexpressed in the most lethal subtype of lung adenocarcinoma.  Targeted LRPPRC protein knockdown is a promising therapeutic strategy for the undruggable LUAD (lung adenocarcinoma).  Nevertheless, LRPPRC is mainly located in mitochondria and degraded by protease.  Current protein knockdown approaches, such as proteolysis-targeting chimeras (PROTACs), have limitations in their applications to the proteins degraded through proteasome-independent ways.  Here, we designed an aptamer-assisted high-throughput method to screen small mols. which could bind to LRPPRC directly, disrupt the interaction of LRPPRC with its stabilizing chaperon protein, and lead to LRPPRC degrdn. by mitochondrial protease.  The screened compd., gossypol-acetic acid (GAA), is an old medicine which can accomplish the new function for targeted LRPPRC knockdown.  It showed significant antitumor effects even with the LRPPRC pos. patient-derived tumor xenograft (PDX) model.  This work not only extended the application of aptamers to screen small-mol. inhibitors for the undruggable lung cancers, but more importantly provided a new strategy to develop protein knockdown methods beyond the proteasome system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_vMzM018-d7Vg90H21EOLACvtfcHk0lhbZjEm0umdZg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitVGmsb%252FO&md5=a1d1c0b0350394293630ddb90ca26bc8</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fjacs.9b08777&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjacs.9b08777%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DW.%26aulast%3DSun%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DZhao%26aufirst%3DL.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DYuan%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DDong%26aufirst%3DZ.%26aulast%3DSong%26aufirst%3DY.%26aulast%3DFang%26aufirst%3DX.%26atitle%3DProteasome-independent%2520protein%2520knockdown%2520by%2520small-molecule%2520inhibitor%2520for%2520the%2520undruggable%2520lung%2520adenocarcinoma%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2019%26volume%3D141%26spage%3D18492%26epage%3D18499%26doi%3D10.1021%2Fjacs.9b08777" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meza-Sosa, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lieberman, J.</span></span> <span> </span><span class="NLM_article-title">PNPT1 release from mitochondria during apoptosis triggers decay of Poly(A) RNAs</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>174</i></span>,  <span class="NLM_fpage">187</span>â <span class="NLM_lpage">201.e12</span>, <span class="refDoi">Â DOI: 10.1016/j.cell.2018.04.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=10.1016%2Fj.cell.2018.04.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=29779946" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=1%3ACAS%3A528%3ADC%252BC1cXpvVemsr0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=174&publication_year=2018&pages=187-201.e12&author=X.+Liuauthor=R.+Fuauthor=Y.+Panauthor=K.+F.+Meza-Sosaauthor=Z.+Zhangauthor=J.+Lieberman&title=PNPT1+release+from+mitochondria+during+apoptosis+triggers+decay+of+Poly%28A%29+RNAs&doi=10.1016%2Fj.cell.2018.04.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">PNPT1 Release from Mitochondria during Apoptosis Triggers Decay of Poly(A) RNAs</span></div><div class="casAuthors">Liu, Xing; Fu, Rui; Pan, Youdong; Meza-Sosa, Karla F.; Zhang, Zhibin; Lieberman, Judy</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">174</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">187-201.e12</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Widespread mRNA decay, an unappreciated feature of apoptosis, enhances cell death and depends on mitochondrial outer membrane permeabilization (MOMP), TUTases, and DIS3L2.  Which RNAs are decayed and the decay-initiating event are unknown.  Here, we show extensive decay of mRNAs and poly(A) noncoding (nc)RNAs at the 3' end, triggered by the mitochondrial intermembrane space 3'-to-5' exoribonuclease PNPT1, released during MOMP.  PNPT1 knockdown inhibits apoptotic RNA decay and reduces apoptosis, while ectopic expression of PNPT1, but not an RNase-deficient mutant, increases RNA decay and cell death.  The 3' end of PNPT1 substrates thread through a narrow channel.  Many non-poly(A) ncRNAs contain 3'-secondary structures or bind proteins that may block PNPT1 activity.  Indeed, mutations that disrupt the 3'-stem-loop of a decay-resistant ncRNA render the transcript susceptible, while adding a 3'-stem-loop to an mRNA prevents its decay.  Thus, PNPT1 release from mitochondria during MOMP initiates apoptotic decay of RNAs lacking 3'-structures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbWSyYeE8zhbVg90H21EOLACvtfcHk0lhbZjEm0umdZg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXpvVemsr0%253D&md5=f6b69297b77fc3bbbf49cb62ddd2569e</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2018.04.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2018.04.017%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DFu%26aufirst%3DR.%26aulast%3DPan%26aufirst%3DY.%26aulast%3DMeza-Sosa%26aufirst%3DK.%2BF.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DLieberman%26aufirst%3DJ.%26atitle%3DPNPT1%2520release%2520from%2520mitochondria%2520during%2520apoptosis%2520triggers%2520decay%2520of%2520Poly%2528A%2529%2520RNAs%26jtitle%3DCell%26date%3D2018%26volume%3D174%26spage%3D187%26epage%3D201.e12%26doi%3D10.1016%2Fj.cell.2018.04.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cuillerier, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honarmand, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cadete, V. J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruiz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forest, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeschÃªnes, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beauchamp, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Consortium, L. S. F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charron, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rioux, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Des Rosiers, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoubridge, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burelle, Y.</span></span> <span> </span><span class="NLM_article-title">Loss of hepatic LRPPRC alters mitochondrial bioenergetics, regulation of permeability transition and trans-membrane ROS diffusion</span>. <i>Hum. Mol. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">3186</span>â <span class="NLM_lpage">3201</span>, <span class="refDoi">Â DOI: 10.1093/hmg/ddx202</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=10.1093%2Fhmg%2Fddx202" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=28575497" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjt1Sqt7s%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2017&pages=3186-3201&author=A.+Cuillerierauthor=S.+Honarmandauthor=V.+J.+J.+Cadeteauthor=M.+Ruizauthor=A.+Forestauthor=S.+Desch%C3%AAnesauthor=C.+Beauchampauthor=L.+S.+F.+C.+Consortiumauthor=G.+Charronauthor=J.+D.+Riouxauthor=C.+Des+Rosiersauthor=E.+A.+Shoubridgeauthor=Y.+Burelle&title=Loss+of+hepatic+LRPPRC+alters+mitochondrial+bioenergetics%2C+regulation+of+permeability+transition+and+trans-membrane+ROS+diffusion&doi=10.1093%2Fhmg%2Fddx202"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Loss of hepatic LRPPRC alters mitochondrial bioenergetics, regulation of permeability transition and trans-membrane ROS diffusion</span></div><div class="casAuthors">Cuillerier, Alexanne; Honarmand, Shamisa; Cadete, Virgilio J. J.; Ruiz, Matthieu; Forest, Anik; Deschenes, Sonia; Beauchamp, Claudine; Consortium, Lsfc; Charron, Guy; Rioux, John D.; Des Rosiers, Christine; Shoubridge, Eric A.; Burelle, Yan</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">3186-3201</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">1460-2083</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The French-Canadian variant of Leigh Syndrome (LSFC) is an autosomal recessive oxidative phosphorylation (OXPHOS) disorder caused by a mutation in LRPPRC, coding for a protein involved in the stability of mitochondrially-encoded mRNAs.  Low levels of LRPPRC are present in all patient tissues, but result in a disproportionately severe OXPHOS defect in the brain and liver, leading to unpredictable subacute metabolic crises.  To investigate the impact of the OXPHOS defect in the liver, we analyzed the mitochondrial phenotype in mice harboring an hepatocyte-specific inactivation of Lrpprc.  Loss of LRPPRC in the liver caused a generalized growth delay, and typical histol. features of mitochondrial hepatopathy.  At the mol. level, LRPPRC deficiency caused destabilization of polyadenylated mitochondrial mRNAs, altered mitochondrial ultrastructure, and a severe complex IV (CIV) and ATP synthase (CV) assembly defect.  The impact of LRPPRC deficiency was not limited to OXPHOS, but also included impairment of long-chain fatty acid oxidn., a striking dysregulation of the mitochondrial permeability transition pore, and an unsuspected alteration of trans-membrane H2O2 diffusion, which was traced to the ATP synthase assembly defect, and to changes in the lipid compn. of mitochondrial membranes.  This study underscores the value of mitochondria phenotyping to uncover complex and unexpected mechanisms contributing to the pathophysiol. of mitochondrial disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIVVeX48HlKbVg90H21EOLACvtfcHk0lgGZ2_0yIQ0Vw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjt1Sqt7s%253D&md5=4767563d96bbd8509be5413d6caf23d7</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2Fddx202&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252Fddx202%26sid%3Dliteratum%253Aachs%26aulast%3DCuillerier%26aufirst%3DA.%26aulast%3DHonarmand%26aufirst%3DS.%26aulast%3DCadete%26aufirst%3DV.%2BJ.%2BJ.%26aulast%3DRuiz%26aufirst%3DM.%26aulast%3DForest%26aufirst%3DA.%26aulast%3DDesch%25C3%25AAnes%26aufirst%3DS.%26aulast%3DBeauchamp%26aufirst%3DC.%26aulast%3DConsortium%26aufirst%3DL.%2BS.%2BF.%2BC.%26aulast%3DCharron%26aufirst%3DG.%26aulast%3DRioux%26aufirst%3DJ.%2BD.%26aulast%3DDes%2BRosiers%26aufirst%3DC.%26aulast%3DShoubridge%26aufirst%3DE.%2BA.%26aulast%3DBurelle%26aufirst%3DY.%26atitle%3DLoss%2520of%2520hepatic%2520LRPPRC%2520alters%2520mitochondrial%2520bioenergetics%252C%2520regulation%2520of%2520permeability%2520transition%2520and%2520trans-membrane%2520ROS%2520diffusion%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2017%26volume%3D26%26spage%3D3186%26epage%3D3201%26doi%3D10.1093%2Fhmg%2Fddx202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Broad Institute TCGA Genome
Data Analysis Center</span>.  <i>Firehose stddata__2016_01_28
run</i>., Broad Institute of MIT Harvard, Cambridge, MA. 2016,
DOI: <span class="refDoi">Â DOI: 10.7908/C11G0KM9</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=10.7908%2FC11G0KM9" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Broad+Institute+TCGA+Genome%0AData+Analysis+Center.+Firehose+stddata__2016_01_28%0Arun.%2C+Broad+Institute+of+MIT+Harvard%2C+Cambridge%2C+MA.+2016%2C%0ADOI%3A+10.7908%2FC11G0KM9."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.7908%2FC11G0KM9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dreport%26id%3Ddoi%3A10.7908%252FC11G0KM9%26sid%3Dliteratum%253Aachs%26aulast%3D%26jtitle%3DFirehose%2520stddata__2016_01_28%250Arun%26doi%3D10.7908%2FC11G0KM9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 3 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Maha Hanafi, Xinde Chen, <span class="NLM_string-name hlFld-ContribAuthor">Nouri Neamati</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a Napabucasin PROTAC as an Effective Degrader of the E3 Ligase ZFP91. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (3)
                                     , 1626-1648. <a href="https://doi.org/10.1021/acs.jmedchem.0c01897" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01897</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01897&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01897%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Ba%252BNapabucasin%252BPROTAC%252Bas%252Ban%252BEffective%252BDegrader%252Bof%252Bthe%252BE3%252BLigase%252BZFP91%26aulast%3DHanafi%26aufirst%3DMaha%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D03112020%26date%3D28012021%26volume%3D64%26issue%3D3%26spage%3D1626%26epage%3D1648" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Li  Zhang</span>, <span class="hlFld-ContribAuthor ">Guiying  Zhang</span>, <span class="hlFld-ContribAuthor ">Shujing  Xu</span>, <span class="hlFld-ContribAuthor ">Yuning  Song</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances of quinones as a privileged structure in drug discovery. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>223 </em>, 113632. <a href="https://doi.org/10.1016/j.ejmech.2021.113632" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113632</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113632&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113632%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRecent%252Badvances%252Bof%252Bquinones%252Bas%252Ba%252Bprivileged%252Bstructure%252Bin%252Bdrug%252Bdiscovery%26aulast%3DZhang%26aufirst%3DLi%26date%3D2021%26volume%3D223%26spage%3D113632" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shuai-Jiang  Liu</span>, <span class="hlFld-ContribAuthor ">Qian  Zhao</span>, <span class="hlFld-ContribAuthor ">Cheng  Peng</span>, <span class="hlFld-ContribAuthor ">Qing  Mao</span>, <span class="hlFld-ContribAuthor ">Fengbo  Wu</span>, <span class="hlFld-ContribAuthor ">Feng-Hua  Zhang</span>, <span class="hlFld-ContribAuthor ">Quan-Sheng  Feng</span>, <span class="hlFld-ContribAuthor ">Gu  He</span>, <span class="hlFld-ContribAuthor ">Bo  Han</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and biological evaluation of nitroisoxazole-containing spiro[pyrrolidin-oxindole] derivatives as novel glutathione peroxidase 4/mouse double minute 2 dual inhibitors that inhibit breast adenocarcinoma cell proliferation. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>217 </em>, 113359. <a href="https://doi.org/10.1016/j.ejmech.2021.113359" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113359</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113359&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113359%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bbiological%252Bevaluation%252Bof%252Bnitroisoxazole-containing%252Bspiro%25255Bpyrrolidin-oxindole%25255D%252Bderivatives%252Bas%252Bnovel%252Bglutathione%252Bperoxidase%252B4%25252Fmouse%252Bdouble%252Bminute%252B2%252Bdual%252Binhibitors%252Bthat%252Binhibit%252Bbreast%252Badenocarcinoma%252Bcell%252Bproliferation%26aulast%3DLiu%26aufirst%3DShuai-Jiang%26date%3D2021%26volume%3D217%26spage%3D113359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01016/20200903/images/medium/jm0c01016_0016.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01016/20200903/images/large/jm0c01016_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01016&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01016/20200903/images/medium/jm0c01016_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01016/20200903/images/large/jm0c01016_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Structures of Representative ROS Inducers under Clinical Evaluation, and Design of Novel Quinazolinedione-Based ROS Modulators</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01016/20200903/images/large/jm0c01016_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01016&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01016/20200903/images/medium/jm0c01016_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01016/20200903/images/large/jm0c01016_0012.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Preparation of QD385 to QD395<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01016/20200903/images/large/jm0c01016_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01016&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) CeCl<sub>3</sub>Â·7H<sub>2</sub>O, abs EtOH, rt, 1.5 h.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01016/20200903/images/medium/jm0c01016_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01016/20200903/images/large/jm0c01016_0013.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthetic Route for the Preparation of the Synthon <b>1</b> and Its Intermediates<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01016/20200903/images/large/jm0c01016_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01016&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) conc. HNO<sub>3</sub>, (CH<sub>3</sub>CO)<sub>2</sub>O, 0 Â°C, 1.5 h; (ii) H<sub>2</sub>NCHO, HCl<sub>(g)</sub> from 40 to 80 Â°C, 1 h; (iii) glacial CH<sub>3</sub>COOH, Zn, 0 Â°C for 2 h, rt for 4 h; (iv) (NH<sub>4</sub>)<sub>2</sub>Ce(NO<sub>3</sub>)<sub>6</sub>, CH<sub>3</sub>CN/H<sub>2</sub>O, 0 Â°C, 20 min. For synthetic details, see ref <a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a>.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01016/20200903/images/medium/jm0c01016_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01016/20200903/images/large/jm0c01016_0014.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthetic Route for the Preparation of QD394-Me<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01016/20200903/images/large/jm0c01016_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01016&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) conc. HNO<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, rt, 24 h; (ii) H<sub>2</sub>NCHO, HCl<sub>(g)</sub> from 40 to 80 Â°C, 1 h; (iii) glacial CH<sub>3</sub>COOH, Zn, 0 Â°C for 2 h, rt for 4 h; (iv) (NH<sub>4</sub>)<sub>2</sub>Ce(NO<sub>3</sub>)<sub>6</sub>, CH<sub>3</sub>CN/H<sub>2</sub>O, 0 Â°C, 20 min; (v) CeCl<sub>3</sub>Â·7H<sub>2</sub>O, abs EtOH, rt, 1.5 h.</p></p></figure><figure data-id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01016/20200903/images/medium/jm0c01016_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01016/20200903/images/large/jm0c01016_0015.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Alternative Synthetic Route for the Preparation of QD394<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01016/20200903/images/large/jm0c01016_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01016&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) HCOONH<sub>4</sub>, Pd/C; (ii) ClCO<sub>2</sub>Et, THF; (iii) (1) HMTA, TFA; (iv) KOH, aqueous EtOH, K<sub>3</sub>Fe(CN)<sub>6</sub>; (v) (NH<sub>4</sub>)<sub>2</sub>Ce(NO<sub>3</sub>)<sub>6</sub>, CH<sub>3</sub>CN/H<sub>2</sub>O; (vi) 4-(4-methylpiperazin-1-yl)aniline, CeCl<sub>3</sub>Â·7H<sub>2</sub>O, abs EtOH.</p></p></figure><figure data-id="fig1" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01016/20200903/images/medium/jm0c01016_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01016/20200903/images/large/jm0c01016_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Transcriptomic profile of QD394 is similar to those of napabucasin (napa) and H<sub>2</sub>O<sub>2</sub>. (A) Pearson correlation between QD394, napabucasin, and H<sub>2</sub>O<sub>2</sub> samples calculated in R. ShrunkenLFC was used to build heatmaps. (B,C) Upregulated and downregulated gene sets in GSEA from QD394 and napabucasin Bru-seq samples. GSEA plots of upregulated (D) and downregulated (E) enriched gene sets from the QD394 samples that are shared with napabucasin are depicted (FDR < 0.001). NES, normalized enrichment score. (F) Cells were treated with QD394 for 4 h at indicated concentrations and analyzed by immunoblot with STAT3, pSTAT3, GAPDH, and pH2AX antibodies.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01016/20200903/images/large/jm0c01016_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01016&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01016/20200903/images/medium/jm0c01016_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01016/20200903/images/large/jm0c01016_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. QD394 increases the cellular ROS level and reduces the GSH/GSSG ratio in MIA PaCa-2 cells. (A) QD394 increased fluorescence (RFU) indicating cellular ROS generation across treatment times (0â4 h). TBHP was used as a positive control. (B) At 30 min, a significant increase of ROS was determined in QD394- and TBHP-treated cells, and NAC (3 mM) reduced the elevated ROS levels. ** denotes <i>p</i> < 0.005, *** denotes <i>p</i> < 0.0005. (C) NAC significantly decreased the cytotoxicity of QD394 in the MTT assay. (D) NAC protected the inhibition of colony formation caused by QD394. (E) QD394 reduced the cellular GSH/GSSG ratio, mainly resulting from GSSG formation. RLU, relative luminescence unit. * denotes <i>p</i> < 0.05, ** denotes <i>p</i> < 0.005, *** denotes <i>p</i> < 0.0005.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01016/20200903/images/large/jm0c01016_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01016&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01016/20200903/images/medium/jm0c01016_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01016/20200903/images/large/jm0c01016_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. QD394 induces iron-dependent and GPX4-mediated ferroptosis in MIA PaCa-2 cells. (A) DFO decreased the inhibition of colony formation caused by QD394. (B) QD394 significantly induced lipid peroxidation after 24 h of treatment, similar to TBHP, RSL3, and erastin. * denotes <i>p</i> < 0.05, ** denotes <i>p</i> < 0.005. (C) The potential interaction between QD394 and GPX4 was determined by the cellular thermal shift assay. Detailed procedures are described in the <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a>. QD394 decreased the melting temperature of the GPX4 protein. ImageJ and GraphPad Prism were used for quantification. QD394 was tested at 100 Î¼M for 1 h. RT: room temperature, around 21 Â°C. (D) Knockdown of GPX4 significantly reduced cytotoxicity of QD394. siNC: samples treated with scrambled siRNA; siGPX4: samples treated with GPX4 siRNA. * denotes <i>p</i> < 0.05. Cells were immunoblotted with the GPX4 antibody to validate GPX4 knockdown. (E) RSL3 inhibited colony formation in pancreatic cancer cells, and QD394 rescued its effect.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01016/20200903/images/large/jm0c01016_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01016&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01016/20200903/images/medium/jm0c01016_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01016/20200903/images/large/jm0c01016_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Common genes/proteins between Bru-seq and proteomics analysis reveal that QD394 interferes with mitochondrial gene expression and RNA catabolic process. (A) Venn diagrams of upregulated and downregulated genes/proteins between Bru-seq (fold change over 2) and proteomics (fold change over 1.5) analysis. (B) STRING analysis of 35 downregulated genes/proteins in common between Bru-seq and proteomics studies. The red circle highlights the genes involved in mitochondrial gene and translation regulation. The blue circle indicates the genes associated with the oxidation reduction process. (C) LRPPRC and PNPT1 are significantly related to the overall survival of pancreatic adenocarcinoma patients in the TCGA data set. (D) QD394 decreased the protein expression of LRPPRC and PNPT1 in MIA PaCa-2 cells. QD394 and napabucasin were tested at 3 Ã IC<sub>50</sub> for 1 and 4 h. QD394 was tested at 2 Ã IC<sub>50</sub> for 24 h. H<sub>2</sub>O<sub>2</sub> was used at 150 Î¼M. * denotes <i>p</i> < 0.05, ** denotes <i>p</i> < 0.005, *** denotes <i>p</i> < 0.0005. (E) The expression levels of mitochondrial proteins decreased in the QD394-treated MIA PaCa-2 cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01016/20200903/images/large/jm0c01016_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01016&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01016/20200903/images/medium/jm0c01016_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01016/20200903/images/large/jm0c01016_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. QD394 is synergistic with select FDA-approved drugs in pancreatic cancer cells. Napabucasin (A), As<sub>2</sub>O<sub>3</sub> (B), and olaparib (C) were added 1 h before QD394. Cells were treated with drugs for 24 h. Red rectangles label the wells showing synergy.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01016/20200903/images/large/jm0c01016_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01016&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01016/20200903/images/medium/jm0c01016_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01016/20200903/images/large/jm0c01016_0008.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Pharmacokinetics-guided optimization of QD394 led to QD394-Me having better stability in mouse plasma. (A) Potential metabolites of QD394 in mouse plasma. The hydroxyl groups could be on either ring highlighted by circles. (B) Structures of QD394 and QD394-Me.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01016/20200903/images/large/jm0c01016_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01016&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01016/20200903/images/medium/jm0c01016_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01016/20200903/images/large/jm0c01016_0009.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. QD394-Me has a similar cellular profile to QD394. (A) QD394-Me increased the cellular ROS level, and NAC reduced the induction of ROS at 30 min. ** denotes <i>p</i> < 0.005, *** denotes <i>p</i> < 0.0005. (B) QD394-Me significantly increased lipid peroxidation in MIA PaCa-2 cells. (C) QD394-Me destabilizes the GPX4 protein in MIA PaCa-2 cells. QD394-Me was tested at 100 Î¼M. (D) The cytotoxicity of QD394-Me was significantly reduced in the GPX4-knockdown MIA PaCa-2 cells. siNC: samples treated with scrambled siRNA; siGPX4: samples treated with GPX4 siRNA. (E) QD394-Me reduced the protein expression of LRPPRC and PNPT1 significantly at 4 h in MIA PaCa-2 cells. QD394-Me was tested at 3 Ã IC<sub>50</sub> for 1 and 4 h and 2 Ã IC<sub>50</sub> for 24 h. * denotes <i>p</i> < 0.05, ** denotes <i>p</i> < 0.005.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01016/20200903/images/large/jm0c01016_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01016&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01016/20200903/images/medium/jm0c01016_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01016/20200903/images/large/jm0c01016_0010.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Select enriched gene sets of QD394-Me in MIA PaCa-2 Bru-seq samples.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01016/20200903/images/large/jm0c01016_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01016&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01016/20200903/images/medium/jm0c01016_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01016/20200903/images/large/jm0c01016_0011.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Summary of the working mechanisms of QD394 and QD394-Me in pancreatic cancer cells. QD394 and QD394-Me increase the cellular ROS level, induce DNA damage, decrease mitochondrial proteins, and promote accumulation of lipid ROS. They oxidize GSH to GSSG and destabilize GPX4 in the cells. Their cytotoxicity is dependent on iron, ROS, and GPX4 expression. Ferroptosis and necrosis are potentially involved in their cell death mechanisms.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01016/20200903/images/large/jm0c01016_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01016&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i74">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88271" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88271" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 47 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jemal, A.</span></span> <span> </span><span class="NLM_article-title">Cancer statistics, 2020</span>. <i>Ca-Cancer J. Clin.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">7</span>â <span class="NLM_lpage">30</span>, <span class="refDoi">Â DOI: 10.3322/caac.21590</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=10.3322%2Fcaac.21590" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=31912902" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=1%3ACAS%3A280%3ADC%252BB3Mbns1emug%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2020&pages=7-30&author=R.+L.+Siegelauthor=K.+D.+Millerauthor=A.+Jemal&title=Cancer+statistics%2C+2020&doi=10.3322%2Fcaac.21590"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer statistics, 2020</span></div><div class="casAuthors">Siegel Rebecca L; Miller Kimberly D; Jemal Ahmedin</div><div class="citationInfo"><span class="NLM_cas:title">CA: a cancer journal for clinicians</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">7-30</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths that will occur in the United States and compiles the most recent data on population-based cancer occurrence.  Incidence data (through 2016) were collected by the Surveillance, Epidemiology, and End Results Program; the National Program of Cancer Registries; and the North American Association of Central Cancer Registries.  Mortality data (through 2017) were collected by the National Center for Health Statistics.  In 2020, 1,806,590 new cancer cases and 606,520 cancer deaths are projected to occur in the United States.  The cancer death rate rose until 1991, then fell continuously through 2017, resulting in an overall decline of 29% that translates into an estimated 2.9 million fewer cancer deaths than would have occurred if peak rates had persisted.  This progress is driven by long-term declines in death rates for the 4 leading cancers (lung, colorectal, breast, prostate); however, over the past decade (2008-2017), reductions slowed for female breast and colorectal cancers, and halted for prostate cancer.  In contrast, declines accelerated for lung cancer, from 3% annually during 2008 through 2013 to 5% during 2013 through 2017 in men and from 2% to almost 4% in women, spurring the largest ever single-year drop in overall cancer mortality of 2.2% from 2016 to 2017.  Yet lung cancer still caused more deaths in 2017 than breast, prostate, colorectal, and brain cancers combined.  Recent mortality declines were also dramatic for melanoma of the skin in the wake of US Food and Drug Administration approval of new therapies for metastatic disease, escalating to 7% annually during 2013 through 2017 from 1% during 2006 through 2010 in men and women aged 50 to 64 years and from 2% to 3% in those aged 20 to 49 years; annual declines of 5% to 6% in individuals aged 65 years and older are particularly striking because rates in this age group were increasing prior to 2013.  It is also notable that long-term rapid increases in liver cancer mortality have attenuated in women and stabilized in men.  In summary, slowing momentum for some cancers amenable to early detection is juxtaposed with notable gains for other common cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQjOzlnUMKF5EwlCcfExbvbfW6udTcc2eZqYXvGd7JajLntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3Mbns1emug%253D%253D&md5=a54b884bbc3c3f592921026db34b29db</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.3322%2Fcaac.21590&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3322%252Fcaac.21590%26sid%3Dliteratum%253Aachs%26aulast%3DSiegel%26aufirst%3DR.%2BL.%26aulast%3DMiller%26aufirst%3DK.%2BD.%26aulast%3DJemal%26aufirst%3DA.%26atitle%3DCancer%2520statistics%252C%25202020%26jtitle%3DCa-Cancer%2520J.%2520Clin.%26date%3D2020%26volume%3D70%26spage%3D7%26epage%3D30%26doi%3D10.3322%2Fcaac.21590" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kamisawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itoi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takaori, K.</span></span> <span> </span><span class="NLM_article-title">Pancreatic cancer</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>388</i></span>,  <span class="NLM_fpage">73</span>â <span class="NLM_lpage">85</span>, <span class="refDoi">Â DOI: 10.1016/S0140-6736(16)00141-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=10.1016%2FS0140-6736%2816%2900141-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=26830752" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhsl2mtb8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=388&publication_year=2016&pages=73-85&author=T.+Kamisawaauthor=L.+D.+Woodauthor=T.+Itoiauthor=K.+Takaori&title=Pancreatic+cancer&doi=10.1016%2FS0140-6736%2816%2900141-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Pancreatic cancer</span></div><div class="casAuthors">Kamisawa, Terumi; Wood, Laura D.; Itoi, Takao; Takaori, Kyoichi</div><div class="citationInfo"><span class="NLM_cas:title">Lancet</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">388</span>
        (<span class="NLM_cas:issue">10039</span>),
    <span class="NLM_cas:pages">73-85</span>CODEN:
                <span class="NLM_cas:coden">LANCAO</span>;
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Pancreatic cancer is a highly lethal disease, for which mortality closely parallels incidence.  Most patients with pancreatic cancer remain asymptomatic until the disease reaches an advanced stage.  There is no std. program for screening patients at high risk of pancreatic cancer (eg, those with a family history of pancreatic cancer and chronic pancreatitis).  Most pancreatic cancers arise from microscopic non-invasive epithelial proliferations within the pancreatic ducts, referred to as pancreatic intraepithelial neoplasias.  There are four major driver genes for pancreatic cancer: KRAS, CDKN2A, TP53, and SMAD4.  KRAS mutation and alterations in CDKN2A are early events in pancreatic tumorigenesis.  Endoscopic ultrasonog. and endoscopic ultrasonog.-guided fine-needle aspiration offer high diagnostic ability for pancreatic cancer.  Surgical resection is regarded as the only potentially curative treatment, and adjuvant chemotherapy with gemcitabine or S-1, an oral fluoropyrimidine deriv., is given after surgery.  FOLFIRINOX (fluorouracil, folinic acid [leucovorin], irinotecan, and oxaliplatin) and gemcitabine plus nanoparticle albumin-bound paclitaxel (nab-paclitaxel) are the treatments of choice for patients who are not surgical candidates but have good performance status.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowv4Kc18l117Vg90H21EOLACvtfcHk0ljwNUhd2tO4jg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhsl2mtb8%253D&md5=008fad5f1be8c3c6f3534c5bc3c3ea3a</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2816%2900141-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252816%252900141-0%26sid%3Dliteratum%253Aachs%26aulast%3DKamisawa%26aufirst%3DT.%26aulast%3DWood%26aufirst%3DL.%2BD.%26aulast%3DItoi%26aufirst%3DT.%26aulast%3DTakaori%26aufirst%3DK.%26atitle%3DPancreatic%2520cancer%26jtitle%3DLancet%26date%3D2016%26volume%3D388%26spage%3D73%26epage%3D85%26doi%3D10.1016%2FS0140-6736%2816%2900141-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rahib, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aizenberg, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenzweig, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fleshman, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matrisian, L. M.</span></span> <span> </span><span class="NLM_article-title">Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>74</i></span>,  <span class="NLM_fpage">2913</span>â <span class="NLM_lpage">2921</span>, <span class="refDoi">Â DOI: 10.1158/0008-5472.CAN-14-0155</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=10.1158%2F0008-5472.CAN-14-0155" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=24840647" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=1%3ACAS%3A528%3ADC%252BC2cXovFalur0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2014&pages=2913-2921&author=L.+Rahibauthor=B.+D.+Smithauthor=R.+Aizenbergauthor=A.+B.+Rosenzweigauthor=J.+M.+Fleshmanauthor=L.+M.+Matrisian&title=Projecting+cancer+incidence+and+deaths+to+2030%3A+the+unexpected+burden+of+thyroid%2C+liver%2C+and+pancreas+cancers+in+the+United+States&doi=10.1158%2F0008-5472.CAN-14-0155"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States</span></div><div class="casAuthors">Rahib, Lola; Smith, Benjamin D.; Aizenberg, Rhonda; Rosenzweig, Allison B.; Fleshman, Julie M.; Matrisian, Lynn M.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2913-2921</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Cancer incidence and deaths in the United States were projected for the most common cancer types for the years 2020 and 2030 based on changing demographics and the av. annual percentage changes in incidence and death rates.  Breast, prostate, and lung cancers will remain the top cancer diagnoses throughout this time, but thyroid cancer will replace colorectal cancer as the fourth leading cancer diagnosis by 2030, and melanoma and uterine cancer will become the fifth and sixth most common cancers, resp.  Lung cancer is projected to remain the top cancer killer throughout this time period.  However, pancreas and liver cancers are projected to surpass breast, prostate, and colorectal cancers to become the second and third leading causes of cancer-related death by 2030, resp.  Advances in screening, prevention, and treatment can change cancer incidence and/or death rates, but it will require a concerted effort by the research and healthcare communities now to effect a substantial change for the future.  Cancer Res; 74(11); 2913-21. Â©2014 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHGt66quENkbVg90H21EOLACvtfcHk0ljwNUhd2tO4jg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXovFalur0%253D&md5=893d688f1ccba88ee094b743f7e4f152</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-14-0155&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-14-0155%26sid%3Dliteratum%253Aachs%26aulast%3DRahib%26aufirst%3DL.%26aulast%3DSmith%26aufirst%3DB.%2BD.%26aulast%3DAizenberg%26aufirst%3DR.%26aulast%3DRosenzweig%26aufirst%3DA.%2BB.%26aulast%3DFleshman%26aufirst%3DJ.%2BM.%26aulast%3DMatrisian%26aufirst%3DL.%2BM.%26atitle%3DProjecting%2520cancer%2520incidence%2520and%2520deaths%2520to%25202030%253A%2520the%2520unexpected%2520burden%2520of%2520thyroid%252C%2520liver%252C%2520and%2520pancreas%2520cancers%2520in%2520the%2520United%2520States%26jtitle%3DCancer%2520Res.%26date%3D2014%26volume%3D74%26spage%3D2913%26epage%3D2921%26doi%3D10.1158%2F0008-5472.CAN-14-0155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mohammad, A. A.</span></span> <span> </span><span class="NLM_article-title">Advanced pancreatic cancer: the standard of care and new opportunities</span>. <i>Oncol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">370</span>, <span class="refDoi">Â DOI: 10.4081/oncol.2018.370</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=10.4081%2Foncol.2018.370" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=30344961" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=1%3ACAS%3A280%3ADC%252BB3cvhslSrtA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2018&pages=370&author=A.+A.+Mohammad&title=Advanced+pancreatic+cancer%3A+the+standard+of+care+and+new+opportunities&doi=10.4081%2Foncol.2018.370"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Advanced pancreatic cancer: The standard of care and new opportunities</span></div><div class="casAuthors">Mohammad Amrallah A</div><div class="citationInfo"><span class="NLM_cas:title">Oncology reviews</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">370</span>
        ISSN:<span class="NLM_cas:issn">1970-5565</span>.
    </div><div class="casAbstract">Presentation of pancreatic cancer is localized, locally advanced or metastatic.  With the later represented the main bulk (more than 80%).  Despite the significant innovation in molecular analysis and therapeutic approach in many types of cancer in the last two decades, still the outcome of advanced pancreatic cancer is disappointing and the mortality rate approximately unchanged.  In this mandated review we intended to highlight the standard of care and emerging agents for advanced pancreatic cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTaPmT8sn-38zjk2McQZ6XmfW6udTcc2ebUDtZv4uuWy7ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cvhslSrtA%253D%253D&md5=1f1821cafc5687f69982120b364702af</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.4081%2Foncol.2018.370&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4081%252Foncol.2018.370%26sid%3Dliteratum%253Aachs%26aulast%3DMohammad%26aufirst%3DA.%2BA.%26atitle%3DAdvanced%2520pancreatic%2520cancer%253A%2520the%2520standard%2520of%2520care%2520and%2520new%2520opportunities%26jtitle%3DOncol.%2520Rev.%26date%3D2018%26volume%3D12%26spage%3D370%26doi%3D10.4081%2Foncol.2018.370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hanahan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinberg, R. A.</span></span> <span> </span><span class="NLM_article-title">Hallmarks of cancer: the next generation</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>144</i></span>,  <span class="NLM_fpage">646</span>â <span class="NLM_lpage">674</span>, <span class="refDoi">Â DOI: 10.1016/j.cell.2011.02.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=10.1016%2Fj.cell.2011.02.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=21376230" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsFeqtrk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=144&publication_year=2011&pages=646-674&author=D.+Hanahanauthor=R.+A.+Weinberg&title=Hallmarks+of+cancer%3A+the+next+generation&doi=10.1016%2Fj.cell.2011.02.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Hallmarks of cancer: the next generation</span></div><div class="casAuthors">Hanahan, Douglas; Weinberg, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">144</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">646-674</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  The hallmarks of cancer comprise six biol. capabilities acquired during the multistep development of human tumors.  The hallmarks constitute an organizing principle for rationalizing the complexities of neoplastic disease.  They include sustaining proliferative signaling, evading growth suppressors, resisting cell death, enabling replicative immortality, inducing angiogenesis, and activating invasion and metastasis.  Underlying these hallmarks are genome instability, which generates the genetic diversity that expedites their acquisition, and inflammation, which fosters multiple hallmark functions.  Conceptual progress in the last decade has added two emerging hallmarks of potential generality to this list-reprogramming of energy metab. and evading immune destruction.  In addn. to cancer cells, tumors exhibit another dimension of complexity: they contain a repertoire of recruited, ostensibly normal cells that contribute to the acquisition of hallmark traits by creating the "tumor microenvironment.".  Recognition of the widespread applicability of these concepts will increasingly affect the development of new means to treat human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTcpqXALcb6LVg90H21EOLACvtfcHk0lgeO0n9jdM8eg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsFeqtrk%253D&md5=b36f160c417a712e83cb83c577f0018e</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2011.02.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2011.02.013%26sid%3Dliteratum%253Aachs%26aulast%3DHanahan%26aufirst%3DD.%26aulast%3DWeinberg%26aufirst%3DR.%2BA.%26atitle%3DHallmarks%2520of%2520cancer%253A%2520the%2520next%2520generation%26jtitle%3DCell%26date%3D2011%26volume%3D144%26spage%3D646%26epage%3D674%26doi%3D10.1016%2Fj.cell.2011.02.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fouad, Y. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aanei, C.</span></span> <span> </span><span class="NLM_article-title">Revisiting the hallmarks of cancer</span>. <i>Am. J. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">1016</span>â <span class="NLM_lpage">1036</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=28560055" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvFOju77N" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=1016-1036&author=Y.+A.+Fouadauthor=C.+Aanei&title=Revisiting+the+hallmarks+of+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Revisiting the hallmarks of cancer</span></div><div class="casAuthors">Fouad, Yousef Ahmed; Aanei, Carmen</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Cancer Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1016-1036</span>CODEN:
                <span class="NLM_cas:coden">AJCRFT</span>;
        ISSN:<span class="NLM_cas:issn">2156-6976</span>.
    
            (<span class="NLM_cas:orgname">e-Century Publishing Corp.</span>)
        </div><div class="casAbstract">The hallmarks of cancer described by Hanahan and Weinberg have proved seminal in our understanding of cancer's common traits and in rational drug design.  Not free of critique and with understanding of different aspects of tumorigenesis coming into clearer focus in the recent years, we attempt to draw a more organized and updated picture of the cancer hallmarks.  We define seven hallmarks of cancer: selective growth and proliferative advantage, altered stress response favoring overall survival, vascularization, invasion and metastasis, metabolic rewiring, an abetting microenvironment, and immune modulation, while highlighting some considerations for the future of the field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQWd_TRJpAJbVg90H21EOLACvtfcHk0lgeO0n9jdM8eg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvFOju77N&md5=f3e523fdecbad82fa94bd3d6c9f365ae</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFouad%26aufirst%3DY.%2BA.%26aulast%3DAanei%26aufirst%3DC.%26atitle%3DRevisiting%2520the%2520hallmarks%2520of%2520cancer%26jtitle%3DAm.%2520J.%2520Cancer%2520Res.%26date%3D2017%26volume%3D7%26spage%3D1016%26epage%3D1036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hornsveld, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dansen, T. B.</span></span> <span> </span><span class="NLM_article-title">The hallmarks of cancer from a redox perspective</span>. <i>Antioxid. Redox Signaling</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">300</span>â <span class="NLM_lpage">325</span>, <span class="refDoi">Â DOI: 10.1089/ars.2015.6580</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=10.1089%2Fars.2015.6580" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=27353526" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlehsLrJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2016&pages=300-325&author=M.+Hornsveldauthor=T.+B.+Dansen&title=The+hallmarks+of+cancer+from+a+redox+perspective&doi=10.1089%2Fars.2015.6580"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">The Hallmarks of Cancer from a Redox Perspective</span></div><div class="casAuthors">Hornsveld, Marten; Dansen, Tobias B.</div><div class="citationInfo"><span class="NLM_cas:title">Antioxidants & Redox Signaling</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">300-325</span>CODEN:
                <span class="NLM_cas:coden">ARSIF2</span>;
        ISSN:<span class="NLM_cas:issn">1523-0864</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">Significance: For a healthy cell to turn into a cancer cell and grow out to become a tumor, it needs to undergo a series of complex changes and acquire certain traits, summarized as "The Hallmarks of Cancer.  " These hallmarks can all be regarded as the result of altered signal transduction cascades and an understanding of these cascades is essential for cancer treatment.  Recent Advances: Redox signaling is a long overlooked form of signal transduction that proceeds through the reversible oxidn. of cysteines in proteins and that uses hydrogen peroxide as a second messenger.  Crit. Issues: In this article, we provide examples that show that redox signaling is involved in the regulation of proteins and signaling cascades that play roles in every hallmark of cancer.  Future Directions: An understanding of how redox signaling and "classical" signal transduction are intertwined could hold promising strategies for cancer therapy in the future.  Antioxid. Redox Signal. 25, 300-325.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqg8Ibw049azbVg90H21EOLACvtfcHk0lgeO0n9jdM8eg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlehsLrJ&md5=43a0fffc6b1765fff0d4b9ce34a04510</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1089%2Fars.2015.6580&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fars.2015.6580%26sid%3Dliteratum%253Aachs%26aulast%3DHornsveld%26aufirst%3DM.%26aulast%3DDansen%26aufirst%3DT.%2BB.%26atitle%3DThe%2520hallmarks%2520of%2520cancer%2520from%2520a%2520redox%2520perspective%26jtitle%3DAntioxid.%2520Redox%2520Signaling%26date%3D2016%26volume%3D25%26spage%3D300%26epage%3D325%26doi%3D10.1089%2Fars.2015.6580" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pavlova, N. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, C. B.</span></span> <span> </span><span class="NLM_article-title">The emerging hallmarks of cancer metabolism</span>. <i>Cell Metab.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">27</span>â <span class="NLM_lpage">47</span>, <span class="refDoi">Â DOI: 10.1016/j.cmet.2015.12.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=10.1016%2Fj.cmet.2015.12.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=26771115" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=1%3ACAS%3A528%3ADC%252BC28XjtFSrtw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2016&pages=27-47&author=N.+N.+Pavlovaauthor=C.+B.+Thompson&title=The+emerging+hallmarks+of+cancer+metabolism&doi=10.1016%2Fj.cmet.2015.12.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The Emerging Hallmarks of Cancer Metabolism</span></div><div class="casAuthors">Pavlova, Natalya N.; Thompson, Craig B.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Metabolism</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">27-47</span>CODEN:
                <span class="NLM_cas:coden">CMEEB5</span>;
        ISSN:<span class="NLM_cas:issn">1550-4131</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Tumorigenesis is dependent on the reprogramming of cellular metab. as both direct and indirect consequence of oncogenic mutations.  A common feature of cancer cell metab. is the ability to acquire necessary nutrients from a frequently nutrient-poor environment and utilize these nutrients to both maintain viability and build new biomass.  The alterations in intracellular and extracellular metabolites that can accompany cancer-assocd. metabolic reprogramming have profound effects on gene expression, cellular differentiation, and the tumor microenvironment.  In this Perspective, we have organized known cancer-assocd. metabolic changes into six hallmarks: (1) deregulated uptake of glucose and amino acids, (2) use of opportunistic modes of nutrient acquisition, (3) use of glycolysis/TCA cycle intermediates for biosynthesis and NADPH prodn., (4) increased demand for nitrogen, (5) alterations in metabolite-driven gene regulation, and (6) metabolic interactions with the microenvironment.  While few tumors display all six hallmarks, most display several.  The specific hallmarks exhibited by an individual tumor may ultimately contribute to better tumor classification and aid in directing treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmqSfgRFEvTrVg90H21EOLACvtfcHk0lhMNV_d-qcY-Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjtFSrtw%253D%253D&md5=d33d8226a68aa5eba6d92a33280ccf2c</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.cmet.2015.12.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmet.2015.12.006%26sid%3Dliteratum%253Aachs%26aulast%3DPavlova%26aufirst%3DN.%2BN.%26aulast%3DThompson%26aufirst%3DC.%2BB.%26atitle%3DThe%2520emerging%2520hallmarks%2520of%2520cancer%2520metabolism%26jtitle%3DCell%2520Metab.%26date%3D2016%26volume%3D23%26spage%3D27%26epage%3D47%26doi%3D10.1016%2Fj.cmet.2015.12.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">DeBerardinis, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandel, N. S.</span></span> <span> </span><span class="NLM_article-title">Fundamentals of cancer metabolism</span>. <i>Sci. Adv.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>2</i></span>, <span class="NLM_elocation-id">e1600200</span> <span class="refDoi">Â DOI: 10.1126/sciadv.1600200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=10.1126%2Fsciadv.1600200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=27386546" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2016&author=R.+J.+DeBerardinisauthor=N.+S.+Chandel&title=Fundamentals+of+cancer+metabolism&doi=10.1126%2Fsciadv.1600200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1126%2Fsciadv.1600200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fsciadv.1600200%26sid%3Dliteratum%253Aachs%26aulast%3DDeBerardinis%26aufirst%3DR.%2BJ.%26aulast%3DChandel%26aufirst%3DN.%2BS.%26atitle%3DFundamentals%2520of%2520cancer%2520metabolism%26jtitle%3DSci.%2520Adv.%26date%3D2016%26volume%3D2%26doi%3D10.1126%2Fsciadv.1600200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gerber, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beg, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fattah, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frankel, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fatunde, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arriaga, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowell, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bisen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leff, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meek, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Putnam, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kallem, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subramaniyan, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolluyt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarode, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boothman, D. A.</span></span> <span> </span><span class="NLM_article-title">Phase 1 study of ARQ 761, a beta-lapachone analogue that promotes NQO1-mediated programmed cancer cell necrosis</span>. <i>Br. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>119</i></span>,  <span class="NLM_fpage">928</span>â <span class="NLM_lpage">936</span>, <span class="refDoi">Â DOI: 10.1038/s41416-018-0278-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=10.1038%2Fs41416-018-0278-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=30318513" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvFChtrvN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2018&pages=928-936&author=D.+E.+Gerberauthor=M.+S.+Begauthor=F.+Fattahauthor=A.+E.+Frankelauthor=O.+Fatundeauthor=Y.+Arriagaauthor=J.+E.+Dowellauthor=A.+Bisenauthor=R.+D.+Leffauthor=C.+C.+Meekauthor=W.+C.+Putnamauthor=R.+R.+Kallemauthor=I.+Subramaniyanauthor=Y.+Dongauthor=J.+Bolluytauthor=V.+Sarodeauthor=X.+Luoauthor=Y.+Xieauthor=B.+Schwartzauthor=D.+A.+Boothman&title=Phase+1+study+of+ARQ+761%2C+a+beta-lapachone+analogue+that+promotes+NQO1-mediated+programmed+cancer+cell+necrosis&doi=10.1038%2Fs41416-018-0278-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Phase 1 study of ARQ 761, a Î²-lapachone analogue that promotes NQO1-mediated programmed cancer cell necrosis</span></div><div class="casAuthors">Gerber, David E.; Beg, M. Shaalan; Fattah, Farjana; Frankel, Arthur E.; Fatunde, Oluwatomilade; Arriaga, Yull; Dowell, Jonathan E.; Bisen, Ajit; Leff, Richard D.; Meek, Claudia C.; Putnam, William C.; Kallem, Raja Reddy; Subramaniyan, Indhumathy; Dong, Ying; Bolluyt, Joyce; Sarode, Venetia; Luo, Xin; Xie, Yang; Schwartz, Brian; Boothman, David A.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">928-936</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Background: NAD(P)H:quinone oxidoreductase 1 (NQO1) is a two-electron oxidoreductase expressed in multiple tumor types.  ARQ 761 is a Î²-lapachone (Î²-lap) analog that exploits the unique elevation of NQO1 found in solid tumors to cause tumor-specific cell death.  Methods: We performed a 3+3 dose escalation study of 3 schedules (weekly, every other week, 2/3 wk) of ARQ 761 in patients with refractory advanced solid tumors.  Tumor tissue was analyzed for NQO1 expression.  After 20 patients were analyzed, enrolment was restricted to patients with NQO1-high tumors (H-score â¥ 200).  Results: A total of 42 patients were treated.  Median no. of prior lines of therapy was 4.  Maximum tolerated dose was 390 mg/m2 as a 2-h infusion every other week.  Dose-limiting toxicity was anemia.  The most common treatment-related adverse events were anemia (79%), fatigue (45%), hypoxia (33%), nausea (17%), and vomiting (17%).  Transient grade 3 hypoxia, reflecting possible methemoglobinemia, occurred in 26% of patients.  Among 32 evaluable patients, best response was stable disease (n = 12); 6 patients had tumor shrinkage.  There was a trend towards improved efficacy in NQO1-high tumors (P = 0.06).  Conclusions: ARQ 761 has modest single-agent activity, which appears assocd. with tumor NQO1 expression.  Principal toxicities include anemia and possible methemoglobinemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRXcIh4QP3ErVg90H21EOLACvtfcHk0lhMNV_d-qcY-Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvFChtrvN&md5=934a577154a762f8db5fa81e82979371</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fs41416-018-0278-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41416-018-0278-4%26sid%3Dliteratum%253Aachs%26aulast%3DGerber%26aufirst%3DD.%2BE.%26aulast%3DBeg%26aufirst%3DM.%2BS.%26aulast%3DFattah%26aufirst%3DF.%26aulast%3DFrankel%26aufirst%3DA.%2BE.%26aulast%3DFatunde%26aufirst%3DO.%26aulast%3DArriaga%26aufirst%3DY.%26aulast%3DDowell%26aufirst%3DJ.%2BE.%26aulast%3DBisen%26aufirst%3DA.%26aulast%3DLeff%26aufirst%3DR.%2BD.%26aulast%3DMeek%26aufirst%3DC.%2BC.%26aulast%3DPutnam%26aufirst%3DW.%2BC.%26aulast%3DKallem%26aufirst%3DR.%2BR.%26aulast%3DSubramaniyan%26aufirst%3DI.%26aulast%3DDong%26aufirst%3DY.%26aulast%3DBolluyt%26aufirst%3DJ.%26aulast%3DSarode%26aufirst%3DV.%26aulast%3DLuo%26aufirst%3DX.%26aulast%3DXie%26aufirst%3DY.%26aulast%3DSchwartz%26aufirst%3DB.%26aulast%3DBoothman%26aufirst%3DD.%2BA.%26atitle%3DPhase%25201%2520study%2520of%2520ARQ%2520761%252C%2520a%2520beta-lapachone%2520analogue%2520that%2520promotes%2520NQO1-mediated%2520programmed%2520cancer%2520cell%2520necrosis%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2018%26volume%3D119%26spage%3D928%26epage%3D936%26doi%3D10.1038%2Fs41416-018-0278-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sonbol, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldstein, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okusaka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tabernero, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macarulla, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">OâNeil, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Cutsem, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bekaii-Saab, T.</span></span> <span> </span><span class="NLM_article-title">CanStem111P trial: a phase III study of napabucasin plus nab-paclitaxel with gemcitabine</span>. <i>Future Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">1295</span>â <span class="NLM_lpage">1302</span>, <span class="refDoi">Â DOI: 10.2217/fon-2018-0903</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=10.2217%2Ffon-2018-0903" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=30768369" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=1%3ACAS%3A528%3ADC%252BC1MXotlWmsbg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2019&pages=1295-1302&author=M.+B.+Sonbolauthor=D.+H.+Ahnauthor=D.+Goldsteinauthor=T.+Okusakaauthor=J.+Taberneroauthor=T.+Macarullaauthor=M.+Reniauthor=C.+P.+Liauthor=B.+O%E2%80%99Neilauthor=E.+Van+Cutsemauthor=T.+Bekaii-Saab&title=CanStem111P+trial%3A+a+phase+III+study+of+napabucasin+plus+nab-paclitaxel+with+gemcitabine&doi=10.2217%2Ffon-2018-0903"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">CanStem111P trial: a Phase III study of napabucasin plus nab-paclitaxel with gemcitabine</span></div><div class="casAuthors">Sonbol, Mohamad Bassam; Ahn, Daniel H.; Goldstein, David; Okusaka, Takuji; Tabernero, Josep; Macarulla, Teresa; Reni, Michele; Li, Chung-Pin; O'Neil, Bert; Van Cutsem, Eric; Bekaii-Saab, Tanios</div><div class="citationInfo"><span class="NLM_cas:title">Future Oncology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1295-1302</span>CODEN:
                <span class="NLM_cas:coden">FOUNBN</span>;
        ISSN:<span class="NLM_cas:issn">1744-8301</span>.
    
            (<span class="NLM_cas:orgname">Future Medicine Ltd.</span>)
        </div><div class="casAbstract">Napabucasin (also known as BBI-608 or BBI608) is an investigational, oral agent hypothesized to inhibit multiple oncogenic pathways.  In this article, we describe the design and rationale for the CanStem111P clin. trial, a multicenter, randomized, open-label, Phase III study designed to det. the efficacy and safety of combining napabucasin with nab-paclitaxel and gemcitabine for first-line treatment of patients with metastatic pancreatic adenocarcinoma (NCT02993731).  Patients were randomized in a 1:1 fashion to receive weekly gemcitabine and nab-paclitaxel with or without napabucasin.  The results of this study will help define the role of this novel agent in the management of advanced pancreatic cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoY0Bk1A2JAWrVg90H21EOLACvtfcHk0lhnpLwoTBX6JQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXotlWmsbg%253D&md5=65a65f835bd6c32a16722fa919f9b5d9</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.2217%2Ffon-2018-0903&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2217%252Ffon-2018-0903%26sid%3Dliteratum%253Aachs%26aulast%3DSonbol%26aufirst%3DM.%2BB.%26aulast%3DAhn%26aufirst%3DD.%2BH.%26aulast%3DGoldstein%26aufirst%3DD.%26aulast%3DOkusaka%26aufirst%3DT.%26aulast%3DTabernero%26aufirst%3DJ.%26aulast%3DMacarulla%26aufirst%3DT.%26aulast%3DReni%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DC.%2BP.%26aulast%3DO%25E2%2580%2599Neil%26aufirst%3DB.%26aulast%3DVan%2BCutsem%26aufirst%3DE.%26aulast%3DBekaii-Saab%26aufirst%3DT.%26atitle%3DCanStem111P%2520trial%253A%2520a%2520phase%2520III%2520study%2520of%2520napabucasin%2520plus%2520nab-paclitaxel%2520with%2520gemcitabine%26jtitle%3DFuture%2520Oncol.%26date%3D2019%26volume%3D15%26spage%3D1295%26epage%3D1302%26doi%3D10.2217%2Ffon-2018-0903" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grothey, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshino, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Cutsem, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taieb, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tebbutt, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falcone, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cervantes, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borodyansky, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span> <span> </span><span class="NLM_article-title">CanStem303C trial: A phase III study of napabucasin (BBI-608) in combination with 5-fluorouracil (5-FU), leucovorin, irinotecan (FOLFIRI) in adult patients with previously treated metastatic colorectal cancer (mCRC)</span>. <i>J. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">TPS3619</span>, <span class="refDoi">Â DOI: 10.1200/JCO.2017.35.15_suppl.TPS3619</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=10.1200%2FJCO.2017.35.15_suppl.TPS3619" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2017&pages=TPS3619&author=A.+Grotheyauthor=M.+A.+Shahauthor=T.+Yoshinoauthor=E.+Van+Cutsemauthor=J.+Taiebauthor=R.+Xuauthor=N.+C.+Tebbuttauthor=A.+Falconeauthor=A.+Cervantesauthor=L.+Borodyanskyauthor=C.+Li&title=CanStem303C+trial%3A+A+phase+III+study+of+napabucasin+%28BBI-608%29+in+combination+with+5-fluorouracil+%285-FU%29%2C+leucovorin%2C+irinotecan+%28FOLFIRI%29+in+adult+patients+with+previously+treated+metastatic+colorectal+cancer+%28mCRC%29&doi=10.1200%2FJCO.2017.35.15_suppl.TPS3619"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1200%2FJCO.2017.35.15_suppl.TPS3619&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2017.35.15_suppl.TPS3619%26sid%3Dliteratum%253Aachs%26aulast%3DGrothey%26aufirst%3DA.%26aulast%3DShah%26aufirst%3DM.%2BA.%26aulast%3DYoshino%26aufirst%3DT.%26aulast%3DVan%2BCutsem%26aufirst%3DE.%26aulast%3DTaieb%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DR.%26aulast%3DTebbutt%26aufirst%3DN.%2BC.%26aulast%3DFalcone%26aufirst%3DA.%26aulast%3DCervantes%26aufirst%3DA.%26aulast%3DBorodyansky%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DC.%26atitle%3DCanStem303C%2520trial%253A%2520A%2520phase%2520III%2520study%2520of%2520napabucasin%2520%2528BBI-608%2529%2520in%2520combination%2520with%25205-fluorouracil%2520%25285-FU%2529%252C%2520leucovorin%252C%2520irinotecan%2520%2528FOLFIRI%2529%2520in%2520adult%2520patients%2520with%2520previously%2520treated%2520metastatic%2520colorectal%2520cancer%2520%2528mCRC%2529%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2017%26volume%3D35%26spage%3DTPS3619%26doi%3D10.1200%2FJCO.2017.35.15_suppl.TPS3619" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Froeling, F. E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swamynathan, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeschÃªnes, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chio, I. I. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brosnan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alagesan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucito, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, A.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trotman, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belleau, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogoff, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuveson, D. A.</span></span> <span> </span><span class="NLM_article-title">Bioactivation of napabucasin triggers reactive oxygen species-mediated cancer cell death</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">7162</span>â <span class="NLM_lpage">7174</span>, <span class="refDoi">Â DOI: 10.1158/1078-0432.CCR-19-0302</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=10.1158%2F1078-0432.CCR-19-0302" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=31527169" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhslWitLvN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2019&pages=7162-7174&author=F.+E.+M.+Froelingauthor=M.+M.+Swamynathanauthor=A.+Desch%C3%AAnesauthor=I.+I.+C.+Chioauthor=E.+Brosnanauthor=M.+A.+Yaoauthor=P.+Alagesanauthor=M.+Lucitoauthor=J.+Liauthor=A.-Y.+Changauthor=L.+C.+Trotmanauthor=P.+Belleauauthor=Y.+Parkauthor=H.+A.+Rogoffauthor=J.+D.+Watsonauthor=D.+A.+Tuveson&title=Bioactivation+of+napabucasin+triggers+reactive+oxygen+species-mediated+cancer+cell+death&doi=10.1158%2F1078-0432.CCR-19-0302"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Bioactivation of napabucasin triggers reactive oxygen species-mediated cancer cell death</span></div><div class="casAuthors">Froeling, Fieke E. M.; Swamynathan, Manojit Mosur; Deschenes, Astrid; Chio, Iok In Christine; Brosnan, Erin; Yao, Melissa A.; Alagesan, Priya; Lucito, Matthew; Li, Juying; Chang, An-Yun; Trotman, Lloyd C.; Belleau, Pascal; Park, Youngkyu; Rogoff, Harry A.; Watson, James D.; Tuveson, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">7162-7174</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: Napabucasin (2-acetylfuro-1,4-naphthoquinone or BBI-608) is a small mol. currently being clin. evaluated in various cancer types.  It has mostly been recognized for its ability to inhibit STAT3 signaling.  However, based on its chem. structure, we hypothesized that napabucasin is a substrate for intracellular oxidoreductases and therefore may exert its anticancer effect through redox cycling, resulting in reactive oxygen species (ROS) prodn. and cell death.  Exptl. Design: Binding of napabucasin to NAD(P)H:quinone oxidoreductase-1 (NQO1), and other oxidoreductases, was measured.  Pancreatic cancer cell lines were treated with napabucasin, and cell survival, ROS generation, DNA damage, transcriptomic changes, and alterations in STAT3 activation were assayed in vitro and in vivo.  Genetic knockout or pharmacol. inhibition with dicoumarol was used to evaluate the dependency on NQO1.  Results: Napabucasin was found to bind with high affinity to NQO1 and to a lesser degree to cytochrome P 450 oxidoreductase (POR).  Treatment resulted in marked induction of ROS and DNA damage with an NQO1- and ROS-dependent decrease in STAT3 phosphorylation.  Differential cytotoxic effects were obsd., where NQO1-expressing cells generating cytotoxic levels of ROS at low napabucasin concns. were more sensitive.  Cells with low or no baseline NQO1 expression also produced ROS in response to napabucasin, albeit to a lesser extent, through the one-electron reductase POR.  Conclusions: Napabucasin is bioactivated by NQO1, and to a lesser degree by POR, resulting in futile redox cycling and ROS generation.  The increased ROS levels result in DNA damage and multiple intracellular changes, one of which is a redn. in STAT3 phosphorylation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobkyO7Js1b7LVg90H21EOLACvtfcHk0lhF1MSXqBgQOg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhslWitLvN&md5=f2bbfdc3e8673c095f1118e361e6f81d</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-19-0302&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-19-0302%26sid%3Dliteratum%253Aachs%26aulast%3DFroeling%26aufirst%3DF.%2BE.%2BM.%26aulast%3DSwamynathan%26aufirst%3DM.%2BM.%26aulast%3DDesch%25C3%25AAnes%26aufirst%3DA.%26aulast%3DChio%26aufirst%3DI.%2BI.%2BC.%26aulast%3DBrosnan%26aufirst%3DE.%26aulast%3DYao%26aufirst%3DM.%2BA.%26aulast%3DAlagesan%26aufirst%3DP.%26aulast%3DLucito%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DChang%26aufirst%3DA.-Y.%26aulast%3DTrotman%26aufirst%3DL.%2BC.%26aulast%3DBelleau%26aufirst%3DP.%26aulast%3DPark%26aufirst%3DY.%26aulast%3DRogoff%26aufirst%3DH.%2BA.%26aulast%3DWatson%26aufirst%3DJ.%2BD.%26aulast%3DTuveson%26aufirst%3DD.%2BA.%26atitle%3DBioactivation%2520of%2520napabucasin%2520triggers%2520reactive%2520oxygen%2520species-mediated%2520cancer%2520cell%2520death%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2019%26volume%3D25%26spage%3D7162%26epage%3D7174%26doi%3D10.1158%2F1078-0432.CCR-19-0302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kuang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sechi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nurra, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ljungman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neamati, N.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of novel reactive oxygen species inducers for the treatment of pancreatic ductal adenocarcinoma</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">1576</span>â <span class="NLM_lpage">1594</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.7b01463</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01463" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=1%3ACAS%3A528%3ADC%252BC1cXotVyqtA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=1576-1594&author=Y.+Kuangauthor=M.+Sechiauthor=S.+Nurraauthor=M.+Ljungmanauthor=N.+Neamati&title=Design+and+synthesis+of+novel+reactive+oxygen+species+inducers+for+the+treatment+of+pancreatic+ductal+adenocarcinoma&doi=10.1021%2Facs.jmedchem.7b01463"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of Novel Reactive Oxygen Species Inducers for the Treatment of Pancreatic Ductal Adenocarcinoma</span></div><div class="casAuthors">Kuang, Yuting; Sechi, Mario; Nurra, Salvatore; Ljungman, Mats; Neamati, Nouri</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1576-1594</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Quinazolinediones such as I were prepd. as inducers of reactive oxygen species (ROS) for potential use as antitumor agents for the treatment of pancreatic ductal adenocarcinoma (PDAC); the inhibition of human PDAC cells was detd. for all of the compds. and the toxicities of selected compds. to normal pancreatic cells, and the effects on various cellular systems was detd. for selected compds.  I was the most potent redox modulator candidate of the tested compds., inducing substantial ROS prodn. in PDAC cells.  Nascent RNA sequencing following treatments with quinazolinediones revealed induction of stress responses in nucleus, endoplasmic reticulum, and mitochondria of pancreatic cancer cells; the quinazolinedione also induced Nrf2-mediated oxidative stress and unfolded protein responses as demonstrated by dose-dependent increases in RNA synthesis of representative genes such as NQO1, HMOX1, DDIT3, and HSPA5.  At 5.0 Î¼M, I blocked mitochondrial function by inhibiting mtDNA transcription and downregulating the mtDNA-encoded OXPHOS enzymes.  Treatment with I was well tolerated in vivo and significantly delayed tumor growth in mice; I was also tested in combination with the current pancreatic cancer agent gemcitabine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4BeZNm8i3TLVg90H21EOLACvtfcHk0lif3RMD60M3vQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXotVyqtA%253D%253D&md5=ec0cb6c8914a7841c7ff8906cf53ef49</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01463%26sid%3Dliteratum%253Aachs%26aulast%3DKuang%26aufirst%3DY.%26aulast%3DSechi%26aufirst%3DM.%26aulast%3DNurra%26aufirst%3DS.%26aulast%3DLjungman%26aufirst%3DM.%26aulast%3DNeamati%26aufirst%3DN.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520novel%2520reactive%2520oxygen%2520species%2520inducers%2520for%2520the%2520treatment%2520of%2520pancreatic%2520ductal%2520adenocarcinoma%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D1576%26epage%3D1594%26doi%3D10.1021%2Facs.jmedchem.7b01463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dixon, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemberg, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamprecht, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skouta, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaitsev, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gleason, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cantley, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrison, B.,  III</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stockwell, B. R.</span></span> <span> </span><span class="NLM_article-title">Ferroptosis: an iron-dependent form of nonapoptotic cell death</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>149</i></span>,  <span class="NLM_fpage">1060</span>â <span class="NLM_lpage">1072</span>, <span class="refDoi">Â DOI: 10.1016/j.cell.2012.03.042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=10.1016%2Fj.cell.2012.03.042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=22632970" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=1%3ACAS%3A528%3ADC%252BC38XnslSntrw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=149&publication_year=2012&pages=1060-1072&author=S.+J.+Dixonauthor=K.+M.+Lembergauthor=M.+R.+Lamprechtauthor=R.+Skoutaauthor=E.+M.+Zaitsevauthor=C.+E.+Gleasonauthor=D.+N.+Patelauthor=A.+J.+Bauerauthor=A.+M.+Cantleyauthor=W.+S.+Yangauthor=B.+Morrisonauthor=B.+R.+Stockwell&title=Ferroptosis%3A+an+iron-dependent+form+of+nonapoptotic+cell+death&doi=10.1016%2Fj.cell.2012.03.042"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death</span></div><div class="casAuthors">Dixon, Scott J.; Lemberg, Kathryn M.; Lamprecht, Michael R.; Skouta, Rachid; Zaitsev, Eleina M.; Gleason, Caroline E.; Patel, Darpan N.; Bauer, Andras J.; Cantley, Alexandra M.; Yang, Wan Seok; Morrison, Barclay; Stockwell, Brent R.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">149</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1060-1072</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Nonapoptotic forms of cell death may facilitate the selective elimination of some tumor cells or be activated in specific pathol. states.  The oncogenic RAS-selective lethal small mol. erastin triggers a unique iron-dependent form of nonapoptotic cell death that we term ferroptosis.  Ferroptosis is dependent upon intracellular iron, but not other metals, and is morphol., biochem., and genetically distinct from apoptosis, necrosis, and autophagy.  We identify the small mol. ferrostatin-1 as a potent inhibitor of ferroptosis in cancer cells and glutamate-induced cell death in organotypic rat brain slices, suggesting similarities between these two processes.  Indeed, erastin, like glutamate, inhibits cystine uptake by the cystine/glutamate antiporter (system xc-), creating a void in the antioxidant defenses of the cell and ultimately leading to iron-dependent, oxidative death.  Thus, activation of ferroptosis results in the nonapoptotic destruction of certain cancer cells, whereas inhibition of this process may protect organisms from neurodegeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzDzMapViBQ7Vg90H21EOLACvtfcHk0lif3RMD60M3vQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnslSntrw%253D&md5=5d3b8c55a053dfde7e758cc1701ef71b</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2012.03.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2012.03.042%26sid%3Dliteratum%253Aachs%26aulast%3DDixon%26aufirst%3DS.%2BJ.%26aulast%3DLemberg%26aufirst%3DK.%2BM.%26aulast%3DLamprecht%26aufirst%3DM.%2BR.%26aulast%3DSkouta%26aufirst%3DR.%26aulast%3DZaitsev%26aufirst%3DE.%2BM.%26aulast%3DGleason%26aufirst%3DC.%2BE.%26aulast%3DPatel%26aufirst%3DD.%2BN.%26aulast%3DBauer%26aufirst%3DA.%2BJ.%26aulast%3DCantley%26aufirst%3DA.%2BM.%26aulast%3DYang%26aufirst%3DW.%2BS.%26aulast%3DMorrison%26aufirst%3DB.%26aulast%3DStockwell%26aufirst%3DB.%2BR.%26atitle%3DFerroptosis%253A%2520an%2520iron-dependent%2520form%2520of%2520nonapoptotic%2520cell%2520death%26jtitle%3DCell%26date%3D2012%26volume%3D149%26spage%3D1060%26epage%3D1072%26doi%3D10.1016%2Fj.cell.2012.03.042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stockwell, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedmann Angeli, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bayir, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bush, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conrad, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dixon, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fulda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">GascÃ³n, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hatzios, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kagan, V. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noel, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linkermann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overholtzer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oyagi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pagnussat, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ran, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenfeld, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salnikow, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torti, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torti, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toyokuni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woerpel, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D. D.</span></span> <span> </span><span class="NLM_article-title">Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>171</i></span>,  <span class="NLM_fpage">273</span>â <span class="NLM_lpage">285</span>, <span class="refDoi">Â DOI: 10.1016/j.cell.2017.09.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=10.1016%2Fj.cell.2017.09.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=28985560" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1Wqs7%252FL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=171&publication_year=2017&pages=273-285&author=B.+R.+Stockwellauthor=J.+P.+Friedmann+Angeliauthor=H.+Bayirauthor=A.+I.+Bushauthor=M.+Conradauthor=S.+J.+Dixonauthor=S.+Fuldaauthor=S.+Gasc%C3%B3nauthor=S.+K.+Hatziosauthor=V.+E.+Kaganauthor=K.+Noelauthor=X.+Jiangauthor=A.+Linkermannauthor=M.+E.+Murphyauthor=M.+Overholtzerauthor=A.+Oyagiauthor=G.+C.+Pagnussatauthor=J.+Parkauthor=Q.+Ranauthor=C.+S.+Rosenfeldauthor=K.+Salnikowauthor=D.+Tangauthor=F.+M.+Tortiauthor=S.+V.+Tortiauthor=S.+Toyokuniauthor=K.+A.+Woerpelauthor=D.+D.+Zhang&title=Ferroptosis%3A+a+regulated+cell+death+nexus+linking+metabolism%2C+redox+biology%2C+and+disease&doi=10.1016%2Fj.cell.2017.09.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Ferroptosis: A regulated cell death nexus linking metabolism, redox biology, and disease</span></div><div class="casAuthors">Stockwell, Brent R.; Friedmann Angeli, Jose Pedro; Bayir, Hulya; Bush, Ashley I.; Conrad, Marcus; Dixon, Scott J.; Fulda, Simone; Gascon, Sergio; Hatzios, Stavroula K.; Kagan, Valerian E.; Noel, Kay; Jiang, Xuejun; Linkermann, Andreas; Murphy, Maureen E.; Overholtzer, Michael; Oyagi, Atsushi; Pagnussat, Gabriela C.; Park, Jason; Ran, Qitao; Rosenfeld, Craig S.; Salnikow, Konstantin; Tang, Daolin; Torti, Frank M.; Torti, Suzy V.; Toyokuni, Shinya; Woerpel, K. A.; Zhang, Donna D.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">171</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">273-285</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Ferroptosis is a form of regulated cell death characterized by the iron-dependent accumulation of lipid hydroperoxides to lethal levels.  Emerging evidence suggests that ferroptosis represents an ancient vulnerability caused by the incorporation of polyunsatd. fatty acids into cellular membranes, and cells have developed complex systems that exploit and defend against this vulnerability in different contexts.  The sensitivity to ferroptosis is tightly linked to numerous biol. processes, including amino acid, iron, and polyunsatd. fatty acid metab., and the biosynthesis of glutathione, phospholipids, NADPH, and coenzyme Q10.  Ferroptosis has been implicated in the pathol. cell death assocd. with degenerative diseases (i.e., Alzheimer's, Huntington's, and Parkinson's diseases), carcinogenesis, stroke, intracerebral hemorrhage, traumatic brain injury, ischemia-reperfusion injury, and kidney degeneration in mammals and is also implicated in heat stress in plants.  Ferroptosis may also have a tumor-suppressor function that could be harnessed for cancer therapy.  This Primer reviews the mechanisms underlying ferroptosis, highlights connections to other areas of biol. and medicine, and recommends tools and guidelines for studying this emerging form of regulated cell death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDa2kEYqbenLVg90H21EOLACvtfcHk0lif3RMD60M3vQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1Wqs7%252FL&md5=0f4684ef43ba7de994d68939e2867410</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2017.09.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2017.09.021%26sid%3Dliteratum%253Aachs%26aulast%3DStockwell%26aufirst%3DB.%2BR.%26aulast%3DFriedmann%2BAngeli%26aufirst%3DJ.%2BP.%26aulast%3DBayir%26aufirst%3DH.%26aulast%3DBush%26aufirst%3DA.%2BI.%26aulast%3DConrad%26aufirst%3DM.%26aulast%3DDixon%26aufirst%3DS.%2BJ.%26aulast%3DFulda%26aufirst%3DS.%26aulast%3DGasc%25C3%25B3n%26aufirst%3DS.%26aulast%3DHatzios%26aufirst%3DS.%2BK.%26aulast%3DKagan%26aufirst%3DV.%2BE.%26aulast%3DNoel%26aufirst%3DK.%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DLinkermann%26aufirst%3DA.%26aulast%3DMurphy%26aufirst%3DM.%2BE.%26aulast%3DOverholtzer%26aufirst%3DM.%26aulast%3DOyagi%26aufirst%3DA.%26aulast%3DPagnussat%26aufirst%3DG.%2BC.%26aulast%3DPark%26aufirst%3DJ.%26aulast%3DRan%26aufirst%3DQ.%26aulast%3DRosenfeld%26aufirst%3DC.%2BS.%26aulast%3DSalnikow%26aufirst%3DK.%26aulast%3DTang%26aufirst%3DD.%26aulast%3DTorti%26aufirst%3DF.%2BM.%26aulast%3DTorti%26aufirst%3DS.%2BV.%26aulast%3DToyokuni%26aufirst%3DS.%26aulast%3DWoerpel%26aufirst%3DK.%2BA.%26aulast%3DZhang%26aufirst%3DD.%2BD.%26atitle%3DFerroptosis%253A%2520a%2520regulated%2520cell%2520death%2520nexus%2520linking%2520metabolism%252C%2520redox%2520biology%252C%2520and%2520disease%26jtitle%3DCell%26date%3D2017%26volume%3D171%26spage%3D273%26epage%3D285%26doi%3D10.1016%2Fj.cell.2017.09.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Galluzzi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vitale, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aaronson, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abrams, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adam, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agostinis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alnemri, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altucci, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amelio, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrews, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Annicchiarico-Petruzzelli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antonov, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arama, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baehrecke, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barlev, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bazan, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernassola, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertrand, M. J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bianchi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagosklonny, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blomgren, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borner, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boya, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brenner, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campanella, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Candi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carmona-Gutierrez, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cecconi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, F. K.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandel, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chipuk, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cidlowski, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciechanover, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conrad, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cubillos-Ruiz, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czabotar, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DâAngiolella, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dawson, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dawson, V. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Laurenzi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Maria, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Debatin, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeBerardinis, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deshmukh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Daniele, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Virgilio, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dixit, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dixon, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duckett, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dynlacht, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Deiry, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elrod, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fimia, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fulda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">GarcÃ­a-SÃ¡ez, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garg, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garrido, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gavathiotis, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golstein, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gottlieb, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greene, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gronemeyer, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gross, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hajnoczky, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hardwick, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, I. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hengartner, M. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hetz, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ichijo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">JÃ¤Ã¤ttelÃ¤, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joseph, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jost, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Juin, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaufmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kepp, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimchi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitsis, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klionsky, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knight, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemasters, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levine, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linkermann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lipton, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lockshin, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LÃ³pez-OtÃ­n, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowe, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luedde, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lugli, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacFarlane, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madeo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malewicz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malorni, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manic, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marine, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinou, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medema, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehlen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meier, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melino, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molkentin, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moll, U. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MuÃ±oz-Pinedo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagata, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">NuÃ±ez, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oberst, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oren, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overholtzer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pagano, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panaretakis, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasparakis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Penninger, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pereira, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pervaiz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peter, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piacentini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinton, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prehn, J. H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puthalakath, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rabinovich, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rehm, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizzuto, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodrigues, C. M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubinsztein, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudel, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryan, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sayan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scorrano, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silke, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simon, H.-U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sistigu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stockwell, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strasser, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szabadkai, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tait, S. W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tavernarakis, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thorburn, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsujimoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turk, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanden Berghe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandenabeele, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vander Heiden, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villunger, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Virgin, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vousden, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vucic, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walczak, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallach, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zakeri, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhivotovsky, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zitvogel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melino, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kroemer, G.</span></span> <span> </span><span class="NLM_article-title">Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018</span>. <i>Cell Death Differ.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">486</span>â <span class="NLM_lpage">541</span>, <span class="refDoi">Â DOI: 10.1038/s41418-017-0012-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=10.1038%2Fs41418-017-0012-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=29362479" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=1%3ACAS%3A280%3ADC%252BC1MvjsFKgug%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2018&pages=486-541&author=L.+Galluzziauthor=I.+Vitaleauthor=S.+A.+Aaronsonauthor=J.+M.+Abramsauthor=D.+Adamauthor=P.+Agostinisauthor=E.+S.+Alnemriauthor=L.+Altucciauthor=I.+Amelioauthor=D.+W.+Andrewsauthor=M.+Annicchiarico-Petruzzelliauthor=A.+V.+Antonovauthor=E.+Aramaauthor=E.+H.+Baehreckeauthor=N.+A.+Barlevauthor=N.+G.+Bazanauthor=F.+Bernassolaauthor=M.+J.+M.+Bertrandauthor=K.+Bianchiauthor=M.+V.+Blagosklonnyauthor=K.+Blomgrenauthor=C.+Bornerauthor=P.+Boyaauthor=C.+Brennerauthor=M.+Campanellaauthor=E.+Candiauthor=D.+Carmona-Gutierrezauthor=F.+Cecconiauthor=F.+K.-M.+Chanauthor=N.+S.+Chandelauthor=E.+H.+Chengauthor=J.+E.+Chipukauthor=J.+A.+Cidlowskiauthor=A.+Ciechanoverauthor=G.+M.+Cohenauthor=M.+Conradauthor=J.+R.+Cubillos-Ruizauthor=P.+E.+Czabotarauthor=V.+D%E2%80%99Angiolellaauthor=T.+M.+Dawsonauthor=V.+L.+Dawsonauthor=V.+De+Laurenziauthor=R.+De+Mariaauthor=K.+M.+Debatinauthor=R.+J.+DeBerardinisauthor=M.+Deshmukhauthor=N.+Di+Danieleauthor=F.+Di+Virgilioauthor=V.+M.+Dixitauthor=S.+J.+Dixonauthor=C.+S.+Duckettauthor=B.+D.+Dynlachtauthor=W.+S.+El-Deiryauthor=J.+W.+Elrodauthor=G.+M.+Fimiaauthor=S.+Fuldaauthor=A.+J.+Garc%C3%ADa-S%C3%A1ezauthor=A.+D.+Gargauthor=C.+Garridoauthor=E.+Gavathiotisauthor=P.+Golsteinauthor=E.+Gottliebauthor=D.+R.+Greenauthor=L.+A.+Greeneauthor=H.+Gronemeyerauthor=A.+Grossauthor=G.+Hajnoczkyauthor=J.+M.+Hardwickauthor=I.+S.+Harrisauthor=M.+O.+Hengartnerauthor=C.+Hetzauthor=H.+Ichijoauthor=M.+J%C3%A4%C3%A4ttel%C3%A4author=B.+Josephauthor=P.+J.+Jostauthor=P.+P.+Juinauthor=W.+J.+Kaiserauthor=M.+Karinauthor=T.+Kaufmannauthor=O.+Keppauthor=A.+Kimchiauthor=R.+N.+Kitsisauthor=D.+J.+Klionskyauthor=R.+A.+Knightauthor=S.+Kumarauthor=S.+W.+Leeauthor=J.+J.+Lemastersauthor=B.+Levineauthor=A.+Linkermannauthor=S.+A.+Liptonauthor=R.+A.+Lockshinauthor=C.+L%C3%B3pez-Ot%C3%ADnauthor=S.+W.+Loweauthor=T.+Lueddeauthor=E.+Lugliauthor=M.+MacFarlaneauthor=F.+Madeoauthor=M.+Malewiczauthor=W.+Malorniauthor=G.+Manicauthor=J.+C.+Marineauthor=S.+J.+Martinauthor=J.+C.+Martinouauthor=J.+P.+Medemaauthor=P.+Mehlenauthor=P.+Meierauthor=S.+Melinoauthor=E.+A.+Miaoauthor=J.+D.+Molkentinauthor=U.+M.+Mollauthor=C.+Mu%C3%B1oz-Pinedoauthor=S.+Nagataauthor=G.+Nu%C3%B1ezauthor=A.+Oberstauthor=M.+Orenauthor=M.+Overholtzerauthor=M.+Paganoauthor=T.+Panaretakisauthor=M.+Pasparakisauthor=J.+M.+Penningerauthor=D.+M.+Pereiraauthor=S.+Pervaizauthor=M.+E.+Peterauthor=M.+Piacentiniauthor=P.+Pintonauthor=J.+H.+M.+Prehnauthor=H.+Puthalakathauthor=G.+A.+Rabinovichauthor=M.+Rehmauthor=R.+Rizzutoauthor=C.+M.+P.+Rodriguesauthor=D.+C.+Rubinszteinauthor=T.+Rudelauthor=K.+M.+Ryanauthor=E.+Sayanauthor=L.+Scorranoauthor=F.+Shaoauthor=Y.+Shiauthor=J.+Silkeauthor=H.-U.+Simonauthor=A.+Sistiguauthor=B.+R.+Stockwellauthor=A.+Strasserauthor=G.+Szabadkaiauthor=S.+W.+G.+Taitauthor=D.+Tangauthor=N.+Tavernarakisauthor=A.+Thorburnauthor=Y.+Tsujimotoauthor=B.+Turkauthor=T.+Vanden+Bergheauthor=P.+Vandenabeeleauthor=M.+G.+Vander+Heidenauthor=A.+Villungerauthor=H.+W.+Virginauthor=K.+H.+Vousdenauthor=D.+Vucicauthor=E.+F.+Wagnerauthor=H.+Walczakauthor=D.+Wallachauthor=Y.+Wangauthor=J.+A.+Wellsauthor=W.+Woodauthor=J.+Yuanauthor=Z.+Zakeriauthor=B.+Zhivotovskyauthor=L.+Zitvogelauthor=G.+Melinoauthor=G.+Kroemer&title=Molecular+mechanisms+of+cell+death%3A+recommendations+of+the+Nomenclature+Committee+on+Cell+Death+2018&doi=10.1038%2Fs41418-017-0012-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018</span></div><div class="casAuthors">Galluzzi Lorenzo; Galluzzi Lorenzo; Cubillos-Ruiz Juan R; Galluzzi Lorenzo; Kepp Oliver; Kroemer Guido; Vitale Ilio; Campanella Michelangelo; Cecconi Francesco; Manic Gwenola; Piacentini Mauro; Vitale Ilio; Campanella Michelangelo; Manic Gwenola; Aaronson Stuart A; Chipuk Jerry E; Abrams John M; Adam Dieter; Agostinis Patrizia; Garg Abhishek D; Alnemri Emad S; Altucci Lucia; Amelio Ivano; Antonov Alexey V; Knight Richard A; MacFarlane Marion; Malewicz Michal; Melino Gerry; Andrews David W; Andrews David W; Andrews David W; Annicchiarico-Petruzzelli Margherita; Candi Eleonora; Arama Eli; Kimchi Adi; Baehrecke Eric H; Barlev Nickolai A; Bazan Nicolas G; Bernassola Francesca; Candi Eleonora; Melino Gerry; Bertrand Mathieu J M; Vanden Berghe Tom; Vandenabeele Peter; Bertrand Mathieu J M; Vanden Berghe Tom; Vandenabeele Peter; Bianchi Katiuscia; Blagosklonny Mikhail V; Blomgren Klas; Kroemer Guido; Blomgren Klas; Borner Christoph; Borner Christoph; Boya Patricia; Brenner Catherine; Brenner Catherine; Campanella Michelangelo; Campanella Michelangelo; Carmona-Gutierrez Didac; Madeo Frank; Cecconi Francesco; Cecconi Francesco; Chan Francis K-M; Chandel Navdeep S; Cheng Emily H; Cidlowski John A; Ciechanover Aaron; Gottlieb Eyal; Cohen Gerald M; Conrad Marcus; Cubillos-Ruiz Juan R; Czabotar Peter E; Strasser Andreas; Czabotar Peter E; Silke John; D'Angiolella Vincenzo; Dawson Ted M; Dawson Valina L; Dawson Ted M; Dawson Valina L; Dawson Ted M; Dawson Ted M; Dawson Valina L; Dawson Valina L; De Laurenzi Vincenzo; De Maria Ruggero; Sistigu Antonella; Debatin Klaus-Michael; DeBerardinis Ralph J; Deshmukh Mohanish; Di Daniele Nicola; Di Virgilio Francesco; Pinton Paolo; Dixit Vishva M; Dixon Scott J; Duckett Colin S; Dynlacht Brian D; Dynlacht Brian D; Pagano Michele; El-Deiry Wafik S; El-Deiry Wafik S; Elrod John W; Fimia Gian Maria; Piacentini Mauro; Fimia Gian Maria; Fulda Simone; Fulda Simone; Fulda Simone; Garcia-Saez Ana J; Garrido Carmen; Garrido Carmen; Garrido Carmen; Gavathiotis Evripidis; Gavathiotis Evripidis; Kitsis Richard N; Gavathiotis Evripidis; Kitsis Richard N; Gavathiotis Evripidis; Kitsis Richard N; Golstein Pierre; Gottlieb Eyal; Ryan Kevin M; Tait Stephen W G; Green Douglas R; Greene Lloyd A; Gronemeyer Hinrich; Gronemeyer Hinrich; Gronemeyer Hinrich; Gronemeyer Hinrich; Gross Atan; Hajnoczky Gyorgy; Hardwick J Marie; Harris Isaac S; Yuan Junying; Hengartner Michael O; Hetz Claudio; Hetz Claudio; Hetz Claudio; Ichijo Hidenori; Jaattela Marja; Joseph Bertrand; Zhivotovsky Boris; Jost Philipp J; Juin Philippe P; Juin Philippe P; Juin Philippe P; Juin Philippe P; Kaiser William J; Karin Michael; Karin Michael; Karin Michael; Karin Michael; Kaufmann Thomas; Simon Hans-Uwe; Kepp Oliver; Zitvogel Laurence; Kepp Oliver; Kroemer Guido; Kepp Oliver; Kroemer Guido; Kepp Oliver; Kroemer Guido; Kepp Oliver; Kroemer Guido; Kitsis Richard N; Kitsis Richard N; Klionsky Daniel J; Klionsky Daniel J; Kumar Sharad; Lee Sam W; Lemasters John J; Lemasters John J; Levine Beth; Levine Beth; Levine Beth; Linkermann Andreas; Lipton Stuart A; Lipton Stuart A; Lipton Stuart A; Lockshin Richard A; Lockshin Richard A; Lopez-Otin Carlos; Lowe Scott W; Lowe Scott W; Luedde Tom; Lugli Enrico; Lugli Enrico; Madeo Frank; Malorni Walter; Marine Jean-Christophe; Marine Jean-Christophe; Martin Seamus J; Martinou Jean-Claude; Medema Jan Paul; Medema Jan Paul; Mehlen Patrick; Mehlen Patrick; Mehlen Patrick; Mehlen Patrick; Mehlen Patrick; Mehlen Patrick; Meier Pascal; Melino Sonia; Miao Edward A; Miao Edward A; Miao Edward A; Molkentin Jeffery D; Moll Ute M; Munoz-Pinedo Cristina; Nagata Shigekazu; Nunez Gabriel; Nunez Gabriel; Oberst Andrew; Oberst Andrew; Oren Moshe; Overholtzer Michael; Pagano Michele; Pagano Michele; Panaretakis Theocharis; Panaretakis Theocharis; Pasparakis Manolis; Pasparakis Manolis; Penninger Josef M; Pereira David M; Pervaiz Shazib; Pervaiz Shazib; Pervaiz Shazib; Peter Marcus E; Peter Marcus E; Pinton Paolo; Pinton Paolo; Prehn Jochen H M; Puthalakath Hamsa; Rabinovich Gabriel A; Rabinovich Gabriel A; Rehm Markus; Rehm Markus; Rizzuto Rosario; Szabadkai Gyorgy; Rodrigues Cecilia M P; Rubinsztein David C; Rudel Thomas; Sayan Emre; Scorrano Luca; Scorrano Luca; Shao Feng; Shi Yufang; Shi Yufang; Shi Yufang; Silke John; Sistigu Antonella; Stockwell Brent R; Stockwell Brent R; Szabadkai Gyorgy; Szabadkai Gyorgy; Vousden Karen H; Tang Daolin; Tang Daolin; Tang Daolin; Tang Daolin; Tang Daolin; Tang Daolin; Tavernarakis Nektarios; Thorburn Andrew; Tsujimoto Yoshihide; Turk Boris; Turk Boris; Vander Heiden Matthew G; Vander Heiden Matthew G; Vander Heiden Matthew G; Villunger Andreas; Virgin Herbert W; Vucic Domagoj; Wagner Erwin F; Walczak Henning; Wallach David; Wang Ying; Wells James A; Wood Will; Yuan Junying; Zakeri Zahra; Zhivotovsky Boris; Zitvogel Laurence; Zitvogel Laurence; Zitvogel Laurence; Kroemer Guido</div><div class="citationInfo"><span class="NLM_cas:title">Cell death and differentiation</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">486-541</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Over the past decade, the Nomenclature Committee on Cell Death (NCCD) has formulated guidelines for the definition and interpretation of cell death from morphological, biochemical, and functional perspectives.  Since the field continues to expand and novel mechanisms that orchestrate multiple cell death pathways are unveiled, we propose an updated classification of cell death subroutines focusing on mechanistic and essential (as opposed to correlative and dispensable) aspects of the process.  As we provide molecularly oriented definitions of terms including intrinsic apoptosis, extrinsic apoptosis, mitochondrial permeability transition (MPT)-driven necrosis, necroptosis, ferroptosis, pyroptosis, parthanatos, entotic cell death, NETotic cell death, lysosome-dependent cell death, autophagy-dependent cell death, immunogenic cell death, cellular senescence, and mitotic catastrophe, we discuss the utility of neologisms that refer to highly specialized instances of these processes.  The mission of the NCCD is to provide a widely accepted nomenclature on cell death in support of the continued development of the field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRVakKpC8MvO-R_TJajKxJDfW6udTcc2ebmkwn4ARZ8JLntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MvjsFKgug%253D%253D&md5=4f2b2e5757ae4448c16f7114cd494a7c</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fs41418-017-0012-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41418-017-0012-4%26sid%3Dliteratum%253Aachs%26aulast%3DGalluzzi%26aufirst%3DL.%26aulast%3DVitale%26aufirst%3DI.%26aulast%3DAaronson%26aufirst%3DS.%2BA.%26aulast%3DAbrams%26aufirst%3DJ.%2BM.%26aulast%3DAdam%26aufirst%3DD.%26aulast%3DAgostinis%26aufirst%3DP.%26aulast%3DAlnemri%26aufirst%3DE.%2BS.%26aulast%3DAltucci%26aufirst%3DL.%26aulast%3DAmelio%26aufirst%3DI.%26aulast%3DAndrews%26aufirst%3DD.%2BW.%26aulast%3DAnnicchiarico-Petruzzelli%26aufirst%3DM.%26aulast%3DAntonov%26aufirst%3DA.%2BV.%26aulast%3DArama%26aufirst%3DE.%26aulast%3DBaehrecke%26aufirst%3DE.%2BH.%26aulast%3DBarlev%26aufirst%3DN.%2BA.%26aulast%3DBazan%26aufirst%3DN.%2BG.%26aulast%3DBernassola%26aufirst%3DF.%26aulast%3DBertrand%26aufirst%3DM.%2BJ.%2BM.%26aulast%3DBianchi%26aufirst%3DK.%26aulast%3DBlagosklonny%26aufirst%3DM.%2BV.%26aulast%3DBlomgren%26aufirst%3DK.%26aulast%3DBorner%26aufirst%3DC.%26aulast%3DBoya%26aufirst%3DP.%26aulast%3DBrenner%26aufirst%3DC.%26aulast%3DCampanella%26aufirst%3DM.%26aulast%3DCandi%26aufirst%3DE.%26aulast%3DCarmona-Gutierrez%26aufirst%3DD.%26aulast%3DCecconi%26aufirst%3DF.%26aulast%3DChan%26aufirst%3DF.%2BK.-M.%26aulast%3DChandel%26aufirst%3DN.%2BS.%26aulast%3DCheng%26aufirst%3DE.%2BH.%26aulast%3DChipuk%26aufirst%3DJ.%2BE.%26aulast%3DCidlowski%26aufirst%3DJ.%2BA.%26aulast%3DCiechanover%26aufirst%3DA.%26aulast%3DCohen%26aufirst%3DG.%2BM.%26aulast%3DConrad%26aufirst%3DM.%26aulast%3DCubillos-Ruiz%26aufirst%3DJ.%2BR.%26aulast%3DCzabotar%26aufirst%3DP.%2BE.%26aulast%3DD%25E2%2580%2599Angiolella%26aufirst%3DV.%26aulast%3DDawson%26aufirst%3DT.%2BM.%26aulast%3DDawson%26aufirst%3DV.%2BL.%26aulast%3DDe%2BLaurenzi%26aufirst%3DV.%26aulast%3DDe%2BMaria%26aufirst%3DR.%26aulast%3DDebatin%26aufirst%3DK.%2BM.%26aulast%3DDeBerardinis%26aufirst%3DR.%2BJ.%26aulast%3DDeshmukh%26aufirst%3DM.%26aulast%3DDi%2BDaniele%26aufirst%3DN.%26aulast%3DDi%2BVirgilio%26aufirst%3DF.%26aulast%3DDixit%26aufirst%3DV.%2BM.%26aulast%3DDixon%26aufirst%3DS.%2BJ.%26aulast%3DDuckett%26aufirst%3DC.%2BS.%26aulast%3DDynlacht%26aufirst%3DB.%2BD.%26aulast%3DEl-Deiry%26aufirst%3DW.%2BS.%26aulast%3DElrod%26aufirst%3DJ.%2BW.%26aulast%3DFimia%26aufirst%3DG.%2BM.%26aulast%3DFulda%26aufirst%3DS.%26aulast%3DGarc%25C3%25ADa-S%25C3%25A1ez%26aufirst%3DA.%2BJ.%26aulast%3DGarg%26aufirst%3DA.%2BD.%26aulast%3DGarrido%26aufirst%3DC.%26aulast%3DGavathiotis%26aufirst%3DE.%26aulast%3DGolstein%26aufirst%3DP.%26aulast%3DGottlieb%26aufirst%3DE.%26aulast%3DGreen%26aufirst%3DD.%2BR.%26aulast%3DGreene%26aufirst%3DL.%2BA.%26aulast%3DGronemeyer%26aufirst%3DH.%26aulast%3DGross%26aufirst%3DA.%26aulast%3DHajnoczky%26aufirst%3DG.%26aulast%3DHardwick%26aufirst%3DJ.%2BM.%26aulast%3DHarris%26aufirst%3DI.%2BS.%26aulast%3DHengartner%26aufirst%3DM.%2BO.%26aulast%3DHetz%26aufirst%3DC.%26aulast%3DIchijo%26aufirst%3DH.%26aulast%3DJ%25C3%25A4%25C3%25A4ttel%25C3%25A4%26aufirst%3DM.%26aulast%3DJoseph%26aufirst%3DB.%26aulast%3DJost%26aufirst%3DP.%2BJ.%26aulast%3DJuin%26aufirst%3DP.%2BP.%26aulast%3DKaiser%26aufirst%3DW.%2BJ.%26aulast%3DKarin%26aufirst%3DM.%26aulast%3DKaufmann%26aufirst%3DT.%26aulast%3DKepp%26aufirst%3DO.%26aulast%3DKimchi%26aufirst%3DA.%26aulast%3DKitsis%26aufirst%3DR.%2BN.%26aulast%3DKlionsky%26aufirst%3DD.%2BJ.%26aulast%3DKnight%26aufirst%3DR.%2BA.%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DS.%2BW.%26aulast%3DLemasters%26aufirst%3DJ.%2BJ.%26aulast%3DLevine%26aufirst%3DB.%26aulast%3DLinkermann%26aufirst%3DA.%26aulast%3DLipton%26aufirst%3DS.%2BA.%26aulast%3DLockshin%26aufirst%3DR.%2BA.%26aulast%3DL%25C3%25B3pez-Ot%25C3%25ADn%26aufirst%3DC.%26aulast%3DLowe%26aufirst%3DS.%2BW.%26aulast%3DLuedde%26aufirst%3DT.%26aulast%3DLugli%26aufirst%3DE.%26aulast%3DMacFarlane%26aufirst%3DM.%26aulast%3DMadeo%26aufirst%3DF.%26aulast%3DMalewicz%26aufirst%3DM.%26aulast%3DMalorni%26aufirst%3DW.%26aulast%3DManic%26aufirst%3DG.%26aulast%3DMarine%26aufirst%3DJ.%2BC.%26aulast%3DMartin%26aufirst%3DS.%2BJ.%26aulast%3DMartinou%26aufirst%3DJ.%2BC.%26aulast%3DMedema%26aufirst%3DJ.%2BP.%26aulast%3DMehlen%26aufirst%3DP.%26aulast%3DMeier%26aufirst%3DP.%26aulast%3DMelino%26aufirst%3DS.%26aulast%3DMiao%26aufirst%3DE.%2BA.%26aulast%3DMolkentin%26aufirst%3DJ.%2BD.%26aulast%3DMoll%26aufirst%3DU.%2BM.%26aulast%3DMu%25C3%25B1oz-Pinedo%26aufirst%3DC.%26aulast%3DNagata%26aufirst%3DS.%26aulast%3DNu%25C3%25B1ez%26aufirst%3DG.%26aulast%3DOberst%26aufirst%3DA.%26aulast%3DOren%26aufirst%3DM.%26aulast%3DOverholtzer%26aufirst%3DM.%26aulast%3DPagano%26aufirst%3DM.%26aulast%3DPanaretakis%26aufirst%3DT.%26aulast%3DPasparakis%26aufirst%3DM.%26aulast%3DPenninger%26aufirst%3DJ.%2BM.%26aulast%3DPereira%26aufirst%3DD.%2BM.%26aulast%3DPervaiz%26aufirst%3DS.%26aulast%3DPeter%26aufirst%3DM.%2BE.%26aulast%3DPiacentini%26aufirst%3DM.%26aulast%3DPinton%26aufirst%3DP.%26aulast%3DPrehn%26aufirst%3DJ.%2BH.%2BM.%26aulast%3DPuthalakath%26aufirst%3DH.%26aulast%3DRabinovich%26aufirst%3DG.%2BA.%26aulast%3DRehm%26aufirst%3DM.%26aulast%3DRizzuto%26aufirst%3DR.%26aulast%3DRodrigues%26aufirst%3DC.%2BM.%2BP.%26aulast%3DRubinsztein%26aufirst%3DD.%2BC.%26aulast%3DRudel%26aufirst%3DT.%26aulast%3DRyan%26aufirst%3DK.%2BM.%26aulast%3DSayan%26aufirst%3DE.%26aulast%3DScorrano%26aufirst%3DL.%26aulast%3DShao%26aufirst%3DF.%26aulast%3DShi%26aufirst%3DY.%26aulast%3DSilke%26aufirst%3DJ.%26aulast%3DSimon%26aufirst%3DH.-U.%26aulast%3DSistigu%26aufirst%3DA.%26aulast%3DStockwell%26aufirst%3DB.%2BR.%26aulast%3DStrasser%26aufirst%3DA.%26aulast%3DSzabadkai%26aufirst%3DG.%26aulast%3DTait%26aufirst%3DS.%2BW.%2BG.%26aulast%3DTang%26aufirst%3DD.%26aulast%3DTavernarakis%26aufirst%3DN.%26aulast%3DThorburn%26aufirst%3DA.%26aulast%3DTsujimoto%26aufirst%3DY.%26aulast%3DTurk%26aufirst%3DB.%26aulast%3DVanden%2BBerghe%26aufirst%3DT.%26aulast%3DVandenabeele%26aufirst%3DP.%26aulast%3DVander%2BHeiden%26aufirst%3DM.%2BG.%26aulast%3DVillunger%26aufirst%3DA.%26aulast%3DVirgin%26aufirst%3DH.%2BW.%26aulast%3DVousden%26aufirst%3DK.%2BH.%26aulast%3DVucic%26aufirst%3DD.%26aulast%3DWagner%26aufirst%3DE.%2BF.%26aulast%3DWalczak%26aufirst%3DH.%26aulast%3DWallach%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DWells%26aufirst%3DJ.%2BA.%26aulast%3DWood%26aufirst%3DW.%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DZakeri%26aufirst%3DZ.%26aulast%3DZhivotovsky%26aufirst%3DB.%26aulast%3DZitvogel%26aufirst%3DL.%26aulast%3DMelino%26aufirst%3DG.%26aulast%3DKroemer%26aufirst%3DG.%26atitle%3DMolecular%2520mechanisms%2520of%2520cell%2520death%253A%2520recommendations%2520of%2520the%2520Nomenclature%2520Committee%2520on%2520Cell%2520Death%25202018%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2018%26volume%3D25%26spage%3D486%26epage%3D541%26doi%3D10.1038%2Fs41418-017-0012-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, B.</span></span> <span> </span><span class="NLM_article-title">Ferroptosis, a new form of cell death: opportunities and challenges in cancer</span>. <i>J. Hematol. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">34</span>, <span class="refDoi">Â DOI: 10.1186/s13045-019-0720-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=10.1186%2Fs13045-019-0720-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=30925886" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=1%3ACAS%3A280%3ADC%252BB3cbpsFKhtg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2019&pages=34&author=Y.+Mouauthor=J.+Wangauthor=J.+Wuauthor=D.+Heauthor=C.+Zhangauthor=C.+Duanauthor=B.+Li&title=Ferroptosis%2C+a+new+form+of+cell+death%3A+opportunities+and+challenges+in+cancer&doi=10.1186%2Fs13045-019-0720-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Ferroptosis, a new form of cell death: opportunities and challenges in cancer</span></div><div class="casAuthors">Mou Yanhua; Wu Jinchun; Duan Chaojun; Li Bin; Mou Yanhua; Wang Jun; Duan Chaojun; Li Bin; He Dan; Zhang Chunfang; Duan Chaojun</div><div class="citationInfo"><span class="NLM_cas:title">Journal of hematology & oncology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">34</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Ferroptosis is a novel type of cell death with distinct properties and recognizing functions involved in physical conditions or various diseases including cancers.  The fast-growing studies of ferroptosis in cancer have boosted a perspective for its usage in cancer therapeutics.  Here, we review the current findings of ferroptosis regulation and especially focus on the function of ncRNAs in mediating the process of cell ferroptotic death and on how ferroptosis was in relation to other regulated cell deaths.  Aberrant ferroptosis in diverse cancer types and tissues were summarized, and we elaborated recent data about the novel actors of some "conventional" drugs or natural compounds as ferroptosis inducers in cancer.  Finally, we deliberate future orientation for ferroptosis in cancer cells and current unsettled issues, which may forward the speed of clinical use of ferroptosis induction in cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSuf8Ef-3V1dAqdek-gHSrIfW6udTcc2ea_O3KK2MPyU7ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cbpsFKhtg%253D%253D&md5=9b6f8daa2e7c5abde56200e8e86cc8b4</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1186%2Fs13045-019-0720-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13045-019-0720-y%26sid%3Dliteratum%253Aachs%26aulast%3DMou%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DHe%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DDuan%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DB.%26atitle%3DFerroptosis%252C%2520a%2520new%2520form%2520of%2520cell%2520death%253A%2520opportunities%2520and%2520challenges%2520in%2520cancer%26jtitle%3DJ.%2520Hematol.%2520Oncol.%26date%3D2019%26volume%3D12%26spage%3D34%26doi%3D10.1186%2Fs13045-019-0720-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ye, L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaudhary, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zandkarimi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harken, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinslow, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Upadhyayula, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dovas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higgins, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buonanno, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T. J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hei, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruce, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canoll, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stockwell, B. R.</span></span> <span> </span><span class="NLM_article-title">Radiation-induced lipid peroxidation triggers ferroptosis and synergizes with ferroptosis inducers</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">469</span>â <span class="NLM_lpage">484</span>, <span class="refDoi">Â DOI: 10.1021/acschembio.9b00939</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.9b00939" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=1%3ACAS%3A528%3ADC%252BB3cXjt1Gmtw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2020&pages=469-484&author=L.+F.+Yeauthor=K.+R.+Chaudharyauthor=F.+Zandkarimiauthor=A.+D.+Harkenauthor=C.+J.+Kinslowauthor=P.+S.+Upadhyayulaauthor=A.+Dovasauthor=D.+M.+Higginsauthor=H.+Tanauthor=Y.+Zhangauthor=M.+Buonannoauthor=T.+J.+C.+Wangauthor=T.+K.+Heiauthor=J.+N.+Bruceauthor=P.+D.+Canollauthor=S.+K.+Chengauthor=B.+R.+Stockwell&title=Radiation-induced+lipid+peroxidation+triggers+ferroptosis+and+synergizes+with+ferroptosis+inducers&doi=10.1021%2Facschembio.9b00939"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Radiation-Induced Lipid Peroxidation Triggers Ferroptosis and Synergizes with Ferroptosis Inducers</span></div><div class="casAuthors">Ye, Ling F.; Chaudhary, Kunal R.; Zandkarimi, Fereshteh; Harken, Andrew D.; Kinslow, Connor J.; Upadhyayula, Pavan S.; Dovas, Athanassios; Higgins, Dominique M.; Tan, Hui; Zhang, Yan; Buonanno, Manuela; Wang, Tony J. C.; Hei, Tom K.; Bruce, Jeffrey N.; Canoll, Peter D.; Cheng, Simon K.; Stockwell, Brent R.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">469-484</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Although radiation is widely used to treat cancers, resistance mechanisms often develop and involve activation of DNA repair and inhibition of apoptosis.  Therefore, compds. that sensitize cancer cells to radiation via alternative cell death pathways are valuable.  We report here that ferroptosis, a form of nonapoptotic cell death driven by lipid peroxidn., is partly responsible for radiation-induced cancer cell death.  Moreover, we found that small mols. activating ferroptosis through system xc- inhibition or GPX4 inhibition synergize with radiation to induce ferroptosis in several cancer types by enhancing cytoplasmic lipid peroxidn. but not increasing DNA damage or caspase activation.  Ferroptosis inducers synergized with cytoplasmic irradn., but not nuclear irradn.  Finally, administration of ferroptosis inducers enhanced the antitumor effect of radiation in a murine xenograft model and in human patient-derived models of lung adenocarcinoma and glioma.  These results suggest that ferroptosis inducers may be effective radiosensitizers that can expand the efficacy and range of indications for radiation therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzYjXEp7fuRrVg90H21EOLACvtfcHk0lgOso5I03Akxw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXjt1Gmtw%253D%253D&md5=2b067453923c02ae41a336bb156dcba5</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Facschembio.9b00939&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.9b00939%26sid%3Dliteratum%253Aachs%26aulast%3DYe%26aufirst%3DL.%2BF.%26aulast%3DChaudhary%26aufirst%3DK.%2BR.%26aulast%3DZandkarimi%26aufirst%3DF.%26aulast%3DHarken%26aufirst%3DA.%2BD.%26aulast%3DKinslow%26aufirst%3DC.%2BJ.%26aulast%3DUpadhyayula%26aufirst%3DP.%2BS.%26aulast%3DDovas%26aufirst%3DA.%26aulast%3DHiggins%26aufirst%3DD.%2BM.%26aulast%3DTan%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DBuonanno%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DT.%2BJ.%2BC.%26aulast%3DHei%26aufirst%3DT.%2BK.%26aulast%3DBruce%26aufirst%3DJ.%2BN.%26aulast%3DCanoll%26aufirst%3DP.%2BD.%26aulast%3DCheng%26aufirst%3DS.%2BK.%26aulast%3DStockwell%26aufirst%3DB.%2BR.%26atitle%3DRadiation-induced%2520lipid%2520peroxidation%2520triggers%2520ferroptosis%2520and%2520synergizes%2520with%2520ferroptosis%2520inducers%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2020%26volume%3D15%26spage%3D469%26epage%3D484%26doi%3D10.1021%2Facschembio.9b00939" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cui, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span> <span> </span><span class="NLM_article-title">LRPPRC: a multifunctional protein involved in energy metabolism and human disease</span>. <i>Front. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">595</span>, <span class="refDoi">Â DOI: 10.3389/fphys.2019.00595</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=10.3389%2Ffphys.2019.00595" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=31178748" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=1%3ACAS%3A280%3ADC%252BB3M3kslehsg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=595&author=J.+Cuiauthor=L.+Wangauthor=X.+Renauthor=Y.+Zhangauthor=H.+Zhang&title=LRPPRC%3A+a+multifunctional+protein+involved+in+energy+metabolism+and+human+disease&doi=10.3389%2Ffphys.2019.00595"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">LRPPRC: A Multifunctional Protein Involved in Energy Metabolism and Human Disease</span></div><div class="casAuthors">Cui Jie; Wang Li; Ren Xiaoyue; Zhang Yamin; Cui Jie; Wang Li; Ren Xiaoyue; Zhang Yamin; Zhang Hongyi; Zhang Hongyi</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in physiology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">595</span>
        ISSN:<span class="NLM_cas:issn">1664-042X</span>.
    </div><div class="casAbstract">The pentatricopeptide repeat (PPR) family plays a major role in RNA stability, regulation, processing, splicing, translation, and editing.  Leucine-rich PPR-motif-containing protein (LRPPRC), a member of the PPR family, is a known gene mutation that causes Leigh syndrome French-Canadian.  Recently, growing evidence has pointed out that LRPPRC dysregulation is related to various diseases ranging from tumors to viral infections.  This review presents available published data on the LRPPRC protein function and its role in tumors and other diseases.  As a multi-functional protein, LRPPRC regulates a myriad of biological processes, including energy metabolism and maturation and the export of nuclear mRNA.  Overexpression of LRPPRC has been observed in various human tumors and is associated with poor prognosis.  Downregulation of LRPPRC inhibits growth and invasion, induces apoptosis, and overcomes drug resistance in tumor cells.  In addition, LRPPRC plays a potential role in Parkinson's disease, neurofibromatosis 1, viral infections, and venous thromboembolism.  Further investigating these new functions of LRPPRC should provide novel opportunities for a better understanding of its pathological role in diseases from tumors to viral infections and as a potential biomarker and molecular target for disease treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTX1yhwJRUF1Awxfk_AGB-EfW6udTcc2ea_O3KK2MPyU7ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3M3kslehsg%253D%253D&md5=a15a14c87772c9b016196961dcabc513</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.3389%2Ffphys.2019.00595&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphys.2019.00595%26sid%3Dliteratum%253Aachs%26aulast%3DCui%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DRen%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DH.%26atitle%3DLRPPRC%253A%2520a%2520multifunctional%2520protein%2520involved%2520in%2520energy%2520metabolism%2520and%2520human%2520disease%26jtitle%3DFront.%2520Physiol.%26date%3D2019%26volume%3D10%26spage%3D595%26doi%3D10.3389%2Ffphys.2019.00595" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matilainen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carroll, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richter, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Euro, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pohjanpelto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paetau, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isohanni, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suomalainen, A.</span></span> <span> </span><span class="NLM_article-title">Defective mitochondrial RNA processing due to PNPT1 variants causes Leigh syndrome</span>. <i>Hum. Mol. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">3352</span>â <span class="NLM_lpage">3361</span>, <span class="refDoi">Â DOI: 10.1093/hmg/ddx221</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=10.1093%2Fhmg%2Fddx221" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=28645153" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=1%3ACAS%3A528%3ADC%252BC1cXmtVyit7s%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2017&pages=3352-3361&author=S.+Matilainenauthor=C.+J.+Carrollauthor=U.+Richterauthor=L.+Euroauthor=M.+Pohjanpeltoauthor=A.+Paetauauthor=P.+Isohanniauthor=A.+Suomalainen&title=Defective+mitochondrial+RNA+processing+due+to+PNPT1+variants+causes+Leigh+syndrome&doi=10.1093%2Fhmg%2Fddx221"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Defective mitochondrial RNA processing due to PNPT1 variants causes Leigh syndrome</span></div><div class="casAuthors">Matilainen, Sanna; Carroll, Christopher J.; Richter, Uwe; Euro, Liliya; Pohjanpelto, Max; Paetau, Anders; Isohanni, Pirjo; Suomalainen, Anu</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">3352-3361</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">1460-2083</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Leigh syndrome is a severe infantile encephalopathy with an exceptionally variable genetic background.  We studied the exome of a child manifesting with Leigh syndrome at one month of age and progressing to death by the age of 2.4 years, and identified novel compd. heterozygous variants in PNPT1, encoding the polynucleotide phosphorylase (PNPase).  Expression of the wild type PNPT1 in the subject's myoblasts functionally complemented the defects, and the pathogenicity was further supported by structural predictions and protein and RNA analyses.  PNPase is a key enzyme in mitochondrial RNA metab., with suggested roles in mitochondrial RNA import and degrdn.  The variants were predicted to locate in the PNPase active site and disturb the RNA processing activity of the enzyme.  The PNPase trimer formation was not affected, but specific RNA processing intermediates derived from mitochondrial transcripts of the ND6 subunit of Complex I, as well as small mRNA fragments, accumulated in the subject's myoblasts.  Mitochondrial RNA processing mediated by the degradosome consisting of hSUV3 and PNPase is poorly characterized, and controversy on the role and location of PNPase within human mitochondria exists.  Our evidence indicates that PNPase activity is essential for the correct maturation of the ND6 transcripts, and likely for the efficient removal of degrdn. intermediates.  Loss of its activity will result in combined respiratory chain deficiency, and a classic respiratory chain-deficiency-assocd. disease, Leigh syndrome, indicating an essential role for the enzyme for normal function of the mitochondrial respiratory chain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeWxcqF5TRfLVg90H21EOLACvtfcHk0liPDwfS7Tj-Cg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXmtVyit7s%253D&md5=cee624126e68c67477d4a808a7742f1a</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2Fddx221&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252Fddx221%26sid%3Dliteratum%253Aachs%26aulast%3DMatilainen%26aufirst%3DS.%26aulast%3DCarroll%26aufirst%3DC.%2BJ.%26aulast%3DRichter%26aufirst%3DU.%26aulast%3DEuro%26aufirst%3DL.%26aulast%3DPohjanpelto%26aufirst%3DM.%26aulast%3DPaetau%26aufirst%3DA.%26aulast%3DIsohanni%26aufirst%3DP.%26aulast%3DSuomalainen%26aufirst%3DA.%26atitle%3DDefective%2520mitochondrial%2520RNA%2520processing%2520due%2520to%2520PNPT1%2520variants%2520causes%2520Leigh%2520syndrome%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2017%26volume%3D26%26spage%3D3352%26epage%3D3361%26doi%3D10.1093%2Fhmg%2Fddx221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chilin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marzaro, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zanatta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbieri, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pastorini, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manzini, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guiotto, A.</span></span> <span> </span><span class="NLM_article-title">A new access to quinazolines from simple anilines</span>. <i>Tetrahedron</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">12351</span>â <span class="NLM_lpage">12356</span>, <span class="refDoi">Â DOI: 10.1016/j.tet.2006.09.103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=10.1016%2Fj.tet.2006.09.103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1Cmtr7F" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2006&pages=12351-12356&author=A.+Chilinauthor=G.+Marzaroauthor=S.+Zanattaauthor=V.+Barbieriauthor=G.+Pastoriniauthor=P.+Manziniauthor=A.+Guiotto&title=A+new+access+to+quinazolines+from+simple+anilines&doi=10.1016%2Fj.tet.2006.09.103"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">A new access to quinazolines from simple anilines</span></div><div class="casAuthors">Chilin, Adriana; Marzaro, Giovanni; Zanatta, Samuele; Barbieri, Vera; Pastorini, Giovanni; Manzini, Paolo; Guiotto, Adriano</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">52</span>),
    <span class="NLM_cas:pages">12351-12356</span>CODEN:
                <span class="NLM_cas:coden">TETRAB</span>;
        ISSN:<span class="NLM_cas:issn">0040-4020</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A new synthetic pathway to quinazolines, e.g., I (R = Me or MeO) was described.  This new method used hexamethylenetetramine in TFA and potassium ferricyanide in aq. ethanolic KOH, starting from simple N-protected anilines.  The method afforded substituted quinazolines with high selectivities and good yields, reducing reaction-time and work-up operations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraKBxLSteff7Vg90H21EOLACvtfcHk0liPDwfS7Tj-Cg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1Cmtr7F&md5=05b4070e94f2711c720df717cccd1722</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.tet.2006.09.103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tet.2006.09.103%26sid%3Dliteratum%253Aachs%26aulast%3DChilin%26aufirst%3DA.%26aulast%3DMarzaro%26aufirst%3DG.%26aulast%3DZanatta%26aufirst%3DS.%26aulast%3DBarbieri%26aufirst%3DV.%26aulast%3DPastorini%26aufirst%3DG.%26aulast%3DManzini%26aufirst%3DP.%26aulast%3DGuiotto%26aufirst%3DA.%26atitle%3DA%2520new%2520access%2520to%2520quinazolines%2520from%2520simple%2520anilines%26jtitle%3DTetrahedron%26date%3D2006%26volume%3D62%26spage%3D12351%26epage%3D12356%26doi%3D10.1016%2Fj.tet.2006.09.103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Paulsen, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veloso, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prasad, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bedi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ljungman, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magnuson, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ljungman, M.</span></span> <span> </span><span class="NLM_article-title">Use of Bru-Seq and BruChase-Seq for genome-wide assessment of the synthesis and stability of RNA</span>. <i>Methods</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">45</span>â <span class="NLM_lpage">54</span>, <span class="refDoi">Â DOI: 10.1016/j.ymeth.2013.08.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=10.1016%2Fj.ymeth.2013.08.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=23973811" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFeksbvN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2014&pages=45-54&author=M.+T.+Paulsenauthor=A.+Velosoauthor=J.+Prasadauthor=K.+Bediauthor=E.+A.+Ljungmanauthor=B.+Magnusonauthor=T.+E.+Wilsonauthor=M.+Ljungman&title=Use+of+Bru-Seq+and+BruChase-Seq+for+genome-wide+assessment+of+the+synthesis+and+stability+of+RNA&doi=10.1016%2Fj.ymeth.2013.08.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Use of Bru-Seq and BruChase-Seq for genome-wide assessment of the synthesis and stability of RNA</span></div><div class="casAuthors">Paulsen, Michelle T.; Veloso, Artur; Prasad, Jayendra; Bedi, Karan; Ljungman, Emily A.; Magnuson, Brian; Wilson, Thomas E.; Ljungman, Mats</div><div class="citationInfo"><span class="NLM_cas:title">Methods (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">45-54</span>CODEN:
                <span class="NLM_cas:coden">MTHDE9</span>;
        ISSN:<span class="NLM_cas:issn">1046-2023</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Gene expression studies commonly examine total cellular RNA, which only provides information about its steady-state pool of RNA.  It remains unclear whether differences in the steady-state reflects variable rates of transcription or RNA degrdn.  To specifically monitor RNA synthesis and degrdn. genome-wide, we developed Bru-Seq and BruChase-Seq.  These assays are based on metabolic pulse-chase labeling of RNA using bromouridine (Bru).  In Bru-Seq, recently labeled RNAs are sequenced to reveal spans of nascent transcription in the genome.  In BruChase-Seq, cells are chased in uridine for different periods of time following Bru-labeling, allowing for the isolation of RNA populations of specific ages.  Here we describe these methodologies in detail and highlight their usefulness in assessing RNA synthesis and stability as well as splicing kinetics with examples of specific genes from different human cell lines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkhkyBLXrRWrVg90H21EOLACvtfcHk0liPDwfS7Tj-Cg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFeksbvN&md5=a18ef08d32830fe03bf5024aa7246fb9</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.ymeth.2013.08.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ymeth.2013.08.015%26sid%3Dliteratum%253Aachs%26aulast%3DPaulsen%26aufirst%3DM.%2BT.%26aulast%3DVeloso%26aufirst%3DA.%26aulast%3DPrasad%26aufirst%3DJ.%26aulast%3DBedi%26aufirst%3DK.%26aulast%3DLjungman%26aufirst%3DE.%2BA.%26aulast%3DMagnuson%26aufirst%3DB.%26aulast%3DWilson%26aufirst%3DT.%2BE.%26aulast%3DLjungman%26aufirst%3DM.%26atitle%3DUse%2520of%2520Bru-Seq%2520and%2520BruChase-Seq%2520for%2520genome-wide%2520assessment%2520of%2520the%2520synthesis%2520and%2520stability%2520of%2520RNA%26jtitle%3DMethods%26date%3D2014%26volume%3D67%26spage%3D45%26epage%3D54%26doi%3D10.1016%2Fj.ymeth.2013.08.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Blaser, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dostert, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mak, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brenner, D.</span></span> <span> </span><span class="NLM_article-title">TNF and ROS crosstalk in inflammation</span>. <i>Trends Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">249</span>â <span class="NLM_lpage">261</span>, <span class="refDoi">Â DOI: 10.1016/j.tcb.2015.12.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=10.1016%2Fj.tcb.2015.12.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=26791157" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitV2ntbvP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=249-261&author=H.+Blaserauthor=C.+Dostertauthor=T.+W.+Makauthor=D.+Brenner&title=TNF+and+ROS+crosstalk+in+inflammation&doi=10.1016%2Fj.tcb.2015.12.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">TNF and ROS Crosstalk in Inflammation</span></div><div class="casAuthors">Blaser, Heiko; Dostert, Catherine; Mak, Tak W.; Brenner, Dirk</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Cell Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">249-261</span>CODEN:
                <span class="NLM_cas:coden">TCBIEK</span>;
        ISSN:<span class="NLM_cas:issn">0962-8924</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Tumor necrosis factor (TNF) is tremendously important for mammalian immunity and cellular homeostasis.  The role of TNF as a master regulator in balancing cell survival, apoptosis and necroptosis has been extensively studied in various cell types and tissues.  Although these findings have revealed much about the direct impact of TNF on the regulation of NF-ÎºB and JNK, there is now rising interest in understanding the emerging function of TNF as a regulator of the generation of reactive oxygen species (ROS) and reactive nitrogen species (RNS).  In this review we summarize work aimed at defining the role of TNF in the control of ROS/RNS signaling that influences innate immune cells under both physiol. and inflammatory conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-8cerxIhhCLVg90H21EOLACvtfcHk0ljnnWzl6fey8A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitV2ntbvP&md5=3005a700a89113c5f68e3bb4d3ee8273</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.tcb.2015.12.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tcb.2015.12.002%26sid%3Dliteratum%253Aachs%26aulast%3DBlaser%26aufirst%3DH.%26aulast%3DDostert%26aufirst%3DC.%26aulast%3DMak%26aufirst%3DT.%2BW.%26aulast%3DBrenner%26aufirst%3DD.%26atitle%3DTNF%2520and%2520ROS%2520crosstalk%2520in%2520inflammation%26jtitle%3DTrends%2520Cell%2520Biol.%26date%3D2016%26volume%3D26%26spage%3D249%26epage%3D261%26doi%3D10.1016%2Fj.tcb.2015.12.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nishigori, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hattori, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toyokuni, S.</span></span> <span> </span><span class="NLM_article-title">Role of reactive oxygen species in skin carcinogenesis</span>. <i>Antioxid. Redox Signaling</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">561</span>â <span class="NLM_lpage">570</span>, <span class="refDoi">Â DOI: 10.1089/152308604773934314</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=10.1089%2F152308604773934314" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=15130282" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjslahu7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2004&pages=561-570&author=C.+Nishigoriauthor=Y.+Hattoriauthor=S.+Toyokuni&title=Role+of+reactive+oxygen+species+in+skin+carcinogenesis&doi=10.1089%2F152308604773934314"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Role of Reactive Oxygen Species in Skin Carcinogenesis</span></div><div class="casAuthors">Nishigori, Chikako; Hattori, Yukari; Toyokuni, Shinya</div><div class="citationInfo"><span class="NLM_cas:title">Antioxidants & Redox Signaling</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">561-570</span>CODEN:
                <span class="NLM_cas:coden">ARSIF2</span>;
        ISSN:<span class="NLM_cas:issn">1523-0864</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">A review.  Reactive oxygen species (ROS) are assocd. not only with initiation, but also with promotion and progression in the multistage carcinogenesis model.  In the present review, we will focus on the involvement of ROS in skin carcinogenesis, esp. that induced by UV radiation.  UV-specific DNA damage has been well studied thus far.  However, recent reports have revealed the previously unknown participation of oxidative stress in UV-induced skin carcinogenesis.  Indeed, in addn. to transition-type mutations at dipyrimidine sites, G:C to T:A transversions, which may be induced by the presence of 8-oxoguanine during DNA replication, are frequently obsd. in the ras oncogene and p53 tumor suppressor gene in human skin cancers of sun-exposed areas and in UV-induced mouse skin cancers.  Recent studies have shown that not only UV-B, but also UV-A is involved in UV-induced carcinogenesis.  A wide variety of biol. phenomena other than direct influence by UV, such as inflammatory and immunol. responses and oxidative modifications of DNA and proteins, appear to play roles in UV-induced skin carcinogenesis.  Furthermore, it has become clear that genetic diseases such as xeroderma pigmentosum show deficient repair of oxidatively modified DNA lesions.  The involvement of ROS in skin carcinogeneisis caused by arsenic and chem. carcinogens will also be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVxlJEZ12RsbVg90H21EOLACvtfcHk0ljnnWzl6fey8A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjslahu7g%253D&md5=80b014f80dee84b1586287253bbdaa14</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1089%2F152308604773934314&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252F152308604773934314%26sid%3Dliteratum%253Aachs%26aulast%3DNishigori%26aufirst%3DC.%26aulast%3DHattori%26aufirst%3DY.%26aulast%3DToyokuni%26aufirst%3DS.%26atitle%3DRole%2520of%2520reactive%2520oxygen%2520species%2520in%2520skin%2520carcinogenesis%26jtitle%3DAntioxid.%2520Redox%2520Signaling%26date%3D2004%26volume%3D6%26spage%3D561%26epage%3D570%26doi%3D10.1089%2F152308604773934314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rodust, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stockfleth, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ulrich, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leverkus, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eberle, J.</span></span> <span> </span><span class="NLM_article-title">UV-induced squamous cell carcinoma--a role for antiapoptotic signalling pathways</span>. <i>Br. J. Dermatol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>161</i></span>,  <span class="NLM_fpage">107</span>â <span class="NLM_lpage">115</span>, <span class="refDoi">Â DOI: 10.1111/j.1365-2133.2009.09458.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=10.1111%2Fj.1365-2133.2009.09458.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=19775366" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlGns7rE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=161&publication_year=2009&pages=107-115&author=P.+M.+Rodustauthor=E.+Stockflethauthor=C.+Ulrichauthor=M.+Leverkusauthor=J.+Eberle&title=UV-induced+squamous+cell+carcinoma%2D%2Da+role+for+antiapoptotic+signalling+pathways&doi=10.1111%2Fj.1365-2133.2009.09458.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">UV-induced squamous cell carcinoma - a role for antiapoptotic signalling pathways</span></div><div class="casAuthors">Rodust, P. M.; Stockfleth, E.; Ulrich, C.; Leverkus, M.; Eberle, J.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Dermatology, Supplement</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">161</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">107-115</span>CODEN:
                <span class="NLM_cas:coden">BJDSA9</span>;
        ISSN:<span class="NLM_cas:issn">0366-077X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  The incidence of nonmelanoma skin cancer including squamous cell carcinoma (SCC) and basal cell carcinoma (BCC) has dramatically increased in the last decades, and chronic sun exposure was identified as a main etiol. agent.  UV radiation may produce DNA damage either directly or through reactive oxygen species (ROS).  As mutations caused by UV may lead to skin cancer due to oncogene activation and tumor suppressor gene inactivation, efficient safeguard mechanisms have been developed during evolution.  These enclose induction of apoptosis and formation sunburn cells aiming at the removal of premalignant cells.  The keratinocyte apoptotic machinery in response to UV consists of both intrinsic/mitochondrial and extrinsic/death receptor-mediated cell-death pathways, which are particularly regulated by mitogen-activated protein kinases (MAPKs, JNK and p38) and the tumor-suppressor protein p53.  For development of skin cancer, it appears that crit. steps in apoptosis control are dysregulated leading to resistance both to death ligand-mediated and intrinsic proapoptotic pathways.  These particularly include inactivation of p53, as well as activation of EGFR, COX-2 and MAPKs, which result in specific regulation of Bcl-2 proteins, death ligands and death receptors.  The final unravelling of apoptosis regulation in epithelial skin cancer may allow the development of new targeted therapeutic strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkWBenLDU_3bVg90H21EOLACvtfcHk0ljnnWzl6fey8A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlGns7rE&md5=76d098f052daa216c8150a627f64405c</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2133.2009.09458.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2133.2009.09458.x%26sid%3Dliteratum%253Aachs%26aulast%3DRodust%26aufirst%3DP.%2BM.%26aulast%3DStockfleth%26aufirst%3DE.%26aulast%3DUlrich%26aufirst%3DC.%26aulast%3DLeverkus%26aufirst%3DM.%26aulast%3DEberle%26aufirst%3DJ.%26atitle%3DUV-induced%2520squamous%2520cell%2520carcinoma--a%2520role%2520for%2520antiapoptotic%2520signalling%2520pathways%26jtitle%3DBr.%2520J.%2520Dermatol.%26date%3D2009%26volume%3D161%26spage%3D107%26epage%3D115%26doi%3D10.1111%2Fj.1365-2133.2009.09458.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">GÃ¶rlach, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dimova, E. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petry, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MartÃ­nez-Ruiz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernansanz-AgustÃ­n, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rolo, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmeira, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kietzmann, T.</span></span> <span> </span><span class="NLM_article-title">Reactive oxygen species, nutrition, hypoxia and diseases: Problems solved?</span>. <i>Redox. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">372</span>â <span class="NLM_lpage">385</span>, <span class="refDoi">Â DOI: 10.1016/j.redox.2015.08.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=10.1016%2Fj.redox.2015.08.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=26339717" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=1%3ACAS%3A280%3ADC%252BC287ptFOhsw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=372-385&author=A.+G%C3%B6rlachauthor=E.+Y.+Dimovaauthor=A.+Petryauthor=A.+Mart%C3%ADnez-Ruizauthor=P.+Hernansanz-Agust%C3%ADnauthor=A.+P.+Roloauthor=C.+M.+Palmeiraauthor=T.+Kietzmann&title=Reactive+oxygen+species%2C+nutrition%2C+hypoxia+and+diseases%3A+Problems+solved%3F&doi=10.1016%2Fj.redox.2015.08.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Reactive oxygen species, nutrition, hypoxia and diseases: Problems solved?</span></div><div class="casAuthors">Gorlach Agnes; Petry Andreas; Dimova Elitsa Y; Martinez-Ruiz Antonio; Hernansanz-Agustin Pablo; Rolo Anabela P; Palmeira Carlos M; Kietzmann Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Redox biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">372-385</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Within the last twenty years the view on reactive oxygen species (ROS) has changed; they are no longer only considered to be harmful but also necessary for cellular communication and homeostasis in different organisms ranging from bacteria to mammals.  In the latter, ROS were shown to modulate diverse physiological processes including the regulation of growth factor signaling, the hypoxic response, inflammation and the immune response.  During the last 60-100 years the life style, at least in the Western world, has changed enormously.  This became obvious with an increase in caloric intake, decreased energy expenditure as well as the appearance of alcoholism and smoking; These changes were shown to contribute to generation of ROS which are, at least in part, associated with the occurrence of several chronic diseases like adiposity, atherosclerosis, type II diabetes, and cancer.  In this review we discuss aspects and problems on the role of intracellular ROS formation and nutrition with the link to diseases and their problematic therapeutical issues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQqVAJA36KLIxgd2Wuil24tfW6udTcc2eYU35IjNx7mqrntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC287ptFOhsw%253D%253D&md5=df38d36c035efdd048e6ef39509070d9</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.redox.2015.08.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.redox.2015.08.016%26sid%3Dliteratum%253Aachs%26aulast%3DG%25C3%25B6rlach%26aufirst%3DA.%26aulast%3DDimova%26aufirst%3DE.%2BY.%26aulast%3DPetry%26aufirst%3DA.%26aulast%3DMart%25C3%25ADnez-Ruiz%26aufirst%3DA.%26aulast%3DHernansanz-Agust%25C3%25ADn%26aufirst%3DP.%26aulast%3DRolo%26aufirst%3DA.%2BP.%26aulast%3DPalmeira%26aufirst%3DC.%2BM.%26aulast%3DKietzmann%26aufirst%3DT.%26atitle%3DReactive%2520oxygen%2520species%252C%2520nutrition%252C%2520hypoxia%2520and%2520diseases%253A%2520Problems%2520solved%253F%26jtitle%3DRedox.%2520Biol.%26date%3D2015%26volume%3D6%26spage%3D372%26epage%3D385%26doi%3D10.1016%2Fj.redox.2015.08.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tafani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sansone, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Limana, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arcangeli, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Santis, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polese, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russo, M. A.</span></span> <span> </span><span class="NLM_article-title">The interplay of reactive oxygen species, hypoxia, inflammation, and sirtuins in cancer initiation and progression</span>. <i>Oxid. Med. Cell. Longevity</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>2016</i></span>,  <span class="NLM_fpage">3907147</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=10.1155%2F2016%2F3907147" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=26798421" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=1%3ACAS%3A280%3ADC%252BC28njsFShug%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2016&publication_year=2016&pages=3907147&author=M.+Tafaniauthor=L.+Sansoneauthor=F.+Limanaauthor=T.+Arcangeliauthor=E.+De+Santisauthor=M.+Poleseauthor=M.+Finiauthor=M.+A.+Russo&title=The+interplay+of+reactive+oxygen+species%2C+hypoxia%2C+inflammation%2C+and+sirtuins+in+cancer+initiation+and+progression"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">The Interplay of Reactive Oxygen Species, Hypoxia, Inflammation, and Sirtuins in Cancer Initiation and Progression</span></div><div class="casAuthors">Tafani Marco; Sansone Luigi; Fini Massimo; Limana Federica; Russo Matteo A; Arcangeli Tania; De Santis Elena; Polese Milena</div><div class="citationInfo"><span class="NLM_cas:title">Oxidative medicine and cellular longevity</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">2016</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">3907147</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The presence of ROS is a constant feature in living cells metabolizing O2.  ROS concentration and compartmentation determine their physiological or pathological effects.  ROS overproduction is a feature of cancer cells and plays several roles during the natural history of malignant tumor.  ROS continuously contribute to each step of cancerogenesis, from the initiation to the malignant progression, acting directly or indirectly.  In this review, we will (a) underline the role of ROS in the pathway leading a normal cell to tumor transformation and progression, (b) define the multiple roles of ROS during the natural history of a tumor, (c) conciliate many conflicting data about harmful or beneficial effects of ROS, (d) rethink the importance of oncogene and tumor suppressor gene mutations in relation to the malignant progression, and (e) collocate all the cancer hallmarks in a mechanistic sequence which could represent a "physiological" response to the initial growth of a transformed stem/pluripotent cell, defining also the role of ROS in each hallmark.  We will provide a simplified sketch about the relationships between ROS and cancer.  The attention will be focused on the contribution of ROS to the signaling of HIF, NFÎºB, and Sirtuins as a leitmotif of cancer initiation and progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRm7LIamzojsg8IxFYvehhofW6udTcc2eYU35IjNx7mqrntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28njsFShug%253D%253D&md5=c881ffb87b9adf92c8702f516e039fcb</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1155%2F2016%2F3907147&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2016%252F3907147%26sid%3Dliteratum%253Aachs%26aulast%3DTafani%26aufirst%3DM.%26aulast%3DSansone%26aufirst%3DL.%26aulast%3DLimana%26aufirst%3DF.%26aulast%3DArcangeli%26aufirst%3DT.%26aulast%3DDe%2BSantis%26aufirst%3DE.%26aulast%3DPolese%26aufirst%3DM.%26aulast%3DFini%26aufirst%3DM.%26aulast%3DRusso%26aufirst%3DM.%2BA.%26atitle%3DThe%2520interplay%2520of%2520reactive%2520oxygen%2520species%252C%2520hypoxia%252C%2520inflammation%252C%2520and%2520sirtuins%2520in%2520cancer%2520initiation%2520and%2520progression%26jtitle%3DOxid.%2520Med.%2520Cell.%2520Longevity%26date%3D2016%26volume%3D2016%26spage%3D3907147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stockwell, B. R.</span></span> <span> </span><span class="NLM_article-title">L-5 - Ferroptosis: death by lipid peroxidation</span>. <i>Free Radical Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>120</i></span>,  <span class="NLM_fpage">S7</span>, <span class="refDoi">Â DOI: 10.1016/j.freeradbiomed.2018.04.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=10.1016%2Fj.freeradbiomed.2018.04.034" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2018&pages=S7&author=B.+R.+Stockwell&title=L-5+-+Ferroptosis%3A+death+by+lipid+peroxidation&doi=10.1016%2Fj.freeradbiomed.2018.04.034"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2018.04.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2018.04.034%26sid%3Dliteratum%253Aachs%26aulast%3DStockwell%26aufirst%3DB.%2BR.%26atitle%3DL-5%2520-%2520Ferroptosis%253A%2520death%2520by%2520lipid%2520peroxidation%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2018%26volume%3D120%26spage%3DS7%26doi%3D10.1016%2Fj.freeradbiomed.2018.04.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Szklarczyk, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gable, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyon, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Junge, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wyder, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huerta-Cepas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simonovic, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doncheva, N. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bork, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mering, C. V.</span></span> <span> </span><span class="NLM_article-title">STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets</span>. <i>Nucleic Acids Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">D607</span>â <span class="NLM_lpage">D613</span>, <span class="refDoi">Â DOI: 10.1093/nar/gky1131</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=10.1093%2Fnar%2Fgky1131" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=30476243" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhs1Gqtr%252FM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2019&pages=D607-D613&author=D.+Szklarczykauthor=A.+L.+Gableauthor=D.+Lyonauthor=A.+Jungeauthor=S.+Wyderauthor=J.+Huerta-Cepasauthor=M.+Simonovicauthor=N.+T.+Donchevaauthor=J.+H.+Morrisauthor=P.+Borkauthor=L.+J.+Jensenauthor=C.+V.+Mering&title=STRING+v11%3A+protein-protein+association+networks+with+increased+coverage%2C+supporting+functional+discovery+in+genome-wide+experimental+datasets&doi=10.1093%2Fnar%2Fgky1131"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">STRING v11: protein-protein association networks with increased coverage supporting functional discovery in genome-wide experimental datasets</span></div><div class="casAuthors">Szklarczyk, Damian; Gable, Annika L.; Lyon, David; Junge, Alexander; Wyder, Stefan; Huerta-Cepas, Jaime; Simonovic, Milan; Doncheva, Nadezhda T.; Morris, John H.; Bork, Peer; Jensen, Lars J.; von Mering, Christian</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">D1</span>),
    <span class="NLM_cas:pages">D607-D613</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">1362-4962</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Proteins and their functional interactions form the backbone of the cellular machinery.  Their connectivity network needs to be considered for the full understanding of biol. phenomena, but the available information on protein-protein assocns. is incomplete and exhibits varying levels of annotation granularity and reliability.  The STRING database aims to collect, score and integrate all publicly available sources of protein-protein interaction information, and to complement these with computational predictions.  Its goal is to achieve a comprehensive and objective global network, including direct (phys.) as well as indirect (functional) interactions.  The latest version of STRING (11.0) more than doubles the no. of organisms it covers, to 5090.  The most important new feature is an option to upload entire, genome-wide datasets as input, allowing users to visualize subsets as interaction networks and to perform gene-set enrichment anal. on the entire input.  For the enrichment anal., STRING implements well-known classification systems such as Gene Ontol. and KEGG, but also offers addnl., new classification systems based on high-throughput text-mining as well as on a hierarchical clustering of the assocn. network itself.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7UX25KcxhhbVg90H21EOLACvtfcHk0lhjmvYuPfhRuQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhs1Gqtr%252FM&md5=43df05a2de505f1df210fb4aaa200f58</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgky1131&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgky1131%26sid%3Dliteratum%253Aachs%26aulast%3DSzklarczyk%26aufirst%3DD.%26aulast%3DGable%26aufirst%3DA.%2BL.%26aulast%3DLyon%26aufirst%3DD.%26aulast%3DJunge%26aufirst%3DA.%26aulast%3DWyder%26aufirst%3DS.%26aulast%3DHuerta-Cepas%26aufirst%3DJ.%26aulast%3DSimonovic%26aufirst%3DM.%26aulast%3DDoncheva%26aufirst%3DN.%2BT.%26aulast%3DMorris%26aufirst%3DJ.%2BH.%26aulast%3DBork%26aufirst%3DP.%26aulast%3DJensen%26aufirst%3DL.%2BJ.%26aulast%3DMering%26aufirst%3DC.%2BV.%26atitle%3DSTRING%2520v11%253A%2520protein-protein%2520association%2520networks%2520with%2520increased%2520coverage%252C%2520supporting%2520functional%2520discovery%2520in%2520genome-wide%2520experimental%2520datasets%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2019%26volume%3D47%26spage%3DD607%26epage%3DD613%26doi%3D10.1093%2Fnar%2Fgky1131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hevia, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patchva, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koh, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aggarwal, B. B.</span></span> <span> </span><span class="NLM_article-title">Upsides and downsides of reactive oxygen species for cancer: the roles of reactive oxygen species in tumorigenesis, prevention, and therapy</span>. <i>Antioxid. Redox Signaling</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">1295</span>â <span class="NLM_lpage">1322</span>, <span class="refDoi">Â DOI: 10.1089/ars.2011.4414</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=10.1089%2Fars.2011.4414" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=22117137" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=1%3ACAS%3A528%3ADC%252BC38Xls1Witbo%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2012&pages=1295-1322&author=S.+C.+Guptaauthor=D.+Heviaauthor=S.+Patchvaauthor=B.+Parkauthor=W.+Kohauthor=B.+B.+Aggarwal&title=Upsides+and+downsides+of+reactive+oxygen+species+for+cancer%3A+the+roles+of+reactive+oxygen+species+in+tumorigenesis%2C+prevention%2C+and+therapy&doi=10.1089%2Fars.2011.4414"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Upsides and Downsides of Reactive Oxygen Species for Cancer: The Roles of Reactive Oxygen Species in Tumorigenesis, Prevention, and Therapy</span></div><div class="casAuthors">Gupta, Subash C.; Hevia, David; Patchva, Sridevi; Park, Byoungduck; Koh, Wonil; Aggarwal, Bharat B.</div><div class="citationInfo"><span class="NLM_cas:title">Antioxidants & Redox Signaling</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1295-1322</span>CODEN:
                <span class="NLM_cas:coden">ARSIF2</span>;
        ISSN:<span class="NLM_cas:issn">1523-0864</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">A review.  Significance: Extensive research during the last quarter century has revealed that reactive oxygen species (ROS) produced in the body, primarily by the mitochondria, play a major role in various cell-signaling pathways.  Most risk factors assocd. with chronic diseases (e.g., cancer), such as stress, tobacco, environmental pollutants, radiation, viral infection, diet, and bacterial infection, interact with cells through the generation of ROS.  Recent Advances: ROS, in turn, activate various transcription factors (e.g., nuclear factor kappa-light-chain-enhancer of activated B cells [NF-ÎºB], activator protein-1, hypoxia-inducible factor-1Î±, and signal transducer and activator of transcription 3), resulting in the expression of proteins that control inflammation, cellular transformation, tumor cell survival, tumor cell proliferation and invasion, angiogenesis, and metastasis.  Paradoxically, ROS also control the expression of various tumor suppressor genes (p53, Rb, and PTEN).  Similarly, Î³-radiation and various chemotherapeutic agents used to treat cancer mediate their effects through the prodn. of ROS.  Interestingly, ROS have also been implicated in the chemopreventive and anti-tumor action of nutraceuticals derived from fruits, vegetables, spices, and other natural products used in traditional medicine.  Crit. Issues: These statements suggest both "upside" (cancer-suppressing) and "downside" (cancer-promoting) actions of the ROS.  Thus, similar to tumor necrosis factor-Î±, inflammation, and NF-ÎºB, ROS act as a double-edged sword.  This paradox provides a great challenge for researchers whose aim is to exploit ROS stress for the development of cancer therapies.  Future Directions: The various mechanisms by which ROS mediate paradoxical effects are discussed in this article.  The outstanding questions and future directions raised by our current understanding are discussed.  Antioxid. Redox Signal. 16, 1295-1322.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTBWYOs696DrVg90H21EOLACvtfcHk0lhjmvYuPfhRuQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xls1Witbo%253D&md5=13ac12b97d9ae9f86589125b070600fe</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1089%2Fars.2011.4414&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fars.2011.4414%26sid%3Dliteratum%253Aachs%26aulast%3DGupta%26aufirst%3DS.%2BC.%26aulast%3DHevia%26aufirst%3DD.%26aulast%3DPatchva%26aufirst%3DS.%26aulast%3DPark%26aufirst%3DB.%26aulast%3DKoh%26aufirst%3DW.%26aulast%3DAggarwal%26aufirst%3DB.%2BB.%26atitle%3DUpsides%2520and%2520downsides%2520of%2520reactive%2520oxygen%2520species%2520for%2520cancer%253A%2520the%2520roles%2520of%2520reactive%2520oxygen%2520species%2520in%2520tumorigenesis%252C%2520prevention%252C%2520and%2520therapy%26jtitle%3DAntioxid.%2520Redox%2520Signaling%26date%3D2012%26volume%3D16%26spage%3D1295%26epage%3D1322%26doi%3D10.1089%2Fars.2011.4414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carney, D. A.</span></span> <span> </span><span class="NLM_article-title">Arsenic trioxide mechanisms of action â looking beyond acute promyelocytic leukemia</span>. <i>Leuk. Lymphoma</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">1846</span>â <span class="NLM_lpage">1851</span>, <span class="refDoi">Â DOI: 10.1080/10428190802464745</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=10.1080%2F10428190802464745" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=18949607" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht12isb%252FF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2008&pages=1846-1851&author=D.+A.+Carney&title=Arsenic+trioxide+mechanisms+of+action+%E2%80%93+looking+beyond+acute+promyelocytic+leukemia&doi=10.1080%2F10428190802464745"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Arsenic trioxide mechanisms of action - looking beyond acute promyelocytic leukemia</span></div><div class="casAuthors">Carney, Dennis A.</div><div class="citationInfo"><span class="NLM_cas:title">Leukemia & Lymphoma</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1846-1851</span>CODEN:
                <span class="NLM_cas:coden">LELYEA</span>;
        ISSN:<span class="NLM_cas:issn">1042-8194</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  The research of Coe and Schimmer (2008) entitled, "Catalase activity and arsenic sensitivity in acute leukemia" is reviewed with commentary and refs.  The authors studied that factors linked with arsenic trioxide (As2O3) sensitivity in myeloid leukemic cell lines and how these may be targeted to improve the cytotoxicity of As2O3 in acute myeloid leukemia other than acute promyelocytic leukemia (APL).  They revealed an inverse assocn. between catalase activity and As2O3 sensitivity in a variety of myeloid leukemia cell lines.  Conversely, catalase inhibition in U937 and HL-60 cell lines did not adequately raise reactive oxygen species (ROS) levels to sensitize the cells to As2O3.  These results indicate other anti-oxidant enzymes and/or buffering mechanisms are active in these cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoS7X1sYQJlpLVg90H21EOLACvtfcHk0lhjmvYuPfhRuQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht12isb%252FF&md5=685e27488efe81f1bc2cf1c6c79de128</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1080%2F10428190802464745&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10428190802464745%26sid%3Dliteratum%253Aachs%26aulast%3DCarney%26aufirst%3DD.%2BA.%26atitle%3DArsenic%2520trioxide%2520mechanisms%2520of%2520action%2520%25E2%2580%2593%2520looking%2520beyond%2520acute%2520promyelocytic%2520leukemia%26jtitle%3DLeuk.%2520Lymphoma%26date%3D2008%26volume%3D49%26spage%3D1846%26epage%3D1851%26doi%3D10.1080%2F10428190802464745" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Prasad, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyagi, A. K.</span></span> <span> </span><span class="NLM_article-title">Reactive oxygen species (ROS) and cancer: role of antioxidative nutraceuticals</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>387</i></span>,  <span class="NLM_fpage">95</span>â <span class="NLM_lpage">105</span>, <span class="refDoi">Â DOI: 10.1016/j.canlet.2016.03.042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=10.1016%2Fj.canlet.2016.03.042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=27037062" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=1%3ACAS%3A528%3ADC%252BC28XltlOktLs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=387&publication_year=2017&pages=95-105&author=S.+Prasadauthor=S.+C.+Guptaauthor=A.+K.+Tyagi&title=Reactive+oxygen+species+%28ROS%29+and+cancer%3A+role+of+antioxidative+nutraceuticals&doi=10.1016%2Fj.canlet.2016.03.042"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Reactive oxygen species (ROS) and cancer: Role of antioxidative nutraceuticals</span></div><div class="casAuthors">Prasad, Sahdeo; Gupta, Subash C.; Tyagi, Amit K.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">387</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">95-105</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Extensive research over the past half a century indicates that reactive oxygen species (ROS) play an important role in cancer.  Although low levels of ROS can be beneficial, excessive accumulation can promote cancer.  One characteristic of cancer cells that distinguishes them from normal cells is their ability to produce increased nos. of ROS and their increased dependence on an antioxidant defense system.  ROS are produced as a byproduct intracellularly by mitochondria and other cellular elements and exogenously by pollutants, tobacco, smoke, drugs, xenobiotics, and radiation.  ROS modulate various cell signaling pathways, which are primarily mediated through the transcription factors NF-ÎºB and STAT3, hypoxia-inducible factor-1Î±, kinases, growth factors, cytokines and other proteins, and enzymes; these pathways have been linked to cellular transformation, inflammation, tumor survival, proliferation, invasion, angiogenesis, and metastasis of cancer.  ROS are also assocd. with epigenetic changes in genes, which is helpful in diagnosing diseases.  This review considers the role of ROS in the various stages of cancer development.  Finally, we provide evidence that nutraceuticals derived from Mother Nature are highly effective in eliminating cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpX83EBzqxUTrVg90H21EOLACvtfcHk0ljdj5MmdyXNMA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XltlOktLs%253D&md5=c33d48489b7872b1220d790176b2ef4b</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2016.03.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2016.03.042%26sid%3Dliteratum%253Aachs%26aulast%3DPrasad%26aufirst%3DS.%26aulast%3DGupta%26aufirst%3DS.%2BC.%26aulast%3DTyagi%26aufirst%3DA.%2BK.%26atitle%3DReactive%2520oxygen%2520species%2520%2528ROS%2529%2520and%2520cancer%253A%2520role%2520of%2520antioxidative%2520nutraceuticals%26jtitle%3DCancer%2520Lett.%26date%3D2017%26volume%3D387%26spage%3D95%26epage%3D105%26doi%3D10.1016%2Fj.canlet.2016.03.042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fang, B.</span></span> <span> </span><span class="NLM_article-title">Genetic interactions of STAT3 and anticancer drug development</span>. <i>Cancers</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">494</span>â <span class="NLM_lpage">525</span>, <span class="refDoi">Â DOI: 10.3390/cancers6010494</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=10.3390%2Fcancers6010494" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=24662938" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=1%3ACAS%3A528%3ADC%252BC2cXptVGmsro%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=494-525&author=B.+Fang&title=Genetic+interactions+of+STAT3+and+anticancer+drug+development&doi=10.3390%2Fcancers6010494"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Genetic interactions of STAT3 and anticancer drug development</span></div><div class="casAuthors">Fang, Bingliang</div><div class="citationInfo"><span class="NLM_cas:title">Cancers</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">494-525, 32 pp.</span>CODEN:
                <span class="NLM_cas:coden">CANCCT</span>;
        ISSN:<span class="NLM_cas:issn">2072-6694</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  Signal transducer and activator of transcription 3 (STAT3) plays crit. roles in tumorigenesis and malignant evolution and has been intensively studied as a therapeutic target for cancer.  A no. of STAT3 inhibitors have been evaluated for their antitumor activity in vitro and in vivo in exptl. tumor models and several approved therapeutic agents have been reported to function as STAT3 inhibitors.  Nevertheless, most STAT3 inhibitors have yet to be translated to clin. evaluation for cancer treatment, presumably because of pharmacokinetic, efficacy, and safety issues.  In fact, a major cause of failure of anticancer drug development is lack of efficacy.  Genetic interactions among various cancer-related pathways often provide redundant input from parallel and/or cooperative pathways that drives and maintains survival environments for cancer cells, leading to low efficacy of single-target agents.  Exploiting genetic interactions of STAT3 with other cancer-related pathways may provide mol. insight into mechanisms of cancer resistance to pathway-targeted therapies and strategies for development of more effective anticancer agents and treatment regimens.  This review focuses on functional regulation of STAT3 activity; possible interactions of the STAT3, RAS, epidermal growth factor receptor, and redn.-oxidn. pathways; and mol. mechanisms that modulate therapeutic efficacies of STAT3 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpS26NLTEhvDLVg90H21EOLACvtfcHk0ljdj5MmdyXNMA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXptVGmsro%253D&md5=ab98f74d7682688e713d7b5ec6740b7d</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.3390%2Fcancers6010494&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fcancers6010494%26sid%3Dliteratum%253Aachs%26aulast%3DFang%26aufirst%3DB.%26atitle%3DGenetic%2520interactions%2520of%2520STAT3%2520and%2520anticancer%2520drug%2520development%26jtitle%3DCancers%26date%3D2014%26volume%3D6%26spage%3D494%26epage%3D525%26doi%3D10.3390%2Fcancers6010494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Annibaldi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meier, P.</span></span> <span> </span><span class="NLM_article-title">Checkpoints in TNF-induced cell death: implications in inflammation and cancer</span>. <i>Trends Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">49</span>â <span class="NLM_lpage">65</span>, <span class="refDoi">Â DOI: 10.1016/j.molmed.2017.11.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=10.1016%2Fj.molmed.2017.11.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=29217118" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFemsbfI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2018&pages=49-65&author=A.+Annibaldiauthor=P.+Meier&title=Checkpoints+in+TNF-induced+cell+death%3A+implications+in+inflammation+and+cancer&doi=10.1016%2Fj.molmed.2017.11.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Checkpoints in TNF-Induced Cell Death: Implications in Inflammation and Cancer</span></div><div class="casAuthors">Annibaldi, Alessandro; Meier, Pascal</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Molecular Medicine</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">49-65</span>CODEN:
                <span class="NLM_cas:coden">TMMRCY</span>;
        ISSN:<span class="NLM_cas:issn">1471-4914</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Tumor necrosis factor (TNF) is a proinflammatory cytokine that coordinates tissue homeostasis by regulating cytokine prodn., cell survival, and cell death.  However, how life and death decisions are made in response to TNF is poorly understood.  Many inflammatory pathologies are now recognized to be driven by aberrant TNF-induced cell death, which, in most circumstances, depends on the kinase Receptor-interacting serine/threonine-protein kinase 1 (RIPK1).  Recent advances have identified ubiquitin (Ub)-mediated phosphorylation of RIPK1 as belonging to crucial checkpoints for cell fate in inflammation and infection.  A better understanding of these checkpoints might lead to new approaches for the treatment of chronic inflammatory diseases fueled by aberrant RIPK1-induced cell death, and/or reveal novel strategies for anticancer immunotherapies, harnessing the ability of RIPK1 to trigger immunogenic cell death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6J_CUKMSRsLVg90H21EOLACvtfcHk0ljdj5MmdyXNMA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFemsbfI&md5=5c8977c0a01478f91c76bad9f80cca52</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.molmed.2017.11.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molmed.2017.11.002%26sid%3Dliteratum%253Aachs%26aulast%3DAnnibaldi%26aufirst%3DA.%26aulast%3DMeier%26aufirst%3DP.%26atitle%3DCheckpoints%2520in%2520TNF-induced%2520cell%2520death%253A%2520implications%2520in%2520inflammation%2520and%2520cancer%26jtitle%3DTrends%2520Mol.%2520Med.%26date%3D2018%26volume%3D24%26spage%3D49%26epage%3D65%26doi%3D10.1016%2Fj.molmed.2017.11.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, C. H.</span></span> <span> </span><span class="NLM_article-title">Anti-cancer therapy with TNFÎ± and IFNÎ³: a comprehensive review</span>. <i>Cell Proliferation</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>51</i></span>, <span class="NLM_elocation-id">e12441</span> <span class="refDoi">Â DOI: 10.1111/cpr.12441</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=10.1111%2Fcpr.12441" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=29484738" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2018&author=J.+Shenauthor=Z.+Xiaoauthor=Q.+Zhaoauthor=M.+Liauthor=X.+Wuauthor=L.+Zhangauthor=W.+Huauthor=C.+H.+Cho&title=Anti-cancer+therapy+with+TNF%CE%B1+and+IFN%CE%B3%3A+a+comprehensive+review&doi=10.1111%2Fcpr.12441"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1111%2Fcpr.12441&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcpr.12441%26sid%3Dliteratum%253Aachs%26aulast%3DShen%26aufirst%3DJ.%26aulast%3DXiao%26aufirst%3DZ.%26aulast%3DZhao%26aufirst%3DQ.%26aulast%3DLi%26aufirst%3DM.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DHu%26aufirst%3DW.%26aulast%3DCho%26aufirst%3DC.%2BH.%26atitle%3DAnti-cancer%2520therapy%2520with%2520TNF%25CE%25B1%2520and%2520IFN%25CE%25B3%253A%2520a%2520comprehensive%2520review%26jtitle%3DCell%2520Proliferation%26date%3D2018%26volume%3D51%26doi%3D10.1111%2Fcpr.12441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Semenza, G. L.</span></span> <span> </span><span class="NLM_article-title">Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">625</span>â <span class="NLM_lpage">634</span>, <span class="refDoi">Â DOI: 10.1038/onc.2009.441</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=10.1038%2Fonc.2009.441" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=19946328" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsV2gt77N" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2010&pages=625-634&author=G.+L.+Semenza&title=Defining+the+role+of+hypoxia-inducible+factor+1+in+cancer+biology+and+therapeutics&doi=10.1038%2Fonc.2009.441"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics</span></div><div class="casAuthors">Semenza, G. L.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">625-634</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Adaptation of cancer cells to their microenvironment is an important driving force in the clonal selection that leads to invasive and metastatic disease.  O2 concns. are markedly reduced in many human cancers compared with normal tissue, and a major mechanism mediating adaptive responses to reduced O2 availability (hypoxia) is the regulation of transcription by hypoxia-inducible factor 1 (HIF-1).  This review summarizes the current state of knowledge regarding the mol. mechanisms by which HIF-1 contributes to cancer progression, focusing on (1) clin. data assocg. increased HIF-1 levels with patient mortality; (2) preclin. data linking HIF-1 activity with tumor growth; (3) mol. data linking specific HIF-1 target gene products to crit. aspects of cancer biol. and (4) pharmacol. data showing anticancer effects of HIF-1 inhibitors in mouse models of human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlXOi-2tydiLVg90H21EOLACvtfcHk0liDK4CkiN6JNg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsV2gt77N&md5=fb8c32b5f05bfad38f4a4ecef9bd98a7</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1038%2Fonc.2009.441&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2009.441%26sid%3Dliteratum%253Aachs%26aulast%3DSemenza%26aufirst%3DG.%2BL.%26atitle%3DDefining%2520the%2520role%2520of%2520hypoxia-inducible%2520factor%25201%2520in%2520cancer%2520biology%2520and%2520therapeutics%26jtitle%3DOncogene%26date%3D2010%26volume%3D29%26spage%3D625%26epage%3D634%26doi%3D10.1038%2Fonc.2009.441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bonello, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">ZÃ¤hringer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">BelAiba, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Djordjevic, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hess, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michiels, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kietzmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">GÃ¶rlach, A.</span></span> <span> </span><span class="NLM_article-title">Reactive oxygen species activate the HIF-1Î± promoter via a functional NFÎºB site</span>. <i>Arterioscler., Thromb., Vasc. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">755</span>â <span class="NLM_lpage">761</span>, <span class="refDoi">Â DOI: 10.1161/01.ATV.0000258979.92828.bc</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=10.1161%2F01.ATV.0000258979.92828.bc" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=17272744" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=1%3ACAS%3A528%3ADC%252BD2sXislCrsrc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2007&pages=755-761&author=S.+Bonelloauthor=C.+Z%C3%A4hringerauthor=R.+S.+BelAibaauthor=T.+Djordjevicauthor=J.+Hessauthor=C.+Michielsauthor=T.+Kietzmannauthor=A.+G%C3%B6rlach&title=Reactive+oxygen+species+activate+the+HIF-1%CE%B1+promoter+via+a+functional+NF%CE%BAB+site&doi=10.1161%2F01.ATV.0000258979.92828.bc"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Reactive oxygen species activate the HIF-1Î± promoter via a functional NFÎºB site</span></div><div class="casAuthors">Bonello, Steve; Zaehringer, Christian; BelAiba, Rachida S.; Djordjevic, Talija; Hess, John; Michiels, Carine; Kietzmann, Thomas; Goerlach, Agnes</div><div class="citationInfo"><span class="NLM_cas:title">Arteriosclerosis, Thrombosis, and Vascular Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">755-761</span>CODEN:
                <span class="NLM_cas:coden">ATVBFA</span>;
        ISSN:<span class="NLM_cas:issn">1079-5642</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Reactive oxygen species have been implicated as signaling mols. modulating the activity of redox-sensitive transcription factors such as nuclear factor kappa B (NF-ÎºB).  Recently, the transcription factor hypoxia-inducible factor-1 (HIF-1), known to mediate gene expression by hypoxia, has been found to be also activated by nonhypoxic factors in a redox-sensitive manner.  We therefore aimed to elucidate the link between these 2 important redox-sensitive transcription factors.  In pulmonary artery smooth muscle cells, reactive oxygen species generated either by exogenous H2O2 or by a NOX4-contg. NADPH oxidase stimulated by thrombin activated or induced NF-ÎºB and HIF-1Î±.  The reactive oxygen species-mediated HIF-1Î± induction occurred on the transcriptional level and was dependent on NF-ÎºB.  Transfection expts. with wild-type or mutant HIF-1Î± promoter constructs revealed the presence of a yet unidentified NF-ÎºB binding element.  Gel shift analyses and chromatin immunopptn. verified binding of NF-ÎºB to this site.  Furthermore, reactive oxygen species enhanced expression of plasminogen activator inhibitor-1, which was prevented by dominant-neg. IÎºB or mutation of the HIF-1 binding site within the plasminogen activator inhibitor-1 promoter.  These findings show for the first time to our knowledge that reactive oxygen species directly link HIF-1Î± and NF-ÎºB, implicating an important pathophysiol. role of this novel pathway in disorders assocd. with elevated levels of reactive oxygen species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqn7Xn8zlRrnrVg90H21EOLACvtfcHk0liDK4CkiN6JNg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXislCrsrc%253D&md5=5df085dd8c8bd8aa48b04e8864a847e6</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1161%2F01.ATV.0000258979.92828.bc&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252F01.ATV.0000258979.92828.bc%26sid%3Dliteratum%253Aachs%26aulast%3DBonello%26aufirst%3DS.%26aulast%3DZ%25C3%25A4hringer%26aufirst%3DC.%26aulast%3DBelAiba%26aufirst%3DR.%2BS.%26aulast%3DDjordjevic%26aufirst%3DT.%26aulast%3DHess%26aufirst%3DJ.%26aulast%3DMichiels%26aufirst%3DC.%26aulast%3DKietzmann%26aufirst%3DT.%26aulast%3DG%25C3%25B6rlach%26aufirst%3DA.%26atitle%3DReactive%2520oxygen%2520species%2520activate%2520the%2520HIF-1%25CE%25B1%2520promoter%2520via%2520a%2520functional%2520NF%25CE%25BAB%2520site%26jtitle%3DArterioscler.%252C%2520Thromb.%252C%2520Vasc.%2520Biol.%26date%3D2007%26volume%3D27%26spage%3D755%26epage%3D761%26doi%3D10.1161%2F01.ATV.0000258979.92828.bc" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Han, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, D.</span></span> <span> </span><span class="NLM_article-title">Napabucasin, a novel STAT<sub>3</sub> inhibitor suppresses proliferation, invasion and stemness of glioblastoma cells</span>. <i>J. Exp. Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">289</span>, <span class="refDoi">Â DOI: 10.1186/s13046-019-1289-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=10.1186%2Fs13046-019-1289-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=31277685" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=1%3ACAS%3A280%3ADC%252BB3MzksFOkuw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2019&pages=289&author=D.+Hanauthor=T.+Yuauthor=N.+Dongauthor=B.+Wangauthor=F.+Sunauthor=D.+Jiang&title=Napabucasin%2C+a+novel+STAT3+inhibitor+suppresses+proliferation%2C+invasion+and+stemness+of+glioblastoma+cells&doi=10.1186%2Fs13046-019-1289-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Napabucasin, a novel STAT3 inhibitor suppresses proliferation, invasion and stemness of glioblastoma cells</span></div><div class="casAuthors">Han Dongfeng; Dong Nan; Wang Bo; Sun Fei; Jiang Dehua; Yu Tianfu; Yu Tianfu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of experimental & clinical cancer research : CR</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">289</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Glioblastoma (GBM) cells with stem cell-like properties are called glioma stem cells (GSCs).  GSCs display highly treatment resistance and are responsible for tumor recurrence.  Napabucasin (BBI608), a novel small molecule inhibitor of STAT3, has been identified to eliminate stemness-like tumor cells in some cancers.  However, the influence of Napabucasin on GBM cells, especially on GSCs, is currently unclear.  In this study, we explored the influence and underlying mechanisms of Napabucasin on GBM cells.  METHODS:  STAT3 expression and its correlation with the glioma grade and patient survival were analyzed using CGGA and TCGA glioma databases.  The influence of Napabucasin on proliferation, stemness, the cell cycle, apoptosis, and invasion of human GBM cell lines U87MG and LN229 was tested by CCK8, EdU incorporation, colony formation, Transwell invasion, and three-dimensional spheroid assays as well as flow cytometry, qPCR, and western blot analysis.  The ability of Napabucasin to inhibit cell proliferation of U87MG tumor xenografts in mice was assessed using a live animal bioluminescence imaging system and immunohistochemistry.  RESULTS:  Napabucasin suppressed the proliferation, colony formation, and invasion of U87MG and LN229 cells.  Furthermore, Napabucasin induced cell cycle arrest and apoptosis.  More importantly, Napabucasin treatment obviously inhibited expression of stemness-associated genes including STAT3 and suppressed the spheroid formation of glioma cells in vitro.  Napabucasin also disrupted the NF-ÎºB signaling pathway via downregulation of RelA (p65).  Finally, glioma growth was effectively impaired by Napabucasin in nude mice bearing intracranial glioma xenografts.  CONCLUSIONS:  Napabucasin treatment may be a novel approach for the treatment of GBM, particularly GSCs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSRIKHLY7Pb48yail4HZd-ifW6udTcc2ebcn1rkIX-oCbntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3MzksFOkuw%253D%253D&md5=8a941303a4a70d3ba1400170ab2054ee</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1186%2Fs13046-019-1289-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13046-019-1289-6%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DD.%26aulast%3DYu%26aufirst%3DT.%26aulast%3DDong%26aufirst%3DN.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DSun%26aufirst%3DF.%26aulast%3DJiang%26aufirst%3DD.%26atitle%3DNapabucasin%252C%2520a%2520novel%2520STAT3%2520inhibitor%2520suppresses%2520proliferation%252C%2520invasion%2520and%2520stemness%2520of%2520glioblastoma%2520cells%26jtitle%3DJ.%2520Exp.%2520Clin.%2520Cancer%2520Res.%26date%3D2019%26volume%3D38%26spage%3D289%26doi%3D10.1186%2Fs13046-019-1289-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sugarman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plenker, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuveson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saif, M. W.</span></span> <span> </span><span class="NLM_article-title">Pharmacokinetics and pharmacodynamics of new drugs for pancreatic cancer</span>. <i>Expert Opin. Drug Metab. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">541</span>â <span class="NLM_lpage">552</span>, <span class="refDoi">Â DOI: 10.1080/17425255.2019.1637417</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=10.1080%2F17425255.2019.1637417" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=31241371" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtlaltr%252FO" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2019&pages=541-552&author=R.+Sugarmanauthor=R.+Patelauthor=S.+Sharmaauthor=D.+Plenkerauthor=D.+Tuvesonauthor=M.+W.+Saif&title=Pharmacokinetics+and+pharmacodynamics+of+new+drugs+for+pancreatic+cancer&doi=10.1080%2F17425255.2019.1637417"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics and pharmacodynamics of new drugs for pancreatic cancer</span></div><div class="casAuthors">Sugarman, Ryan; Patel, Rajvi; Sharma, Sandhya; Plenker, Dennis; Tuveson, David; Saif, Muhammad Wasif</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Metabolism & Toxicology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">541-552</span>CODEN:
                <span class="NLM_cas:coden">EODMAP</span>;
        ISSN:<span class="NLM_cas:issn">1742-5255</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">A review.  : Pancreatic cancer (PC) remains a disease with a dismal prognosis.  Despite accounting for only 3% of cancer diagnosis, 7% of all cancer deaths in the United States are from PC.  This is explained by many being diagnosed with late-stage disease and the cancer's resistance to chemotherapy.  Since 1996 there have only been two upfront regimens found to be superior to gemcitabine, FOLFIRINOX (5-fluorouracil/leucovorin and oxaliplatin) and gemcitabine plus nab-paclitaxel.: Clin. pharmacol. of newer agents that are either approved or being investigated in the management of PC.  Knowledge of their pharmacokinetics, pharmacodynamics, and pharmacogenetics can be used to predict outcomes for specific patient populations.  Drugs discussed include nanoliposomal irinotecan, pegvorhyaluronidase alfa, poly (ADP-ribose) polymerase enzyme inhibitors, larotrectinib, and napabucasin.: PC is a heterogeneous disease and outcomes are likely to improve as better predictive models of an individual's response to different therapies are developed.  This may be best accomplished through phase 0 studies and the use of tumor organoid models grown from initial biopsies or resected tissue.  The genetic and phys. makeup of the tumor as well as the functional characterization in patient-derived organoids (PDOs), can help guide which agents may be most efficacious or toxic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGry7xpjA8hxRLVg90H21EOLACvtfcHk0ljzN1QmBdAlyg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtlaltr%252FO&md5=b2a3a8415c681b9dafa96e54205962ca</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1080%2F17425255.2019.1637417&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F17425255.2019.1637417%26sid%3Dliteratum%253Aachs%26aulast%3DSugarman%26aufirst%3DR.%26aulast%3DPatel%26aufirst%3DR.%26aulast%3DSharma%26aufirst%3DS.%26aulast%3DPlenker%26aufirst%3DD.%26aulast%3DTuveson%26aufirst%3DD.%26aulast%3DSaif%26aufirst%3DM.%2BW.%26atitle%3DPharmacokinetics%2520and%2520pharmacodynamics%2520of%2520new%2520drugs%2520for%2520pancreatic%2520cancer%26jtitle%3DExpert%2520Opin.%2520Drug%2520Metab.%2520Toxicol.%26date%3D2019%26volume%3D15%26spage%3D541%26epage%3D552%26doi%3D10.1080%2F17425255.2019.1637417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Friedmann
Angeli, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proneth, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyurina, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyurin, V. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammond, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herbach, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aichler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walch, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eggenhofer, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basavarajappa, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">RÃ¥dmark, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seibt, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beck, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neff, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esposito, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wanke, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">FÃ¶rster, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yefremova, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinrichmeyer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bornkamm, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geissler, E. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stockwell, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">OâDonnell, V. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kagan, V. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schick, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conrad, M.</span></span> <span> </span><span class="NLM_article-title">Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice</span>. <i>Nat. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">1180</span>â <span class="NLM_lpage">1191</span>, <span class="refDoi">Â DOI: 10.1038/ncb3064</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=10.1038%2Fncb3064" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=25402683" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFKlsrrF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2014&pages=1180-1191&author=J.+P.+Friedmann%0AAngeliauthor=M.+Schneiderauthor=B.+Pronethauthor=Y.+Y.+Tyurinaauthor=V.+A.+Tyurinauthor=V.+J.+Hammondauthor=N.+Herbachauthor=M.+Aichlerauthor=A.+Walchauthor=E.+Eggenhoferauthor=D.+Basavarajappaauthor=O.+R%C3%A5dmarkauthor=S.+Kobayashiauthor=T.+Seibtauthor=H.+Beckauthor=F.+Neffauthor=I.+Espositoauthor=R.+Wankeauthor=H.+F%C3%B6rsterauthor=O.+Yefremovaauthor=M.+Heinrichmeyerauthor=G.+W.+Bornkammauthor=E.+K.+Geisslerauthor=S.+B.+Thomasauthor=B.+R.+Stockwellauthor=V.+B.+O%E2%80%99Donnellauthor=V.+E.+Kaganauthor=J.+A.+Schickauthor=M.+Conrad&title=Inactivation+of+the+ferroptosis+regulator+Gpx4+triggers+acute+renal+failure+in+mice&doi=10.1038%2Fncb3064"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice</span></div><div class="casAuthors">Friedmann Angeli, Jose Pedro; Schneider, Manuela; Proneth, Bettina; Tyurina, Yulia Y.; Tyurin, Vladimir A.; Hammond, Victoria J.; Herbach, Nadja; Aichler, Michaela; Walch, Axel; Eggenhofer, Elke; Basavarajappa, Devaraj; Radmark, Olof; Kobayashi, Sho; Seibt, Tobias; Beck, Heike; Neff, Frauke; Esposito, Irene; Wanke, Ruediger; Foerster, Heidi; Yefremova, Olena; Heinrichmeyer, Marc; Bornkamm, Georg W.; Geissler, Edward K.; Thomas, Stephen B.; Stockwell, Brent R.; O'Donnell, Valerie B.; Kagan, Valerian E.; Schick, Joel A.; Conrad, Marcus</div><div class="citationInfo"><span class="NLM_cas:title">Nature Cell Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1180-1191</span>CODEN:
                <span class="NLM_cas:coden">NCBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1465-7392</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Ferroptosis is a non-apoptotic form of cell death induced by small mols. in specific tumor types, and in engineered cells overexpressing oncogenic RAS.  Yet, its relevance in non-transformed cells and tissues is unexplored and remains enigmatic.  Here, we provide direct genetic evidence that the knockout of glutathione peroxidase 4 (Gpx4) causes cell death in a pathol. relevant form of ferroptosis.  Using inducible Gpx4-/- mice, we elucidate an essential role for the glutathione/Gpx4 axis in preventing lipid-oxidn.-induced acute renal failure and assocd. death.  We furthermore systematically evaluated a library of small mols. for possible ferroptosis inhibitors, leading to the discovery of a potent spiroquinoxalinamine deriv. called Liproxstatin-1, which is able to suppress ferroptosis in cells, in Gpx4-/- mice, and in a pre-clin. model of ischemia/reperfusion-induced hepatic damage.  In sum, we demonstrate that ferroptosis is a pervasive and dynamic form of cell death, which, when impeded, promises substantial cytoprotection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuBNbniop_ibVg90H21EOLACvtfcHk0ljzN1QmBdAlyg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFKlsrrF&md5=0d095f1a6206ab1dae7e04089847becf</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1038%2Fncb3064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncb3064%26sid%3Dliteratum%253Aachs%26aulast%3DFriedmann%2BAngeli%26aufirst%3DJ.%2BP.%26aulast%3DSchneider%26aufirst%3DM.%26aulast%3DProneth%26aufirst%3DB.%26aulast%3DTyurina%26aufirst%3DY.%2BY.%26aulast%3DTyurin%26aufirst%3DV.%2BA.%26aulast%3DHammond%26aufirst%3DV.%2BJ.%26aulast%3DHerbach%26aufirst%3DN.%26aulast%3DAichler%26aufirst%3DM.%26aulast%3DWalch%26aufirst%3DA.%26aulast%3DEggenhofer%26aufirst%3DE.%26aulast%3DBasavarajappa%26aufirst%3DD.%26aulast%3DR%25C3%25A5dmark%26aufirst%3DO.%26aulast%3DKobayashi%26aufirst%3DS.%26aulast%3DSeibt%26aufirst%3DT.%26aulast%3DBeck%26aufirst%3DH.%26aulast%3DNeff%26aufirst%3DF.%26aulast%3DEsposito%26aufirst%3DI.%26aulast%3DWanke%26aufirst%3DR.%26aulast%3DF%25C3%25B6rster%26aufirst%3DH.%26aulast%3DYefremova%26aufirst%3DO.%26aulast%3DHeinrichmeyer%26aufirst%3DM.%26aulast%3DBornkamm%26aufirst%3DG.%2BW.%26aulast%3DGeissler%26aufirst%3DE.%2BK.%26aulast%3DThomas%26aufirst%3DS.%2BB.%26aulast%3DStockwell%26aufirst%3DB.%2BR.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DV.%2BB.%26aulast%3DKagan%26aufirst%3DV.%2BE.%26aulast%3DSchick%26aufirst%3DJ.%2BA.%26aulast%3DConrad%26aufirst%3DM.%26atitle%3DInactivation%2520of%2520the%2520ferroptosis%2520regulator%2520Gpx4%2520triggers%2520acute%2520renal%2520failure%2520in%2520mice%26jtitle%3DNat.%2520Cell%2520Biol.%26date%3D2014%26volume%3D16%26spage%3D1180%26epage%3D1191%26doi%3D10.1038%2Fncb3064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, D.</span></span> <span> </span><span class="NLM_article-title">Ferroptosis: process and function</span>. <i>Cell Death Differ.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">369</span>â <span class="NLM_lpage">379</span>, <span class="refDoi">Â DOI: 10.1038/cdd.2015.158</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=10.1038%2Fcdd.2015.158" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=26794443" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhsl2jtbk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2016&pages=369-379&author=Y.+Xieauthor=W.+Houauthor=X.+Songauthor=Y.+Yuauthor=J.+Huangauthor=X.+Sunauthor=R.+Kangauthor=D.+Tang&title=Ferroptosis%3A+process+and+function&doi=10.1038%2Fcdd.2015.158"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Ferroptosis: process and function</span></div><div class="casAuthors">Xie, Y.; Hou, W.; Song, X.; Yu, Y.; Huang, J.; Sun, X.; Kang, R.; Tang, D.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Differentiation</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">369-379</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Ferroptosis is a recently recognized form of regulated cell death.  It is characterized morphol. by the presence of smaller than normal mitochondria with condensed mitochondrial membrane densities, redn. or vanishing of mitochondria crista, and outer mitochondrial membrane rupture.  It can be induced by exptl. compds. (e.g., erastin, Ras-selective lethal small mol. 3, and buthionine sulfoximine) or clin. drugs (e.g., sulfasalazine, sorafenib, and artesunate) in cancer cells and certain normal cells (e.g., kidney tubule cells, neurons, fibroblasts, and T cells).  Activation of mitochondrial voltage-dependent anion channels and mitogen-activated protein kinases, upregulation of endoplasmic reticulum stress, and inhibition of cystine/glutamate antiporter is involved in the induction of ferroptosis.  This process is characterized by the accumulation of lipid peroxidn. products and lethal reactive oxygen species (ROS) derived from iron metab. and can be pharmacol. inhibited by iron chelators (e.g., deferoxamine and desferrioxamine mesylate) and lipid peroxidn. inhibitors (e.g., ferrostatin, liproxstatin, and zileuton).  Glutathione peroxidase 4, heat shock protein beta-1, and nuclear factor erythroid 2-related factor 2 function as neg. regulators of ferroptosis by limiting ROS prodn. and reducing cellular iron uptake, resp.  In contrast, NADPH oxidase and p53 (esp. acetylation-defective mutant p53) act as pos. regulators of ferroptosis by promotion of ROS prodn. and inhibition of expression of SLC7A11 (a specific light-chain subunit of the cystine/glutamate antiporter), resp.  Misregulated ferroptosis has been implicated in multiple physiol. and pathol. processes, including cancer cell death, neurotoxicity, neurodegenerative diseases, acute renal failure, drug-induced hepatotoxicity, hepatic and heart ischemia/reperfusion injury, and T-cell immunity.  In this review, we summarize the regulation mechanisms and signaling pathways of ferroptosis and discuss the role of ferroptosis in disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPYoAemdpXQrVg90H21EOLACvtfcHk0ljYN33hv87Ixw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhsl2jtbk%253D&md5=1d0b55e47c4ed56444149c7ba35efb58</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1038%2Fcdd.2015.158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcdd.2015.158%26sid%3Dliteratum%253Aachs%26aulast%3DXie%26aufirst%3DY.%26aulast%3DHou%26aufirst%3DW.%26aulast%3DSong%26aufirst%3DX.%26aulast%3DYu%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DSun%26aufirst%3DX.%26aulast%3DKang%26aufirst%3DR.%26aulast%3DTang%26aufirst%3DD.%26atitle%3DFerroptosis%253A%2520process%2520and%2520function%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2016%26volume%3D23%26spage%3D369%26epage%3D379%26doi%3D10.1038%2Fcdd.2015.158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shah, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Margison, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pratt, D. A.</span></span> <span> </span><span class="NLM_article-title">The potency of diarylamine radical-trapping antioxidants as inhibitors of ferroptosis underscores the role of autoxidation in the mechanism of cell death</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">2538</span>â <span class="NLM_lpage">2545</span>, <span class="refDoi">Â DOI: 10.1021/acschembio.7b00730</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.7b00730" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlOksLnM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&pages=2538-2545&author=R.+Shahauthor=K.+Margisonauthor=D.+A.+Pratt&title=The+potency+of+diarylamine+radical-trapping+antioxidants+as+inhibitors+of+ferroptosis+underscores+the+role+of+autoxidation+in+the+mechanism+of+cell+death&doi=10.1021%2Facschembio.7b00730"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">The Potency of Diarylamine Radical-Trapping Antioxidants as Inhibitors of Ferroptosis Underscores the Role of Autoxidation in the Mechanism of Cell Death</span></div><div class="casAuthors">Shah, Ron; Margison, Kaitlyn; Pratt, Derek A.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2538-2545</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Two arom. amines (ferrostatin-1 and liproxstatin-1) were recently identified from high-throughput screening efforts to uncover potent inhibitors of ferroptosis, the necrotic-like cell death induced by inhibition of glutathione peroxidase 4 (GPX4), deletion of the corresponding gpx4 gene, or starvation of GPX4 of its reducing cosubstrate, glutathione (GSH).  We have since demonstrated that these two arom. amines are highly effective radical-trapping antioxidants (RTAs) in lipid bilayers, suggesting that they subvert ferroptosis by inhibiting lipid peroxidn. (autoxidn.) and, thus, that this process drives the execution of ferroptosis.  Herein, we show that diarylamine RTAs used to protect petroleum-derived products from autoxidn. can be potent inhibitors of ferroptosis.  The diarylamines investigated include representative examples of additives to engine oils, greases and rubber (4,4'-dialkyldiphenylamines), core structures of dyes and pharmaceuticals (phenoxazines and phenothiazines), and aza-analogs of these three classes of compds. that we have recently shown can be modified to achieve much greater reactivity.  We find that regardless of how ferroptosis is induced (GPX4 inhibition, gpx4 deletion or GSH depletion), compds. which possess good RTA activity in org. soln. (kinh > 105 M-1 s-1) and lipid bilayers (kinh > 104 M-1 s-1) are generally potent inhibitors of ferroptosis (in mouse embryonic fibroblasts).  Likewise, structural analogs that do not possess RTA activity are devoid of antiferroptotic activity.  These results further support the argument that lipid peroxidn. (autoxidn.) plays a major role in the mechanism of cell death induced by either GPX4 inhibition, gpx4 deletion, or GSH depletion.  Moreover, it offers clear direction that ongoing medicinal chem. efforts on liproxstatin and ferrostatin derivs., which have been proposed as lead compds. for the treatment and/or prevention of ischemia/reperfusion injury, renal failure, and neurodegeneration, can be widened to include other aminic RTAs.  To aid in these efforts, some relevant structure-reactivity relationships are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGray_NCtHIr-bVg90H21EOLACvtfcHk0ljYN33hv87Ixw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlOksLnM&md5=fefdd6246359c57145f57e52148d8449</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Facschembio.7b00730&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.7b00730%26sid%3Dliteratum%253Aachs%26aulast%3DShah%26aufirst%3DR.%26aulast%3DMargison%26aufirst%3DK.%26aulast%3DPratt%26aufirst%3DD.%2BA.%26atitle%3DThe%2520potency%2520of%2520diarylamine%2520radical-trapping%2520antioxidants%2520as%2520inhibitors%2520of%2520ferroptosis%2520underscores%2520the%2520role%2520of%2520autoxidation%2520in%2520the%2520mechanism%2520of%2520cell%2520death%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2017%26volume%3D12%26spage%3D2538%26epage%3D2545%26doi%3D10.1021%2Facschembio.7b00730" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, X.</span></span> <span> </span><span class="NLM_article-title">Proteasome-independent protein knockdown by small-molecule inhibitor for the undruggable lung adenocarcinoma</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>141</i></span>,  <span class="NLM_fpage">18492</span>â <span class="NLM_lpage">18499</span>, <span class="refDoi">Â DOI: 10.1021/jacs.9b08777</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jacs.9b08777" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitVGmsb%252FO" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=141&publication_year=2019&pages=18492-18499&author=W.+Zhouauthor=G.+Sunauthor=Z.+Zhangauthor=L.+Zhaoauthor=L.+Xuauthor=H.+Yuanauthor=S.+Liauthor=Z.+Dongauthor=Y.+Songauthor=X.+Fang&title=Proteasome-independent+protein+knockdown+by+small-molecule+inhibitor+for+the+undruggable+lung+adenocarcinoma&doi=10.1021%2Fjacs.9b08777"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Proteasome-Independent Protein Knockdown by Small-Molecule Inhibitor for the Undruggable Lung Adenocarcinoma</span></div><div class="casAuthors">Zhou, Wei; Sun, Guogui; Zhang, Zhen; Zhao, Libo; Xu, Li; Yuan, Hongyu; Li, Shumu; Dong, Zaizai; Song, Yongmei; Fang, Xiaohong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">141</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">18492-18499</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Therapeutic target identification and corresponding drug development is a demanding task for the treatment of lung adenocarcinoma, esp. the most malignant proximal-proliferative subtype without druggable protein kinase mutations.  Using a cell-SELEX-generated aptamer, we discovered a new tumor driver protein, leucine-rich pentatricopeptide repeat-contg. protein (LRPPRC), which is specifically overexpressed in the most lethal subtype of lung adenocarcinoma.  Targeted LRPPRC protein knockdown is a promising therapeutic strategy for the undruggable LUAD (lung adenocarcinoma).  Nevertheless, LRPPRC is mainly located in mitochondria and degraded by protease.  Current protein knockdown approaches, such as proteolysis-targeting chimeras (PROTACs), have limitations in their applications to the proteins degraded through proteasome-independent ways.  Here, we designed an aptamer-assisted high-throughput method to screen small mols. which could bind to LRPPRC directly, disrupt the interaction of LRPPRC with its stabilizing chaperon protein, and lead to LRPPRC degrdn. by mitochondrial protease.  The screened compd., gossypol-acetic acid (GAA), is an old medicine which can accomplish the new function for targeted LRPPRC knockdown.  It showed significant antitumor effects even with the LRPPRC pos. patient-derived tumor xenograft (PDX) model.  This work not only extended the application of aptamers to screen small-mol. inhibitors for the undruggable lung cancers, but more importantly provided a new strategy to develop protein knockdown methods beyond the proteasome system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_vMzM018-d7Vg90H21EOLACvtfcHk0ljYN33hv87Ixw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitVGmsb%252FO&md5=a1d1c0b0350394293630ddb90ca26bc8</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fjacs.9b08777&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjacs.9b08777%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DW.%26aulast%3DSun%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DZhao%26aufirst%3DL.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DYuan%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DDong%26aufirst%3DZ.%26aulast%3DSong%26aufirst%3DY.%26aulast%3DFang%26aufirst%3DX.%26atitle%3DProteasome-independent%2520protein%2520knockdown%2520by%2520small-molecule%2520inhibitor%2520for%2520the%2520undruggable%2520lung%2520adenocarcinoma%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2019%26volume%3D141%26spage%3D18492%26epage%3D18499%26doi%3D10.1021%2Fjacs.9b08777" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meza-Sosa, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lieberman, J.</span></span> <span> </span><span class="NLM_article-title">PNPT1 release from mitochondria during apoptosis triggers decay of Poly(A) RNAs</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>174</i></span>,  <span class="NLM_fpage">187</span>â <span class="NLM_lpage">201.e12</span>, <span class="refDoi">Â DOI: 10.1016/j.cell.2018.04.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=10.1016%2Fj.cell.2018.04.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=29779946" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=1%3ACAS%3A528%3ADC%252BC1cXpvVemsr0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=174&publication_year=2018&pages=187-201.e12&author=X.+Liuauthor=R.+Fuauthor=Y.+Panauthor=K.+F.+Meza-Sosaauthor=Z.+Zhangauthor=J.+Lieberman&title=PNPT1+release+from+mitochondria+during+apoptosis+triggers+decay+of+Poly%28A%29+RNAs&doi=10.1016%2Fj.cell.2018.04.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">PNPT1 Release from Mitochondria during Apoptosis Triggers Decay of Poly(A) RNAs</span></div><div class="casAuthors">Liu, Xing; Fu, Rui; Pan, Youdong; Meza-Sosa, Karla F.; Zhang, Zhibin; Lieberman, Judy</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">174</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">187-201.e12</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Widespread mRNA decay, an unappreciated feature of apoptosis, enhances cell death and depends on mitochondrial outer membrane permeabilization (MOMP), TUTases, and DIS3L2.  Which RNAs are decayed and the decay-initiating event are unknown.  Here, we show extensive decay of mRNAs and poly(A) noncoding (nc)RNAs at the 3' end, triggered by the mitochondrial intermembrane space 3'-to-5' exoribonuclease PNPT1, released during MOMP.  PNPT1 knockdown inhibits apoptotic RNA decay and reduces apoptosis, while ectopic expression of PNPT1, but not an RNase-deficient mutant, increases RNA decay and cell death.  The 3' end of PNPT1 substrates thread through a narrow channel.  Many non-poly(A) ncRNAs contain 3'-secondary structures or bind proteins that may block PNPT1 activity.  Indeed, mutations that disrupt the 3'-stem-loop of a decay-resistant ncRNA render the transcript susceptible, while adding a 3'-stem-loop to an mRNA prevents its decay.  Thus, PNPT1 release from mitochondria during MOMP initiates apoptotic decay of RNAs lacking 3'-structures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbWSyYeE8zhbVg90H21EOLACvtfcHk0ljXJv69Gj1lbg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXpvVemsr0%253D&md5=f6b69297b77fc3bbbf49cb62ddd2569e</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2018.04.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2018.04.017%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DFu%26aufirst%3DR.%26aulast%3DPan%26aufirst%3DY.%26aulast%3DMeza-Sosa%26aufirst%3DK.%2BF.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DLieberman%26aufirst%3DJ.%26atitle%3DPNPT1%2520release%2520from%2520mitochondria%2520during%2520apoptosis%2520triggers%2520decay%2520of%2520Poly%2528A%2529%2520RNAs%26jtitle%3DCell%26date%3D2018%26volume%3D174%26spage%3D187%26epage%3D201.e12%26doi%3D10.1016%2Fj.cell.2018.04.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cuillerier, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honarmand, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cadete, V. J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruiz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forest, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeschÃªnes, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beauchamp, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Consortium, L. S. F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charron, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rioux, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Des Rosiers, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoubridge, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burelle, Y.</span></span> <span> </span><span class="NLM_article-title">Loss of hepatic LRPPRC alters mitochondrial bioenergetics, regulation of permeability transition and trans-membrane ROS diffusion</span>. <i>Hum. Mol. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">3186</span>â <span class="NLM_lpage">3201</span>, <span class="refDoi">Â DOI: 10.1093/hmg/ddx202</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=10.1093%2Fhmg%2Fddx202" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=28575497" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjt1Sqt7s%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2017&pages=3186-3201&author=A.+Cuillerierauthor=S.+Honarmandauthor=V.+J.+J.+Cadeteauthor=M.+Ruizauthor=A.+Forestauthor=S.+Desch%C3%AAnesauthor=C.+Beauchampauthor=L.+S.+F.+C.+Consortiumauthor=G.+Charronauthor=J.+D.+Riouxauthor=C.+Des+Rosiersauthor=E.+A.+Shoubridgeauthor=Y.+Burelle&title=Loss+of+hepatic+LRPPRC+alters+mitochondrial+bioenergetics%2C+regulation+of+permeability+transition+and+trans-membrane+ROS+diffusion&doi=10.1093%2Fhmg%2Fddx202"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Loss of hepatic LRPPRC alters mitochondrial bioenergetics, regulation of permeability transition and trans-membrane ROS diffusion</span></div><div class="casAuthors">Cuillerier, Alexanne; Honarmand, Shamisa; Cadete, Virgilio J. J.; Ruiz, Matthieu; Forest, Anik; Deschenes, Sonia; Beauchamp, Claudine; Consortium, Lsfc; Charron, Guy; Rioux, John D.; Des Rosiers, Christine; Shoubridge, Eric A.; Burelle, Yan</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">3186-3201</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">1460-2083</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The French-Canadian variant of Leigh Syndrome (LSFC) is an autosomal recessive oxidative phosphorylation (OXPHOS) disorder caused by a mutation in LRPPRC, coding for a protein involved in the stability of mitochondrially-encoded mRNAs.  Low levels of LRPPRC are present in all patient tissues, but result in a disproportionately severe OXPHOS defect in the brain and liver, leading to unpredictable subacute metabolic crises.  To investigate the impact of the OXPHOS defect in the liver, we analyzed the mitochondrial phenotype in mice harboring an hepatocyte-specific inactivation of Lrpprc.  Loss of LRPPRC in the liver caused a generalized growth delay, and typical histol. features of mitochondrial hepatopathy.  At the mol. level, LRPPRC deficiency caused destabilization of polyadenylated mitochondrial mRNAs, altered mitochondrial ultrastructure, and a severe complex IV (CIV) and ATP synthase (CV) assembly defect.  The impact of LRPPRC deficiency was not limited to OXPHOS, but also included impairment of long-chain fatty acid oxidn., a striking dysregulation of the mitochondrial permeability transition pore, and an unsuspected alteration of trans-membrane H2O2 diffusion, which was traced to the ATP synthase assembly defect, and to changes in the lipid compn. of mitochondrial membranes.  This study underscores the value of mitochondria phenotyping to uncover complex and unexpected mechanisms contributing to the pathophysiol. of mitochondrial disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIVVeX48HlKbVg90H21EOLACvtfcHk0ljXJv69Gj1lbg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjt1Sqt7s%253D&md5=4767563d96bbd8509be5413d6caf23d7</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2Fddx202&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252Fddx202%26sid%3Dliteratum%253Aachs%26aulast%3DCuillerier%26aufirst%3DA.%26aulast%3DHonarmand%26aufirst%3DS.%26aulast%3DCadete%26aufirst%3DV.%2BJ.%2BJ.%26aulast%3DRuiz%26aufirst%3DM.%26aulast%3DForest%26aufirst%3DA.%26aulast%3DDesch%25C3%25AAnes%26aufirst%3DS.%26aulast%3DBeauchamp%26aufirst%3DC.%26aulast%3DConsortium%26aufirst%3DL.%2BS.%2BF.%2BC.%26aulast%3DCharron%26aufirst%3DG.%26aulast%3DRioux%26aufirst%3DJ.%2BD.%26aulast%3DDes%2BRosiers%26aufirst%3DC.%26aulast%3DShoubridge%26aufirst%3DE.%2BA.%26aulast%3DBurelle%26aufirst%3DY.%26atitle%3DLoss%2520of%2520hepatic%2520LRPPRC%2520alters%2520mitochondrial%2520bioenergetics%252C%2520regulation%2520of%2520permeability%2520transition%2520and%2520trans-membrane%2520ROS%2520diffusion%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2017%26volume%3D26%26spage%3D3186%26epage%3D3201%26doi%3D10.1093%2Fhmg%2Fddx202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Broad Institute TCGA Genome
Data Analysis Center</span>.  <i>Firehose stddata__2016_01_28
run</i>., Broad Institute of MIT Harvard, Cambridge, MA. 2016,
DOI: <span class="refDoi">Â DOI: 10.7908/C11G0KM9</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;key=10.7908%2FC11G0KM9" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Broad+Institute+TCGA+Genome%0AData+Analysis+Center.+Firehose+stddata__2016_01_28%0Arun.%2C+Broad+Institute+of+MIT+Harvard%2C+Cambridge%2C+MA.+2016%2C%0ADOI%3A+10.7908%2FC11G0KM9."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.7908%2FC11G0KM9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dreport%26id%3Ddoi%3A10.7908%252FC11G0KM9%26sid%3Dliteratum%253Aachs%26aulast%3D%26jtitle%3DFirehose%2520stddata__2016_01_28%250Arun%26doi%3D10.7908%2FC11G0KM9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i71"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01016">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_33050"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c01016?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01016</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">ROS assay of QD394 analogs; colony formation assay of QD394 analogs; GSH levels in pancreatic cancer cells treated with QD394, napabucasin, and BSO; colony formation assay of combination studies; CETSA in PANC-1 cells; combination of NAC, dicoumarol with QD394, QD394-Me, napabucasin, and H<sub>2</sub>O<sub>2</sub> in probing LRPPRC and PNPT1 in pancreatic cancer cells; combination of QD394 and napabucasin in PANC-1 cells; plasma concentrations of QD394 and QD394-Me in CD-1 mice; major metabolite of QD394-Me in mouse plasma and its abundance profiles in mice; in vivo study with female Balb/c mice implanted subcutaneously with CT-26 cells; HPLC analyses for QD394 and QD394-Me; elemental analyses for QD394 analogs; molecular formula strings for all QD394 analogs; top 25 upregulated and downregulated enriched C2 gene sets in QD394-treated MIA PaCa-2 cells; STRING analysis of 17 upregulated genes/proteins in common between Bru-seq and proteomics; STRING analysis of 35 downregulated genes/proteins in common between Bru-seq and proteomics; tissue distribution of QD394-Me in mouse; cytotoxicities of QD394, QD394-Me, and napabucasin in GPX4-knockdown PANC-1 and BxPC-3 cells; top upregulated and downregulated enriched hallmark gene sets in QD394-Me-treated MIA PaCa-2 cells; top upregulated enriched KEGG gene sets in QD394-Me-treated MIA PaCa-2 cells (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01016/suppl_file/jm0c01016_si_001.pdf">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01016/suppl_file/jm0c01016_si_001.pdf">jm0c01016_si_001.pdf (1.39 MB)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.0c01016&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2020.63.issue-17%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.0c01016%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.0c01016" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                5MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright Â© 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">Youâve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"66e0b0455b0f24bf","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.6.0","si":10}'></script>
</body>
</html>
